Articles100
$2.7 Million in Product Orders Outpace Shipments of $2.0 Million Company Has Received Product Orders for Fiscal Year 2026 of $11.2 Million; Working with Suppliers to Maximize Product Shipments Through End of Fiscal Year Received ISO 13485 Certification Ahead of Schedule; International Expansion Planned StereoCED™ Drug Delivery System Expected to be Available for Research and Investigational Clinical Studies by the End of Fiscal Year 2026 Management to Host Conference Call at 8:30 a.m. Eastern Time Today EDEN PRAIRIE, MINN. - August 13, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, has reported financial results and provided a business update for the third quarter of fiscal year 2026 ended June 30, 2026. FY Q3 2026 Financial Highlights Product revenue increased 16% to $2.0 million, compared to $1.7 million in the same year-ago period. The Company received $2.7 million of new product orders to ship during the quarter, representing 43% growth in product orders year over year. Product orders exceeded recognized revenue during the quarter with backlog of $1.7 million as of June 30, 2026. The Company has received product orders of $11.2 million for fiscal year 2026. Recognized revenue is expected to range from $9.2 million to $10.5 million depending primarily on manufacturing completion and timing of shipments, with any unshipped orders contributing to backlog. The Company is working closely with manufacturing partners to maximize shipments. Product gross profit increased 29% to $1.2 million, compared to $0.9 million in the same year-ago quarter. Product gross margins increased to 59.9%, compared to 53.9% in the same year-ago quarter. Subsequent to quarter end, our lead investor increased ownership of NeuroOne’s outstanding common stock from 7.4% to 12.5%. Recent Operational Highlights The Company received ISO 13485:2016 Certification enabling the Company to commercialize across different countries. Geographies may have additional requirements to gain commercial access, although this is a major achievement signaling that the Company follows an internationally recognized quality management system that will provide near term commercial opportunities to help grow product revenues. The Journal of Neurosurgery published an article by the Mayo Clinic in Jacksonville, Florida titled, ”Stereo-electroencephalography–guided radiofrequency thermocoagulation in patients with implanted neuromodulation devices: patient series” which evaluated the use of NeuroOne’s OneRF® Brain Ablation System in patients who have implanted neuromodulation devices. The article concluded that these procedures may be performed without interfering with existing hardware as well as providing meaningful seizure reduction. This expands the pool of treatable patients to include those with existing neuromodulation implants. NeuroOne expects its StereoCED™ platform to be available by the end of fiscal year 2026 for animal research and FDA IDE approved studies. In advance of this, the Company released a breakthrough white paper titled "StereoCED™ - A Scalable Platform for CNS Drug Delivery" – highlighting how its drug delivery platform leverages robotic stereotactic systems already established in neurosurgical operating rooms and has the potential to significantly reduce procedure time while addressing key barriers to the scalable commercial delivery of brain therapeutics. The white paper comes at a pivotal time, as the first potential blockbuster intraparenchymal brain-delivered therapy could receive FDA approval as early as 2027. Expanded drug delivery program through collaboration with Mayo Clinic supporting a newly funded research program by CURE Childhood Cancer to evaluate a novel treatment approach for pediatric diffuse midline glioma (DMG), one of the most aggressive and difficult-to-treat childhood brain cancers. The study will utilize NeuroOne's StereoCED™ drug delivery platform, which combines precision intracranial drug delivery with a simultaneous neural recording, offering investigators additional insight into both drug delivery and the effects on the surrounding neural environment. Advanced brain drug delivery platform through collaboration with University of Minnesota to advance a study evaluating next-generation epilepsy therapies using NeuroOne’s StereoCED™ drug delivery platform. The study is designed to test novel therapeutics delivered locally into specific brain regions involved in sustaining seizures with the goal of improving clinical efficacy and lowering systemic toxicity and off-target effects. Advanced discussions underway with a tier-one potential strategic partner to develop and supply the access tools for our basivertebral nerve ablation system to treat lower back pain. The Company was added to the Russell Microcap Index as part of the semi-annual June 2026 reconstitution of the Russell US Indexes. Management Commentary “This quarter marked another period of revenue growth compared to 2025, with product revenue increasing 16% year-over-year to $2.0 million,” said Dave Rosa, CEO of NeuroOne. “Importantly, this growth is improving margins – product gross margins reached a record 59.9%, driven by a 29% increase in product gross profit to $1.2 million compared to the prior year period. Even more encouraging is that new product orders of $2.7 million during the quarter meaningfully outpaced revenue recognized during the quarter, growing our backlog to $1.7 million. “Looking at the rest of the fiscal year, there's a lot to be excited about: the launch of our StereoCED™ drug delivery platform for investigational and animal studies, continued growth of the OneRF® Brain Ablation System, onboarding independent distributor reps for the OneRF® Trigeminal Nerve Ablation System, selecting a partner for our basivertebral nerve ablation access tools, and planning for international expansion. In total, we continue to make meaningful progress with our technology platform across all verticals while adding to the patient success stories for those who are treated with our technology. This is our driving motivation.” Summary of NeuroOne Therapies OneRF® Trigeminal Nerve Ablation System: Scheduling evaluations at new centers based on interest generated at the American Society for Stereotactic and Functional Neurosurgery Biennial Meeting this past June. Interviewed distributors to expand commercialization efforts to support a direct regional sales distribution model. SteroeCED™ Drug Delivery Program: White paper released discussing potential benefits of the system. Preparing for launch of animal research studies and FDA approved IDE gene and/or cell therapies by the end of fiscal year 2026. Selected by the Mayo Clinic in Rochester, Minnesota to supply devices for a study to treat a form of pediatric glioblastomas (brain tumors). Selected by the University of Minnesota to supply devices for a study to treat drug resistant epilepsy. Basivertebral Nerve Ablation: Regulatory strategy complete; expected FDA 510(k) pathway. In discussions with potential partner to develop access tools for system. Device optimization for target lesion size in process. OneRF® Ablation System in the Brain: ISO 13485 certification received in August 2026. This will allow the Company to selectively target international markets. Expect to enroll first patient by the end of September for the brain ablation post-market registry, with five centers currently participating. The Journal of Neurosurgery published an article by the Mayo Clinic in Jacksonville, Florida titled: ”Stereo-electroencephalography–guided radiofrequency thermocoagulation in patients with implanted neuromodulation devices: patient series” which evaluated the use of NeuroOne’s OneRF® Brain Ablation System in patients who have implanted neuromodulation devices. Third Quarter Fiscal 2026 Financial Results Product revenue increased to $2.0 million in the third quarter of fiscal 2026, a 16% increase compared to $1.7 million in the same year-ago quarter. The increase was primarily driven by higher sales of OneRF® Products. Product gross profit increased 29% to $1.2 million, driving a product gross margin expansion to a record 59.9% in the third quarter of fiscal 2026, compared to $0.9 million, or 53.9%, in the same year-ago quarter. This 6.0 percentage point increase reflects a more favorable sales mix toward higher margin products. Total operating expenses were $3.6 million in the third quarter of fiscal 2026, compared to $2.8 million in the same year-ago quarter. Selling, General & Administrative expenses were $2.2 million, compared to $1.6 million as a result of increased headcount, sales and marketing costs, professional fees and other operating costs in the same year-ago quarter. Research & Development expenses were $1.4 million, compared to $1.2 million in the same year-ago quarter, reflecting the timing of product development activities. Net loss in the third quarter of fiscal 2026 was $2.0 million, or ($0.23) per basic share and ($0.28) per diluted share, compared to net loss of $1.5 million, or ($0.19) per basic share and ($0.19) per diluted share, in the prior-year quarter. As of June 30, 2026, cash and cash equivalents totaled $2.0 million, compared to $6.6 million as of September 30, 2025. Accounts receivable were $1.1 million as of June 30, 2026, compared to $1.3 million as of September 30, 2025, and inventory, net was $2.3 million as of June 30, 2026, compared to $2.2 million as of September 30, 2025. During the third quarter of fiscal 2026, the Company raised $0.4 million through its at-the-market offering program. Through June 30, 2026, the Company raised gross proceeds of $8.4 million under the at-the-market (“ATM”) program. Subsequent to quarter-end, on July 13, 2026, the Company raised another $1.0 million through the issuance of 400,346 shares under the ATM program representing the second time in calendar 2026 the ATM was utilized. The Company had working capital of $3.7 million as of June 30, 2026, compared to working capital of $7.9 million as of September 30, 2025. The Company had no debt outstanding as of June 30, 2026. All share and per share amounts in this release have been retroactively adjusted to reflect the one-for-six reverse stock split of the Company’s issued and outstanding common stock, which began trading on a split-adjusted basis on The Nasdaq Capital Market on April 16, 2026. Conference Call and Webcast Management will host an investor conference call and webcast today, Thursday, August 13, 2026, at 8:30 a.m. Eastern time to discuss the Company’s fiscal third quarter 2026 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information: Date: Thursday, August 13, 2026 Time: 8:30 a.m. Eastern time U.S. Dial-In (Toll Free): 888-506-0062 International Dial-In: 973-528-0011 Participant Access Code: 549778 Webcast: NMTC FY Q3 2026 Earnings Call Webcast Please join at least five minutes before the start of the call to ensure timely participation. A playback of the call will be available through Thursday, August 27, 2026. To listen to the replay, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 54304. A webcast replay will also be available using the webcast link above through August 13, 2027. About NeuroOne NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne markets a minimally invasive and high-definition/high-precision electrode technology platform with four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering diagnostic and therapeutic functions. The Company is engaged in research and development for drug delivery, basivertebral nerve ablation and spinal cord stimulation programs. For more information, please visit nmtc1.com. Forward Looking Statements This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Except for statements of historical fact, any information contained in this press release may be a forward looking statement that reflects NeuroOne's current views about future events and are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. In some cases, you can identify forward looking statements by the words or phrases "may," "might," "will," "could," "would," "should," "expect," "intend," "plan," "forecasts," "objective," "anticipate," "believe," "estimate," "predict," "project," "potential," "target," "seek," "contemplate," "continue, "focused on," "committed to" and "ongoing," or the negative of these terms, or other comparable terminology intended to identify statements about the future. Forward looking statements may include statements regarding the potential sales of the StereoCEDTM drug delivery platform in investigational clinical studies or animals in Q4 fiscal 2026, 2026 guidance, the collaborations with the University of Minnesota and other companies, our ability to expand internationally, our ability to ship back-ordered product, our ability to expand the sales of our OneRF® Trigeminal Nerve Ablation System, our and the Company’s ability to expand revenue. Although NeuroOne believes that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain. Our actual future results may be materially different from what we expect due to factors largely outside our control, including risks related to whether the Company will continue to maintain compliance with all Nasdaq continued listing requirements, risks that our strategic partnerships may not facilitate the commercialization or market acceptance of our technology whether due to supply chain disruptions, labor shortages or otherwise risks that our technology will not perform as expected based on results of our pre-clinical and clinical trials risks related to uncertainties associated with the Company's capital requirements to achieve its business objectives and ability to raise additional funds: the risk that we may not be able to secure or retain coverage or adequate reimbursement for our technology uncertainties inherent in the development process of our technology risks related to changes in regulatory requirements or decisions of regulatory authorities that we may not have accurately estimated the size and growth potential of the markets for our technology risks related to clinical trial patient enrollment and the results of clinical trials that we may be unable to protect our intellectual property rights and other risks, uncertainties and assumptions, including those described under the heading "Risk Factors" in our filings with the Securities and Exchange Commission. These forward looking statements speak only as of the date of this press release and NeuroOne undertakes no obligation to revise or update any forward looking statements for any reason, even if new information becomes available in the future. Caution: Federal law restricts this device to sale by or on the order of a physician. * Disclaimer: This recounts several patients’ experiences and may not be representative of all patient outcomes. IR Contact MZ Group – MZ North America NMTC@mzgroup.us NeuroOne Medical Technologies Corporation Condensed Balance Sheets As of June 30, 2026 (Unaudited) September 30, 2025 Assets Current assets: Cash and cash equivalents $ 2,047,596 $ 6,570,382 Accounts receivable 1,098,965 1,264,805 Inventory, net 2,290,254 2,226,805 Deferred offering costs 33,046 22,920 Prepaid expenses 318,940 141,372 Total current assets 5,788,801 10,226,284 Intangible assets, net 28,210 44,946 Right-of-use asset 166,751 255,195 Property and equipment, net 202,333 259,222 Total assets $ 6,186,095 $ 10,785,647 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 905,716 $ 1,010,369 Accrued expenses and other liabilities 1,135,711 1,292,714 Total current liabilities 2,041,427 2,303,083 Warrant liability 303,805 1,266,894 Operating lease liability, long term 73,320 143,148 Total liabilities 2,418,552 3,713,125 Commitments and contingencies (Note 4) Stockholders’ equity: Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding. - - Common stock, $0.001 par value; 100,000,000 shares authorized; 8,702,982 and 8,334,336 shares issued and outstanding as of June 30, 2026 and September 30, 2025, respectively. 8,703 8,334 Additional paid–in capital 88,194,870 85,673,975 Accumulated deficit (84,436,030) (78,609,787) Total stockholders’ equity 3,767,543 7,072,522 Total liabilities and stockholders’ equity $ 6,186,095 $ 10,785,647 NeuroOne Medical Technologies Corporation Condensed Statements of Operations (unaudited) For the Three Months Ended June 30, For the Nine Months Ended June 30, 2026 2025 2026 2025 Product revenue $ 1,973,105 $ 1,696,050 $ 6,727,790 $ 6,356,767 Cost of product revenue 790,496 781,215 2,987,089 2,743,982 Product gross profit 1,182,609 914,835 3,740,701 3,612,785 License revenue - - - 3,000,000 Operating expenses: Selling, general and administrative 2,181,768 1,618,950 5,986,594 5,602,818 Research and development 1,425,153 1,182,485 4,282,923 3,865,376 Total operating expenses 3,606,921 2,801,435 10,269,517 9,468,194 Loss from operations (2,424,312) (1,886,600) (6,528,816) (2,855,409) Fair value change in warrant liability 405,702 319,625 620,171 1,099,421 Financing costs - (9,325) - (334,063) Other income 12,279 75,432 82,402 103,898 Loss before income taxes (2,006,331) (1,500,868) (5,826,243) (1,986,153) Provision for income taxes - - - - Net loss $ (2,006,331) $ (1,500,868) $ (5,826,243) $ (1,986,153) Net loss per share (Note 3): Basic $ (0.23) $ (0.19) $ (0.68) $ (0.32) Diluted $ (0.28) $ (0.19) $ (0.75) $ (0.32) Number of shares used in per share calculations (Note 3): Basic 8,661,624 8,100,603 8,511,313 6,141,509 Diluted 8,739,505 8,100,603 8,621,075 6,141,509 View the original release on www.newmediawire.com
VANCOUVER, B.C. and HOUSTON, TX - August 12, 2026 (NEWMEDIAWIRE) - CleanGo Innovations Inc. (CSE: CGII) (OTC: CLGOF) (FRA: APO2) (“CleanGo” or the “Company”)Kubera Black Energy, a wholly owned subsidiary of CleanGo Innovations Inc., announced today that it has officially launched its global Gain of Revenue (GOR) program. The company is actively looking for oil well operators globally to enter the program, offering a true environmental solution that is good for the environment and good for you. Zero Upfront Chemical Cost and Production-Driven Model Under the proprietary GOR business model, Kubera Black Energy absorbs 100 percent of the upfront chemical cost and risk. Zero Initial Chemical Cost: We supply the chemical at zero upfront cost to the well owner. Protecting the Baseline: Technical analysts audit recent production history to establish an auditable baseline. Operators retain 100 percent of the revenue from their baseline production. For example, if an existing well produces 20 barrels per day, that baseline is entirely protected and untouched. Profiting from Incremental Gains: Through the application of our CG-100 green chemistry, if production increases to 60 barrels per day, the extra production is split on a collaborative revenue basis. Operator Control: Your Crews, Your Implementation To ensure absolute comfort and operational continuity, well operators use their own field crews for all on-site implementations. Kubera does not handle the implementation; operators maintain complete control over their leases. Kubera simply supplies the engineering and advanced proprietary green chemistry, Kubera will only assist at the operator's direct request. Certified Green Product vs. Toxic Alternatives Unlike the typical toxic products and harsh chemicals most well operators use - such as steel-damaging acid washes or temporary hot oiling - CG-100 is a certified green product. Utilizing advanced green emulsification and targeted structural breakdown, the formulation permanently solves downhole production bottlenecks, including macrocrystalline paraffin waxes, asphaltene aggregations, and organic binder scales. The technology lowers interfacial tension, alters thermodynamic wettability to a water-wet state, and encapsulates wax molecules inside stable chemical micelles to guarantee permanent fluidization. Private Placement CleanGo also wishes to announce that it intends to close a non-brokered private placement (the “Offering”) of up to 974,025 units of the Company (each, a “Unit”) at a price of $0.77 per Unit for aggregate gross proceeds of up to approximately $750,000. Each Unit will consist of one common share in the capital of the Company (each, a “Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will entitle the holder to acquire one additional Share at an exercise price of $0.85 per Share for a period of two years from the date of issuance. The Company intends to use the net proceeds from the Offering for general working capital and corporate purposes. The securities to be issued pursuant to the Offering will be subject to a statutory hold period of four months and one day from the date of issuance in accordance with applicable Canadian securities laws. About CleanGo Innovations Inc. CleanGo Innovations Inc. is an international, publicly traded company that specializes in the development of early-staged, green, non-toxic and sustainable products used in retail, commercial and industrial applications. The company is proud of its suite of proprietary, Green Seal Certified non-toxic green products that are Health Canada approved to claim 99.9% disinfecting of viruses and bacteria on a hard surface. CleanGo’s portfolio is proud to be a part of Cruelty Free / Leaping Bunny as a certified product while being both family and pet safe. It is CleanGo’s mission to create the world’s leading non-toxic, green solutions for the worlds cleaning problems. CleanGo Innovations Inc. is an international company specializing in green cleaning, technological, and industrial solutions. Through its portfolio of specialized subsidiaries, CleanGo fosters engineering, blockchain, and financial innovations that modernize traditional industries for a highly connected global economy. CleanGo Innovation’s experienced team brings new ideas and innovation based on science to find solutions to the problems of the current world we live in. Customers rely on quality, nontoxic products to keep their homes and business’s clean and their loved ones safe. CleanGo also has several Commercial and Industrial applications to solve many problems of the worlds heavier and large-scale cleaning problems. Partner with Kubera Black Energy for Oil Well Optimization Kubera Black Energy is actively seeking multi-well regional partnerships with E&P operators, asset managers, and operations directors worldwide to scale aggregate corporate production curves safely and efficiently. Interested oil well operators and industry partners are invited to submit asset information for a full assessment of a possible partnership with Kubera Black Energy. For Inquiries Contact: inquiries@cleangogreengo.com For more details on the GOR program and technological framework, visit the official web portal at www.kuberablackenergy.com. On behalf of the CEO & Board of Directors Anthony Sarvucci Chief Executive Officer CleanGo Innovations Inc. For More information Contact: info@cleangogreengo.com Phone 1 346 202 6202 Forward-looking Information This news release contains forward-looking information and forward-looking statements (collectively, “forward-looking information”) within the meaning of applicable Canadian securities legislation. Forward-looking information in this news release includes, but is not limited to, statements regarding the launch, implementation, expansion and potential commercial success of Kubera Black Energy’s Gain of Revenue (“GOR”) program; the anticipated performance, effectiveness and benefits of CG-100, including its potential to address downhole production bottlenecks and increase oil well production; the ability of Kubera Black Energy to identify and enter into partnerships with oil well operators, E&P operators, asset managers and other industry participants; the potential for the GOR program to generate incremental production and revenue; and the Company’s plans to expand the program globally. Forward-looking information also includes statements regarding the Company’s intention to complete and close the non-brokered private placement (the “Offering”), the anticipated gross proceeds of the Offering, the issuance of the Units and the securities comprising the Units, the intended use of proceeds, the timing and completion of the Offering and the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange. Forward-looking information is based on management’s current expectations, estimates, assumptions and projections and is subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or events to differ materially from those expressed or implied by such forward-looking information. Such risks and uncertainties include, among others, the ability of the GOR program and CG-100 to achieve anticipated results under varying well and operating conditions; the ability to secure and maintain operator and industry partnerships; market acceptance and demand for the Company’s products and programs; operational, technical, regulatory and commercial risks associated with the oil and gas industry; and the risk that the Offering may not be completed on the terms described herein or at all, or that required regulatory approvals may not be obtained. Readers are cautioned not to place undue reliance on forward-looking information. There can be no assurance that the plans, intentions or expectations upon which such forward-looking information is based will occur. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. View the original release on www.newmediawire.com
Implementation of the restructuring plan: Property sales of around EUR 78 million completed since the start of the restructuring process; additional purchase agreements worth EUR 16 million signed Financing structure further improved: Financial liabilities reduced to EUR 311.5 million (30 September 2025: EUR 471.1 million); net LTV at 41.1% (30 September 2025: 57.8%) Portfolio revaluation as of 30 June 2026 results in a valuation loss of EUR 41.6 million Funds from Operations (FFO) increase to EUR 14.5 million (9M 2024/2025: EUR 9.9 million) POTSDAM, GERMANY - August 12, 2026 (NEWMEDIAWIRE) - Deutsche Konsum Real Estate AG (“Company”, “DKR”) (ISIN: DE000A14KRD3 | WKN: A14KRD | ticker symbol: DKG) today published its financial results for the first nine months of the 2025/2026 financial year. Restructuring progress strengthens the financing structure The Company continued to implement its restructuring plan during the reporting period. The already completed restructuring capital increase, including the debt-to-equity swap, as well as ongoing property sales are contributing to further reduction of debt. From the start of the restructuring process through 30 June 2026, property sales totalling around EUR 78 million were completed. Purchase agreements for two additional properties with a total purchase price of EUR 16 million were signed. The successful reduction in debt has strengthened the Company’s financing structure. Equity increased to EUR 397.0 million (30 September 2025: EUR 304.3 million), while financial liabilities decreased to EUR 311.5 million (30 September 2025: EUR 471.1 million), and net LTV improved to 41.1% (30 September 2025: 57.8%). Interest expenses declined to EUR 10.7 million (9M 2024/2025: EUR 18.7 million). Operating business progresses as planned As a result of the ongoing property sales, rental income decreased to EUR 48.0 million (9M 2024/2025: EUR 52.7 million). Net rental income remained almost flat year-on-year at EUR 29.2 million (9M 2024/2025: EUR 29.8 million). Lower interest expense had a positive impact on operating earnings, with Funds from Operations (FFO) increasing to EUR 14.5 million (9M 2024/2025: EUR 9.9 million). Due to the higher number of shares outstanding, FFO per share decreased year-on-year to EUR 0.18 (9M 2024/2025: EUR 0.24). The result for the period improved to EUR -25.7 million (9M 2024/2025: EUR -32.6 million). As of 30 June 2026, the portfolio comprised 140 properties with a balance sheet of EUR 693.7 million. The portfolio was revalued by CBRE as of 30 June 2026, resulting in a valuation loss of EUR 41.6 million, corresponding to approximately 5.7% decrease. Changes to the Management and Supervisory Board During the reporting period, changes were made to the composition of the Management and Supervisory Board. Daniel Lohken, previously Chairman of the Supervisory Board, was appointed to the Management Board as Chief Executive Officer for a term of three years with effect from 1 July 2026. Kyrill Turchaninov stepped down from the Management Board as planned on 31 July 2026. The new Chairman of the Supervisory Board is Dr. Kai Gregor Klinger. Sebastian Wasser remains Vice Chairman of the Supervisory Board. At the Annual General Meeting on 17 April 2026, shareholders also resolved to elect Thorsten Arsan to the Supervisory Board and to create new Authorised Capital and Conditional Capital. Hank Boot did not stand for re-election and stepped down from the Supervisory Board upon conclusion of the Annual General Meeting. Outlook In addition to the continuing operational development of the portfolio, the Company’s focus in the coming months will remain on implementing the restructuring measures. The restructuring plan provides for property disposals of up to EUR 220 million by September 2027. As a result of the property sales, rental income is expected to decline in line with plan. For the 2025/2026 financial year the Company continues to anticipate rental income in the range of EUR 58 million to EUR 63 million, while FFO is expected to increase due to lower interest expenses. The implementation of the planned property sales remains subject to uncertainties arising from the persistently challenging geopolitical environment and its resulting impact on the transaction market. Conference Call Deutsche Konsum Real Estate AG will hold an analyst conference (webcast and conference call) on the results of the first nine months of the 2025/2026 financial year today, 12 August 2026, at 10:00 a.m. CEST. The corresponding presentation and further information on the webcast and the conference call can be found at https://www.deutsche-konsum.de/en/investor-relations. The quarterly report for the third quarter of the 2025/2026 financial year is available for download at https://www.deutsche-konsum.de/en/investor-relations/financial-reports. About Deutsche Konsum Real Estate AG Deutsche Konsum Real Estate AG, Broderstorf, is a listed real estate company with a focus on German retail properties for everyday goods in established micro-locations. The Company’s primary focus is on acquiring, managing and developing local supply properties to achieve consistent performance and leverage hidden reserves. The shares of the Company are listed on the Prime Standard of the Deutsche Borse (ISIN: DE000A14KRD3). Contact: Deutsche Konsum Real Estate AG Mareike Kuliberda Investor Relations Marlene-Dietrich-Allee 12b 14482 Potsdam Tel: 0331 / 74 00 76 - 533 Fax: 0331 / 74 00 76 - 599 E-Mail: mk@deutsche-konsum.de View the original release on www.newmediawire.com
MANNHEIM, GERMANY - August 12, 2026 (NEWMEDIAWIRE) - The FUCHS Group, which operates globally in the lubricants industry, opened its new Americas Technology Center in Taunton, Massachusetts, on August 10, 2026. The Technology Center serves as a hub for research, development, and technical support, with a focus on advanced lubrication and specialty solutions across the Americas. The 55,000 square-foot R&D facility represents a significant investment in customer collaboration through application-driven innovation, and manufacturing competitiveness in the region. “Our customers are under constant pressure to improve performance, increase efficiency, and stay ahead of change,” said Megan O’Meara, President and CEO of FUCHS Lubricants Co. “This Technology Center allows us to work more closely with them, apply our expertise to their unique challenges, and help them develop solutions that drive results. Ultimately, our goal is simple: to help our customers win.” As part of FUCHS’ global innovation network, the Taunton facility will connect local expertise with scientists, engineers and customer-facing teams worldwide. It will accelerate the development and commercialization of innovative lubrication solutions while strengthening customer collaboration across the Americas. “More than a facility, this Technology Center is a strategic extension of our global R&D network and an integral part of our FUCHS100 strategy. It enables us to combine knowledge from across the world to accelerate innovation, and deliver meaningful value for our customers,” remarked Dr. Timo Reister, Deputy Chairman of the Executive Board at FUCHS SE. The FUCHS Americas Technology Center will support the development of lubrication solutions for a wide range of demanding industrial applications and future-oriented technologies, ranging from high-load industrial gearboxes and metalworking operations to semiconductor chip manufacturing and space exploration applications. “Innovation is built on the ability to understand complex challenges, generate new knowledge, and validate solutions with scientific precision,” commented Mathieu Boulandet, Member of the Executive Board and Chief Technology Officer of FUCHS SE. FUCHS SE Public Relations EinsteinstraBe 11 68169 Mannheim Telefon +49 621 3802-1104 E-Mail: tina.vogel@fuchs.com The following information can be accessed via the Internet: Image and video material: https://www.fuchs.com/gb-en/photo-gallery/ About FUCHS Founded in 1931 as a family business in Mannheim, FUCHS is now the world's largest independent supplier of innovative lubrication solutions, covering almost every industry and application. Today, the company's almost 7,000 employees in over 50 countries still share the same goal: to keep the world moving both sustainably and efficiently. To live up to this claim, we think in terms of perfection, not merely standards. When developing individual solutions, we enter into an intensive customer dialogue – acting as an experienced consultant, innovative problem solver and reliable team partner. Additional features: Picture: https://nwr.eqs-cockpit.com/fncls2.ssx?fn=redirect&u=233d0f1ec83d3646f40e12e8fb134fc2 Subtitle: Americas Technology Center, Taunton View the original release on www.newmediawire.com
TALLINN, ESTONIA - August 12, 2026 (NEWMEDIAWIRE) - Iute Group, a leading European personal finance group, cordially invites investors and analysts to an earnings webcast/call with the Management Board on 27 August 2026, 15.00 CEST, following the publication of its unaudited 6M 2026 results on the same day. Earnings Call: CEO Tarmo Sild and CFO Kristel Kurvits will comment on the unaudited results by means of a webcast presentation. The webcast/call will be held in English. Please register in time to participate in the webcast/call at: Iute Group – Earnings Call 6M 2026. The corresponding presentation will also be available on the Company's website prior to the earnings webcast/call. Contact: Kristel Kurvits, Group Chief Financial Officer (CFO) Email: investor@iute.com Phone: +372 622 9177 About Iute Group: Iute Group is a digital banking group focused on everyday financial services in Southeast Europe. Established in 2008 and headquartered in Estonia, Iute serves customers in Albania, Bulgaria, Moldova, North Macedonia, and Ukraine. Through the Myiute app and its local operations, Iute provides digital financial services including payments, banking, financing, and insurance intermediation. Iute Group finances its operations through equity, deposits, and secured bonds listed on the Regulated Market of the Frankfurt Stock Exchange and the Nasdaq Baltic Main List. www.iute.com View the original release on www.newmediawire.com
ZUG, SWITZERLAND - August 12, 2026 (NEWMEDIAWIRE) - LION E-Mobility AG (LION; ISIN: CH0560888270), a leading manufacturer of battery packs for electric mobility and energy storage solutions, published its preliminary consolidated H1 2026 figures today. In Q2 2026, LION’s battery pack production was temporarily affected by a planned two-month factory shutdown for conversion works regarding the transition to the high-performance NMC+ battery-pack technology. As a result, the Group generated revenue of EUR 6.9 million in the first half of 2026, compared with EUR 10.4 million in the first half of 2025. The sales in Q2 were generated primarily from the inventory of battery packs produced before tempory factory shutdown. EBITDA amounted to EUR 0.1 million in the first half of 2026, compared with EUR 1.3 million in the prior-year period. The production was successfully resumed at the end of June, as planned, marking an important operational and strategic milestone for the Group. LION’s new high-performance NMC+ battery packs combine outstanding performance with a robust system architecture. They are designed for demanding applications in e-mobility, industrial applications and safety-critical segments. Dr. Joachim Damasky, CEO of LION E-Mobility AG, comments: “The successful resumption of production of our high-performance NMC+ battery packs marks an important milestone for LION E-Mobility. We are entering the second half of the year with a strong technology platform, growing market interest and promising opportunities across e-mobility and stationary energy storage. While the transition affected our performance in the first half, we remain confident in our ability to deliver significant revenue growth and strongly positive EBITDA for the full year 2026.” Strong BESS pipeline LION’s Finsterwalde BESS project in cooperation with Renoc GmbH has completed the first construction phase. The facility provides an installed capacity of 5 MW with a storage capacity of 20 MWh. The project uses LION Smart BESS containers specifically designed for grid-connected applications, meeting the highest standards of reliability, safety, and system integration. In the second construction phase, storage capacity is planned to increase to a total of 40 MWh at an installed power of 15 MW. The expansion is planned for early 2027. The BESS project pipeline of LION is growing. The company is positioning itself as a systems supplier and technology partner for grid-scale storage solutions across Germany and Europe. The Finsterwalde facility serves as a reference and showcase project for future customers and investors. Outlook 2026 Looking ahead to 2026, LION expects revenue to exceed EUR 35 million, accompanied by strongly positive EBITDA. Following the transition to NMC+ battery packs during the first half of the year, a substantial share of the Group’s 2026 revenue is expected to be generated in the second half of the year, with Q4 being the strongest quarter. In addition to its core business, LION sees further growth potential in stationary battery energy storage systems (BESS). The Company is strengthening its team and has identified a number of promising opportunities to accelerate the expansion of this business. About LION E-Mobility AG LION E-Mobility AG is a manufacturer of lithium-ion battery packs. The company offers customized plug-and-play solutions for electric vehicles as well as for stationary and industrial applications. The company operates highly automated module assembly lines at its own production facility in Germany. LION's battery packs offer the highest standards in terms of safety, quality, and reliability. Founded in 2011, LION E-Mobility AG (ISIN: CH0560888270, WKN: A2QH 97) is listed on the stock exchanges in Munich, Frankfurt, and Hamburg. www.lionemobility.com LION E-Mobility Investor Relations: Kirchhoff Consult lion@kirchhoff.de ir@lionemobility.com | www.lionemobility.com Disclaimer: Statements that express or contain forecasts, expectations, views, plans, goals and assumptions regarding future events or performance are not considered historical facts and may therefore be forward-looking statements. Forward-looking statements are based on the expectations, estimates and plans at the time the statements were made, and therefore involve a number of risks and uncertainties that could cause actual results or events to differ materially from those currently anticipated become. LION E-Mobility AG is under no obligation to update the forward-looking statements in this press release. View the original release on www.newmediawire.com
New Service Will Help Narrative Entertainment Unify and Strengthen Audience Engagement, Expand Viewer Insight and Accelerate Service Innovation and Monetization Across Streaming and Connected TV Platforms CHESEAUX-SUR-LAUSANNE, SWITZERLAND and PHOENIX, AZ - August 12, 2026 (NEWMEDIAWIRE) - NAGRAVISION, a Kudelski Group (SIX:KUD.S) company and the world's leading independent provider of content protection and media and entertainment solutions, today announced a new partnership with Narrative Entertainment, one of the UK’s leading independent broadcasters and streaming media companies, to enhance its streaming services through OpenTV ENTera, NAGRAVISION's cloud-native platform for content discovery, personalization and service orchestration. As broadcasters seek to build stronger direct relationships with viewers, the ability to better understand audience behavior, preferences and engagement has become essential to growth. With OpenTV ENTera, Narrative Entertainment is building a more unified audience engagement strategy across its digital services by strengthening its first-party viewer data using richer viewer profiles and advanced content discovery. This empowers them to deliver more relevant, personalized and engaging viewing experiences, increase viewer loyalty, and unlock greater value from advertising and monetization initiatives. In addition, by leveraging NAGRAVISION's expertise in platform integration, certification and accreditation to simplify and de-risk onboarding to complex platforms, the solution will extend Narrative Entertainment's reach across key connected TV and broadcast ecosystems including YouView and Freeview. "As we continue to evolve our digital services, our focus is on delivering highly relevant and engaging experiences while deepening our understanding of audience behavior,” said Kate Garland, head of digital at Narrative Entertainment. “NAGRAVISION’s OpenTV ENTera enables us to unify data, personalization and ecosystem innovation into a single platform. This ensures we can strengthen engagement today while creating a scalable foundation for long-term growth and monetization.” "We are delighted to be working with Narrative Entertainment as they continue to evolve their audience engagement strategy," said Morten Solbakken, EVP and COO at NAGRAVISION. "As broadcasters increasingly look to unify traditional broadcast and streaming experiences and turn audience insight into measurable business outcomes, OpenTV ENTera gives them the blueprint to accelerate service modernization across multiple platforms in a flexible ecosystem that reduces operational complexity." Unlike traditional platform approaches that can lock broadcasters into a single technology stack, NAGRAVISION’s OpenTV ENTera enables operators to integrate and manage best-of-breed solutions while maintaining a unified operational environment. The platform enables service providers to evolve their streaming experiences faster while leveraging the flexibility of an open ecosystem and the simplicity of a fully integrated solution. OpenTV ENTera also combines a best-in-class ecosystem of technology partners within a single, integrated framework designed to simplify service evolution. For Narrative Entertainment, NAGRAVISION is working alongside Sofia Digital to deliver a user experience complemented by advanced personalization, audience management and platform services, providing a scalable foundation for future innovation. For more information on how OpenTV ENTera enables service modernization for broadcasters, please click here, or visit NAGRAVISION booth 1.C81 at the IBC show in Amsterdam, from September 11-14, 2026. About NAGRAVISION NAGRAVISION, the media and entertainment technology division of the Kudelski Group (SIX:KUD.S), enables content creators, providers and operators worldwide to launch, monetize and scale services at speed, offering their subscribers compelling, personalized user experiences. Its portfolio of award-winning products and services spans traditional video security, cybersecurity, cloud-based video and streaming solutions, turnkey direct-to-consumer solutions for the sports industry, and rich personalization services that drive subscriber loyalty. For more information, visit nagra.vision or follow us on LinkedIn and X. About Narrative Entertainment UK Narrative Entertainment is the UK’s largest independent broadcaster of free-to-air TV, with a portfolio that includes Movies, Entertainment and Kids’ channels. Narrative Entertainment provides advertisers with access to valuable and hard to reach household audiences through its free-to-air (FTA) Great! and Pop network of channels. Great! is an active campaigner for representation of audiences across television programming and advertising, and in September 2025 launched The Upper Third report to shine a brighter, kinder light on the UK’s 22 million TV viewers over 55. Narrative Entertainment’s channels are available across a wide range of linear and digital platforms, including Freeview, Sky and Virgin Media, FAST channels on Samsung TV Plus, LG, Netgem, Pluto TV and Titan OS, and the dedicated Great! Player. Media contacts: Gary Crosilla Senior Corporate Communication Manager NAGRAVISION Kudelski Group +41 79 593 93 25 gary.crosilla@nagra.com Alex Crabb Caster Communications for NAGRAVISION +1 (401) 318-2229 nagravision@castercomm.com Howard Jones Communications Director Narrative Entertainment +44 7500 849 738 hjones@narrative.com View the original release on www.newmediawire.com
TORONTO, ONTARIO - August 12, 2026 (NEWMEDIAWIRE) - NeuroThera Labs Inc. (the “Company” or “NeuroThera”) (TSXV: NTLX), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd., is pleased to announce that it has closed the first tranche (the “First Tranche”) of its non-brokered private placement (the “Offering”), as previously announced on June 30, 2026 and July 2, 2026. Under the First Tranche, the Company raised C$2,700,000 from the sale of 22,500,000 units (each, a “Unit”) at C$0.12 per Unit. Each Unit is comprised of one common share in the capital of the Company (each, a “Common Share”) and one Common Share purchase warrant (each, a “Unit Warrant”). Each Unit Warrant entitles the holder to purchase one Common Share for US$0.115 per Common Share, equivalent to C$0.16 per Common Share, until August 12, 2029. The Unit Warrants will also have an acceleration provision whereby upon the securities of NeuroThera being approved for trading on the Nasdaq Stock Market, the Company will accelerate the expiry date of 50% of the unexercised Unit Warrants and provide three (3) business days’ advance written notice to holders thereof of such accelerated expiry date. The Unit Warrants are non-transferable. The Company intends to use the net proceeds of the First Tranche for general working capital purposes, including the evaluation of prospective transactions, settlement of liabilities, including repayment of outstanding indebtedness owed to SciSparc Ltd. and other corporate and administrative expenses. All securities issued in connection with the First Tranche, including any Common Shares and Common Shares issuable upon exercise of Unit Warrant, are subject to a restricted period of four months and one day from the date hereof. The Offering is subject to the final approval of the TSX Venture Exchange and any other applicable regulatory approvals. In connection with the First Tranche, the Company paid an aggregate of C$222,750 in finder's fees to a qualified arm's length party (the “Finder”). The Finder was also issued 2,812,500 Common Shares as compensation to the Finder. The securities of the Company referred to in this press release have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws. Accordingly, the securities of the Company may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to an exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company in any jurisdiction in which such offer, solicitation or sale would be unlawful. About NeuroThera Labs Inc. NeuroThera Labs Inc.(TSXV:NTLX) is a clinical-stage pharmaceutical company focused on developing novel therapeutics for central nervous system disorders and other underserved health conditions through collaborations and innovative combinations. For further information, please contact: Michal Efraty IR Manager NeuroThera Labs Inc. Telephone:+972-3-7617108 Email:michal@efraty.com Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities legislation. All statements in this news release that are not purely historical are forward-looking statements and include statements regarding beliefs, plans, expectations and intentions of the Company. Forward-looking statements in this news release include, but are not limited to, statements regarding: the intended use of the net proceeds of the First Tranche; the closing of any additional tranche or tranches of the Offering and the timing and size thereof; the evaluation of prospective transactions; the repayment of outstanding indebtedness owed to SciSparc Ltd.; the potential approval of the Company's securities for trading on the Nasdaq Stock Market and the resulting acceleration of the expiry date of the Unit Warrants; and the receipt of all necessary regulatory approvals, including final acceptance of the TSX Venture Exchange. Forward-looking statements are frequently identified by words such as “intends”, “expects”, “anticipates”, “believes”, “plans”, “will”, “may”, “prospective” and similar expressions, or statements that events, conditions or results “will”, “may”, “could” or “should” occur or be achieved. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and reflect management's current expectations and assumptions, including assumptions regarding: the Company's ability to satisfy the conditions to closing of any additional tranche of the Offering; the receipt of all required regulatory approvals; the sufficiency of the net proceeds for their intended purposes; and general market conditions remaining stable. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements. Such risks and uncertainties include, among others: the risk that any additional tranche of the Offering may not close on the terms announced, on anticipated timelines, or at all; the risk that the Company may not receive final acceptance of the TSX Venture Exchange; the risk that the Company's securities may not be approved for trading on the Nasdaq Stock Market; the risk that the net proceeds may be used for purposes other than those currently intended; risks associated with the Company's clinical-stage development programs; the Company's need for additional financing and the availability of such financing on acceptable terms; risks relating to the Company's relationship with, and indebtedness owed to, SciSparc Ltd.; changes in laws, regulations and policies; and general economic, market and business conditions. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. View the original release on www.newmediawire.com
LOS ANGELES, CA - August 12, 2026 (NEWMEDIAWIRE) - Wrap Technologies (NASDAQ: WRAP), a global leader in innovative public safety technologies, reported second-quarter 2026 revenue of $2.1 million, up 103% from $1.0 million a year earlier, while gross profit increased 217% to $1.5 million and gross margin expanded to approximately 75% from 48%. Loss from operations improved 21% to $2.3 million and net loss improved 39% to $2.3 million. Cash and cash equivalents totaled $4.8 million at June 30, up from $3.5 million at year-end. For the first six months of 2026, revenue increased 78% to $3.2 million, including product sales of $2.6 million, while gross profit rose 106% to $2.2 million. Subsequent to quarter end, the U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives (“ATF”) classified BolaWrap 150 as an instrument of restraint and rescue rather than a firearm or weapon under applicable federal statutes, which Wrap said expands potential applications beyond law enforcement into the private security market. The company also made a strategic investment in Frenel Imaging Ltd. to anchor the detection layer of its new WrapShield platform, which targets public safety, homeland security, defense and technology opportunities including advanced sensing, counter-uncrewed aerial systems and autonomous systems. Management said it is not updating its previously disclosed target of 100% revenue growth for 2026, noting that the timing of revenue recognition could cause final results to differ materially from current expectations. To view the full press release, visit https://ibn.fm/eK3bs About Wrap Technologies, Inc. Wrap Technologies, Inc. a global leader in innovative public safety technologies and non-lethal tools, delivering cutting-edge technology with exceptional people to address the complex, modern day challenges facing public safety organizations. WRAP’s complete public safety portfolio includes the non-lethal BolaWrap(R) 150 device, Wrap Reality(R) immersive training platform, WrapVision(TM) body-worn camera system, WrapTactics(TM) training programs, and next-generation C-UAS solutions like PAN-DA and the 1KC Kinetic Anti-Drone Cassette, all of which supports the Company’s mission to provide safer, scalable, and cost-effective technologies for public safety, defense, and critical infrastructure markets. With a growing demand for non-lethal tools and techniques to create time, distance and tactical advantage in non-criminal calls, Wrap’s BolaWrap(R) 150 incorporates a multi-sensory distraction of sight and sound as a first response, followed by a non-lethal restraint if further escalation is required. This approach reduces the risk of injury to officers, subjects, and the community. Wrap’s BolaWrap(R) 150 solution is intended to provide law enforcement with a safer choice for nearly every phase of a critical incident. This innovative, patented device deploys a multi-sensory, cognitive disruption to expand the pre-escalation period and gives officers the advantage and critical time to manage non-compliant subjects before resorting to higher-force options. The BolaWrap(R) 150 is not pain-based compliance. It does not shoot, strike, shock, or incapacitate, instead, it helps officers strategically operate pre-escalation on the force continuum, reducing the risk of injury to both officers and subjects. Used by over 1,000 agencies across the U.S. and in 60 countries, BolaWrap(R) is backed by training certified by the International Association of Directors of Law Enforcement Standards and Training (IADLEST), reinforcing Wrap’s commitment to public safety through cutting-edge technology and expert training. WrapReality(TM) VR is a fully immersive training simulator to enhance decision-making under stress. As a comprehensive public safety training platform, it provides first responders with realistic, interactive scenarios that reflect the evolving challenges of modern law enforcement. By offering a growing library of real-world situations, WrapReality(TM) is intended to equip officers with the skills and confidence to navigate high stakes encounters effectively, which we believe leads to safer outcomes for both responders and the communities they serve. WrapVision is an all-new body-worn camera and evidence management system built for efficiency. Designed for efficiency, security, and transparency to meet the rigorous demands of modern law enforcement, WrapVision captures, stores, and helps manage digital evidence, ensuring operational security, regulatory compliance, and enhanced video picture quality and field of view. The WrapVision camera, powered by IONODES, boasts streamlined cloud integration and final North American assembly, with a critical made-in-America roadmap projected for early 2026. This track helps ensure data integrity and helps eliminate critical concerns over unauthorized access or foreign surveillance risks. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to WRAP are available in the company’s newsroom at https://ibn.fm/WRAP Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
LOS ANGELES, CA - August 12, 2026 (NEWMEDIAWIRE) - Beeline Holdings (NASDAQ: BLNE), a technology-driven mortgage lender and fractional equity platform, announced that CEO Nicholas Liuzza has invested an additional $500,000 in the company through a board-approved convertible note. The note will automatically convert into Beeline common stock at 4 p.m. ET on Aug. 19, 2026, at the higher of $1.50 per share or the average closing five-day volume-weighted average price during regular trading hours beginning Aug. 12. Liuzza said the investment reflects confidence in Beeline’s strategy and recent operating progress, citing revenue growth, improving margins, reduced expenses and an increased focus on higher-margin products. He also highlighted the proposed TYTL combination and BeelineEquity as an opportunity to add a residential equity product whose economics are not directly tied to interest rates. The proposed TYTL transaction remains subject to due diligence, definitive agreements, a fairness opinion, valuation analyses, shareholder approval and other customary closing conditions. To view the full press release, visit https://ibn.fm/BiRGa About Beeline Holdings, Inc. Beeline Holdings, Inc. is a technology-driven mortgage platform focused on simplifying home financing through AI-powered digital mortgage origination, Non-QM lending, title, and settlement services. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to BLNE are available in the company’s newsroom at https://ibn.fm/BLNE Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
Detailed Mapping, Channel Sampling and Drill-Collar Ground Truthing to Target Expansion of Historically Documented Tungsten Mineralization at Eagle Point, New Mexico VANCOUVER, BC - August 12, 2026 (NEWMEDIAWIRE) - Western Star Resources Inc. (CSE: WSR) (OTC: WSRIF) (FRA: 4K2) (the “Company” or “Western Star”) is pleased to announce that it is commencing its maiden field exploration and drill-planning program at the Company’s Eagle Point Tungsten Project (“Eagle Point” or the “Property”), located in Hidalgo County, New Mexico, USA. The program represents the next stage in Western Star’s systematic advancement of Eagle Point following the Company’s acquisition of the past-producing tungsten property and is designed to validate and refine the geological model, evaluate the continuity and potential extent of tungsten mineralization, and ground-truth proposed drill locations ahead of a future drilling program. Western Star has engaged Dahrouge Geological Consulting Ltd. (“Dahrouge”) to undertake the program. Dahrouge’s scope includes detailed geological and structural mapping, channel and grab sampling, validation of existing project data and ground-truthing of proposed drill-hole collar locations. Importantly, the field team will also evaluate areas surrounding the proposed drilling targets with the objective of identifying opportunities to expand the existing exploration target areas. EAGLE POINT – FROM HISTORICAL TUNGSTEN PRODUCER TO MODERN EXPLORATION TARGET Eagle Point represents a compelling component of Western Star’s expanding U.S. tungsten strategy. The Property is a past-producing tungsten skarn system comprising 24 lode mining claims in the Granite Pass area of the Little Hatchet mining district. Historical records indicate approximately 1,800 tons of scheelite-bearing material were mined and shipped to the U.S. Government stockpile at Deming during 1943-44, settled on a basis of 0.48% WO(3) [1][2]. Historical U.S. Government work subsequently outlined the tonnage of mineralised tactite exposed at surface. J. N. Faick, Geologist, U.S. Geological Survey, and Harrison Schmitt, Consulting Geologist to the then applicant, estimated a historical mineralized system on the order of approximately 170,000 tons, comprising approximately 70,000 tons grading 0.40% WO(3) and approximately 100,000 tons grading 0.25% WO(3)[3]. These figures are historical estimates only and are not current mineral resources or reserves. The historical work ultimately resulted in the U.S. Government preparing and recommending a Defense Minerals Exploration Administration exploration contract (Idm-E783, Docket DMEA-3701) under which it would have funded 75% of a proposed shaft-sinking and diamond-drilling program. That contract never became effective [3], and therefore the program was never carried out, leaving the principal exploration objectives largely untested. More recently, United States Geological Survey and New Mexico Bureau of Geology and Mineral Resources (USGS/NMBGMR) [4] sampling provided additional evidence of high-grade tungsten mineralization at surface, including sample LH705, a scheelite-rich outcrop composite, returning 27.6% WO(3) and 0.98% molybdenum, together with additional selective and composite samples returning elevated tungsten values. These samples are selective in nature and should not be considered representative of the average grade of mineralization on the Property. Composite samples LH700avg and LH701 from the same programme returned 0.35% and 0.40% WO(3) respectively, consistent with the grade of the material historically shipped [4]. 2026 EAGLE POINT FIELD PROGRAM The upcoming program is intended to move Eagle Point from compilation of historical information toward a modern, field-validated geological and drill-targeting model. The program will include: - Detailed geological and structural mapping, including strike-and-dip measurements and digital field mapping; - Systematic channel and grab sampling, with samples documented, photographed, uniquely identified and submitted to ALS Tucson; - Ground-truthing of local geology and proposed drill-hole collar locations; - Field evaluation around proposed drilling targets, specifically aimed at identifying opportunities to expand the exploration target areas; - Review and validation of existing historical and modern project data; and - Integration of the new field information with the Company’s existing Eagle Point geological database to assist in refining future drill targets. A SYSTEM THAT REMAINS LARGELY UNTESTED BY MODERN EXPLORATION One of the features management considers particularly significant at Eagle Point is the contrast between the amount of mineralization exposed and historically investigated at surface and the limited amount of drilling completed on the Property. Historical records describe eight skarn bodies exposed through an open cut, trenches and bulldozer cuts, while historical drilling was limited principally to a small number of shallow holes concentrated around the main open-cut area. The Property therefore remains largely untested at depth and along strike using modern exploration methods. The tungsten mineralization occurs within a contact-metamorphic skarn system developed along the limestone-granitic intrusive contact. Historical mapping indicates individual tactite bodies extending up to approximately 140 feet in length and approximately 30 feet in width, within a mineralized geological setting extending approximately 1,500-2,000 feet along the prospective contact [3]. The limestone host is interpreted to be underlain by granite at approximately 200-300 feet depth, a constraint the programme is intended to test [3] Western Star believes that systematically mapping, sampling and ultimately drill-testing this geological architecture provides the Company with an opportunity to determine whether the historically identified surface mineralization continues at depth, along strike and into areas that received little or no historical exploration. There can be no assurance that future exploration will result in the delineation of a mineral resource. CEO COMMENT Blake Morgan, President and CEO of Western Star Resources, commented: “This is the program we have been eager to commence since acquiring Eagle Point. We are moving from historical records and exceptional surface indications to boots on the ground, systematic modern exploration and the identification and validation of drill locations. “Eagle Point has a combination that is increasingly difficult to find in the United States: documented historical tungsten production, multiple mineralized skarn bodies exposed at surface, significant historical U.S. Government involvement and modern government sampling that has confirmed very high-grade tungsten mineralization at surface. “What excites us most, however, is what has not been done. The U.S. Government previously agreed to support a drilling program at Eagle Point, yet that program was never completed, and the system has never been comprehensively tested using modern exploration techniques. “Our objective with Dahrouge is straightforward: understand the geology in substantially greater detail, systematically sample the exposed mineralization, ground-truth our proposed drill locations and investigate the surrounding areas for additional targets. We want the next phase of drilling to test the geological system intelligently and aggressively. “Western Star is building its U.S. tungsten portfolio at a time when establishing secure domestic supplies of critical minerals has become a strategic priority. Eagle Point, together with our Nevada tungsten assets, gives Western Star exposure to multiple past-producing U.S. tungsten systems. We believe the work now underway can begin demonstrating the scale and significance of what we have assembled.” BUILDING A U.S.-FOCUSED TUNGSTEN EXPLORATION PLATFORM The Eagle Point program forms part of Western Star’s broader strategy of assembling and systematically advancing past-producing and historically explored tungsten assets in the United States. The Company is advancing Eagle Point alongside its tungsten portfolio in Nevada, including the Rowland and White Star projects, where Western Star has also been applying modern geophysical, geochemical and geological exploration methods to historically productive tungsten systems. Western Star’s strategy is to use modern exploration to systematically evaluate these historically recognized mineralized systems, generate and prioritize drill targets, and advance the most compelling targets toward drilling. Tungsten is designated as a critical mineral by the United States and is essential to a range of defence, aerospace, industrial and advanced manufacturing applications. Western Star believes the combination of increasing Western focus on critical-mineral security and the scarcity of domestic primary tungsten supply provides a strong strategic backdrop for the advancement of U.S.-based tungsten projects. NEXT STEPS Following completion of the Eagle Point field program, Western Star expects to integrate the mapping, structural measurements, channel and grab sampling and drill-location ground truthing with the Property’s historical database. The resulting geological interpretation is expected to assist the Company in ranking and refining targets for subsequent drill testing, subject to permitting, technical review, financing and other customary considerations. Dahrouge is scheduled to provide a field summary/assessment report following completion of the program, with the current project schedule targeting completion by during September 2026. References Moore, J. I., Jr., 1952. Report of the Eagle Point Mine, Hidalgo County, New Mexico. Haile Mines, Inc., May 1952. New Mexico Bureau of Geology and Mineral Resources, mine file 4208. Report of the Eagle Point Mine, Hidalgo County, New Mexico. Undated typescript (archival annotation “1948?”). New Mexico Bureau of Geology and Mineral Resources, mine file 4207. U.S. Bureau of Mines and U.S. Geological Survey. Examination, exploration-assistance and production records, Eagle Point tungsten deposit, Granite Pass, Hidalgo County, New Mexico. Defense Minerals Administration and Defense Minerals Exploration Administration Dockets DMA-1475, DMA-1476X, DMEA-3276 and DMEA-3701, 1941–1957. U.S. National Archives, Record Group 70. McLemore, V. T., 2025. Earth MRI – Database of chemical analyses of critical mineral deposits in New Mexico. New Mexico Bureau of Geology and Mineral Resources, Socorro, New Mexico. Samples LH700–LH711, Eureka area, Hidalgo County; analyses by the U.S. Geological Survey, laboratory file MRP-21541; collected 26–27 November 2024, analysed 27 March 2025. Dale, V. B. and McKinney, W. A., 1959. Tungsten deposits of New Mexico. U.S. Bureau of Mines Report of Investigations 5517, 72 p. WO₃ values quoted in this news release are calculated from elemental tungsten (W) using a conversion factor of 1.2611. Historical Estimates The historical estimates referenced in this news release are historical in nature and were prepared prior to the implementation of National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”). A Qualified Person has not completed sufficient work to classify the historical estimates as current mineral resources or mineral reserves, and the Company is not treating the historical estimates as current mineral resources or mineral reserves. The estimates rest on surface trenching, ultraviolet-lamp observation and sparse grab and chip sampling, without drill support or documented quality control, and separate estimates diverge by a factor of three to four; the Company therefore regards their reliability as low and their relevance as limited to context on historical exploration. Verification as current mineral resources would require detailed mapping, systematic channel sampling under a documented QA/QC protocol, and drilling of sufficient density to establish grade and geometric continuity, followed by independent data verification and estimation by a Qualified Person. The historical estimates are presented solely to provide context regarding the historical exploration of the Eagle Point Property and should not be relied upon as current mineral resources or reserves. Qualified Person Jasper Mowatt, MIMMM (No. 0486653) and MAusIMM (No. 3178851), a consultant to the Company and a Qualified Person as defined by NI 43-101, has reviewed and approved the scientific and technical information contained in this news release. Mr Mowatt is not independent of the Company. The historical and third-party information disclosed above is drawn from the sources listed above; the Qualified Person has reviewed those sources but has not verified the underlying sampling, assaying or survey data, which are not available, and has visited the Property in June 2026. About Western Star Resources Inc. Western Star Resources Inc. is a mineral exploration company focused on the acquisition, exploration and advancement of critical-mineral assets in North America, with an increasing strategic focus on tungsten in the United States. The Company’s U.S. tungsten portfolio includes the Eagle Point Tungsten Project in New Mexico and the Rowland and White Star tungsten projects in Nevada. Western Star’s strategy is focused on applying modern exploration methods to historically productive and underexplored mineral systems with the objective of identifying and advancing significant new critical-mineral opportunities. For further information, please contact: Blake Morgan President & Chief Executive Officer Western Star Resources Inc. CSE: WSR | OTC: WSRIF | FRA: 4K2 Forward-Looking Information This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation, including statements regarding the timing and completion of the Eagle Point exploration program; the identification, refinement and expansion of exploration and drill targets; future drilling and permitting; the potential continuity, extent and significance of tungsten mineralization; the advancement of the Company’s U.S. tungsten properties; and the Company’s exploration and corporate strategy. Forward-looking information is based on assumptions considered reasonable by management at the date such statements are made and is subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied. There can be no assurance that exploration will result in the discovery or delineation of a mineral resource, that proposed exploration or drilling will be completed as contemplated, or that any mineralization identified will prove economically recoverable. The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release. View the original release on www.newmediawire.com
VANCOUVER, BC - August 12, 2026 (NEWMEDIAWIRE) - Golden Cariboo Resources Ltd. (the “Company”) (CSE:GCC) (OTC:GCCFF) (WKN:A402CQ) (FSE:3TZ) announces the completion of core logging and sampling for diamond drill hole QGQ26-30, which targeted the western margin of the Company's Halo zone at its flagship Quesnelle Gold Quartz Mine Property, located approximately 4 kilometres (2.5 miles) northeast of Hixon, British Columbia. The Halo zone forms part of the Company's broader mineralized corridor at the Property and has become a significant focus of ongoing exploration. Drill hole QGQ26-30, completed to a final logged depth of 402.38 m (1,320.14 ft), successfully intersected broad intervals of intense sericite and carbonate altered volcanic rocks dominated by andesite tuff, along with distinctive chromium-mica (fuchsite) alteration. Mineralized quartz and quartz-carbonate veining was common throughout the hole and appears to be closely associated with gold mineralization. Visible gold was observed on several occasions as irregular shaped flecks, typically less than 1 mm in size but reaching up to 3 mm, occurring adjacent to and within quartz-carbonate veins containing disseminated to cubic pyrite. Sulphide mineralization is dominated by pyrite with minor chalcopyrite and rare pyrrhotite, as well as localized semi-massive to massive sulphide intervals. Notably, visible gold measuring approximately 2 to 3 mm was identified in close proximity to subhedral to near-euhedral pyrite cubes up to 1 cm in size, as shown in the photo below. Listwanite was intersected near the bottom of the hole between 384.77 m and 385.25 m, enveloped within an andesitic volcanosedimentary unit and surrounded by a 16.27 m halo of disseminated sulphide mineralization containing up to 20% replacement pyrite. These initial observations from QGQ26-30 indicates gold mineralization exists at least 200 metres west of QGQ24-20 which reported 1.55 g/t gold with 16.05 g/t silver over 137.17 m (450.0 ft) (News Release dated August 12, 2025) and suggests mineralization continues to be open in all directions. "This represents an important step out from previously defined mineralization and further demonstrates the lateral continuity and scale potential of the Halo system," said Frank Callaghan, President and CEO. Photo 1: Visible gold above the euhedral pyrite cube to the left and possible sub mm sized gold flecks along the margins of the 1 cm pyrite cube to the right. All samples from QGQ26-30 have been submitted to MSALabs in Prince George, British Columbia, for photon assay analysis, with results pending. The results will be included in the Golden Cariboo’s upcoming Mineral Resource Estimate (MRE) as also described in the News Release dated July 22, 2026. The technical information in this news release has been reviewed and approved by Jean Paulter, an independent consultant commissioned by the Company. Jean Paulter is a Professional Geoscientist (P.Geo.) registered with the Association of Professional Engineers and Geoscientists of the Province of BC (“APEGBC”) and licensed by Engineers and Geoscientists BC and is a “Qualified Person” with respect to NI 43-101. About Golden Cariboo Resources Ltd. Golden Cariboo Resources Ltd. is rediscovering the Cariboo Gold Rush by proceeding with highly targeted drilling and trenching programs on its Quesnelle Gold Quartz Mine property which is bordered by Osisko Development, partly intertwined with them at the north end of the Cariboo Gold Project, and located along a favourable corridor adjacent to the Spanish and Eureka thrust faults over a 94,899 hectare (234,501 acre) area. Historically, over 101 placer gold creeks on the 90-kilometer (56 mile) trend, from the Cariboo Hudson mine north to the Quesnelle Gold Quartz Mine property, have recorded production with successful placer mining continuing to this day. Golden Cariboo’s Quesnelle Gold Quartz Mine property is 4 kilometers (2.5 miles) northeast of, and road accessible from, Hixon in central British Columbia. The Property includes the Quesnelle Quartz gold-silver deposit, which was discovered in 1865 and developed over a footprint of about 150m x 150m (less than 6 acres) at the Main zone straddling Hixon Creek. Overall, the geological setting of the gold mineralization at the Company’s Quesnelle Gold Quartz Mine property shows strong similarities with the Spanish Mountain gold deposit, situated 120 km (75 miles) towards the southeast along the same geological trend. As a sediment-hosted vein (SHV) deposit, the Spanish Mountain deposit is considered to belong to the epizonal orogenic subclass of gold deposits which include some of the world’s largest deposits such as Muruntau, Uzbekistan and Bendigo, Australia. For further information please contact: GOLDEN CARIBOO RESOURCES LTD “J. Frank Callaghan” J. Frank Callaghan, President & CEO Tel: 604-669-6463 VISIT OUR WEBSITE FOR MORE DETAILS www.goldencariboo.com LIKE AND FOLLOW Instagram, Facebook, X (Twitter), LinkedIn Neither the “CSE” Canadian Securities Exchange nor its Regulation Service Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Cautionary Statements: This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and plans of the Company. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding; the expectation that the Company will receive all necessary exemptions and approvals to complete the Offering; the expectation that the Company will complete the Offering on the terms disclosed, or at all; the expectation that the proceeds will be used for property exploration and for general working capital; the Company’s exploration plans with respect to its Quesnelle Gold Quartz Mine property; and the anticipated participation of the insider in the Offering. Such forward-looking statements are based on a number of assumptions of management, including, without limitation, that the Company will receive all necessary exemptions and approvals to complete the Offering; that the Company will complete the Offering on the terms disclosed, or at all; that the proceeds will be used for property exploration and for general working capital; that the Company will have the resources required to proceed with its exploration plans; that the Company will not run into regulatory or other barriers in carrying out its business plans; that the insider will participate in the Offering, on the terms and conditions and in the amount currently expected by management; and that the Company will be able to rely on the exemption from the formal valuation and minority shareholder approval requirements on the basis anticipated. Additionally, forward-looking information involve a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of the Company to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that the Company will not receive the necessary exemptions and approvals to complete the Offering; that the Company will not complete the Offering on the terms disclosed, or at all; that the Company will be unable to use the proceeds for property exploration and for general working capital; that the Company may incur unanticipated costs; that the Company may not have the resources required to pursue its exploration plans; that the Company’s operations could be adversely affected by possible future government legislation policies and controls or by changes in applicable laws and regulations; that the insider may not participate in the Offering on the terms and conditions and in the amount currently expected by management, or at all; and that the Company may not be able to rely on the exemption from the formal valuation and minority shareholder approval requirements on the basis currently expected. Such forward-looking information represents management’s best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release. Neither the Company nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this news release by you or any of your representatives or for omissions from the information in this news release. The forward-looking statements herein speak only as of the date they were originally made. The Company has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. View the original release on www.newmediawire.com
GRANDE PRAIRIE, AB - August 12, 2026 (NEWMEDIAWIRE) - ANGKOR RESOURCES CORP. (TSXV: ANK) (“ANGKOR” OR “THE COMPANY”) announces that senior representatives of its Cambodian energy subsidiary, EnerCam Resources Co., Ltd. (“EnerCam”), met with potential drilling contractors to assess drill sites in anticipation of mobilizing and demobilizing drilling equipment for drilling exploratory wells on Block VIII. EnerCam’s team provided technical presentations to several potential drilling companies for the planned exploratory wells to be drilled in Block VIII as Cambodia’s first onshore oil and gas wells. Teams then travelled to the field to examine the roads and infrastructure providing access to each of the four sub-basins that are drill targets. Bridges are an important part of the assessment to ensure the significant load and equipment can be carried. Figure 1 EnerCam management with potential drilling contractor assess bridges to the drill targets to ensure load bearing and width capacity for the necessary drilling equipment. The teams collaborated on technical information from the seismic results and the drill plan for various wells to be drilled to a depth of up to 3300 metres. They then travelled to the Kirirom and South, Central, and North Bokor prospects to analyze various requirements in mobilizing large drilling equipment to the various drill sites. John Koch, EnerCam’s drilling manager, travelled to Cambodia to meet the teams and cover the details of the drilling, completion, and production testing requirements of each well. John Koch commented on the trip: “Clearly the required services and equipment are available to undertake our exploration program and meet our technical requirements in a cost-effective manner. The access and terrain in Block VIII lends itself to efficient execution.” Figure 2 Team members assess the Kirirom drill target in the northeast corner of Block VIII. Drilling contractors are selected based on a tendered bid that is first approved by Ministry of Mines and Energy and then published in various media outlets. EnerCam has undertaken its own due diligence on a number of possible drilling contractors over the past five months to expedite the process and advance the project ahead of schedule where possible. Team members like John Koch have done this type of work in over 60 countries, designing and building oil and gas drill programs and drill sites to meet safe and efficient practices. These models implement global best practices and set a high standard for the entire industry. The Environmental Impact Assessment (“EIA”) on the four subbasins to be drilled is in its final stages of approval with the Ministry of Environment, having completed an inter-ministerial meeting of government ministries in mid July. ANGKOR RESOURCES’ ENERCAM ADVANCES TO INTER-MINISTERIAL REVIEW OF EXPLORATION DRILLING PROGRAM IN BLOCK VIII, CAMBODIA - Angkor Resources Corp. Mike Weeks, President of EnerCam, comments, “While the final review of the EIA progresses, we take on a great deal of other work to prepare for the actual drilling and that includes due diligence by our teams ahead of the actual bid. As these exploratory wells will be the first onshore to be drilled, we are developing a system and a precedent for both EnerCam and Cambodia that can be implemented on additional oil and gas projects as the sector develops.” Figure 3 A typical drilling site, one of several thousand sites that the EnerCam drilling team has undertaken across 60 countries. ABOUT ANGKOR RESOURCES CORP. ANGKOR Resources Corp. is a public company, listed on the TSX-Venture Exchange, and is a leading resource explorer and developer in Cambodia working towards mineral and energy solutions across the country. The Company's mineral subsidiary, Angkor Gold Corp. Co., Ltd., currently holds two mineral exploration licenses in Cambodia with multiple prospects in copper and gold. Both licenses are in their first two-year renewal term. Angkor’s Cambodian energy subsidiary, EnerCam Resources Co., Ltd., was granted an onshore oil and gas license in the southwest quadrant of Cambodia called Block VIII. The Company removed all parks and sensitive areas from the original 7,300 km(2) license and now Block VIII is approximately 4,095 km(2). EnerCam is actively advancing oil and gas exploration activities onshore to meet its mission to prove Cambodia as a nation with its own oil and gas resources. The Company completed 2D-seismic in 2025 and has identified multiple drill targets with multiple target zones. Following the identification of drill targets, the Company completed an additional Environmental Impact Assessment on the drilling target areas, which is now submitted for approval by the Ministry of Environment. the Company plans to follow with drilling Cambodia’s first privately financed onshore exploratory oil and gas wells under a 30-year signed Production Sharing Contract. CONTACT: Delayne Weeks - CEO Email:- info@angkorresources.com Website: angkorresources.com Telephone: +1 (780) 831-8722 Please follow @AngkorResources on LinkedIn, Facebook, Twitter, Instagram and YouTube. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to oil and gas risks of the seismic interpretation uncertainty and the preliminary nature of structural closure estimates; drilling risk and the absence of a drilled well on the Concession; reservoir and fluid uncertainty; PSC compliance obligations and the risk of relinquishment for non-performance; oil price exposure; and Cambodia-specific sovereign and regulatory risk. As well, additional uncertainties on the mineral projects exist regarding the potential for gold and/or other minerals at any of the Company’s properties, the prospective nature of any claims comprising the Company’s property interests, the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, uncertainty of sample results, timing and results of future exploration, and the availability of financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. View the original release on www.newmediawire.com
TORONTO, ONTARIO - August 12, 2026 (NEWMEDIAWIRE) - NeuroThera Labs Inc. (TSXV: NTLX) (the "Company" or "NeuroThera"), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd., today announced that the Japanese Patent Office has granted the company a patent for its pharmacological combination titled “Compositions and Methods for Potentiating Derivatives of 4-Aminophenols.” The newly granted Japanese patent covers pharmaceutical compositions and methods comprising proprietary combinations of 4-aminophenols derivatives (including paracetamol) and N-acylethanolamines. These combinations are designed to enhance the analgesic and antipyretic performance of 4-aminophenol-based therapies. NeuroThera believes this synergistic approach may enable lower effective dosing while helping to mitigate dose‑related side‑effect concerns associated with established treatments. This patent further strengthens NeuroThera’s expanding intellectual property portfolio, reinforcing protection for its combination-therapy platforms designed to optimize and modernize standard treatments for pain, fever, and related conditions. The addition of Japanese patent coverage marks an important strategic milestone as the Company advances its next‑generation therapeutic innovations across global markets. NeuroThera Labs continues to advance its therapeutic platforms with the goal of delivering safe, effective, and accessible treatments to patients worldwide. About NeuroThera Labs Inc. NeuroThera Labs Inc.(TSXV: NTLX) is a clinical-stage pharmaceutical company focused on developing novel therapeutics for central nervous system disorders and other underserved health conditions through collaborations and innovative combinations. For further information, please contact: MichalEfraty IRManager NeuroThera Labs Inc. Telephone:+972-3-7617108 Email:michal@efraty.com Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. Cautionary Notice on Forward-Looking Statements This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking information and are based on expectations, estimates and projections as at the date of this news release. Forward-looking information in this news release includes statements regarding the potential benefits of the patented combinations, including their potential to enhance the effects of 4-aminophenol derivatives, potentially enable lower effective doses and address dose-related side effects, as well as the potential for NeuroThera’s proprietary combination platforms to improve established therapies for pain, fever and related conditions; the Company's plans to advance its next-generation therapeutic innovations and therapeutic platforms across global markets; and the Company's goal of developing and delivering safe, effective and accessible treatments to patients worldwide, including novel therapeutics for central nervous system disorders and other underserved conditions. These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking information necessarily involves known and unknown risks and uncertainties, which may cause the Company's actual performance and results to differ materially from any projections of future performance or results expressed or implied by such forward-looking information. Such factors include, without limitation the risks described in the Company's continuous disclosure documents filed on SEDAR+ (www.sedarplus.ca). The Company does not undertake any obligation to update or revise any forward-looking information, except as required by applicable securities laws. View the original release on www.newmediawire.com
CARACAS, VENEZUELA - August 12, 2026 (NEWMEDIAWIRE) - LataMed AI Corp. (OTC: LMED) (formerly OTC: LMEDD) (“LataMed AI” or the “Company”), an artificial intelligence and technology company focused on developing and applying AI-powered solutions across healthcare and other industries, today announced that its Venezuelan operating subsidiary, LataMed AI VE, has entered into a strategic collaboration with Caracas FC to explore the application of artificial intelligence, predictive analytics and data-driven technologies across athletic performance and selected operational functions. The collaboration is expected to evaluate potential applications of LataMed AI’s technology in areas such as athlete workload analysis, biometric data assessment, computer vision, performance monitoring, predictive modeling and the analysis of historical and real-time performance data. The parties also intend to explore opportunities to apply AI-driven tools to selected administrative and operational workflows within the organization. Professional sports organizations generate significant amounts of data across training, competition, athlete monitoring, performance evaluation and day-to-day operations. LataMed AI believes that applying artificial intelligence to these data sets may help organizations identify patterns more efficiently, improve the organization and interpretation of information and provide coaches, performance personnel and administrators with additional data-driven tools to support decision-making. As part of the collaboration, LataMed AI and Caracas FC intend to identify areas where the Company’s technologies may be evaluated in a practical professional sports environment. Potential areas of assessment may include analyzing athlete workload and performance trends, evaluating biometric and training data, utilizing computer vision to assist in the review of athletic activity and examining opportunities to automate or improve the analysis of operational information. The collaboration is also expected to provide LataMed AI with an opportunity to further evaluate how technologies originally developed around complex healthcare and data-analysis environments may be adapted for additional industries. The Company’s broader technology strategy is centered on building AI-powered systems capable of collecting, organizing and analyzing complex information and supporting data-driven decision-making. While healthcare remains an important area of focus for LataMed AI, the Company believes many of its underlying technological capabilities, including predictive modeling, machine learning, automation, computer vision and real-time information processing, may have applications across a variety of commercial and institutional environments. “Professional sports is increasingly data-driven, and organizations now have access to more performance information than ever before,” said Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp. “The challenge is not simply collecting information, but determining how that information can be organized, analyzed and used effectively. Our collaboration with Caracas FC gives us an opportunity to explore how our artificial intelligence capabilities can be applied in a demanding, real-world environment where performance data and timely decision-making are particularly important.” Dr. Levy continued, “We also view this collaboration as an opportunity to demonstrate the broader versatility of the technology platform we are building. The same core capabilities that allow artificial intelligence to analyze complex healthcare information can potentially be adapted to other environments where large volumes of data must be interpreted quickly and efficiently.” In addition to athletic performance applications, the parties intend to evaluate whether LataMed AI’s automation and analytical technologies may be useful within selected administrative and operational functions of the organization. The Company believes these evaluations may provide additional insight into the scalability of its technology across multiple departments and use cases. The Company intends to work with Caracas FC to identify appropriate areas for implementation, testing and evaluation as the collaboration progresses. The scope and timing of any specific deployment will depend upon the requirements of the parties, available data, technical integration and other operational considerations. LataMed AI believes collaborations such as this may help create practical environments in which its artificial intelligence technologies can be evaluated outside of their initial healthcare applications while providing the Company with additional information and experience that may inform future technology development. The Company continues to pursue opportunities to apply its artificial intelligence technologies across healthcare, industrial, institutional and other data-intensive environments where predictive analytics, automation and advanced data processing may improve efficiency, accessibility and decision-making. For additional information, please visit https://latamed.ai, follow the Company’s official social media channels, or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov. About LataMed AI Corp. LataMed AI Corp. is a healthcare technology company focused on developing digital health infrastructure and artificial intelligence-supported medical solutions for Latin America. The Company’s strategy includes the development of a telemedicine ecosystem designed to improve access to healthcare services and support connections among patients, medical professionals, pharmacies, insurers, payment providers, wellness organizations, educational institutions, and other participants in the healthcare system. The Company is also developing CardioAI, PulmoAI, and NeuroAI, artificial intelligence-supported platforms intended to assist healthcare professionals in the evaluation and management of cardiovascular, pulmonary, and neurological health information. These platforms remain subject to continued development, testing, applicable regulatory requirements, and commercial implementation. Forward-Looking Statements This press release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements regarding the anticipated scope, implementation, testing, development and potential benefits of the Company’s collaboration with Caracas FC; the potential application of the Company’s artificial intelligence technologies in athletic performance, biometric analysis, computer vision, operational analytics and other industries; the adaptability and scalability of the Company’s technology platform; and the Company’s future business plans and development activities. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include the availability and suitability of data, technical integration requirements, implementation and testing timelines, operational considerations, the continued development of the Company’s technologies, and the ability of the collaboration to result in broader deployment, commercial adoption, revenue or other business benefits. There can be no assurance that the collaboration will result in any particular commercial deployment, revenue or other business outcome. The Company undertakes no obligation to update any forward-looking statement except as required by applicable law. Disclaimer The Company’s technologies are under development and are not intended to replace the independent professional judgment of qualified healthcare providers, athletic trainers, coaches, performance professionals, engineers, researchers, laboratory personnel or other authorized professionals. No statement in this release should be interpreted as a representation or guarantee regarding technology performance, athletic or medical outcomes, regulatory authorization, commercial adoption, revenue, market acceptance or financial performance. This announcement is being issued solely to provide shareholders and market participants with information regarding the Company’s business development activities. It does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company. Investor Relations LataMed AI Corp. ir@latamed.ai +1 (787) 476-2350 https://latamed.ai View the original release on www.newmediawire.com
MIAMI, FL - August 12, 2026 (NEWMEDIAWIRE) - Travaleo, the branded luxury real estate digital investment platform of Genesis Holdings, Inc. (OTC: GNIS), in partnership with Aurami Capital, today outlined how the companies are positioning to serve as a destination for institutional and digitally-driven capital as the Clarity Act moves toward potential effectiveness. The partners believe clearer digital-asset market structure will accelerate the reallocation of capital toward high-quality digitalized real-world assets, and they have structured their platform, developer relationships, and asset focus to meet that demand. Global liquidity conditions continue to evolve. Long-standing sources of foreign demand for U.S. assets - including flows historically associated with the yen carry trade and Japan’s role as a major holder of Treasuries - face shifting interest-rate differentials and policy dynamics. These pressures can affect demand for government debt and increase the importance of scalable, regulated private-sector channels for capital allocation. In this environment, frameworks such as the Clarity Act and existing digital-asset market rules take on added significance: once fully effective, they enable larger, more transparent participation in both short-term government securities and, over time, digitalized real assets. High-end branded luxury real estate has long functioned as a preferred liquidity sink for global high-net-worth and ultra-high-net-worth capital. The concentration of surplus among the top cohorts of wealth already channels substantial absolute amounts into scarce, brand-protected assets that combine status, pricing power, operational cash flow, and relative resilience. Digitalizing this specific segment makes those assets more transparent, fractional, and usable for larger institutional pools that will be seeking differentiated real-asset exposure as regulatory clarity improves and capital continues to rotate. The strategy rests on three elements. First, direct partnerships with investment managers and wealth management firms across Miami, the United States, and Latin America to launch strategy-specific funds. Second, Aurami Capital’s established priority access to leading Miami developers specializing in branded luxury, including Related Group and Terra Group. Third, the placement of these assets onto compliant digital investment infrastructure. Together, these create a differentiated offering in a category that already attracts and retains concentrated wealth. “Clarity Act effectiveness is the practical inflection point,” said Oscar Brito, CEO of Genesis Holdings and Co-CEO of Travaleo. “Once the rules are clear, large pools of capital - including wealth platforms and other digitally-linked capital - will look for high-quality, transparent, digitalized real assets. Branded luxury is structurally well-placed to absorb meaningful liquidity because it is already the preferred real-asset destination of those with the most surplus. We have built the developer relationships, the structuring capability, and the platform so that this segment is ready when that search intensifies.” Hans Baumgartner, CEO of Aurami Capital and Co-CEO of Travaleo, added: “Very few platforms combine deep relationships with the top branded-luxury developers in Miami with institutional-grade digital investment infrastructure. That combination, plus distribution through professional wealth managers, positions us to participate in the broader reallocation that greater regulatory clarity and evolving global liquidity dynamics are expected to support. Making these assets available in a structured, transparent, digital format is the logical next step for a segment that has historically absorbed significant capital from the highest end of the wealth spectrum.” Capital formation is focused on partnerships with investment managers, wealth management firms, and real estate investment firms. At the same time, the act of digitalizing proven branded luxury portfolios is intended to create a structural differentiator that attracts additional institutional interest beyond the relationships the companies actively pursue. All offerings remain limited to accredited or otherwise qualified investors under applicable securities exemptions, with full KYC/AML processes and transfer restrictions. Secondary liquidity will be developed only through compliant venues as the market structure matures. The partnership continues to prioritize disciplined asset selection, operator accountability, and the creation of a recognizable investment category in anticipation of the institutional capital flows that clearer regulation and shifting global demand patterns are expected to unlock. About Aurami Capital Aurami Capital is an institutional-grade luxury real estate investment platform and a subsidiary of Miami Real Investment (MRI), one of South Florida’s most active luxury real estate advisory firms with 21 years of market leadership and over $1 billion in branded luxury transactions in the past four years alone. Aurami Capital combines MRI’s proprietary developer access and deal flow with institutional fund structure, regulatory compliance, and digital infrastructure - offering accredited investors access to branded luxury residential and hospitality opportunities in South Florida’s most supply-constrained submarkets. https://auramicapital.com/ info@auramicapital.com About Miami Real Investment (MRI) With over 20 years of experience, Miami Real Investment is a leading brokerage firm specializing in branded luxury pre-construction real estate in Miami. With a track record of handling transactions for VIP clients, F1 drivers, public figures, and international investors, Miami Real Investment offers unmatched expertise and dedicated service, ensuring client satisfaction at every step of the buying process. The company offers a 360 approach, including investment portfolio design, market analysis, tax planning, and legal advice from top real estate lawyers. https://miamirealinvestment.com/ info@miamirealinvestment.com About Travaleo Travaleo is a branded real estate investment and development platform wholly owned by Genesis Holdings, Inc. (OTC: GNIS), focused on identifying, structuring, and managing income-producing and development-oriented real estate projects. The platform emphasizes professionally underwritten assets, brand-driven developments, and disciplined execution aligned with long-term ownership strategies. Travaleo’s digital investment infrastructure enables accredited investors to participate in curated branded luxury real estate opportunities through structured investment vehicles designed to enhance transparency, efficiency, and investor access. https://www.travaleo.com/ X: @Travaleo_ invest@travaleo.com About Genesis Holdings, Inc. Genesis Holdings is a publicly traded holding company focused on the development, acquisition, and management of operating businesses and real-asset-related initiatives. The Company emphasizes disciplined capital allocation, sound governance practices, and long-term value creation for shareholders. https://www.regen.digital/ X: @regnisnyc Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements that are not historical in nature, including the words “anticipate,” “expect,” “suggest,” “plan,” “believe,” “intend,” “estimates,” “targets,” “projects,” “should,” “could,” “would,” “may,” “will,” “forecast” and other similar expressions are intended to identify forward-looking statements. Statements in this letter regarding the anticipated timing, size, or completion of any fund launch, any potential relationship with a Mexico-based wealth management firm, the relaunch of MetroCrowd, any potential acquisitions, and any anticipated national exchange listing are forward-looking statements, and no assurance can be given that any of these initiatives will be completed on the timeline described, or at all. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. There are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: general economic and business conditions, competitive and technological factors, markets, services, products and prices, the failure to retain management and/or key employees, availability and cost of capital, success of growth initiatives, limited operating history, failure to successfully close any proposed transactions, failure to raise sufficient capital, failure to file any required filings properly, and other risks discussed in the Company’s filings with the OTC Markets. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Genesis Holdings assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. View the original release on www.newmediawire.com
Scottsdale-based Startup Unveils the Rubicon 6-Ton and 10-Ton RTU Systems: Hyper-efficient, Thermal-boosted Rooftop Units, Assembled in the USA. They Think for Themselves and pay for Themselves. Boring HVAC, Meet your Replacement. SCOTTSDALE, AZ - August 12, 2026 (NEWMEDIAWIRE) - NVIRIQ Inc, built to disrupt next-generation HVAC, today announced the official launch of the Rubicon commercial HVAC platform. It's a line of hyper-efficient rooftop units (RTUs) built to replace tired, dumb commercial air conditioning systems with something that actually earns its spot on your roof. Assembled in the USA and now available in 6-Ton and 10-Ton configurations, Rubicon drops in as a direct replacement for standard commercial RTUs. No redesign, no drama, no excuses. At the heart of the Rubicon platform is a patented thermal collector, working alongside the variable-speed inverter heat pump to deliver average energy savings of 30 to 40% over conventional rooftop units. Peak performance hits up to 31 IEER on the 10-Ton model and 6 COP in heating mode across the line. Every system features a live cloud performance dashboard, so building owners see energy use, system health, and maintenance needs in real time. Problems get caught before they turn into a five-figure emergency call. "Commercial building owners have been stuck with the same outdated HVAC playbook for decades," said Devin Cooley, President and Co-Founder of NVIRIQ. "When a rooftop unit dies in the middle of a summer heatwave, the answer shouldn't be 'call your contractor and replace it with the same thing.' Rubicon was built to break that cycle. It's a system that pays for itself, tells you when it needs attention, and qualifies for serious federal incentives. This isn't just an equipment upgrade. It's an upgrade to the way you think about your roof." Key Features of the Rubicon Platform Patented Thermal Collectors: The NTX-32 thermal collector integrates directly with the RTU, banking 1 to 4 hours of daily thermal storage and up to 72,000 BTUs of supplemental capacity per collector. No battery required, no compromises made. Proudly made in the USA, and it shows. Live Cloud Dashboard + Predictive Diagnostics: Owners and facility managers get real-time performance data, remote diagnostics, proactive maintenance alerts, and energy tracking. Systems get fixed before they fail, not after the building's already sweating. Direct RTU Replacement: Rubicon units are built for fast, frictionless installation as a direct swap for standard commercial rooftop units. Less downtime, lower install costs, zero headaches. 40% Federal Tax Credit Eligibility: Rubicon systems qualify for a 40% federal tax credit under current clean energy incentive programs. That's not a rounding error, that's real money back in your pocket. Zero Out-of-Pocket Financing: NVIRIQ offers no-down-payment financing, so commercial building owners can upgrade today without tying up a dollar of capital. 5-Year “Bumper-to-Bumper” Warranty: Every Rubicon unit is backed by a comprehensive 5-year parts and labor warranty, with parts on hand and short lead times. We stand behind what we build, full stop. First Installations Underway in California and Arizona NVIRIQ's first commercial deployments are already live. Pilot installations are running in Sacramento, CA, on the facility of a local Sacramento-based contractor, and in Phoenix, AZ, at a 20-year-old local printing business near Phoenix Sky Harbor International Airport. Both sites are running the Rubicon 6-Ton RTU and will serve as real-world proof points as NVIRIQ builds out its national footprint. Built for Commercial Building Owners, Property Investors, and Facility Managers The Rubicon platform is purpose-built for owners and operators of commercial office, retail, industrial, QSR, convenience store, and mixed-use properties. It's especially suited for those carrying HVAC operating costs under triple-net or owner-occupied arrangements. NVIRIQ can facilitate the full sales and installation process, backed by a network of trusted, trained contractors. Customers never have to navigate the old-school HVAC procurement maze to get next-generation technology on their roof. "We're making this as easy as possible," added Cooley. "You shouldn't have to be an HVAC expert to get a better system. We handle it end to end, so you can get back to running your business." About NVIRIQ NVIRIQ Inc is a Scottsdale, Arizona-based commercial HVAC technology company built to disrupt how buildings heat and cool. It's built on more than a decade of industry experience and a portfolio of thermal technology. NVIRIQ's Rubicon platform pairs a patented thermal collector with a real-time cloud dashboard to slash energy consumption by 30 to 40%, predict system failures before they happen, and deliver efficiency ratings that redefine commercial climate control. Rubicon RTUs are assembled in the USA, and NVIRIQ's thermal collectors are proudly made in the USA. Innovative by design, pressure-tested by experience, NVIRIQ is setting a new standard in commercial cooling and heating. Learn more at NVIRIQ.com. Media Contact: media@nviriq.com
Think Business, Think Hong Kong Attracts Some 1,600 Business Leaders, Connecting Malaysian Companies to Capital, Expertise and Opportunities KUALA LUMPUR, MALAYSIA - August 12, 2026 (NEWMEDIAWIRE) - The Hong Kong Trade Development Council (HKTDC) today hosted its flagship overseas promotion, Think Business, Think Hong Kong (TBTHK), in Kuala Lumpur, offering Malaysian business leaders direct access to government officials, investors, founders, innovators and professional service providers. The symposium brought together some 1,600 business leaders from Hong Kong and Malaysia for a day of dialogue, networking, business matching and one-on-one consultations. Among them are over 200 government and business leaders, start-up entrepreneurs and professional service providers from Hong Kong, marking a historic high. During the event, over 300 tailored business matching meetings were lined up to help Malaysian companies find the right Hong Kong partners to expand internationally. As businesses navigate shifting global trade dynamics and seek more resilient pathways for international growth, the symposium offered vast opportunities for Malaysian businesses to access capital, diversify their business networks, establish cross-border partnerships and expand into the Guangdong-Hong Kong-Macao Greater Bay Area (GBA), the wider Chinese Mainland and global markets through Hong Kong. The opening ceremony was officiated by Prof Frederick Ma, Chairman of HKTDC, together with The Honourable Algernon Yau, Secretary for Commerce and Economic Development of the Hong Kong SAR Government, and YB Loke Siew Fook, Malaysia's Minister of Transport. In his welcome remarks, Prof Ma said: “Especially at times like these – when businesses are navigating geopolitical uncertainty, evolving supply chains and rapid advances in technology – trusted connections and strong networks are more valuable than ever. First launched in 2011 and held in major cities all around the world, TBTHK has proven to be popular and successful. It is a platform via which networks are expanded, relationships are deepened and new partnerships are forged. Today’s symposium is a timely opportunity to build on the close ties that we have all benefitted from – in so many different and rewarding ways – over the years.” In his opening remarks, Mr Yau said: “For Malaysian companies, the Chinese Mainland is for no doubt a huge market not to be missed. Especially at times like this, everyone is talking about diversification. Apart from strengthening your operations in the local market, it is always good to tap the potentials from overseas markets, including the Chinese Mainland. Hong Kong has the knowhow and expertise to help Malaysian companies to navigate the Chinese Mainland markets. We have been doing it for a long time, and we are good at it. The other way around, we are also supporting Chinese Mainland enterprises to go overseas via Hong Kong. We established the GoGlobal Task Force (Task Force on Supporting Mainland Enterprises in Going Global) last year to provide one-stop, customised support services to facilitate outbound direct investment into overseas markets, including Malaysia and beyond.” In his special remarks, Mr Loke said connectivity Is the precondition for movement of capital and people, with Kuala Lumpur and Hong Kong being under four hours flight apart and sharing the same time zone. “The same logic governs freight. Hong Kong International Airport is among the busiest cargo gateways in the world, while Port Klang sits on one of the most heavily used shipping lanes globally. Malaysia's exports are increasingly electronics, semiconductors and other high-value goods that are time-sensitive and travel by air. Therefore, Hong Kong's depth in logistics, trade finance, arbitration and professional services is the natural complement to that. If your business depends on moving a product from a Malaysian factory to a customer anywhere in Asia, Europe or North America quickly and with the documentation in order, this is a corridor you should be examining closely,” he said. Mr Loke also pointed out that Malaysia wants more events of TBTHK’s calibre to be held in the country, to facilitate business discussions, networking and build foundations for future collaborations. Opening new growth pathways for Malaysian businesses The programme featured a flagship plenary session chaired by Lincoln Pan, Chief Executive Officer of Jardine Matheson Holdings Limited, with heavyweight speakers, including Bonnie Y Chan, Chief Executive Officer of Hong Kong Exchanges and Clearing Limited, Tan Sri Dato’ David Chiu, Chairman and Chief Executive Officer of Far East Consortium International Limited, Daniel R Fung, Senior Counsel, Des Voeux Chambers; Founding Chairman, ASEAN Chamber of Commerce (Hong Kong); Vice Chairman, Financial Services Development Council, Datuk Wira Song Hoi See, Founder and Chief Executive Officer, Plaza Premium Group; Chairman, Malaysian Chamber of Commerce Hong Kong and Macau, and Thomas Tsao, Co-founder and Chair of Gobi Partners, who discussed Asia's evolving business landscape and how companies can position themselves to capture emerging regional opportunities. Reflecting Malaysia's growing strategic importance in ASEAN and the evolving priorities of businesses across the region, four thematic sessions explored key areas of collaboration between Hong Kong and Malaysia. The Capturing RMB Opportunities in Trade, Financing and Investment – Hong Kong’s Strategic Role session, co-organised with the Hong Kong Monetary Authority, explored the growing role of the Renminbi in trade, investment and treasury management. Speakers discussed how Malaysian businesses can leverage Hong Kong's position as the world's leading offshore RMB hub to support regional and Chinese Mainland expansion. The GreenBiz Hong Kong: Driving the Green Transition with Green Finance, Innovation and Cross-Border Collaboration session, supported by the Hong Kong Cyberport Management Company Limited, examined how sustainable growth can be achieved. Participants highlighted opportunities in green finance, climate technology and data-driven solutions as well as Hong Kong's role in connecting green capital and innovation across the region. Following the luncheon, the Strategic Resilience: Capitalising on Hong Kong as a Base for Regional Expansion session, co-organised with Invest Hong Kong, explored how companies can strengthen regional expansion strategies amid a changing global business landscape. Featuring firsthand insights from international tech pioneers, expanding educational operators, and premier regional advisors, this session demonstrated how partnering with Hong Kong provides the structural stability to optimise corporate assets, mitigate geopolitical risk, and accelerate growth across ASEAN and Greater China. The Accelerating the Global Expansion of Life and Health Technology Through Ecosystem Collaboration session, co-organised with the Hong Kong-Shenzhen Innovation and Technology Park, focused on how ecosystem collaboration can accelerate the commercialisation and global expansion of health and biotech innovations. Industry leaders shared insights on leveraging partnerships, talent and innovation networks to scale new technologies internationally. 10 MoUs, over 300 business matching meetings forge new partnerships This year’s TBTHK also witnessed the signing of 10 memoranda of understanding (MoUs), including those signed by various media companies with their respective partners, underscoring growing collaboration between Hong Kong’s services sector and Malaysia’s business community. In addition to the symposium, some 30 Hong Kong service providers and start-ups featured their flagship products and solutions in the exhibition’s Business Support Zone and InnoVenture Salon to create opportunities for collaboration with Malaysian participants. Over 300 one-on-one business consultations and on-site business matching also facilitated deals and cooperation between Malaysian and Hong Kong companies. The Hong Kong Tourism Board also brought a taste of Hong Kong's vibrant culinary culture to TBTHK. Participants had the opportunity to sample signature offerings from Chinesology, Hong Kong's pioneering Muslim-friendly fine-dining Chinese restaurant, and Bar Leone, the first Asian bar to top The World's 50 Best Bars list, highlighting the city's creativity, diversity and world-class hospitality. The Hong Kong Luncheon held during the symposium was hosted by Mr Yau and Malaysia’s Deputy Minister of Finance YB Liew Chin Tong. It was attended by over 300 prominent guests from government and business sectors. This promotion is also part of the Hong Kong SAR Government’s Economic Trade and Express initiative encouraging Hong Kong SMEs and startups to conduct more overseas visits exploring business opportunities, while bringing in more enterprises to invest in and establish businesses in Hong Kong. Event highlight video: https://youtu.be/chRbKeEzF2A Photo Download: https://bit.ly/3TQ7nyL Media enquiries HKTDC’s Kuala Lumpur office: Celine Low Tel: (603) 2381 1061 Email: celine.ps.low@hktdc.org Zeno: Jacqueline Khoo Tel: (6016) 453 8183 Email: jacqueline.khoo@zenogroup.com Sally Lee Tel: (6018) 918 8072 Email: sally.lee@zenogroup.com HKTDC’s Communications & Public Affairs Department: Jane Cheung Tel: (852) 2584 4137 Email: jane.mh.cheung@hktdc.org Sam Ho Tel: (852) 2584 4569 Email: sam.sy.ho@hktdc.org HKTDC Media Room: http://mediaroom.hktdc.com About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via trade publications, research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. View the original release on www.newmediawire.com
LINZ, AUSTRIA - August 11, 2026 (NEWMEDIAWIRE) - Kontron AG, a global leader in IoT technology, announces that all terms and conditions of the offer have been met and that the Foreign Direct Investment (FDI) has already been cleared in Germany. According to Ennoconn Corporation, the closing of the offer will take place on August 20, 2026. There has been no material shift in the shares offered. At the settlement, Ennoconn holds 48.36% of the shares in Kontron AG in accordance with the shareholding notification and will not hold a majority of the voting rights after the completion of the offer. Ennoconn does not plan to further expand its shareholding in Kontron AG. Kontron will remain independent. The existing management will continue to pursue the course of technological leadership and the expansion of the Software and Solutions segment. To this end, it is also planned to push ahead with the cooperation with Foxconn/Ennoconn and thus achieve EUR 40 million in synergies in the medium term. Follow Kontron: Kontron on LinkedIn Current information about Kontron can also be found in the official Kontron Blog About Kontron Kontron AG (www.kontron.com, ISIN AT0000A0E9W5, WKN A0X9EJ, KTN) is a leading IoT technology company. For more than 20 years, Kontron has been supporting companies from a wide range of industries in achieving economic goals with intelligent solutions. From automated industrial operations, smarter and safer transportation to advanced communications, connectivity, medical and energy solutions, the company provides value-added technologies to its customers. Kontron is listed on the SDAX® and TecDAX® of Deutsche Börse and employs around 6,500 people in over 20 countries worldwide. Media Contacts Alexandra Kentros Kontron AG - Communications Phone: +49 (0) 151 151 938 81 group-pr@kontron.com Jan Lauer Profile Marketing OHG Phone: +49 (0) 531 387 33-18 kontron@profil-marketing.com Leon-Philipp Kleiss Kontron AG – Investor Relations Phone: +43 664 60191 5153 ir@kontron.com All rights reserved. Kontron is a trademark or registered trademark of Kontron AG. All data is for information purposes only and not guaranteed for legal purposes. Information in this press release has been carefully checked and is believed to be accurate; however, no responsibility is assumed for inaccuracies. View the original release on www.newmediawire.com
Total capacity expansion: seven new 3D metal printers by September, US manufacturing space up 50% to over 2,100 m(2) 3T Additive Manufacturing awarded “Tech SME of the Year” at the Thames Valley Tech & Innovation Awards 2026 Diversification strategy: SBO strengthens its position in the additive manufacturing market, forecasted to grow from USD 1.5 billion (2025) to USD 4.8 billion (2030) TERNITZ, AUSTRIA - August 11, 2026 (NEWMEDIAWIRE) - SBO AG, listed on the leading index ATX of the Vienna Stock Exchange, is expanding its 3D metal printing capacity in the US and the UK and strengthening its market position in Europe through an award for its subsidiary 3T. Both steps advance SBO's diversification strategy in the growing additive manufacturing market. In the US, SBO has expanded additive manufacturing capacity by adding one VELO XC and two Renishaw 500Q printers for high-performance alloys Inconel and Titanium in Q2 2026. In addition, two more VELO XC printers have been ordered and will be delivered and operational in Q3 2026. In parallel, SBO expands the additive manufacturing space at its Houston, Texas site by 50% to more than 2,100 m². This additional capacity in conjunction with the existing excellence in high-precision post-processing serves rising customer demand from the space, aerospace, defense, semiconductor, energy and other industries. This positions SBO well for the strong growth of the additive manufacturing market from roughly USD 1.5 bn in 2025 to USD 4.8 bn by 2030. SBO is also strengthening its market position in 3D metal printing in Europe. 3T Additive Manufacturing Limited, based in Newbury, UK, has been part of SBO’s Precision Technology division since October 2025 and recently received market recognition: at the Thames Valley Tech & Innovation Awards 2026, 3T was named “Tech SME of the Year”. The jury recognized the team’s technical expertise, its leadership in material and process data, and its continued growth in metal additive manufacturing. In addition, 3T has also expanded its printing capacity by adding another M400 to its fleet of EOS printers in Q2 2026. In Q3 2026, a second printer has also been ordered and will be delivered by the end of the quarter. 3T has also invested further in post-processing equipment. With the acquisition of 3T, SBO expands its customer base in the high-growth industries of space, aerospace, defense and semiconductors. Klaus Mader, CEO of SBO, says: “3D metal printing is a key pillar of our diversification strategy, through which we are broadening our business beyond the oil and gas industry and continuing our transformation into a high-precision technology group. It is an attractive growth market: 3D metal printing is growing significantly faster than our core business and is gaining further momentum. We are capitalizing on that dynamic. We leverage our core capabilities in high-performance materials and high-precision manufacturing, offering the entire value chain from a single source, from printing to post-processing. With the new printers and expanded manufacturing space in the US and the award-winning performance of 3T in Europe, we are expanding where demand is highest: in space, aerospace, defense and semiconductors.” About SBO SBO AG is leading in the manufacture of high-alloy, non-magnetic steels, high-precision components and high-tech equipment for the energy sector and other industrial sectors. The global high-precision technology group, headquartered in Ternitz, Austria, operates worldwide at more than 20 locations with around 1,500 employees. The group delivers cutting-edge technologies backed by a highly innovative product portfolio and strong intellectual property. In its Precision Technology division, SBO specializes in high-precision metal components, ranging from complex steel parts to additive manufacturing solutions for industries requiring maximum accuracy and performance. In the Energy Equipment division, SBO provides high-tech equipment for directional drilling and well completion including high-precision flow control products. Designed for extreme conditions, these solutions perform in high-temperature and high-pressure environments, serving important industries including oil and gas, energy and other industrial sectors. SBO is listed in the leading index ATX of the Vienna Stock Exchange (ISIN AT0000946652). More information: www.sbo.at Contact: Judit Helenyi, Director Investor Relations, SBO AG phone: +43 2630 315 253 email: investor.relations@sbo.at media.relations@sbo.at View the original release on www.newmediawire.com
TALLINN, ESTONIA - August 11, 2026 (NEWMEDIAWIRE) - Iute Group, a leading European personal finance group, has taken another strategic step in expanding the functionality of Myiute, its digital banking platform, with the launch of iuteMarket, an integrated commerce service. By integrating everyday commerce with payments, financing, banking, and insurance in a single digital environment, Myiute continues to evolve as a comprehensive platform for customers’ everyday financial lives. As of the end of the first quarter of 2026, the Group served more than 247,000 active customers, the Myiute app had been downloaded more than 1.75 million times, and Iute cooperated with more than 4,650 active points of sale, providing a strong foundation for further expanding the platform across its markets. Following its launch in Albania and North Macedonia, iuteMarket will be rolled out across Iute’s other markets over time. Allar Niinepuu, Chief Commercial Officer of Iute Group: “Our ambition is for Myiute to become the primary digital interface for our customers’ everyday financial lives. Every new service we introduce strengthens customer engagement, deepens customer relationships, and increases the value of the platform for both users and merchant partners. With iuteMarket, we are expanding Myiute beyond traditional financial services by connecting everyday commerce with financing, payments, and banking in one seamless digital experience. This is another important milestone in our journey toward becoming the preferred digital banking platform for our customers.” Available to all Myiute customers in Albania and North Macedonia, iuteMarket enables customers to discover, finance, and purchase products without leaving the app. The platform offers a broad selection across hundreds of categories, including home appliances, consumer electronics, refurbished devices, beauty and personal care, furniture, and fitness. Customers receive personalized product recommendations and can complete purchases through a seamless digital journey with financing embedded directly into the buying experience. Beyond enhancing the customer experience, iuteMarket expands Iute’s ecosystem for merchant partners. By integrating product discovery, financing, payments, and other everyday financial services into a single customer journey, the platform creates a new digital sales channel and expands merchants’ access to Iute’s growing customer base. Contact: Kristel Kurvits, Group Chief Financial Officer (CFO) Email: investor@iute.com Phone: +372 622 9177 About Iute Group: Iute Group is a digital banking group focused on everyday financial services in Southeast Europe. Established in 2008 and headquartered in Estonia, Iute serves customers in Albania, Bulgaria, Moldova, North Macedonia, and Ukraine. Through the Myiute app and its local operations, Iute provides digital financial services including payments, banking, financing, and insurance intermediation. Iute Group finances its operations through equity, deposits, and secured bonds listed on the Regulated Market of the Frankfurt Stock Exchange and the Nasdaq Baltic Main List. www.iute.com View the original release on www.newmediawire.com
LOS ANGELES, CA - August 11, 2026 (NEWMEDIAWIRE) - The Martial Arts History Museum will be hosting a Movie Screening Marathon for The Match-Stick Flame 1, 2, and 3 this Saturday August 15, 2026 starting at 1:00 pm located at 201 N Brand Blvd B100 Glendale, CA 91203. The Match-Stick Flame 3: Red Mafia, recently released in February 2026, is about Detective Dalton (Craig Bruss), now a Bounty Hunter, who is finishing his assignment given by DEA Agent Prasad (Vineeta Prasad), to take down the remaining Lunada Bay gang members in Rancho Palos Verdes, California. Dalton is a Navy Seal veteran with PTSD who is seeking alternative medicine strategies with karate Sensei Darryl Vidal as well as traditional therapy. However, Dalton has to hunt down the Russian Mob called “Red Mafia” to save Agent Prasad who was taken. Dalton reconnects with Chief Higgins, the Match Stick Mobsters, and Jake in order to rescue Agent Prasad. "The film screening of The Match-Stick Flame 1, 2, and 3 seems like a natural fit since they are action films with mixed martial arts featuring highly experienced actors/martial artists such as Darryl Vidal, known for the “crane kick” in The Karate Kid and playing a referee in Cobra Kai Season 6 ", stated Michael Matsuda, Museum Director. "We are excited to offer this special event for all who want to come to Glendale." The Match Stick Flame movie series attracts enthusiasts of martial arts and cinema, fostering engagement in online streaming services. The Match-Stick Flame 3: Red Mafia underscores the growing intersection of martial arts narratives in media. Moreover, Craig Bruss who wrote all three “The Match-Stick Flame” screenplays, explained that the film explores complex themes such as PTSD and resilience within action frameworks. All three films are now streaming on Amazon Prime, Tubi, YouTube, and Fawesome. The Match-Stick Flame Tubi link: https://link.tubi.tv/ufOgoEMNs0b and The Match-Stick Flame 2: Lunada Bay Tubi link: https://link.tubi.tv/UsW1b0XP7Zb and The Match-Stick Flame 3: Red Mafia Amazon Prime link: https://www.amazon.com/Match-Stick-Flame-Red-Mafia/dp/B0GQCVY219 are attached here for immediate viewing. Please buy tickets at the door (credit cards accepted): $12 for adults, $5 for kids (age 17 and under). Martial Arts History Museum is located at the corner of Brand and Wilson, next to Muay Thai School. Parking: Use the 4-story tower at 222 N. Orange Street ( the first 90 minutes are free). For more Information please call Vineeta Prasad, Executive Producer and Director of The Match Stick Flame 1, 2, and 3, at 813-784-5352 or email at vineetamaryprasad@gmail.com View the original release on www.newmediawire.com
LOS ANGELES, CA - August 11, 2026 (NEWMEDIAWIRE) - Greenland Mines (NASDAQ: GRML) announced that drilling has commenced at its Skaergaard gold, palladium and platinum project in southeast Greenland following the arrival of its support vessel Argus and successful mobilization of equipment and infrastructure ashore. Diamond drill rigs supplied and operated by Nordisk Fundering, including two new heli-portable units, have been assembled and are operating, with the first holes expected to be completed within days. Initial LiDAR drone surveys have also been completed, approximately one-third of planned drill locations have been identified and marked and the Sodalen airstrip has been confirmed operational. The 2026 field program is designed to support further upgrading of the Skaergaard Mineral Resource, advance metallurgical and engineering studies through bulk sampling and generate environmental, geotechnical and infrastructure data needed to move the project toward an Initial Assessment and its next phase of development. Greenland Mines said the team is positioned to execute the program over the coming two months with Argus on site, equipment ashore and drilling underway. To view the full press release, visit https://ibn.fm/1LRbQ About Greenland Mines Greenland Mines Ltd. is a Nasdaq-listed company with two operating divisions: (1) Mining, focused on the exploration and development of the Skaergaard Project in southeast Greenland and, subject to closing of the previously announced transaction, the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland; and (2) Biotech, including Klotho’s KLTO‑202 primary indication for ALS. The Company’s strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
Veteran Compliance, Finance, and Capital Markets Leaders Join as the Company Scales Its Digital Asset Advisory CHICAGO, IL - August 11, 2026 (NEWMEDIAWIRE) - Prime Ledger today announced three senior appointments as the company enters its next phase of growth. Lesley O’Neill joins as Chief Risk and Compliance Officer, and Ankur Rakshit joins as Chief Financial Officer, strengthening the company’s operating team across risk, regulatory, and financial functions. Separately, Chuck Thompson has been appointed to Prime Ledger’s Board of Directors. The appointments bring Prime Ledger decades of combined experience across regulated financial services, digital assets, and global capital markets at a moment when institutional expectations for compliance rigor and financial discipline in the sector have never been higher. “Building durable infrastructure in this industry demands more than technology; it demands people who have operated inside the most heavily scrutinized institutions in finance and know how to build for that standard from day one,” said Robert Hoffman, Chief Executive Officer and Co-Founder of Prime Ledger. “Lesley, Ankur, and Chuck each bring exactly that. Together they give us the depth to scale responsibly and the credibility to earn the trust of partners, regulators, and clients.” Lesley O’Neill, Chief Risk & Compliance Officer Lesley O’Neill brings more than 15 years of experience across fintech, digital assets and Web3, and artificial intelligence. A New York–admitted attorney and seasoned chief compliance officer, she has deep expertise building bank-grade BSA/AML, enterprise risk, and data protection programs, driving corporate governance, and scaling operational frameworks. O’Neill joins Prime Ledger from Binance.US, where she served as Chief Compliance Officer overseeing the exchange’s AML/KYC, antifraud, internal audit, and risk management programs. She served on the exchange’s Listings Committee and supported banking partner relationships, and most recently led preparedness for the launch of its new CFTC-regulated products as the primary compliance liaison with the regulator. Prior to Binance.US, O’Neill spent five years as Chief Compliance Officer, and interim General Counsel, at Prove Identity, where she stood up a global compliance program through three acquisitions and IPO readiness. Earlier in her career, she led global cybersecurity policy at Bloomberg and served as Global Privacy Counsel at EY. She is a Certified Information Privacy Professional (CIPP/E). At Prime Ledger, O’Neill will lead risk and compliance across the organization. “What drew me to Prime Ledger is a leadership team that treats compliance as core infrastructure rather than an afterthought,” said O’Neill. “The combination of digital assets, financial services regulation, privacy, and security is where the hardest problems in this industry live, and it’s where I’ve spent my career. I’m looking forward to building a program that scales with the business.” Ankur Rakshit, Chief Financial Officer Ankur Rakshit is an executive finance and operations leader with nearly two decades of experience scaling high-growth Web3 protocols, digital asset exchanges, and Wall Street institutions, including Citigroup, American Express, Fidelity Investments, and Kraken. As a founder, CFO, and seasoned operator, Rakshit has built and led high-performing FP&A, strategic finance, and global treasury functions from the ground up, guiding organizations through periods of rapid scaling, complex capital allocation, and strategic expansion. His expertise spans long-range financial planning, capital markets, process optimization, AI-augmented financial operations, and corporate development and execution; enabling companies to build sustainable, scalable financial foundations while maintaining operational discipline and driving long-term value creation. Rakshit holds an MBA in Finance & Strategy from Cornell University and a background in computer science engineering, combining technical depth with data-driven executive leadership. “The companies that endure in this market are the ones that pair ambition with financial discipline,” said Rakshit. “Prime Ledger has the former in abundance, and I’m joining to help build the latter, a finance function that gives the team real visibility, real optionality, and the foundation to scale for the long term.” Chuck Thompson, Board of Directors Chuck Thompson brings 30+ years of leadership across investment management and financial services, with deep experience in corporate strategy, board governance, fund trusteeship, product development, and mergers and acquisitions. Thompson’s governance experience, distribution expertise, and track record of executing and integrating strategic acquisitions will support Prime Ledger’s board as the company expands its advisory and institutional relationships. “I have spent three decades in asset management where infrastructure evolves quickly, and the shift underway now in digital assets is as consequential a trend as anything I have seen,” said Thompson. “Prime Ledger is building with high integrity and discipline, the governance standards that institutional allocators will require, and I am glad to join the board to help be a resource and sounding board for that important work.” About Prime Ledger Prime Ledger is the full-service digital asset firm for real-world assets. Headquartered in Chicago, the company guides asset owners from initial structuring through regulated issuance and into ongoing management; replacing the five or more fragmented vendors that digital assets typically require with a single, accountable partner. Prime Ledger’s lifecycle infrastructure spans advisory and legal structuring, digital asset engineering, regulated distribution, and ongoing compliance, reporting, and asset management, delivered through its Prime Path framework across four core verticals: real estate, hospitality, sports and entertainment, and investment firms. Learn more at primeledger.io. Media Contact: Head of Marketing Jacquie Lane jacquie.lane@primeledger.io View the original release on www.newmediawire.com
FDA Approval of Replimune's Intratumoral Therapy in Combination With Checkpoint Inhibition Reinforces Growing Momentum Behind Tumor-Directed Approaches Designed to Enhance Anti-Tumor Immune Response ATLANTA, GA - August 11, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and solid tumors, today highlighted the recent U.S. Food and Drug Administration (FDA) accelerated approval of Replimune Group, Inc.’s TUDRIQEV™ (formerly RP1) in combination with nivolumab as an important milestone in the evolution of intratumoral cancer immunotherapy. The FDA approved TUDRIQEV in combination with nivolumab for adults with unresectable advanced cutaneous melanoma whose disease has progressed following prior anti-PD-1 therapy. The approval followed a favorable FDA Advisory Committee recommendation and represents an important regulatory milestone for localized tumor-directed therapies used in combination with immune checkpoint inhibitors (ICIs). While TUDRIQEV and GeoVax’s investigational solid tumor therapy Gedeptin® employ different mechanisms of action to achieve tumor cell killing, GeoVax believes the approval reinforces a broader therapeutic paradigm: local destruction of tumor masses may modify the tumor microenvironment and potentially enhance immune responses both within directly treated tumors and at distant tumor sites. “This approval represents an important milestone that extends well beyond any individual product,” said David A. Dodd, Chairman and Chief Executive Officer of GeoVax. “It provides clinical and regulatory precedent for locally administered therapies used in combination with checkpoint inhibition. We believe this represents an increasingly important direction for cancer immunotherapy.” Overcoming the “Cold Tumor” Barrier Earlier this year, Mr. Dodd outlined this emerging concept in an Onco’Zine commentary entitled The Cold Tumor Barrier: Why Promising Oncology Therapies Fail In Vivo – and What It Will Take to Overcome It (Onco'Zine Cold Tumor Barrier). The article describes immunologically “cold” tumors - characterized by limited T-cell infiltration, poor antigen presentation and an immunosuppressive tumor microenvironment - as a fundamental barrier limiting the effectiveness of checkpoint inhibitors and other immunotherapies. The article argues that durable advances in immuno-oncology may increasingly depend upon therapies capable of priming the tumor microenvironment and converting immunologically “cold” tumors into immune-responsive “hot” tumors, thereby creating the biological conditions necessary for checkpoint inhibitors to function more effectively. GeoVax believes Gedeptin® represents a differentiated approach to this emerging therapeutic paradigm. Unlike replication-dependent oncolytic viruses, Gedeptin utilizes a gene-directed enzyme prodrug therapy (GDEPT) approach in which a replication-deficient adenoviral vector delivers a bacterial enzyme, purine nucleoside phosphorylase (PNP), directly into tumor tissue. Following administration of fludarabine phosphate, the enzyme converts the inactive prodrug into a potent cytotoxic metabolite within the tumor microenvironment, producing localized tumor destruction and a demonstrated preclinical bystander effect extending beyond directly transduced tumor cells, while promoting anti-tumor immune responses. Importantly, GeoVax believes Gedeptin’s potential therapeutic value extends beyond localized cytotoxicity. Published Evidence Supporting Tumor Priming and Checkpoint Inhibitor Synergy In recently published research in JCI Insight, Gedeptin combined with anti-PD-1 therapy in an immunocompetent preclinical model demonstrated enhanced anti-tumor immune responses, increased CD8+ T-cell infiltration, systemic anti-tumor activity and improved therapeutic outcomes compared with checkpoint inhibition alone. These findings provide scientific support for the thesis that Gedeptin may function as a tumor-priming immunotherapy, using localized tumor destruction and immune activation to help transform immunologically resistant tumors into tumors more responsive to checkpoint inhibition. “The objective is not simply to destroy tumor cells locally,” said Kelly McKee, M.D., Chief Medical Officer of GeoVax. “The greater opportunity is to initiate the immune recognition necessary for checkpoint inhibitors to work more effectively. These findings demonstrate Gedeptin’s potential to combine extensive localized tumor killing with immune activation, creating a more favorable tumor microenvironment for checkpoint inhibition.” A Converging Immuno-Oncology Strategy GeoVax believes several recent developments now point toward a converging therapeutic strategy within immuno-oncology: Regulatory precedent: FDA accelerated approval of TUDRIQEV plus nivolumab establishes an approved intratumoral immunotherapy/checkpoint inhibitor combination for patients with advanced melanoma following anti-PD-1 therapy. Scientific evidence: The JCI Insight publication provides preclinical evidence that Gedeptin can enhance anti-tumor immune activity and checkpoint inhibitor responsiveness. Tumor-priming strategy: Growing scientific understanding of the “cold tumor” barrier supports approaches designed to modify the tumor microenvironment before or in conjunction with checkpoint inhibition. Gedeptin is mechanistically distinct from TUDRIQEV. Rather than relying on viral replication and oncolysis, Gedeptin is designed to generate potent cytotoxic activity directly within the tumor through enzyme-directed prodrug activation, with a substantial bystander effect capable of extending tumor killing beyond cells directly reached by the vector. GeoVax believes this differentiated mechanism has the potential to position Gedeptin as a tumor-priming immunotherapy designed to enhance the effectiveness of established immunotherapies, rather than simply as another intratumoral therapy. The Company is continuing preparations for the next phase of Gedeptin’s clinical development in combination with pembrolizumab for patients with head and neck squamous cell carcinoma. The planned study is expected to evaluate clinical activity together with biomarkers of immune activation, tumor microenvironment modulation and pathological tumor response. “The FDA approval of an intratumoral therapy combined with checkpoint inhibition reinforces a therapeutic direction that we believe has significant potential,” concluded Mr. Dodd. “Our objective with Gedeptin is to address one of the fundamental barriers limiting immunotherapy - the inability of immunologically cold tumors to generate an effective anti-tumor immune response. Our published science provides an important foundation for that strategy, and we believe Gedeptin’s differentiated mechanism warrants continued clinical development.” About Gedeptin® Gedeptin® is GeoVax’s investigational gene-directed enzyme prodrug therapy (GDEPT) for the treatment of solid tumors. The therapy utilizes a replication-deficient adenoviral vector to deliver the bacterial enzyme purine nucleoside phosphorylase (PNP) directly into tumors. Following administration of fludarabine phosphate, the PNP enzyme converts the inactive prodrug into a potent cytotoxic metabolite within the tumor microenvironment, producing localized tumor cell death while promoting anti-tumor immune responses. Gedeptin is being developed in combination with immune checkpoint inhibitors for the treatment of solid tumors. About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company focused on the development of vaccines and immunotherapies addressing high-consequence infectious diseases and solid tumor cancers. GeoVax’s priority program is GEO-MVA, a Modified Vaccinia Ankara (MVA)–based vaccine targeting mpox and smallpox. The program is advancing under an expedited regulatory pathway, with plans to initiate a pivotal Phase 3 clinical trial in the second half of 2026, to address critical global needs for expanded orthopoxvirus vaccine supply and biodefense preparedness. In oncology, GeoVax is developing Gedeptin®, a gene-directed enzyme prodrug therapy (GDEPT) designed to enhance immune checkpoint inhibitor activity. Gedeptin has completed a multicenter Phase 1/2 clinical trial in advanced head and neck cancer and is being advanced into combination strategies, including planned neoadjuvant and first-line settings. GeoVax maintains a global intellectual property portfolio supporting its infectious disease and oncology programs and continues to evaluate strategic partnerships and funding opportunities aligned with its development priorities. For more information, visit www.geovax.com. Forward-Looking Statements This release contains forward-looking statements regarding GeoVax’s business plans. The words “believe,” “look forward to,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax’s immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax’s immuno-oncology products and preventative vaccines will be safe for human use, GeoVax’s vaccines will effectively prevent targeted infections in humans, GeoVax’s immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax’s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Company Contact: info@geovax.com 678-384-7220 Media Contact: Jessica Starman media@geovax.com
VANCOUVER, BC - August 11, 2026 (NEWMEDIAWIRE) - North Atlantic Titanium Corp. (CSE: NATO) (OTCQB: NATQ.F) (FSE: Y33) (“North Atlantic Titanium” or the “Company”) is pleased to announce that it will be attending the U.S. Defense Industrial Base Accelerator 2026 (DIBX) event in Philadelphia on August 25-27. The main focus and core theme for DIBX 2026 is "Revolutionizing Defense Investment," targeting supply chain resilience, manufacturing capacity, and a live $25M pitch competition. The Company is a member of the Defense Industrial Base Consortium (“DIBC”), a collaborative initiative focused on advancing secure, innovative, and resilient solutions for the defense industrial base. Membership in the DIBC allows the Company to participate and provide an opportunity to engage directly with the Office of the Assistant Secretary of War for Industrial Base Policy (OASW(IBP)) during the Defense Industrial Base Accelerator 2026 (DIBX) event in Philadelphia August 25-27. OASW(IBP) will be hosting a series of networking sessions during the event, which are designed to strengthen collaboration, accelerate innovation, and expand connections across the growing Defense Industrial Base (DIB). The primary focus and key initiatives are to Fuel the Arsenal of Freedom by rebuilding and expanding the Defense Industrial Base, Procure Industry-Driven Solutions that meet warfighter needs with speed and agility, and strengthening collaboration and innovation across the defense ecosystem by removing barriers, and building a more robust and resilient industrial base. Dwayne Yaretz, CEO and Director of North Atlantic Titanium, stated: “Attending the Defense Industrial Base Accelerator (DIBX) reflects North Atlantic Titanium’s commitment to contributing to secure resilient North American critical-mineral supply chains. Titanium, vanadium, and phosphate each have important industrial and strategic applications, and the Company looks forward to presenting opportunity for technical collaboration, supply-chain discussions, and potential future critical-mineral opportunities.” About the Defense Industrial Base Consortium The U.S. Department of War’s Warfighting Investments, Resourcing, and Execution (WIRE) directorate established the DIBC OTA to enable rapid research, access to commercial solutions for defense requirements, and innovations from industry, academia, and non-traditional contractors. DIBC members focus on identifying, developing, and testing cutting-edge capabilities at the speed of innovation. The DIBC is managed by Advanced Technology International (“ATI”), which serves as the consortium manager. According to ATI, the DIBC aims to diversify and expand the defense industrial base and enable small and non-traditional businesses to work with government and access research and prototyping teaming opportunities. The DIBC OTA enhances WIRE’s mission of addressing defense supply chain issues, developing the industrial workforce, sustaining critical production, commercializing Research and Development (R&D) efforts, and rapidly scaling emerging technologies to build a robust, resilient defense industrial base. Membership in the DIBC does not imply U.S. Government endorsement, project approval, funding, or the award of any contract or agreement. About North Atlantic Titanium Corp. North Atlantic Titanium Corp. is focused on developing the Everett titanium-vanadium project in Québec, targeting the production of high-quality titanium feedstocks with potential value-added vanadium and phosphate coproducts. The Company also holds a 100-per-cent interest in the Sleeping Giant South gold project, located in the Abitibi greenstone belt, approximately 75 kilometres south of Matagami, Que. For more information, please visit our website at www.natitanium.com. ON BEHALF OF THE BOARD OF DIRECTORS Dwayne Yaretz, CEO North Atlantic Titanium Corp. Phone: 778-709-3398 Email: info@natitanium.com Website: www.natitanium.com Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release contains certain statements which constitute forward-looking statements or information under applicable Canadian securities laws. Such forward-looking statements are subject to numerous known and unknown risks, uncertainties and other factors, some of which are beyond North Atlantic Titanium’s control, which could cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. These risks and uncertainties include general economic and capital markets conditions, stock market volatility. Although North Atlantic Titanium believes that the forward-looking statements in this news release are reasonable, they are based on factors and assumptions, based on currently available information, concerning future events, which may prove to be inaccurate. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future plans, operations, results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, North Atlantic Titanium does not undertake any obligation to publicly update or to revise any of the forward-looking statements, whether as a result of new information, future events or otherwise. The securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent U.S. registration or an applicable exemption from the U.S. registration requirements. This news release does not constitute an offer for sale of securities, nor a solicitation for offers to buy any securities. View the original release on www.newmediawire.com
Certification Provides Key Step for the Company Towards Commercializing Internationally and Offering a New Opportunity for Revenue Growth Achievement Highlights the Company's Robust Quality System and Strong Compliance Capabilities EDEN PRAIRIE, MINN. - August 11, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announced it has received ISO 13485-2016 certification. ISO 13485 is the international standard for Quality Management Systems in the Medical Device Industry; with particular emphasis on risk management, design controls, and continuous improvement. In achieving this certification, NeuroOne has demonstrated the continued capability to ensure safe product design, quality and traceability in manufacturing, and compliance with regulatory requirements; thereby reducing the likelihood of product failures. Specific to NeuroOne, the certification includes the design and development, manufacture and distribution of electrosurgical generators and electrosurgical lesioning instruments, as well as diagnostic neurophysiological instruments, anchor bolts, and cable assemblies used for recording, monitoring, stimulation, and radiofrequency lesioning of nervous system tissue. This certification will allow the Company to pursue international marketing opportunities for the Company’s Evo® Cortical and Evo® sEEG Electrodes, as well as the OneRF® Brain Ablation System. Some geographies may have additional requirements before the Company can commercialize the products. “Yet again, the team at NeuroOne delivers on another critical milestone earlier than planned," said Dave Rosa, President and Chief Executive Officer of NeuroOne. "We are excited to have received ISO 13485 certification as it opens the door for international revenue growth. While we have other technologies to help accelerate growth, this provides us nearer term revenue potential. We will begin working with our distribution partner, Zimmer Biomet, to formulate a plan for entering markets that have short-term paths to entry. For those geographies that are currently held solely by NeuroOne, we will also explore independent distributor partnerships. We hope to add to this certification as we execute on our current technologies in development.” About NeuroOne NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne markets a minimally invasive and high-definition/high-precision electrode technology platform with four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering diagnostic and therapeutic functions. The Company is engaged in research and development for drug delivery, basivertebral nerve ablation and spinal cord stimulation programs. For more information, visit nmtc1.com. Forward Looking Statements This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Except for statements of historical fact, any information contained in this press release may be a forward–looking statement that reflects NeuroOne’s current views about future events and are subject to known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. In some cases, you can identify forward–looking statements by the words or phrases "may," "might," "will," "could," "would," "should," "expect," "intend," "plan," "objective," "anticipate," "believe," "estimate," "predict," "project," "potential," "target," "seek," "contemplate," "continue, "focused on," "committed to" and "ongoing," or the negative of these terms, or other comparable terminology intended to identify statements about the future. Forward–looking statements may include statements regarding potential international expansion, both through our distribution partner Zimmer Biomet and the potential to explore independent distributor partnerships, the ability to receive revenue in the short term for international sales, and the ability to add to the current certification. Although NeuroOne believes that we have a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain. Our actual future results may be materially different from what we expect due to factors largely outside our control, our partnerships may not facilitate the commercialization or market acceptance of our technology; whether due to supply chain disruptions, labor shortages, risks that our technology will not perform as expected based on results of our pre-clinical and clinical trials; risks related to uncertainties associated with the Company's capital requirements to achieve its business objectives and ability to raise additional funds: the risk that we may not be able to secure or retain coverage or adequate reimbursement for our technology; uncertainties inherent in the development process of our technology; risks related to changes in regulatory requirements or decisions of regulatory authorities; that we may not have accurately estimated the size and growth potential of the markets for our technology; risks related to our ability to protect our intellectual property rights; and other risks, uncertainties and assumptions, including those described under the heading "Risk Factors" in our filings with the Securities and Exchange Commission. These forward–looking statements speak only as of the date of this press release and NeuroOne undertakes no obligation to revise or update any forward–looking statements for any reason, even if new information becomes available in the future. IR Contact MZ Group – MZ North America NMTC@mzgroup.us View the original release on www.newmediawire.com
NEW YORK, NY - August 11, 2026 (NEWMEDIAWIRE) - Synbio International, Inc. (OTC: SYIN) today marks a significant milestone in its evolution. After an extended period focused on corporate restructuring, strategic partnerships, and business development, the Company is now entering commercial operations with the launch of its Healing Force™ nutraceutical division and first consumer product. Company Begins Executing Revenue Generation Strategy through First Commercial Product Launch The launch marks Synbio's transition from a development-stage company to an operating business. It also reflects the Company's strategy of combining near-term revenue generation through commercial wellness products with the long-term value creation potential of its AI-driven healthcare technologies. The first product to be offered under the Healing Force™ brand will be Healing Force™ Anxiety Relief, a natural wellness formulation designed to support individuals seeking non-pharmaceutical approaches to managing everyday stress and anxiety. Unlike pharmaceutical products, nutraceuticals can be brought to market without lengthy pre-market approval processes, allowing Synbio to commercialize developed formulations and pursue near-term revenue opportunities rapidly. "This announcement represents much more than the launch of a single product," said Claudio Solitario, Chief Executive Officer of Synbio International. "It marks Synbio's transition into an operating company and the beginning of a strategy designed to create sustainable long-term shareholder value through multiple revenue streams. "We are launching Healing Force™ at a time when the global nutraceuticals market is experiencing extraordinary growth. With the market expected to grow from approximately US$684 billion today to more than US$1.1 trillion by 2033, driven by increasing consumer demand for preventative healthcare and natural wellness products, we believe Synbio is entering this sector at exactly the right time. "The Healing Force™ operations are expected to serve as a foundation for future product expansion, with additional wellness formulations currently under evaluation for potential commercialization. After years of laying the foundation, today we begin building the business.” Building a Diversified Wellness and Healthcare Platform Synbio is building a diversified healthcare company that combines medical technologies with science-based wellness products. By balancing near-term commercial opportunities with longer-term technology development, the Company believes it can create multiple sources of revenue and sustainable growth. The Company continues to advance its healthcare technology initiatives, including the validation of the FacialDx Inc. facial analysis platform for mental health, while simultaneously developing wellness products. Management believes this dual-track strategy provides opportunities for both near-term revenue generation and long-term value creation. Experienced Medical and Scientific Leadership The Healing Force™ product line has been developed under the guidance of Dr. David Anderson, M.D. Dr. Anderson has spent decades developing, evaluating and scientifically validating nutraceuticals, wellness products and related healthcare technologies. His experience spans medical research, product development and scientific substantiation, providing Synbio with a strong scientific foundation for its expanding Healing Force™ product portfolio. He previously served as a Research Physician and Senior Research Scientist and has coordinated numerous medical and scientific research programs involving academic institutions, physicians, government agencies, and commercial organizations. "Consumers are increasingly seeking evidence-based wellness solutions that support healthy lifestyles," said Dr. Anderson. "Our goal is to develop products grounded in scientific principles while addressing growing consumer demand for natural approaches to stress management and emotional well-being." Capital-Efficient Commercialization Strategy To maximize capital efficiency, Synbio plans to initially market and distribute Healing Force™ products through direct-to-consumer online channels. Initially, Synbio will commercialize Healing Force™ through direct-to-consumer online sales supported by targeted digital marketing and e-commerce initiatives. Management believes this capital-efficient model will enable the Company to scale rapidly while preserving financial flexibility as additional products are introduced. About Synbio International Inc. Synbio International Inc (SYIN) is a company focused on clinically validating an AI-driven software that will screen for mental health conditions using facial analysis. Through strategic partnerships and research collaborations, Synbio aims to help develop and validate science-based solutions that improve the quality of life and empower healthcare providers. To generate early revenue while its software advances through validation, Synbio plans to launch a line of nutraceutical products sold directly to consumers online in 2026. For inquiries, please contact: Synbio International Inc. info@synbiointl.com (646) 359-4854 www.synbiointl.com Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements in this press include, among others, statements about our renegotiated settlement agreement. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans, and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our limited operating history; our dependence on third parties for many aspects of our business; general market and economic conditions; technical factors; the availability of outside capital; our receipt of revenues; legislative developments; changes in our expenditures and other uses of cash; our ability to find, recruit and retain personnel in sufficient numbers to support our growth; our ability to manage growth; and general market, economic and business conditions. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. View the original release on www.newmediawire.com
VANCOUVER, BC - August 11, 2026 (NEWMEDIAWIRE) - Andina Copper Corporation (TSX-V: ANDC | FSE: FIR | OTCQB: PMMCF) is pleased to report additional outstanding drill results from its large-scale Cobrasco Porphyry Copper-Moly Discovery in Choco, Colombia. Andina Copper is in the early stages of a systematic, wide-spaced scout drilling programme using substantial step-outs to delineate the lateral extent and limits of this exciting new discovery. Hole CDH010, collared from the same drill pad as CDH006 - CDH009 (refer 24 June 2026 News Release) and drilled to the WSW, intersected a strongly mineralized upper interval commencing at 36m and extending to 540m downhole. Moderate to lower grade mineralization continues at depth to approximately 820m downhole. The hole was terminated at a final depth of 844.65m. Hole CDH010 further extends and confirms the continuity of shallow Cu–Mo mineralization within the central portion of the Cobrasco system. HIGHLIGHTS: 504m @ 0.48% Cu, 37ppm Mo from 36m Incl. 264m @ 0.63% Cu, 35ppm Mo from 36m and 36m @ 0.62% Cu from 486m 84m @ 0.40% Cu, 91ppm Mo from 660m Incl. 44m @ 0.45% Cu, 120ppm Mo from 700m - An additional drillhole (CDH011) has been completed from the same pad as CDH006-CDH010 (Figure 1, Pad 3), and multiple holes have recently been drilled from a large step-out position located 350m to the NW. Results are pending. - A mineralized footprint of approximately 1,200m by 550-700m has been delineated from the initial 10 diamond drillholes reported to date for approximately 11,000m, and the system remains wide open in multiple directions. Joseph van den Elsen, Andina Copper President and CEO stated: “Andina Copper continues to systematically advance its wide spaced scout drilling programme, with hole CDH010 returning another high grade near surface intercept. Every hole completed from this platform has intersected long runs of shallow copper mineralization, underlining the exceptional continuity of the Cobrasco system. "The drill defined footprint of the Cobrasco mineralized porphyry system now measures approximately 1,200m x 550-700m and remains open in all directions. With results from CDH011 imminent, and drilling continuing from a new platform 350m to the NW, we look forward to a continuing steady flow of results and the systematic expansion of the Cobrasco Deposit." Figure 1: Cobrasco Project plan view - copper soil geochemistry and drillhole traces with downhole Cu assays. CDH010 intercepts as labelled; CDH011 results pending; mineralization open in multiple directions. Figure 2: Cobrasco cross section (looking East) showing CDH010 downhole Cu assays and adjacent drillholes from Pads 1, 3 and 4. CDH011 completed, results pending. Geology and Mineralization - Drillhole CDH010 Hole CDH010 was collared from the same drill pad as CDH006 - CDH009 (and subsequent hole CDH011). It was drilled WSW to bisect the wide untested area between CDH006 and CDH009 and to test the continuation of shallow mineralization previously intersected from this collar position. All holes completed thus far from this pad have intersected consistent intervals of shallow, continuous moderate to high grade Cu-Mo mineralization beginning immediately below the base of oxidation. Hole CDH010 (Az: 260 degree Dip: -60 degree Depth: 844.65m) was the fifth hole drilled from this drill pad, designed to test approximately 410m horizontally and 735m vertically. The hole intersected a supergene-leached zone extending to approximately 36m downhole. From the base of this zone to approximately 54m downhole, moderate supergene chalcocite enrichment occurs as coatings on pyrite and chalcopyrite. Below the supergene-enriched zone, significant hypogene chalcopyrite mineralization continues to approximately 322m downhole as disseminations and veinlets hosted by rhyolite porphyries and subordinate daci-andesitic porphyries, microdiorite, and magmatic-hydrothermal breccias. Magmatic-hydrothermal breccias and adjacent structurally controlled zones between 186m and 312m downhole host the highest copper grades intersected in the hole, including 60m @ 0.74% Cu from 186m and 20m @ 1.18% Cu from 216m. Figure 3: Hole CDH010 core photography from the high grade magmatic-hydrothermal breccia zone. Top: 231.00m, magmatic-hydrothermal breccia with predominance of diorite fragments and infill of chalcopyrite cement, sericite-illite altered (4.47% Cu, 35ppm Mo). Bottom: 240.10m, magmatic-hydrothermal breccia with fragments of diorite and quartz-eye porphyries, rhyolitic matrix with chalcopyrite-molybdenite-silica-sericite cement (0.51% Cu, 167ppm Mo). Below 322m, mineralization continues at moderate grades within rhyolite porphyries and magmatic-hydrothermal breccias, including 36m @ 0.62% Cu from 486m. At greater depth, molybdenite-bearing B-type quartz veins occur within an interval returning 84m @ 0.40% Cu and 91ppm Mo from 660m. In broad terms, the rhyolite porphyries intrude the intermediate-composition daci-andesitic porphyries and microdiorites. The highest copper grades in CDH010 are associated with intense white sericite–illite alteration, particularly within magmatic-hydrothermal breccias intersected between 216m and 296m downhole. Representative core photography from this zone is shown in Figure 3, and the regional context of the Cobrasco district, including the Southern Block, is shown in Figure 4. Figure 4: Cobrasco district soil geochemistry (Cu ppm) with +200ppm Cu soil anomaly outlines, Cobrasco Northern and Southern Blocks (Rio Tinto Comita Project block shown for reference). The Company’s Corporate Presentation is available at: Andina Copper Corporate Presentation Interested parties can subscribe to our mailing list and follow our social media channels in the links below: Mailing List | Andina Copper LinkedIn | Andina Copper X ON BEHALF OF THE BOARD Joseph van den Elsen President & Chief Executive Officer joseph@andinacopper.com Jordan Webster VP – Technical Communications jordan@andinacopper.com QUALIFIED PERSON Gustavo Zulliger, a consultant of Andina Copper Corp and a “qualified person” (“QP”) within the definition of that term in National Instrument 43-101, Standards of Disclosure for Mineral Projects, has reviewed and approved the technical information contained in this news release. Gustavo Zulliger is a Certified Professional Geologist with the American Institute of Professional Geologists (CPG #11165). QAQC CDH010 was collared with a PQ size drill string to a depth of 180.50m and continued with HQ/HQ3 to a final depth of 844.65m. In all cases the drill core was extracted from the core barrel by the drill contractor under the supervision of Andina Copper personnel and placed in core boxes with appropriate depth markers (core blocks) and padding added for extra protection during transport. Full core boxes were then strapped closed before being transported by helicopter and pickup truck to the Cobrasco core cutting facility in Quibdó. The drill core was cleaned where required, marked-up and photographed, prior to undergoing geotechnical and geological logging. All core segments were cut by diamond saw by Andina Copper technicians, other than the top saprolite intervals that could be cut and sampled using hand tools. All sampling was conducted in nominal 2m intervals with cut-lines marked by the supervising geologists to ensure representative sampling. Samples were placed in plastic bags with non-repeatable sample tags and bagged in polyweave sacks ready for transport. The core trays with the remaining half-core are stored at the Andina Copper facility in Quibdo for ongoing geotechnical (Terraspec spectral analysis, magnetic susceptibility readings, rock density measurements) and follow-up detailed geological logging. From Quibdo, core samples were sent to the ALS sample preparation facility in Medellin, an accredited laboratory which is independent of the Company. Prepared sample pulps were then forwarded to the ALS laboratory in Lima, Peru for gold (Au-AA23), multi-elements (ME-MS61), and “overlimits” analysis (ME-OG62 including copper Cu-OG62). Coarse and fine rejects are routinely returned by ALS Medellin for storage at the Andina Copper storage facility. Table 1: Cobrasco Project – Significant Drill Intercepts Table 2: Cobrasco Project – Drill Collar Parameters (WGS84, UTM Zone 18N) ABOUT ANDINA COPPER Andina Copper Corporation is a unique South America-focused copper explorer listed on the TSX Venture Exchange (TSXV:ANDC), Frankfurt (FSE: FIR), and OTC (OTCQB: PMMCF) exchanges. The Company holds two significant discoveries along the world’s premier copper producing Andean porphyry belt in Argentina and Colombia, and a compelling undrilled copper-gold target in the prolific copper production district of the Coastal Cordillera of Chile. FORWARD-LOOKING STATEMENT This news release contains certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical fact, that address events or developments that Andina Copper expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects" and similar expressions, or that events or conditions "will" or "may" occur. These statements are subject to various risks. Although Andina Copper believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are no guarantee of future performance, and actual results may differ materially from those in forward-looking statements. Neither the TSXV nor the Canadian Investment Regulatory Organization accepts responsibility for the adequacy or accuracy of this release.
TORONTO, ON - August 11, 2026 (NEWMEDIAWIRE) - Silver Crown Royalties Inc. (Cboe: SCRI, OTCQX: SLCRF, BF: QS0) (“Silver Crown”, “SCRi”, the “Corporation”, or the “Company”) is pleased to announce the release of its financial results for the quarter ended June 30, 2026. The company has filed its unaudited interim condensed consolidated financial statements, along with management’s discussion and analysis, for the quarter ended June 30, 2026 on SEDAR+ (www.sedarplus.ca) and will be uploading these filings to its website today. All amounts are in Canadian dollars, unless otherwise indicated. FIRST QUARTER FINANCIAL AND CORPORATE HIGHLIGHTS: - Record Quarterly Revenue: Generated $1,867,056 in royalty revenue for the three months ended June 30, 2026, representing a 598% increase compared to $267,350 in Q2 2025, and nearly triple the $665,854 generated in Q1 2026. The increase was primarily driven by growing royalty income from the Igor 4 royalty in Peru. - New Royalty Acquisition: Effective June 30, 2026, the Company acquired two existing privately held 1% net smelter return royalties (a cumulative 2% gross smelter return royalty) on Titiminas Silver Inc.'s Madre Sierra deposit in Jauja, Peru, for cash consideration of US$6,000,000 paid at closing, with an additional US$2,000,000 payable upon receipt of the first payment under the royalties. - Growth initiatives: Effective April 15, 2026, the Company closed a non-brokered private placement with two strategic investors, issuing 321,429 shares at a price of $14.00 per share for aggregate gross proceeds of $4,500,006. - Achieved Profitability: Net income for the quarter ended June 30, 2026 was $137,983, compared to a net loss of $571,397 for the quarter ended June 30, 2025 and a net loss of $654,071 for the quarter ended March 31, 2026. SUMMARY OF QUARTERLY RESULTS: click here SILVER OUNCES AND REVENUE GROWTH PROFILE SINCE INCEPTION/ SILVER OUNCES AND MARKET CAP PER QUARTER VS. SILVER PRICE: click here “The quarter represents the first instance of positive earnings and cash from operations (before working capital adjustments) since the company went public in July 2024. We are very proud of this achievement and look forward to adding more silver ounce revenues and growing the company in the coming quarters,” stated Peter Bures, CEO. For complete details, please refer to the Audited Consolidated Financial Statements and associated Management Discussion and Analysis for the quarter ended June 30, 2026, available on SEDAR+ at sedarplus.ca or on the Company’s website at silvercrownroyalties.com. ABOUT SILVER CROWN ROYALTIES INC. Founded by seasoned industry professionals, Silver Crown Royalties (Cboe: SCRI | OTCQX: SLCRF | BF: QS0) is a publicly traded silver royalty company dedicated to generating free cash flow. Silver Crown currently holds seven royalties. Its business model offers investors exposure to precious metals, providing a natural hedge against currency devaluation while mitigating the adverse effects of production-related cost inflation. Silver Crown strives to minimize the economic burden on mining projects while simultaneously maximizing shareholder returns. For further information, please contact: Silver Crown Royalties Inc. Peter Bures, Chairman and CEO T: (416) 481-1744 | pbures@silvercrownroyalties.com FORWARD-LOOKING STATEMENTS This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable Canadian and U.S. securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “should”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. The forward-looking information contained herein is provided for the purpose of assisting readers in understanding management’s current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. Forward-looking statements and information include, but are not limited to, “We are very proud of this achievement and look forward to adding more silver ounce revenues and growing the company in the coming quarters; These results demonstrate we are well positioned for continued growth” . With over C$7 million in cash and silver bullion. Our pipeline remains robust and we continue to advance a number of royalty opportunities presently” and the Company anticipates significantly higher royalty payments under the PPX Royalty with the minimum payment obligations commencing on the date hereof. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual actions, events or results to be materially different from those expressed or implied by such forward-looking information, including but not limited to: the impact of general business and economic conditions; the absence of control over mining operations from which SCRI will purchase silver and other metals or from which it will receive royalty payments and risks related to those mining operations, including risks related to international operations, government and environmental regulation, delays in mine construction and operations, actual results of mining and current exploration activities, conclusions of economic evaluations and changes in project parameters as plans continue to be refined; accidents, equipment breakdowns, title matters, labor disputes or other unanticipated difficulties or interruptions in operations; SCRI’s ability to enter into definitive agreements and close proposed royalty transactions; the inherent uncertainties related to the valuations ascribed by SCRI to its royalty interests; problems inherent to the marketability of silver and other metals; the inherent uncertainty of production and cost estimates and the potential for unexpected costs and expenses; industry conditions, including fluctuations in the price of the primary commodities mined at such operations, fluctuations in foreign exchange rates and fluctuations in interest rates; government entities interpreting existing tax legislation or enacting new tax legislation in a way which adversely affects SCRI; stock market volatility; regulatory restrictions; liability, competition, the potential impact of epidemics, pandemics or other public health crises on SCRI’s business, operations and financial condition, loss of key employees. SCRI has attempted to identify important factors that could cause actual results to differ materially from those contained in forward looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information. SCRI undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents management's best judgment based on information currently available. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements. This document does not constitute an offer to sell, or a solicitation of an offer to buy, securities of the Company in Canada, the United States, or any other jurisdiction. Any such offer to sell or solicitation of an offer to buy the securities described herein will be made only pursuant to subscription documentation between the Company and prospective purchasers. Any such offering will be made in reliance upon exemptions from the prospectus and registration requirements under applicable securities laws, pursuant to a subscription agreement to be entered into by the Company and prospective investors. CBOE CANADA DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE. View the original release on www.newmediawire.com
Since acquisition, DiversiTech has seen revenues rise 60%, with PremiStar revenues doubling over the same period Strong financial performance reflects tailwinds in the US HVAC market, which are driving demand for both parts and maintenance services Partners Group has recognized best practices across DiversiTech and PremiStar to implement transformational value creation plans DENVER, CO - August 10, 2026 (NEWMEDIAWIRE) - Partners Group, one of the largest firms in the global private markets industry, is seeing strong growth at its two direct private equity portfolio companies that offer exposure to the heating, ventilation, and air conditioning ("HVAC") market in the US. This reflects tailwinds across the HVAC market as extreme weather increases demand for cooling. Partners Group acquired DiversiTech, a manufacturer and distributor of parts and supplies for HVAC units, and PremiStar, one of the largest commercial HVAC services providers, in 2021 through its direct private equity program. Since then, DiversiTech has seen revenues increase 60%, with PremiStar revenues doubling over the same period. The companies have delivered EBITDA growth of 14% CAGR and 22% CAGR respectively. This strong financial performance reflects tailwinds in the US HVAC market. In particular, the increasing occurrence of extreme weather conditions is highlighting the importance of HVAC system maintenance to maximize unit performance and efficiency. Other tailwinds include the rapidly ageing installed base of HVAC units, the need to upgrade units to be more energy efficient, and the rise of building automation solutions. Leveraging its investment platform, Partners Group has recognized best practices across both DiversiTech and PremiStar to implement transformational value creation plans that are designed to support future growth. This includes investing in operations, supply chains, and technology, as well as executing selective add-on acquisitions. Wolf Scheider, Head of Private Equity, Partners Group, says: "Across our HVAC portfolio, we are seeing organic, disciplined growth. As heat waves become a defining challenge of how we live and work, demand for HVAC parts and maintenance is rising. Our portfolio companies are essential to helping communities and enterprises adapt to these conditions, with meaningful growth runway ahead as value creation initiatives mature." About Partners Group Partners Group is one of the largest firms in the global private markets industry, with around 2’000 professionals and over USD 186 billion in assets under management globally. The firm has investment programs and custom mandates spanning private equity, private credit, infrastructure, real estate, royalties, and special opportunities. With its heritage in Switzerland and primary presence in the Americas in Colorado, Partners Group is built differently from the rest of the industry. The firm leverages its differentiated culture and its operationally oriented approach to identify attractive investment themes and to transform businesses and assets into market leaders. For more information, please visit www.partnersgroup.com or follow us on LinkedIn. Partners Group media relations contact Henry Weston Phone: +44 207 575 2593 Email: henry.weston@partnersgroup.com View the original release on www.newmediawire.com
PLIEZHAUSEN, GERMANY - August 10, 2026 (NEWMEDIAWIRE) - Following a public tender, DATAGROUP has been awarded the contract to provide workplace services - with a focus on device lifecycle management - for Investitionsbank Berlin (IBB). The collaboration is set to last five years and involves managing approximately 1,300 end devices. The goal of the partnership is to further develop IBB’s digital workplace environment in an efficient, secure, sustainable, and user-oriented manner. As part of the contract, DATAGROUP will handle all services throughout the end-user devices’ lifecycle - from provisioning, configuration, and logistics, through operation and support, to replacement, as well as secure take-back and recycling at the end of their useful life. This provides IBB with a single service partner for all key tasks related to workplace provisioning. A key benefit of the project lies in the holistic management of the device fleet. Transparent processes throughout the entire service life enable better planning of investments and replacement cycles, as well as more efficient management of existing end devices. This shortens deployment times, reduces administrative overhead, and increases user satisfaction. “In DATAGROUP, we have found an experienced and capable partner for our workplace infrastructure. Through the comprehensive management of our end devices – from deployment to recycling - we are jointly creating a modern and reliable workplace solution that optimally supports our employees,” said Wolf Diederich, Head of IT at IBB. IT security and compliance are also of particular importance. Standardized operating and deployment processes, as well as defined security and control mechanisms, ensure that the end devices in use meet organizational and regulatory requirements. This is complemented by clear governance structures, regular reporting, and continuous quality management. Sustainability is also a central component of the service approach. DATAGROUP follows a lifecycle-oriented approach that encompasses maximizing the useful life of hardware, refurbishing suitable devices, and ensuring their secure and traceable disposal. This supports the responsible use of resources and contributes to the circular economy. “We are delighted by the trust placed in us by Investitionsbank Berlin and look forward to jointly further developing the bank’s digital work environment. Device lifecycle management is a central component of modern workplace services and contributes significantly to efficient, secure, and sustainable IT workplace provision. Our goal is to create real added value for Investitionsbank Berlin and its employees through high-quality service, standardized processes, and a close partnership,” said Peter Vages, Managing Director at DATAGROUP. Investitionsbank Berlin and DATAGROUP view this collaboration as a long-term partnership. The focus is on the continuous improvement of workplace services as well as adaptation to future technological and organizational requirements. The goal is a modern, secure, and scalable workplace environment that optimally supports employees and promotes the long-term success of Investitionsbank Berlin. About DATAGROUP DATAGROUP is one of the leading German IT service providers. Approximately 4,000 employees at locations throughout Germany and, since June 2026, also in the Netherlands design, implement, and operate IT infrastructures and business applications. With its CORBOX product, DATAGROUP is a full-service provider, supporting global IT workplaces for medium and large enterprises as well as public authorities. DATAGROUP is growing organically and through acquisitions. The acquisition strategy is particularly noted for its optimal integration of new companies. DATAGROUP is actively participating in the consolidation process with its “buy and turn around” and its “buy and build” strategy. www.datagroup.de CONTACT Anke Banaschewski Investor Relations & Corporate Communication presse@datagroup.de View the original release on www.newmediawire.com
VIENNA, AUSTRIA - August 10, 2026 (NEWMEDIAWIRE) - wienerberger, a leading international provider of innovative, ecological solutions for the entire building envelope, in the fields of new build and renovation, as well as infrastructure in water and energy management, announces that Heimo Scheuch is stepping down as CEO for personal health reasons with immediate effect. After more than 17 years at the helm, he has asked the Supervisory Board to accept the early termination of his mandate. The Supervisory Board has accepted his decision and appointed Gerhard Hanke, Chief Operating Officer Central & East and Deputy Chairman of the Managing Board, as Interim CEO. wienerberger is now conducting a structured search for a permanent successor. Gerhard Hanke brings more than 25 years of experience at wienerberger to his role as Interim CEO. He served as CFO from 2021 to 2025, has been COO Central & East since March 2025, and has served as Deputy Chairman of the Managing Board since June 2026. The responsibilities of Dagmar Steinert (CFO) and Harald Schwarzmayr (COO West) remain unchanged. Heimo Scheuch has served as CEO of wienerberger since 2009, leading the company through a fundamental strategic transformation from a traditional brick manufacturer into a leading international provider of innovative and ecological building material and infrastructure solutions across Europe and North America. Under his leadership, wienerberger significantly expanded its geographic footprint, and built a strong position in water and energy infrastructure alongside its core building envelope business. Peter Steiner, Chairman of the Supervisory Board, said: "On behalf of the entire Supervisory Board, I want to express my profound gratitude to Heimo for what he has built in 17 years as CEO. When he took the helm in 2009, wienerberger was a brick manufacturer. Today, it is a leading international group with more than 20,000 employees, a resilient business model spanning the entire building envelope and infrastructure, and a clear sustainability agenda. This successful transformation is his achievement. We deeply respect his decision to prioritize his health, and we wish him a full and swift recovery. Gerhard Hanke is an experienced, deeply trusted leader who knows every dimension of wienerberger. With him, we are well positioned to ensure continuity and pursue our goals while we conduct a thorough search for the right successor." Heimo Scheuch, outgoing CEO, said: “wienerberger has been my home for thirty years – from my first days as an assistant to leading this group as CEO. I would like to thank our customers, business partners and shareholders as well as the Supervisory Board, my fellow Managing Board members, and the global wienerberger team for their trust and commitment over the past years. We have achieved a great deal together, and I am proud of every step. I had looked forward to continuing as CEO as planned, but the time has come to focus on my health. I am leaving the company in the best possible hands and have no doubt that wienerberger will continue its success story." wienerberger will present its results for the second quarter and first half of 2026 as planned on 12 August 2026. For further information, please contact: Claudia Hajdinyak, Head of Corporate Communications Wienerberger AG t +43 664 828 31 83 | claudia.hajdinyak@wienerberger.com Alfredo Sibilia, Senior Officer Investor Relations Wienerberger AG t +43 664 812 10 72 | investor@wienerberger.com wienerberger wienerberger is a leading international provider of innovative, ecological solutions for the entire building envelope, in the fields of new build and renovation, as well as infrastructure in water and energy management. With more than 20,000 employees worldwide, wienerberger's solutions enable energy-efficient, healthy, climate-friendly, and affordable living. wienerberger is the world’s largest producer of bricks and the market leader in clay roof tiles in Europe as well as concrete pavers in Eastern Europe. In pipe systems (ceramic and plastic pipes), the company is one of the leading suppliers in Europe and a leading supplier of facade products in North America. With its more than 200 production sites, wienerberger generated revenues of EUR 4.6 billion and an operating EBITDA of approx. EUR 754 million in 2025. View the original release on www.newmediawire.com
RELLINGEN, GERMANY - August 10, 2026 (NEWMEDIAWIRE) - Viromed Medical AG (“Viromed”; ISIN: DE000A3MQR65), a medical technology company and pioneer in cold plasma technology, has entered into several new distribution partnerships for its ViroCAP® product. The agreements provide for distribution in Spain, Portugal, Greece, the Balkan region, Romania and Saudi Arabia, significantly expanding the company’s international presence. The agreements were concluded with six separate companies and each relate to an individual market. Minimum purchase quantities were agreed in each of the partnerships. On the basis of these contracts, Viromed expects additional sales of at least 3,000 devices per year. ViroCAP® is a mobile medical device for the treatment of skin conditions using cold atmospheric plasma. It is aimed at hospitals, physicians in private practice and surgically active medical specialists. Uwe Perbandt, Chief Executive Officer of Viromed Medical AG: “With these new distribution partners, we are opening up several attractive markets in Southern and South-Eastern Europe as well as in the Middle East. The strong interest shown by our distribution partners underlines the high demand for our cold plasma technology. The new distribution partnerships are another important step in the implementation of our dynamic growth phase. Partnerships for additional countries are in preparation and are expected to be signed within the next four to six weeks.” With these new agreements, Viromed continues to expand its international distribution network. The company already has numerous distribution and marketing partnerships in place. These include, among others, the exclusive distribution agreement with the Korean company UMECO, covering ten Asian countries, as well as a distribution partnership with TriPart TITAN GmbH & Co. KG for the Turkish market. About Viromed Medical AG Viromed Medical AG specializes in the development, manufacture and distribution of medical products. The operating business of the company, which has been listed on the stock exchange since October 2022, focuses on the distribution of innovative cold plasma technology for medical applications via its wholly owned subsidiary Viromed Medical GmbH. Viromed can draw on a broad customer base in the DACH region and beyond. Viromed is pursuing the goal of further advancing the use of cold plasma technology in medicine in the coming years and realizing the corresponding growth potential. www.viromed-medical-ag.de Contact Viromed E-Mail: kontakt@viromed-medical.de Press contact E-Mail: viromed@kirchhoff.de View the original release on www.newmediawire.com
EBITDA increased by 46.6% to EUR 42.7m (H1 2025: EUR 29.1m), driven by continued cost discipline and improved operational efficiency EBITDA margin improved significantly to 31.6% (H1 2025: 21.5%) Recurring management fees continued to more than cover operating expenses, demonstrating the resilience and quality of PATRIZIA’s earnings Transaction activity remained resilient showing a gradual recovery, with transactions signed increasing by 15.6% to EUR 1.6bn; equity raised from clients grew significantly to EUR 0.8bn (H1 2025: EUR 0.3bn) Financial strength improved further, supported by increased available liquidity of EUR 122.2m and a robust 72.7% net equity ratio Guidance confirmed AUGSBURG, GERMANY - August 10, 2026 (NEWMEDIAWIRE) - PATRIZIA, a leading independent investment manager for real assets, today published its H1 2026 financial results. Against a backdrop of gradually recovering real asset markets, PATRIZIA delivered strong earnings growth in the first half of 2026. The Company increased EBITDA by 46.6% to EUR 42.7m (H1 2025: EUR 29.1m), on the back of continued cost discipline and improved operational efficiency. The EBITDA margin increased significantly to 31.6% (H1 2025: 21.5%), reflecting the scalability of PATRIZIA’s platform and a structurally leaner cost base. Recurring management fees continued to more than cover operating expenses, thereby strengthening earnings quality and supporting profitable growth. Market environment and business development Real asset markets continued to recover during the first half of 2026, although the pace of recovery remained gradual and uneven. Within this environment, transaction activity remained resilient, with transactions signed increasing by 15.6% to EUR 1.6bn, primarily driven by disposal activity. Transactions closed amounted to EUR 1.1bn (H1 2025: EUR 1.5bn), reflecting the gradual pace of market recovery. At the same time, fundraising momentum improved significantly. Equity raised from clients increased to EUR 0.8bn (H1 2025: EUR 0.3bn). Following equity raised of only EUR 0.1bn during the first quarter 2026, fundraising accelerated during the second quarter, reflecting stronger client activity following a subdued start to the year. Financial performance Total service fee income remained broadly stable at EUR 127.3m in H1 2026 (H1 2025: EUR 128.3m; -0.8%). Recurring management fees amounted to EUR 110.2m in H1 2026, representing a moderate decline compared to EUR 113.4m in the prior-year period (-2.8%). The management fees in H1 2025 benefited from stronger development-related service fees. Transaction fees amounted to EUR 3.8m (H1 2025: EUR 3.6m; +5.3%) and were primarily driven by disposal fees and realisations on behalf of clients. Performance fees increased by 16.8% to EUR 13.2m (H1 2025: EUR 11.3m), mainly driven by higher Dawonia distributions and fees generated from disposal activity. Net sales revenues and co-investment income increased to EUR 8.0m in H1 2026 (H1 2025: EUR 7.3m), driven by higher dividend income from increased co-investments, while rental revenues generated from consolidated real estate investments remained almost stable. Operating expenses, excluding reorganisation expenses, decreased by 10.9% to EUR 99.8m in H1 2026 (H1 2025: EUR 112.1m). The reduction was primarily driven by lower staff costs, which decreased to EUR 64.9m (H1 2025: EUR 74.9m), reflecting the lower FTE base. Other operating expenses decreased further to EUR 25.5m (H1 2025: EUR 29.2m), supported by ongoing platform optimisation initiatives. Other expenses amounted to EUR 9.4m (H1 2025: EUR 8.0m). Other income, excluding reorganisation income, increased to EUR 7.7m (H1 2025: EUR 5.6m), primarily due to higher releases of provisions compared to the prior-year period. During the reporting period, the reorganisation result amounted to EUR -0.3m (H1 2025: EUR 0m). As a result of the factors described above, EBITDA increased significantly to EUR 42.7m in H1 2026 (H1 2025: EUR 29.1m). The EBITDA margin jumped to 31.6% (H1 2025: 21.5%), driven by improved efficiency across the platform and continued cost discipline. Net profit for the period increased significantly to EUR 14.7m in H1 2026 (H1 2025: EUR 4.7m). Assets under management As at 30 June 2026, assets under management (AUM) stood at EUR 55.9bn compared to EUR 56.2bn as at 31 December 2025. The slight decrease was primarily attributable to disposal activity. Guidance 2026 confirmed During the first half of 2026, the Iran conflict negatively impacted inflation and interest rate developments, resulting in a temporary deterioration of the investment environment. Since then, market sentiment has recovered again despite continued market volatility. Against this backdrop, PATRIZIA continues to expect fundraising volumes and transaction activity to increase compared to 2025. Thus, the guidance presented for financial year 2026 remains unchanged with management expecting: Assets under Management in a range between EUR 55.0 – 60.0bn at the end of 2026, excluding potential currency impacts EBITDA in a range between EUR 60.0 – 75.0m and EBITDA margin in a range between 22.0 – 26.5%. Asoka Wöhrmann, CEO of PATRIZIA SE, comments: “The first half of 2026 was marked by a gradual recovery in fundraising, with stronger client activity in the second quarter following a subdued start to the year. While the real asset markets continue their gradual recovery on an often uneven path, the underlying market fundamentals are strengthening. PATRIZIA is well positioned to capture attractive investment opportunities for clients across real asset markets." Martin Praum, CFO of PATRIZIA SE, adds: “During the first half of 2026, we further strengthened PATRIZIA’s financial position and resilience. Supported by the realisation of a first exit carry tranche in one of our residential portfolios, we increased our participations and recurring income, covered dividend payments and simultaneously grew our available liquidity. In addition, the significant expansion of our EBITDA margin to 31.6% underscores the scalability of our platform, disciplined cost management and the benefits of a structurally leaner operating model. This financial strength gives us the flexibility to continue investing in our platform and in the markets while creating long-term value for shareholders.” PATRIZIA: Investment manager for international smart real assets PATRIZIA has been providing investment opportunities in smart real assets for institutional, semi-professional, and private investors for more than 40 years, focusing on real estate and infrastructure. PATRIZIA’s investment solutions are driven by the “DUEL” megatrends – Digital, Urban, Energy and Living transitions – and capitalise on the opportunities arising from these transformative global shifts. PATRIZIA currently has approximately EUR 56bn in assets under management (AUM) and employs around 800 professionals across 26 locations worldwide. PATRIZIA has been committed to making a positive impact since its founding. In 1992, the company began collaborating closely with Bunter Kreis (“Colourful Circle”) in Germany to provide aftercare for children with severe diseases. Since 1999, the PATRIZIA Foundation has provided 800,000 children and young people worldwide with access to education, healthcare and a safe home, enabling them to live better, self-determined lives. For more information, visit www.patrizia.ag and www.patrizia.foundation Contact Dr Janina Rochell Director Investor Relations Phone:+49 69 643505-1229 Mobile: +49 151 64085881 investor.relations@patrizia.ag View the original release on www.newmediawire.com
LOS ANGELES, CA - August 10, 2026 (NEWMEDIAWIRE) - Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that the U.S. Food and Drug Administration has approved its Investigational New Drug (“IND”) application for Lucid-MS (Lucid-21-302), clearing the company to advance the patented, first-in-class multiple sclerosis candidate into Phase 2 clinical development. The planned randomized, double-blind, placebo-controlled study will evaluate efficacy, safety and tolerability in people with MS using clinical and radiological measures. Trial start-up activities, including site selection, are underway, with patient enrollment and drug administration expected to begin as quickly as possible. Lucid-MS is designed to provide neuroprotection by inhibiting demyelination, differentiating it from existing MS therapies that primarily focus on modulating the immune system. The candidate targets protein arginine deiminase 2 (“PAD2”), an enzyme implicated in myelin degradation, and has demonstrated the ability to prevent and reverse myelin breakdown in preclinical models. Quantum BioPharma said Lucid-MS demonstrated a favorable safety profile and was well tolerated in prior Phase 1 trials in healthy participants. The company reported more than $10 million in cash, digital assets and liquid investments as of March 31, 2026. To view the full press release, visit https://ibn.fm/HyWYH About Quantum BioPharma Ltd. Quantum is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), Quantum is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum invented UNBUZZD(TM) and spun out its OTC version to a company, Unbuzzd Wellness Inc. (“Unbuzzd”) (formerly, Celly Nutrition Corp.), led by industry veterans. Quantum retains ownership of 19.84% (as of March 31, 2026) of Unbuzzd at www.unbuzzd.com. The agreement with Unbuzzd also includes royalty payments of 7% of sales from unbuzzd(TM) until payments to Quantum total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Quantum retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to QNTM are available in the company’s newsroom at https://ibn.fm/QNTM Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
VANCOUVER, BC - August 10, 2026 (NEWMEDIAWIRE) - Trailbreaker Resources Ltd. (TBK.V) ("Trailbreaker" or "the Company") is pleased to announce the completion of its maiden drill program at the Swan Zone, within Trailbreaker’s 100%-owned, 300 km(2) Atsutla Gold Project in northwestern British Columbia (BC), Canada. The Swan Zone is a Cu-Au-Ag (copper-gold-silver) porphyry target defined by coincident geochemical and geophysical anomalies. The recently completed diamond drill program was part of a larger drill program that also targeted the Highlands Zone, a high-grade vein-hosted gold target. The two zones are 26 km apart and hosted in entirely different geological units. The Highlands Zone is hosted in the Jurassic Christmas Creek batholith, and the Swan Zone is hosted in the Cretaceous Glundebery batholith. Figure 1: Diamond drill rig at the Swan Zone, targeting a 1.5 km x 1.5 km multi-element soil geochemical anomaly coincident with a 2.1 km x 1.4 km chargeability anomaly. The completed diamond drill program at the Swan Zone consisted of two holes totalling 801.00 metres (see Table 1 for collar information). The drilling comprised initial testing along a strike length of 1,000 m and a vertical extent of 395 m. For details on the Swan Zone drill target, see the July 27, 2026 news release. The preceding diamond drill program at the Highlands Zone consisted of four holes totalling 883.40 metres. The drilling tested a strike length of 500 m and a vertical extent of 412 m. For details on the Highlands Zone drill target, see the June 29, 2026 news release. Table 1: Drill collar details for the 2026 program A total of 1,000 drill core samples (including standard reference material and blank samples placed at regular intervals) were submitted to Bureau Veritas’ prep lab in Whitehorse, YT. Assay results will be released following compilation and data verification. Message from the President "This was a well-executed drill program that provided us with an excellent opportunity to finally test two quality targets that we have been developing for the past five years. This was a first-pass, exploratory program, and we achieved our goals while remaining within budget. I would like to thank our drill contractor, Empire Drilling, and the Trailbreaker team for all of their hard work.” - Daithi Mac Gearailt More about the Atsutla Gold Project The Atsutla Gold Project is centered over the regional-scale Teslin-Thibert fault system which marks the contact between the Quesnel and Cache Creek terranes. Gold mineralization is associated with two distinct Mesozoic batholitic intrusions that are the predominant geological units on the property. Since discovery in 2020, Trailbreaker has outlined five significant zones of gold mineralization on the property, across a span of 26 kilometers. These are: Highlands Zone - A 2.0 km by 1.5 km area in the western Atsutla Gold Project region, with veins containing coarse visible gold assaying up to 630 g/t Au and 1,894 g/t Ag. Christmas Creek Zone - Gold-bearing quartz veins 1.5 km east of the Highlands Zone, with rock samples assaying up to 102 g/t Au and 524 g/t Ag. Snook Zone - High-grade veins 3.5 km northeast of the Highlands Zone, with rock samples assaying up to 53.3 g/t. Willie Jack Zone - 1.25 km long gold-in-soil anomaly with soil samples assaying up to 3.77 g/t Au and rock samples up to 9.9 g/t Au. Swan Zone - A Cu-Au-Ag porphyry target defined by a 1.5 km x 1.5 km multi-element soil geochemical anomaly (Au-Cu-Ag-As [arsenic]-Mo [molybdenum]-Sb [antimony]-Bi [bismuth]), with rock grab samples grading up to 11.7 g/t Au, 212 g/t Ag, and 0.81% Cu. The geochemical anomaly is coincident with a 2.1 km x 1.4 km donut-shaped chargeability high (defined by a 2024 induced polarization survey) as well as a zone of elevated potassium marked by a magnetic low signature indicated from a 2024 airborne magnetic and radiometric survey. About Trailbreaker Resources Trailbreaker Resources is a mining exploration company focused primarily on mining-friendly British Columbia and Yukon Territory, Canada. Trailbreaker is committed to continuous exploration and research, allowing maintenance of a portfolio of quality mineral properties which in turn provides value for shareholders. The company has an experienced management team with a proven track record as explorers and developers throughout the Yukon Territory, British Columbia, Alaska and Nevada. ON BEHALF OF THE BOARD Daithi Mac Gearailt President and Chief Executive Officer Carl Schulze, P. Geo., Consulting Geologist with Aurora Geosciences Ltd, is a qualified person as defined by National Instrument 43-101 for Trailbreaker's BC and Yukon exploration projects, and has reviewed and approved the technical information in this release. Other For new information about the Company’s projects, please visit Trailbreaker’s website at TrailbreakerResources.com and sign up to receive news. For further information, follow Trailbreaker’s tweets at Twitter.com/TrailbreakerLtd, use the ‘Contact’ section of our website, or contact us at (604) 681-1820 or at info@trailbreakerresources.com. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Statements Statements contained in this news release that are not historical facts are "forward-looking information" or "forward-looking statements" (collectively, "Forward-Looking Information") within the meaning of applicable Canadian securities legislation and the United States Private Securities Litigation Reform Act of 1995. Forward-Looking Information includes, but is not limited to, disclosure regarding possible events, conditions or financial performance that is based on assumptions about future economic conditions and courses of action; expectations regarding future exploration and drilling programs and receipt of related permitting. In certain cases, Forward-Looking Information can be identified by the use of words and phrases such as "anticipates", "expects", "understanding", "has agreed to" or variations of such words and phrases or statements that certain actions, events or results "would", "occur" or "be achieved". Although Trailbreaker has attempted to identify important factors that could affect Trailbreaker and may cause actual actions, events or results to differ materially from those described in Forward-Looking Information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. In making the forward-looking statements in this news release, if any, Trailbreaker has applied several material assumptions, including the assumption that general business and economic conditions will not change in a materially adverse manner. There can be no assurance that Forward-Looking Information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on Forward-Looking Information. Except as required by law, Trailbreaker does not assume any obligation to release publicly any revisions to Forward-Looking Information contained in this news release to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. View the original release on www.newmediawire.com
CALGARY, ALBERTA - August 10, 2026 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V: VM) (OTC Pink: VYYRF) (“Voyageur” or the “Company”), a Canadian developer of pharmaceutical-grade barium and iodine contrast media for medical imaging, is pleased to provide an update on the advancement of its proprietary patent-pending Mueller iodine extraction process. The Mueller process is being developed to recover high-purity iodine from iodine-rich oilfield brine, supporting Voyageur’s strategy to establish a domestic iodine supply for the North American radiology contrast media market, while offering oil and gas producers and midstream water operators a new pathway to generate value from produced brine. Recent laboratory work has successfully produced iodine at 99.8% purity, with overall process recovery exceeding 90%. Houston Laboratory Progress and Field Pilot Deployment Voyageur has established a laboratory and fabrication site in Houston, Texas, dedicated to advancing the Mueller process using Anadarko and Permian Basin produced water. Laboratory operations have demonstrated the process under controlled conditions and generated clean brine suitable for disposal or reinjection, consistent with zero-liquid-discharge performance objectives. With a field-capable pilot unit now built and field testing set to begin in the coming weeks, the Mueller process is moving beyond bench-scale validation toward continuous, real-world field operation using unaltered oilfield brine, a distinction the Company views as critical for any technology intended for commercial deployment. Laboratory and lab pilot highlights achieved to date include: Production of iodine at 99.8% purity Overall recovery exceeding 90% Continuous operation using real oilfield brine feed Constructed a mobile, field-capable pilot unit sized to 80,000 L/d Generation of clean brine suitable for integration into existing disposal, reinjection, or clean feed for DLE and desalination infrastructure Validation of key process parameters supporting scale-up to field deployment Completed a preliminary design basis for a 200 mt/y plant Completed techno-economic and environmental validation supporting a low-cost OPEX and environmental profile The Company is constructing a transportable, small-scale iodine extraction field unit designed to treat up to approximately 80,000 litres per day on a batch-continuous basis. The pilot unit is scheduled to commence field testing in the coming weeks, with operations planned for September 2026. Field testing is expected to provide operating data under real-world conditions and support the design basis for modular, relocatable production units capable of recovering iodine from iodine-rich oilfield brine. Voyageur’s modular production concept is designed to allow 200 tonne/yr field units to be deployed at multiple saltwater disposal sites, where iodine concentrate can be produced and transported to a central hub for final polishing, prilling, and packaging. Engineering and Scale-Up Planning Engineering and project planning are progressing to support the continued development of the Mueller process from laboratory validation to field demonstration and commercial-scale design. Current work is focused on finalizing process systems for iodine polishing, prilling, and packaging, while further defining the modular field unit and central processing hub configuration. Subsequent engineering phases are expected to advance through front-end loading stages, including concept design and basic design, to define a practical demonstration-scale configuration. This work is intended to improve engineering definition, refine cost estimates, and support future commercial deployment planning. Strategic Context For oil and gas operators, produced water midstream companies, and investors focused on the energy value chain, produced brine represents a largely untapped resource: billions of barrels are handled and disposed of each year at meaningful cost, while only a small fraction of the iodine they contain is ever recovered. Voyageur’s goal is to be the first company to change that equation. The Company is working to build what it believes will be the first economically profitable, field-proven iodine extraction process, helping lead the broader industry’s effort toward brine valorization. Voyageur’s vertically integrated strategy aims to improve supply-chain security, reduce reliance on imported raw materials, and lower operating costs for the production of medical imaging contrast agents. The Mueller process is a key component of this strategy, as iodine is a critical raw material used in iodinated contrast media. “The continued advancement of the Mueller process is an important step in Voyageur’s plan to develop a reliable North American source of high-purity iodine,” said Brent Willis, President and Chief Executive Officer of Voyageur. “Achieving 99.8% purity and greater than 90% recovery in laboratory testing using real oilfield brine provides meaningful technical validation as we prepare for field pilot operations. This work supports our broader strategy of building a secure, vertically integrated supply chain for radiology drugs.As part of its long-term vertically integrated manufacturing strategy, Voyageur plans to develop iodine production capacity of up to 1,000 tonnes per year to support its future iodine-based contrast pharmaceutical production requirements.” Mr. Willis added: “Our staged approach is designed to validate iodine recovery in the field, advance modular production, and ultimately support future iodine-based drug manufacturing. By developing the Mueller process alongside our Frances Creek barium project and planned manufacturing capabilities, Voyageur is working to position itself across key parts of the medical imaging contrast media value chain.” The Company will provide further updates as field testing begins, operating data is collected, and additional technical milestones are achieved. About Voyageur Pharmaceuticals Ltd. Voyageur, a Canadian public company trading under the symbol VM on the TSXV, is in development of barium and iodine Active Pharmaceutical Ingredients (API) and intends to offer high-performance, cost-effective imaging contrast agents. With a strategic focus on vertically integrating the barium and iodine contrast markets, Voyageur aims to become a key player by producing its own barium & iodine. Voyageur has developed five barium contrast products that have Health Canada licenses. Voyageur's business plan is set to generate cash flow by partnering with established third-party GMP pharmaceutical manufacturers in Canada, thereby ensuring the validation of its products by regulatory agencies worldwide. As Voyageur solidifies its presence in the market, it plans to transition into a high-margin domestic manufacturer of radiology drugs, further expanding its revenue streams. At the core of its operations, Voyageur owns a 100% interest in the Frances Creek barium sulfate (barite) project. Currently, the world’s pharmaceutical barium sulfate is almost entirely synthetically produced which management believes results in a less effective imaging quality product. Voyageur’s Frances Creek resource boasts a rare and high grade mineral suitable for the pharmaceutical marketplace that Voyageur believes will replace the current synthetic products with higher quality lower cost imaging products. Voyageur's ambitious vision is to become the first vertically integrated company in the radiology contrast media drug market. By controlling all primary input costs, from the sourcing of raw materials to final production, Voyageur intends to ensure quality and cost efficiency. With its approach, it embodies the motto of "From Earth to Bottle," highlighting Voyageur's commitment to responsible sourcing and manufacturing practices. For Further Information: Brent Willis, CEO Albert Deslauriers, CFO Brent@vpharma.ca, 403-923-5944 Albert@vpharma.ca info@vpharma.ca https://voyageurpharmaceuticals.ca Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. Cautionary Statement Regarding “Forward-Looking” Information This news release may contain certain forward-looking statements and forward-looking information (collectively, "forward-looking statements"), including without limitation: the successful field pilot testing and successful development of the Mueller iodine extraction process; obtaining Health Canada, FDA and other international regulatory approvals with reasonable timelines; the testing, refining, market launch, manufacturing, sales and revenue from Voyageur's barium and iodine contrast products; the Company’s business plan and the Company successfully raising additional financing to support the business plan; the Company's aim to become a key player in the barium and iodine contrast markets; the Company's plan to transition into a high-margin manufacturer of radiology drugs; the Company's belief that the Frances Creek Project's mineral will replace the current synthetic products in the pharmaceutical marketplace with higher quality imaging products; and the Company's belief that it can ensure quality and cost efficiency by controlling all primary input costs. Forward-looking statements normally contain words like "will", "intend", "anticipate", "could", "should", "may", "might", "expect", "estimate", "forecast", "plan", "potential", "project", "assume", "contemplate", "believe", "shall", "scheduled", and similar terms. Forward-looking statements are not guarantees of future performance, actions, or developments and are based on expectations, assumptions, and other factors that management currently believes are relevant, reasonable, and appropriate in the circumstances. Although management believes that the forward-looking statements herein are reasonable, actual results could be substantially different due to the risks and uncertainties associated with and inherent to Voyageur's business. Additional material risks and uncertainties applicable to the forward-looking statements herein include, without limitation, the impact of general economic conditions, and unforeseen events and developments. This list is not exhaustive of the factors that may affect the Company's forward-looking statements. Many of these factors are beyond the control of Voyageur. All forward-looking statements included in this news release are expressly qualified in their entirety by these cautionary statements. The forward-looking statements contained in this news release are made as at the date hereof, and Voyageur undertakes no obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by applicable securities laws. Risks and uncertainties about the Company's business are more fully discussed under the heading "Risk Factors" in its most recent filings. They are otherwise disclosed in its filings with securities regulatory authorities available on SEDAR+ at www.sedarplus.ca. View the original release on www.newmediawire.com
By Beamr DETROIT, MICHIGAN - August 7, 2026 (NEWMEDIAWIRE) - The Beamr (NASDAQ: BMR) stack turns lower-resolution feeds into the 4K viewers expect - without the delivery-cost penalty upscaling normally carries. Real viewers confirm the result Billions of viewers spent this summer watching the World Cup, and many of them did it on 4K screens. They carry that expectation to everything they watch next, but what they don't always know is how often the "4K" they see is actually upscaled 4K. A large share of premium live sports still leaves the venue as a lower-resolution feed. The jump to 4K happens somewhere else, often inside the television set itself, without production control over the result. Rebuilding contribution infrastructure to native 4K is a multi-year process. The gap between what leaves the venue and what viewers expect needs closing now. Beamr closes this gap on the broadcaster's existing infrastructure, and without the delivery-cost penalty. AI super resolution upscales the lower-resolution feed up to 4K. Then Beamr's Emmy® Award-winning content-adaptive bitrate (CABR) technology holds the result at up to 50% lower bitrate than a standard solution. That difference matters: HD to 4K can mean up to nine times the pixels, and CABR is what keeps that from becoming nine times the bandwidth - the difference between a 4K stream a broadcaster can actually ship and one that breaks delivery economics. Visual improvement is only half the story. Whether an upscaled stream actually looks better to viewers depends on the source - the motion, lighting, and on-screen graphics of the specific content. That is the question Beamr VISTA is built to answer. VISTA is a subjective quality-testing platform that compares two versions using real viewers rather than an algorithm. It runs on the broadcaster's own footage and returns the confirmation in days, unlike traditional testing that takes weeks. The full workflow - AI upscaling, CABR compression, and VISTA verification - will be demonstrated live at IBC 2026 in Amsterdam, September 11-14, at Stand 1.D22 (Hall 1). Broadcasters, rights holders, and streaming platforms can arrange a private meeting and demonstration at beamr.com/ibc26. Learn more: read the press release Beamr Brings NVIDIA Video Super Resolution to Live Sports and Broadcast Video About Beamr Beamr (NASDAQ: BMR) is a world leader in content-adaptive video compression, trusted by top media companies including Netflix and Paramount. Beamr’s perceptual optimization technology (CABR) is backed by 53 patents and a winner of Emmy® Award for Technology and Engineering. The innovative technology reduces video file sizes by up to 50% while preserving quality and enabling AI-powered enhancements. Beamr powers efficient video workflows across high-growth markets, such as media and entertainment, user-generated content, machine learning, and autonomous vehicles. Its flexible deployment options include on-premises, private or public cloud, with convenient availability for Amazon Web Services (AWS) and Oracle Cloud Infrastructure (OCI) customers. For more details, please visit www.beamr.com or the investors’ website www.investors.beamr.com and follow us on LinkedIn and X. Featured image from Beamr. This content was originally contributed to and published on Benzinga.com. Read further disclosures here. This post was authored by an external contributor and does not represent Benzinga's opinions and has not been edited for content. This contains sponsored content and is for informational purposes only and not intended to be investing advice. View the original release on www.newmediawire.com
LOS ANGELES, CA - August 7, 2026 (NEWMEDIAWIRE) - Wrap Technologies (NASDAQ: WRAP) announced the commercial launch of WrapTactics(TM) Learning Management System (“LMS”), completing the training foundation of its WrapShield(TM) six-tier human-centered response architecture. The platform provides digital learning, certification management, immersive virtual reality training, compliance reporting and mobile learning to support deployment of the company’s non-lethal response technologies, including BolaWrap(R) 150. The launch follows the U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives’ 2026 classification of BolaWrap 150 as an instrument of restraint rather than a firearm or weapon, a determination the company said expands procurement opportunities beyond traditional law enforcement markets. Wrap said WrapTactics is designed to create recurring subscription revenue through ongoing certification, curriculum updates and compliance services while supporting expansion into adjacent markets including private security, healthcare, corrections, education and transportation. The company also plans to broaden the platform with AI-assisted training assessment, additional digital certifications, advanced analytics and partner-developed content as it targets federal, defense and international opportunities. To view the full press release, visit https://nnw.fm/8oY2Z About Wrap Technologies, Inc. Wrap Technologies, Inc., a global leader in innovative public safety technologies and non-lethal tools, delivering cutting-edge technology with exceptional people to address the complex, modern day challenges facing public safety organizations. WRAP’s complete public safety portfolio includes the non-lethal BolaWrap(R) 150 device, Wrap Reality(R) immersive training platform, WrapVision(TM) body-worn camera system, WrapTactics(TM) training programs, and next-generation C-UAS solutions like PAN-DA and the 1KC Kinetic Anti-Drone Cassette, all of which supports the Company’s mission to provide safer, scalable, and cost-effective technologies for public safety, defense, and critical infrastructure markets. With a growing demand for non-lethal tools and techniques to create time, distance and tactical advantage in non-criminal calls, Wrap’s BolaWrap(R) 150 incorporates a multi-sensory distraction of sight and sound as a first response, followed by a non-lethal restraint if further escalation is required. This approach reduces the risk of injury to officers, subjects, and the community. Wrap’s BolaWrap(R) 150 solution is intended to provide law enforcement with a safer choice for nearly every phase of a critical incident. This innovative, patented device deploys a multi-sensory, cognitive disruption to expand the pre-escalation period and gives officers the advantage and critical time to manage non-compliant subjects before resorting to higher-force options. The BolaWrap(R) 150 is not pain-based compliance. It does not shoot, strike, shock, or incapacitate, instead, it helps officers strategically operate pre-escalation on the force continuum, reducing the risk of injury to both officers and subjects. Used by over 1,000 agencies across the U.S. and in 60 countries, BolaWrap(R) is backed by training certified by the International Association of Directors of Law Enforcement Standards and Training (IADLEST), reinforcing Wrap’s commitment to public safety through cutting-edge technology and expert training. WrapReality(TM) VR is a fully immersive training simulator to enhance decision-making under stress. As a comprehensive public safety training platform, it provides first responders with realistic, interactive scenarios that reflect the evolving challenges of modern law enforcement. By offering a growing library of real-world situations, WrapReality(TM) is intended to equip officers with the skills and confidence to navigate high stakes encounters effectively, which we believe leads to safer outcomes for both responders and the communities they serve. WrapVision is an all-new body-worn camera and evidence management system built for efficiency. Designed for efficiency, security, and transparency to meet the rigorous demands of modern law enforcement, WrapVision captures, stores, and helps manage digital evidence, ensuring operational security, regulatory compliance, and enhanced video picture quality and field of view. The WrapVision camera, powered by IONODES, boasts streamlined cloud integration and final North American assembly, with a critical made-in-America roadmap projected for early 2026. This track helps ensure data integrity and helps eliminate critical concerns over unauthorized access or foreign surveillance risks. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to WRAP are available in the company’s newsroom at https://ibn.fm/WRAP Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
The company launches its 2026 season, designed to move its Skaergaard project into its next phase of development. Key critical minerals mined at Skaergaard, including palladium and platinum serve critical industrial functions with few viable substitutes. Skaergaard ranks among the world’s largest undeveloped palladium, gold and platinum deposits, and Greenland Mines holds an 80% interest in the licenses covering it. LOS ANGELES, CA - August 7, 2026 (NEWMEDIAWIRE) - Argus, a support vessel loaded with drill rigs, just sailed out of Reykjavik, and it is carrying more than equipment. The ship is carrying the opening move of Greenland Mines’ (NASDAQ: GRML) most ambitious field season yet at its Skaergaard project, part of a broader push into the critical minerals the modern economy cannot function without. “This is the moment the whole season has been building toward,” said Greenland Mines president Dr. Bo Moller Stensgaard. “Argus is loaded, the team is aboard, and we are underway to Skaergaard with everything we need to have a great season - more than 40 experts, three drill rigs drilling, machinery and equipment for bulk-sample blasting and sampling… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
Following the Company’s Notice of Intent Letter for Pre-Application Regulatory Engagement on the Tesseract TGR Under the 10 CFR Part 53 Framework, the NRC has Assigned a Project Number and a Project Manager to Facilitate the Pre-Application Activities TORONTO, ONTARIO and KNOXVILLE, TENN. - August 7, 2026 (NEWMEDIAWIRE) - Thorium Atomics Inc. today announced that it has commenced pre-application regulatory engagement with the U.S. Nuclear Regulatory Commission (NRC) for its Tesseract TGR advanced reactor, following the company’s submission of a notice of intent letter outlining its planned interactions with NRC staff. Thorium Atomics submitted the notice of intent letter on June 23, 2026. In response, by letter dated July 24, 2026, the NRC assigned NRC Project No. 99902174 to the Tesseract TGR and designated a project manager in the NRC’s Office of Advanced Reactors to coordinate pre-application activities. The project number provides an administrative and tracking reference for future correspondence, meetings, submissions and staff reviews associated with the company’s pre-application activities. The notice letter is publicly available in the NRC’s Agencywide Documents Access and Management System (ADAMS) under Accession No. ML26189A392. Direct link: https://www.nrc.gov/docs/ML2618/ML26189A392.pdf Important context. Assignment of a project number is an administrative step. It does not constitute submission or acceptance of a license application and does not represent NRC approval, endorsement or certification of the Tesseract TGR design. Thorium Atomics plans to engage with the NRC under 10 CFR Part 53, the agency’s risk-informed, performance-based and technology-inclusive licensing framework for commercial nuclear power plants. Part 53 became available for use on April 29, 2026. The company is preparing a Regulatory Engagement Plan describing the Tesseract technology, its proposed licensing strategy and the sequence of planned pre-application submissions. “A project number and an assigned project manager give us a defined NRC point of contact and a trackable reference for our future pre-application work. Part 53 is risk-informed and technology-inclusive, making it well suited to a high-temperature gas-cooled reactor. Commencing that engagement while the design is still being developed serves to ensure that regulatory expectations are clearly understood and addressed, thereby informing the design development process and helping to de-risk the future licensing pathway.” - Dr. Jack Vecchiarelli, Chief Scientific and Regulatory Officer, Thorium Atomics “This is a clear external marker of where our program stands. It comes alongside our application to Idaho National Laboratory’s Nuclear Energy Launch Pad program and our proposed pathway for independent, qualified-code reactor-physics verification at a U.S. national laboratory. We are deliberately building the regulatory, engineering and technical-validation records in parallel.” - Young Hwang, Founder and Chief Executive Officer, Thorium Atomics About the Tesseract TGR The Tesseract TGR (thorium-augmented gas-cooled reactor) is a pebble-bed type of high-temperature reactor rather than a conventional water-cooled design. It uses helium as a reactor coolant and coated-particle TRISO fuel, an architecture in which the advanced safety response is enabled by passive physical phenomena rather than by active systems and high-pressure water infrastructure. The design is in development and has not yet been built, licensed or independently validated. This is a small modular reactor designed for a thermal output of 250 MWth, delivering approximately 100 MWe of firm electricity or industrial process heat at temperatures up to 750 degrees Celsius. Heat at that temperature is difficult to supply with electricity and is currently met almost entirely by combustion. The Tesseract TGR uses uranium TRISO fuel enriched below 10% U-235 as its initial fissile driver. The reactor incorporates a thorium-bearing fertile blanket designed to capture neutrons that would otherwise leave the core and to convert thorium-232 into fissile uranium-233 during operation. This uranium-fueled, thorium-augmented architecture is intended to diversify the nuclear fuel supply chain and improve lifetime uranium utilization while keeping the fuel and licensing pathway grounded in established uranium and TRISO-fuel infrastructure. Current analysis estimates that the architecture could reduce mined-uranium requirements by approximately half per unit of energy relative to a comparable Generation II light-water reactor. That estimate is subject to further engineering, design optimization and independent validation using qualified analysis codes. About Thorium Atomics Thorium Atomics Inc. is an advanced nuclear reactor developer with offices in Toronto, Ontario, and Knoxville, Tennessee. The company is developing the Tesseract TGR, a uranium-fueled, pebble-bed high-temperature gas-cooled reactor designed to provide firm electricity and high-temperature industrial process heat. Tesseract augments its uranium fuel cycle with a thorium-bearing fertile blanket intended to improve lifetime uranium utilization by breeding uranium-233 during operation. Thorium Atomics is conducting pre-application activities with the U.S. Nuclear Regulatory Commission and maintaining a parallel regulatory pathway with the Canadian Nuclear Safety Commission. Further information is available at thoriumatomics.com. Forward-Looking Statements This release contains forward-looking information within the meaning of applicable securities laws. Forward-looking information includes statements that are not statements of historical fact and may be identified by words such as “expects,” “anticipates,” “plans,” “estimates,” “believes,” “intends,” “may,” “could,” “would,” “might” or “will,” and similar expressions. Forward-looking information in this release includes statements concerning the company’s planned regulatory submissions and licensing strategy; the continued design and development of the Tesseract TGR; the company’s proposed engagement with national laboratories and other technical partners; anticipated reactor performance; fuel utilization; construction and deployment strategy; and the timing or outcome of regulatory, engineering and validation activities. Forward-looking information is based on assumptions that management considers reasonable in light of the information presently available. It is subject to known and unknown risks, uncertainties and other factors that may cause actual events, results or performance to differ materially from those expressed or implied. These risks and uncertainties include the timing and outcome of regulatory reviews; the availability of capital on acceptable terms; completion and results of engineering, testing and independent validation; future legislative and regulatory developments; availability of nuclear fuel, qualified suppliers and specialized personnel; intellectual-property risks; competition; general economic and market conditions; and other risks affecting the advanced nuclear industry. Forward-looking statements are made as of the date of this release. Thorium Atomics and its directors, officers and employees undertake no obligation to update forward-looking information as a result of new information, future events or otherwise, except as required by applicable law. There can be no assurance that forward-looking statements will prove accurate, and readers should not place undue reliance on them. This release does not constitute an offer to sell or the solicitation of an offer to purchase any securities and does not form part of any securities offering. No securities commission or other regulatory authority in Canada, the United States or any other jurisdiction has passed upon the information contained in this release. Media Contact Michael Cho Thorium Atomics Inc. media@thoriumatomics.com View the original release on www.newmediawire.com
GLENDALE, CA - August 6, 2026 (NEWMEDIAWIRE) - The Martial Arts History Museum, the world’s first and only museum dedicated to preserving martial arts history, is set to be featured on “LA in a Minute,” one of the internet’s premier Southern California culture and history series. Reminiscent of classic public television programming like Huell Howser’s California’s Gold, “LA in a Minute” offers fast-paced, deeply researched spotlights on the unique neighborhoods, rich history, and modern developments that define Los Angeles. Founded in 2022 by Evan Lovett - a California native, former Los Angeles Times writer, and NBC journalist - the platform aims to instill civic pride across Greater Los Angeles through concise, minute-long deep dives into local culture. In the upcoming episode, Lovett turns his camera on Glendale to uncover the Martial Arts History Museum, a hidden cultural gem in the region. The feature explores Southern California's rich connections to martial arts lore, highlighting legendary figures who built their legacies in the area - including Benny "The Jet" Urquidez, Chuck Norris, and Bruce Lee, who was famously discovered at the Long Beach International Karate Championships. “The museum offers a rare, educational glimpse into how Asian art, history, and culture intersect with the martial arts,” said Lovett. “It reveals the deep roots that world-renowned pioneers established right here in Los Angeles.” Audiences can stream the episode across "LA in a Minute" digital channels, including YouTube and Instagram. To learn more about the museum, plan a visit, or support its programs, visit official website at MAMuseum.com. View the original release on www.newmediawire.com
Seven transactions: three new investments (Hipp Technology Group, Bug Bounty Switzerland, TNL Group) and four disposals (including duagon and Kraft & Bauer) 26.1 million euros returned to shareholders via dividends and share buybacks; NAV per share as at 30 June 2026: 33.65 euros[1] (31 December 2025: 36.37 euros), negatively impacted by low valuation multiples for peer group companies as at the reporting date Robust performance by portfolio companies, with positive overall contributions to gross gains and losses on measurement and disposal EBITA from Fund Investment Services: 6.8 million euros (H1 2025: 7.1 million euros) Forecast for financial year 2026 adjusted on 16 July 2026, prompted by declining valuation multiples for peer group companies FRANKFURT AM MAIN, GERMANY - August 6, 2026 (NEWMEDIAWIRE) - Deutsche Beteiligungs AG (DBAG) showed a mixed picture in the first half of 2026. The robust operational performance of DBAG’s portfolio companies made positive overall contributions to DBAG’s gross gains and losses on measurement and disposal. At the same time, the valuation multiples for peer group companies – based on which DBAG values its portfolio companies – were down, which more than offset the operational progress that had been made. In view of this, DBAG adjusted its forecast for the financial year 2026 on 16 July 2026. Its available liquidity amounted to 96.7 million euros as at 30 June 2026 (31 December 2025: 103.1 million euros). Net asset value (NAV) per share was 33.65 euros as at the 30 June 2026 reporting date (31 December 2025: 36.37 euros). Net income totalled -34 million euros in the first half of 2026 (H1 2025: 8.2 million euros), driven largely by valuation-related effects. EBITA from Fund Investment Services amounted to 6.8 million euros (H1 2025: 7.1 million euros). DBAG allocated 90.5 million euros to new investments in the first half of 2026 and agreed upon or closed seven transactions: three acquisitions and four disposals. Seven transactions; 90.5 million euros for new investments DBAG agreed upon or closed seven transactions in the first six months of 2026, of which three were acquisitions and four disposals. The exits of duagon and Kraft & Bauer from DBAG Fund VII, which is advised by DBAG, were especially noteworthy. DBAG is working on further disposals with a view to raising funds for investing in high-growth companies and structuring new investments. Furthermore, in the first half of the year, DBAG provided 90.5 million euros for new investments. DBAG-advised DBAG Fund VIII acquired a majority stake in Hipp Technology Group via a management buyout, strengthening DBAG’s exposure to the fast-growing healthcare sector. DBAG also acquired a minority stake in Bug Bounty Switzerland as a Long-Term Investment, financing it exclusively from its own balance sheet. The Swiss company is a pioneer in AI-driven cybersecurity testing and protects organisations such as the Swiss National Cyber Security Centre. Furthermore, DBAG-advised DBAG ECF IV agreed to acquire a majority stake in the TNL Group via a management buyout. The TNL Group is a service provider that helps to drive the energy transition by securing environmental permits and providing construction services for power lines, wind and solar power projects, and traffic infrastructure. DBAG expects the transaction to be closed in the third quarter of 2026. Robust performance by portfolio companies Those factors that DBAG is able to influence directly developed positively. Its portfolio companies withstood the macroeconomic headwinds, making positive overall contributions to gross gains and losses on measurement and disposal. This also applied to our investments in the IT services and software sector. However, this positive performance was not enough to cushion the negative impact of declining valuation multiples for peer group companies. Shareholder-oriented distribution policy to continue A total of 26.1 million euros was returned to shareholders via dividends and share buybacks in the first six months of 2026. In the future, DBAG will continue to aim for a cash dividend of at least 1.00 euro per share every year and will also examine possible share buyback programmes on a regular basis. Geopolitical challenges take their toll on capital markets Fundamental geopolitical changes – such as the armed conflict in the Middle East, the disruption of one of the most important sea routes for global energy security, and the constant announcements of higher tariffs – are putting a strain on free global trade. This has a dampening effect on growth in Europe and exerts pressure on Germany’s export-driven economy. While the ongoing development of AI-based software solutions is enabling significant productivity gains for many business models in the IT sector, it is threatening the very foundations of others. As a result, the valuation multiples for peer group companies were down in the period under review, which in turn had a negative impact on DBAG’s net gains and losses on measurement and disposal. “From an operational perspective, our portfolio companies generated positive earnings contributions in the first half of the year, but this was more than offset by lower valuation multiples for peer group companies in certain sectors. That is why we revised our forecast for 2026 on 16 July,” says Tom Alzin, Spokesman of the Board of Management of Deutsche Beteiligungs AG. “That makes no difference to our course: we still invest where we see structural growth and sell when the conditions are right. It is precisely during periods like these that attractive opportunities for sustainable value growth present themselves.” [1] Number of shares outstanding as at 30 June 2026: 17,240,951 Contact: Brigitte Friedrich-Haack Director Shareholder Relations Email: brigitte.friedrich-haack@dbag.de Telephone: +49 69 95787 293 View the original release on www.newmediawire.com
Increase in Group revenues to EUR 24.6 million in the first quarter of 2026/2027 Full-year 2026/2027 forecast confirmed Revenues for the quarter boosted by top releases under new and established imprints COLOGNE, GERMANY - August 6, 2026 (NEWMEDIAWIRE) - Bastei Lubbe AG, a general-interest publishing group listed in the Prime Standard of the Frankfurt Stock Exchange (ISIN DE000A1X3YY0), entered its 2026/2027 financial year with higher revenues despite the persistently muted conditions in the German book market. In the period from April to June 2026, Group revenues totalled EUR 24.6 million. Group EBIT amounted to EUR 1.1 million in the reporting period, translating into an EBIT margin of 4.4%. Soheil Dastyari, CEO of Bastei Lubbe AG: “Once again, we were able to boost our revenues and also make significant progress in terms of profitability compared to the previous quarter. We will be systematically continuing on this trajectory as the year progresses.” The good revenue performance of the classic formats in the first quarter was particularly encouraging. Against this backdrop, the proportion of revenues contributed by the community-driven business models contracted to 24 percent in the first three months of the 2026/2027 financial year, down from 31 percent in the same period of the previous year. The share of digital products in revenues reached 35 percent in the period under review (previous year: 38 percent). Revenues boosted by top releases under new and established imprints Although the persistently tense situation in the book market left traces on all parts of the portfolio, Bastei Lubbe AG recorded solid revenue growth in the first quarter of 2026/2027. Revenues of EUR 22.9 million (previous year: EUR 21.4 million) were achieved in the “Book” segment, with the new “Pfaueninsel” imprint and the classic “Lübbe” imprint in particular performing well. In the case of “Pfaueninsel”, this was mainly due to the great success of the new top release and SPIEGEL bestseller “Traume aus Feuer” by Florian Illies, which has remained in the top ten since being published, even achieving top place on repeated occasions. Another permanent fixture among the top titles on the SPIEGEL bestseller list was Lucy Astner’s novel “Kein Sommer ohne August” under the Lubbe imprint. The strong paperback edition of Ken Follett’s novel “The Armour of Light” and Eva Almstadt’s crime thriller “Akte Nordsee – Die letzte Predigt” also contributed to the “Lubbe” imprint’s strong showing. Segment EBIT came to EUR 1.0 million, down from EUR 1.2 million in the same quarter of the previous year. In the “Novel Booklets” segment, revenues rose slightly to EUR 1.7 million in the period under review, up from EUR 1.6 million in the previous year. Segment EBIT improved to EUR 0.1 million in the first three months of the 2026/2027 financial year (previous year: EUR 0.0 million). Higher costs leaving traces on earnings At EUR 12.4 million in the period under review, the cost of materials was up on the previous year (EUR 10.6 million). This is primarily attributable to increased printing costs ahead of the new releases in the coming quarters. Personnel expenses climbed from EUR 5.7 million in the previous year to EUR 6.1 million. In addition to scheduled salary adjustments, this is also due to the higher number of employees as a result of vacant positions being filled at Bastei Lubbe AG. Consolidated earnings before taxes (EBT) came to EUR 1.0 million in the first three months of 2026/2027 (previous year: EUR 1.2 million). The consolidated net profit for the period attributable to the shareholders of Bastei Lübbe AG totalled EUR 0.7 million in the reporting period (previous year: EUR 0.8 million). Accordingly, earnings per share stood at EUR 0.05 (previous year: EUR 0.06). As of 30 June 2026, total Group assets were valued at EUR 107.2 million, down from EUR 109.0 million as of 31 March 2026. The balance sheet structure was largely stable. At EUR 66.4 million on 30 June 2026, the share of equity attributable to the equity holders of the parent company was EUR 0.7 million higher than on 31 March 2026 (EUR 65.7 million). Full-year forecast confirmed Compared to the information provided in the annual report for the 2025/2026 financial year, the forecast for the 2026/2027 financial year is unchanged. The Executive Board continues to expect revenues in a range of EUR 118 - 122 million and EBIT of EUR 10.0 - 12.0 million. The Group’s profitability has already improved noticeably since the fourth quarter of 2025/2026 and is thus approaching the target. Bastei Lubbe AG’s interim statement for the first three months of the 2026/2027 financial year is available at www.bastei-luebbe.de. About Bastei Lubbe AG: Bastei Lubbe AG is the leading independent publishing group in Germany. Based in Cologne, it publishes books, audio books and e-books featuring high-quality popular entertainment as well as periodical novel booklets. In total, the Company owns more than 14 imprints. Bastei Lubbe sees itself as an innovation driver in the industry and has successfully established several rapidly expanding community-driven business models, among other things. Bastei Lubbe AG is also a pioneer of digital media, producing thousands of audio and eBooks, which are distributed via all digital exploitation channels. The Group generates annual revenues of over EUR 118 million (2025/2026 financial year). Its shares have been listed in the Prime Standard of the Frankfurt Stock Exchange (WKN A1X3YY, ISIN DE000A1X3YY0) since 2013. Further information can be found at www.bastei-luebbe.de. Contact Bastei Lubbe AG: Julia Kikillis Head of Press and Public Relations Phone: +49 (0)221 8200 2850 E-Mail: julia.kikillis@bastei-luebbe.de View the original release on www.newmediawire.com
Group sales amounted to EUR 35.0 million (H1 2025: EUR 34.4 million) Industry & Infrastructure grew strongly in the second quarter EBIT negative at minus EUR 1.1 million (H1 2025: minus EUR 1.3 million) Orders on hand above the prior-year level at EUR 81.4 million (June 30, 2025: EUR 76.7 million) PASSAU, GERMANY - August 6, 2026 (NEWMEDIAWIRE) - InTiCa Systems SE (Prime Standard, ISIN DE0005874846, ticker IS7) today published the interim report for the first six months of 2026. Group sales were still up slightly at the end of the first six months and earnings indicators also improved slightly. Overall, however, the Group reported a significant loss for the period. Dr. Gregor Wasle, CEO of InTiCa Systems SE, on the company’s business performance: “The challenging market conditions for automotive producers have not spared InTiCa Systems SE in the second quarter. However, this was more than offset by significant growth in business with inverters and charging systems in the Industry & Infrastructure segment. On the earnings side, InTiCa is affected by the hike in copper prices and the increase in the price of precursors that are dependent on the oil price, such as plastics and enamelled copper wire. This overshadows successful measures to reduce costs and enhance productivity.” Earnings, asset and financial position Group sales increased by 1.5% year-on-year to EUR 35.0 million in the first six months of 2026 (H1 2025: EUR 34.4 million). In the Mobility segment, sales fell by 6.4% to EUR 30.0 million following a weaker second quarter (H1 2025: EUR 32.0 million). By contrast, the Industry & Infrastructure segment posted significant growth compared with the low level of the previous year. Sales of EUR 5.0 million correspond to a rise of 104.8% compared to the first half of 2025 (H1 2025: EUR 2.4 million). The ratio of material costs to total output increased significantly to 61.1% in the reporting period (H1 2025: 57.2%). The change was primarily due to the sharp rise in copper prices. The personnel expense ratio (including agency staff) also increased slightly from 23.2% to 23.6%. Other operating expenses decreased to EUR 4.3 million (H1 2025: EUR 5.2 million). EBITDA (earnings before interest, taxes, depreciation and amortization) was up year-on-year at EUR 2.0 million (H1 2025: EUR 1.9 million). As a result, the EBITDA margin of 5.8% was slightly above the previous year's level (H1 2025: 5.6%). At minus EUR 1.1 million EBIT (earnings before interest and taxes) was negative again (H1 2025: minus EUR 1.3 million). At segment level, Mobility reported EBIT of minus EUR 1.1 million in the first six months of 2026 (H1 2025: minus EUR 0.7 million) while the Industry & Infrastructure segment reported a positive EBIT of EUR 0.1 million (H1 2025: negative EBIT of minus EUR 0.6 million). The financial result was minus EUR 0.7 million in the reporting period (H1 2025: minus EUR 0.8 million). Tax income of EUR 2 thousand was registered in the reporting period (H1 2025: tax income of EUR 13 thousand). Group net income was therefore minus EUR 1.8 million in the first six months of 2026 (H1 2025: minus EUR 2.1 million). Earnings per share were minus EUR 0.42 (H1 2025: minus EUR 0.49). The net loss also had a negative impact on cash flow in the reporting period. Both, the net cash outflow for operating activities of EUR 0.6 million (H1 2025: inflow of EUR 2.8 million) and total cash outflow of minus EUR 0.1 million (H1 2025: minus EUR 0.9 million) were negative. Consequently, liquidity management still has very high priority. Due to the increase in current financial liabilities, the equity ratio decreased in the reporting period but at 28.0%, it is still at a solid level (December 31, 2025: 32.1%). Outlook The macroeconomic environment is still dominated by numerous risk factors. Despite the challenging environment, orders on hand stabilized. At the end of the first half of the year, they were above the prior-year level at EUR 81.4 million (June 30, 2025: EUR 76.7 million). 93% of orders were for the Mobility segment (June 30, 2025: 92%). In the first six months, new orders were mainly for inverter components. In the Mobility segment, extending the term of contracts is a recurrent issue as a result of European manufacturers’ model policies. It remains to be seen whether the stabilization of the order situation is sustained. Adjustments are to be expected, especially in the fourth quarter. Friedrich Erfuth of the Board of Directors on the outlook for the InTiCa Systems Group: “The development of orders and the volatility of order offtake were in line with expectations and liquidity is protected by the standstill agreements with the banks. We are consistently continuing the transformation we have initiated through diversification, specialization and localization. The focus on electric motors and EMC filters will be stepped up further in the second half of the year, with increased attention being paid to the new areas of business. The local-to-local approach still plays an important role, especially in North America.“ At present, the Board of Directors still assumes that, taking into account the ongoing high uncertainty for the 2026 financial year, Group sales will be between EUR 68.0 million and EUR 73.0 million, while EBIT will be between minus EUR 1.5 million and minus EUR 2.5 million, corresponding to an EBIT margin between -2,1% and -3.7%. Where possible, the material cost ratio should be optimized further in both segments and the equity ratio should remain stable. The assumptions underlying the forecast for 2026 are that the cyclical trend does not deteriorate further, the geopolitical and trade policy conflicts do not escalate further, no new conflicts emerge and financing is ensured. However, unforeseeable negative effects could affect suppliers, have a direct impact on InTiCa Systems, or affect its customers, resulting in an inability to meet or fully meet expectations. The complete interim report for H1 2026 is available for download from the Investor Relations section of InTiCa Systems’ website at www.intica-systems.com. InTiCa Systems SE The Board of Directors CONTACT Dr. Gregor Wasle | CEO TEL +49 (0) 851 – 966 92 – 0 FAX +49 (0) 851 – 966 92 – 15 EMAIL investor.relations@intica-systems.com About InTiCa Systems InTiCa Systems SE is an international provider of electronic components and systems. Its innovative solutions for the automotive industry, renewable energy, industrial applications and other sectors make a contribution to a more sustainable, networked future. You can find further information at www.intica-systems.com. Forward-looking statements and predictions This press release contains statements and forecasts referring to the future development of InTiCa Systems SE which are based on current assumptions and estimates by the management that are made using information currently available to them. If the underlying assumptions do not materialize, the actual figures may differ substantially from such estimates. Future developments and results are in fact dependent on a large number of factors; they contain different risks and imponderables and are based on assumptions that may not be accurate. We neither intend nor assume any obligation to update forward-looking statements on an ongoing basis as these are based exclusively on the circumstances prevailing on the date of publication. View the original release on www.newmediawire.com
STEYR, AUSTRIA - August 6, 2026 (NEWMEDIAWIRE) - Steyr Motors AG (ISIN AT0000A3FW25), one of the world's leading companies in the field of customized engines for mission-critical defense and civil applications, will publish its Half-Year Report 2026 on August 19, 2026. On the same day, the Company will host an Earnings Call at 10:00 a.m. (CEST). The Earnings Call will be hosted by Julian Cassutti (CEO) and Bjorn Krausmann (CFO). They will present the results for the first half of 2026, provide an outlook for the remainder of the year, and give an overview of Steyr Motors' business performance. The presentation will be followed by a Q&A session. The Earnings Call will be held in English. To participate in the Earnings Call, please register here: https://webcast.meetyoo.de/reg/RztXfrLA2T49 All participants will be muted during the presentation. Participants wishing to ask a question may do so during the Q&A session following the presentation. Prior to the start of the Earnings Call, the unaudited Half-Year Report 2026 and the presentation will be available on the Company's website at: https://ir.steyr-motors.com/en/publications/ Company profile of Steyr Motors AG Headquartered in Steyr, Austria, Steyr Motors AG is a global leader in the development and production of high-performance customized special engines with high power density and durability. The Company’s engines are primarily used for military special vehicles, boats (both military and civilian) and as auxiliary power units (“APU”) for main battle tanks and locomotives. For further information, please contact: Steyr Motors AG Investor Relations Phone: +436766222367 E-mail: ir@steyr-motors.com www.steyr-motors.com Press Contact in Germany, Austria, Switzerland CROSS ALLIANCE communication GmbH Susan Hoffmeister Phone: +49 89 125 09 0333 E-mail: sh@crossalliance.de www.crossalliance.de View the original release on www.newmediawire.com
Targeted investment by the Group in expansion of regional health networks Number of patients treated rose by 9 percent with revenues at EUR 863.6 million. Upcoming reforms shape further strategic direction and investment capacity BAD NEUSTADT, GERMANY - August 6, 2026 (NEWMEDIAWIRE) - RHON-KLINIKUM AG reports another stable business performance in the first half of 2026. Consolidated revenue of EUR 863.6 million slightly exceeded the previous year’s level (H1 2025: EUR 833.5 million), and EBITDA was EUR 57.0 million (H1 2025: EUR 46.7 million). Consolidated profit totalled EUR 22.5 million (H1 2025: EUR 14.7 million). The result was marked to a significant extent by the immediate transformation costs established until November 2026 to offset higher personnel and material costs in the previous years. From January to June a total of 513,700 patients were treated on an outpatient and inpatient basis in the Group’s hospitals and medical care centres - an increase of 9% (H1 2025: 471,295). The sites are continuously evolving to expand and improve regional healthcare provision. In addition to the major investments in state-of-the-art medical technology planned for 2026 at all sites, medical and therapeutic care offerings are being further expanded and regional cooperation networks established. In Hesse, for example, Universitatsklinikum Marburg and the pulmonary clinic Lungenfachklinik Immenhausen are pooling their expertise. The purpose of this strategic partnership is to effectively promote the care of lung patients by working together. Parallel to these developments, the care network in Brandenburg is growing. With the newly opened child protection emergency service at the RHON-KLINIKUM Frankfurt (Oder) site, a strong regional network has been created. The newly signed cooperation agreements between the hospital, the City of Frankfurt (Oder) and the District of Oder-Spree ensure close, inter-institutional collaboration to seamlessly coordinate fast and effective help for affected children and adolescents. Dr. Gunther K. WeiB, member of the Board of Management of RHON-KLINIKUM AG: “Regional networks form a vital and essential part of any future healthcare system. Rigid sectoral boundaries make it more difficult to provide patients with the care they need and saddle our healthcare system with unnecessary costs. It is only when general practitioners, specialists, medical facilities, nurses and therapists work together as a team that we can pool our resources efficiently. In the face of mounting pressures, such collaboration across providers is the only way to ensure comprehensive and high-quality care to patients, especially in rural areas.” Dr. Stefan Stranz, member of the Board of Management of RHON-KLINIKUM AG: “The Statutory Health Insurance Contribution Rate Stabilization Act imposes further burdens on hospitals. Instead of reducing bureaucracy and refocusing on patient care, the reform saddles already overburdened hospitals with even more documentation requirements, excessive budget cuts, and financial risks.” Outlook for 2026 For the current financial year, we expect revenues of EUR 1.7 billion within a range of plus or minus 5%. For earnings before interest, tax and depreciation/amortisation (EBITDA), we expect a level of between EUR 110 million and EUR 125 million. In addition to financial performance indicators, we also take account of the non-financial performance indicators of number of cases and cost weights in the management of the company and expect these to show a moderate improvement over the previous year. The financial year will be significantly impacted by the unfolding legislation process and the considerable uncertainties it holds. Particularly, the Hospital Reform Adjustment Act (Krankenhausreformanpassungsgesetz, KHAG) that entered into force on 15 April 2026 and the Statutory Health Insurance (SHI) Contribution Rate Stabilisation Act (GKV-Beitragsstabilisierungsgesetz, GKV-BstabG) (GKV-BStabG) adopted by the German Federal Parliament on 10 July 2026 seek to further enhance quality and efficiency in the healthcare system, but at the same time will put hospitals under greater financial pressure in the short term. The company’s forecast is therefore subject to particular uncertainties. It is not yet possible at this time to reliably forecast what overall impact the ongoing regulatory interference, the implementation of the hospital reform as well as further possible adjustments by the legislator will have. On top of that, the ongoing global crises and negative economic impacts are resulting among other things in higher prices, supply bottlenecks and general market volatility. This Interim Report – Report on the First Half of 2026 – is published on the Internet . CONTACT RHON-KLINIKUM AG | Head of Group Finance Norman Dittes | T. +49 9771 65-12210 | norman.dittes@rhoen-klinikum-ag.com RHON-KLINIKUM AG | Corporate Communications Heike Ochmann | T. +49 9771 65-12130 | heike.ochmann@rhoen-klinikum-ag.com RHON-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale RHON-KLINIKUM AG is one of the largest healthcare providers in Germany, with five highly specialised maximum- and intermediate-care facilities: Campus Bad Neustadt, Zentralklinik Bad Berka, Klinikum Frankfurt (Oder) as well as the Giessen and Marburg University Hospitals (UKGM). As a modern, diverse and future-oriented Company, RHON-KLINIKUM AG is attractive both as a provider of training and an employer. With over 19,100 employees, the Group offers excellent medical care with a direct tie-in to research and teaching. Each year, we treat a total of 938,000 patients at our hospitals and medical care centres (MVZs) on an outpatient and inpatient basis. Die RHON-KLINIKUM AG is a company of the ASKLEPIOS Group. www.rhoen-klinikum-ag.com View the original release on www.newmediawire.com
Digital Asset Security Issued by Zion Peaks, Inc. Advances From Primary Issuance to Secondary Trading on the tZERO Securities ATS NEW YORK, NY - August 6, 2026 (NEWMEDIAWIRE) - tZERO Group, Inc., a leader in blockchain-based financial infrastructure, announces that the digital asset security issued by Zion Peaks, Inc., a wholly owned subsidiary of Bed Bath & Beyond, Inc. (NYSE: BBBY) - the buybuy BABY® Intellectual Property Token - is now accepting orders on the tZERO Securities Alternative Trading System (ATS), with trading expected to commence on August 12, 2026. The security, known as the “BABY” Digital Token, is linked to certain intellectual property associated with the buybuy BABY brand. It was initially offered through a Regulation Crowdfunding (Reg CF) primary issuance conducted exclusively on the tZERO platform in 2025. With the commencement of secondary trading, eligible investors will be able to transact the security on tZERO’s regulated marketplace, providing an avenue for liquidity and price discovery following the completion of the primary offering. The BABY Digital Token is designed to connect brand affinity with economic participation. Holders are entitled to receive an annual pro rata dividend derived from 1% of net sales from buybuyBABY.com, subject to Zion Peaks’ lawful ability to pay and declaration of the dividend. “This transition from primary issuance to regulated secondary trading demonstrates how tokenization can support an asset throughout its lifecycle,” said Alan Konevsky, Chief Executive Officer of tZERO. “By combining capital formation, digital issuance and secondary liquidity within regulated infrastructure, tZERO enables issuers to bring new categories of investable assets to market and establish an ongoing connection with their investor communities.” Zion Peaks is tokenizing intellectual property tied to the buybuy BABY brand through a model intended to allow token holders to share in brand-related revenues while becoming engaged customers and advocates for the brand. tZERO’s regulated infrastructure supported the BABY Digital Token’s initial capital raise and now facilitates its transition to secondary trading. The addition of the security to the tZERO Securities ATS further demonstrates the platform’s ability to support the complete lifecycle of tokenized securities and a broad range of asset types, including intellectual property-linked investments. Eligible investors can learn more and access trading here. tZERO MEDIA CONTACT: Julie Ros, Head of Marketing & Communications jros@tzero.com About tZERO Group, Inc. tZERO Group, Inc. (tZERO) and its broker-dealer subsidiaries provide an innovative liquidity platform for private companies and assets. We offer institutional-grade solutions for issuers looking to digitize their capital table through blockchain technology, and make such equity available for trading on an alternative trading system. tZERO, through its broker-dealer subsidiaries, democratizes access to private assets by providing a simple, automated, and efficient trading venue to broker-dealers, institutions, and investors. All technology services are offered through tZERO Technologies, LLC. For more information, please visit our website. About tZERO Digital Asset Securities, LLC tZERO Digital Asset Securities, LLC is a broker-dealer registered with the SEC and a member of FINRA and SIPC. It is the broker-dealer custodian of all digital asset securities offered on tZERO’s online brokerage platform. Digital asset securities may not be “securities” as defined under the Securities Investor Protection Act (SIPA)-and in particular, digital asset securities that are “investment contracts” under the Howey test but are not registered with the Securities and Exchange Commission are excluded from SIPA’s definition of “securities”-and thus the protections afforded to securities customers under SIPA may not apply. More information about tZERO Digital Asset Securities may be found on FINRA’s BrokerCheck. About tZERO Securities, LLC tZERO Securities, LLC is a broker-dealer registered with the SEC and a member of FINRA and SIPC. It is the operator of the tZERO Securities ATS. More information about tZERO Securities may be found on FINRA’s BrokerCheck. Investor Notice Digital asset securities, as well as any particular investment, may not be suitable or appropriate for everyone. Investors should note that investing or trading in securities could involve substantial risks, including no guarantee of returns, costs associated with selling and purchasing, and no assurance of liquidity which could impact their price and investors’ ability to sell, and possible loss of principal invested. There is always the potential of losing money when you invest in securities. There are also unique risks specific to digital asset securities, including, without limitation, fraud, manipulation, theft, and loss. No Offer, Solicitation, Investment Advice or Recommendations This release is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, nor does it constitute an offer to provide investment advisory or other services by tZERO, Bed Bath & Beyond, Inc., or any of their respective affiliates, subsidiaries, officers, directors or employees. No reference to any specific security constitutes a recommendation to buy, sell, or hold that security or any other security. Nothing in this release shall be considered a solicitation or offer to buy or sell any security, future, option or other financial instrument or to offer or provide any investment advice or service to any person in any jurisdiction. Nothing contained in this release constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed in this release should not be taken as advice to buy, sell or hold any security. In preparing the information contained in this release, we have not taken into account the investment needs, objectives, and financial circumstances of any particular investor. This information has no regard to the specific investment objectives, financial situation, and particular needs of any specific recipient of this information and investments discussed may not be suitable for all investors. Any views expressed in this release by us were prepared based upon the information available to us at the time such views were written. Changed or additional information could cause such views to change. All information is subject to possible corrections. Information may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances. Forward-Looking Statements This release contains forward-looking statements. In addition, from time to time, tZERO, its subsidiaries, or its representatives may make forward-looking statements orally or in writing. These forward-looking statements are based on expectations and projections about future events, which is derived from currently available information. Such forward-looking statements relate to future events or future performance, including financial performance and projections; growth in revenue and earnings; and business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including, without limitation: the ability of tZERO and its subsidiaries to change the direction; tZERO’s ability to keep pace with new technology and changing market needs; performance of individual transactions; regulatory developments and matters; and competition. These and other factors may cause actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or their respective representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions. tZERO, its subsidiaries, and its representatives are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or its representatives might not occur. This press release is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any security. The securities described herein are subject to qualification by the U.S. Securities and Exchange Commission under Regulation A+ (Tier 2) and have not yet been so qualified. No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is qualified, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance given after the date of qualification. A person's indication of interest involves no obligation or commitment of any kind.
A key acquisition brought in the Skaergaard project, a palladium, gold and platinum deposit in southeast Greenland now held through the company’s subsidiary Major Precious Greenland A/S. Additional acquisitions, including a rare earths asset, represent the company’s focus on becoming a significant player in the mining space. LOS ANGELES, CA - August 6, 2026 (NEWMEDIAWIRE) - A company can rarely reinvent itself overnight, but Greenland Mines (NASDAQ: GRML), has come close. What started the year as a biotech firm has become a two-division mining company in the span of a few months, and its acquisition activity since then shows no sign of slowing. Previously known as Klotho Neurosciences Inc., the company traded under the ticker KLTO. In March 2026, however, the company announced two significant changes: a name change to Greenland Mines Ltd and a NASDAQ ticker switch to GRML. In addition, the announcement noted a strategic acquisition that shifted the company’s core focus. The filing was announced… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
The company has advanced its VXA-222 bispecific antibody-drug conjugate (“bsADC”) program into the next stage of development following completion of the discovery phase with OmniAb. OmniAb delivered a portfolio of therapeutic antibody binders, with VERAXA now responsible for engineering the final bispecific ADC candidate and advancing preclinical validation. Although VXA-222 is not based on VERAXA’s BiTAC platform, it leverages the company’s proprietary antibody engineering, linker and conjugation technologies and represents one of its more advanced development programs. VERAXA recently expanded its intellectual property portfolio with its first BiTAC-related patent filings alongside additional patents supporting conjugation chemistry, payloads and antibody technologies. The company now holds more than 50 granted owned or exclusively licensed patents across 26 patent families in 14 countries, with newly filed applications expected to extend protection into at least 2047. VERAXA continues building a diversified oncology pipeline spanning bispecific antibody-drug conjugates, T-cell engagers, and engineered antibody formats targeting difficult-to-treat cancers. LOS ANGELES, CA - August 6, 2026 (NEWMEDIAWIRE) - VERAXA (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has reached another development milestone in its oncology pipeline, announcing that its VXA-222 bispecific antibody-drug conjugate (“bsADC”) program has advanced beyond the discovery phase and into the next stage of development. The milestone reflects continued progress across the company’s therapeutic portfolio as it simultaneously expands the intellectual property supporting its next generation of antibody-based cancer therapies. The announcement marks the successful completion of the discovery portion of VERAXA’s collaboration with OmniAb Inc., which began in May 2025 (https://nnw.fm/nIprz). With the discovery work completed, VERAXA will now focus on building the final therapeutic candidate by combining the antibody binders identified through the collaboration with its own… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to VRXA are available in the company’s newsroom at https://ibn.fm/VRXA Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
Manufacturing, Regulatory, Clinical and Preclinical Milestones Completed in Support of Scheduled Fourth Quarter 2026 Initiation of Pivotal Immune-Bridging Study ATLANTA, GA - August 6, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and solid tumors, today announced the completion of key manufacturing, regulatory, clinical and preclinical milestones supporting the initiation of its pivotal Phase 3 GEO-MVA immune-bridging study, scheduled to initiate in the fourth quarter of 2026. "Completion of these milestones marks a significant inflection point for the GEO-MVA program as we prepare to initiate our pivotal immune-bridging study later this year," said David A. Dodd, Chairman and Chief Executive Officer of GeoVax. "We have systematically executed the manufacturing, regulatory, clinical and scientific activities required to support successful study completion, preparing for regulatory registration and ultimate commercialization." Dodd continued, "Of special note, we recently completed a comparative nonclinical immunogenicity study evaluating GEO-MVA alongside the licensed MVA vaccine, Imvanex®, using both binding antibody and neutralizing antibody assays. The study demonstrated that GEO-MVA generated robust orthopoxvirus-specific immune responses. These findings further strengthen our confidence in GEO-MVA as we prepare to initiate our pivotal immune-bridging study later this year. Together with our manufacturing progress and favorable regulatory interactions, these data continue to support advancement of GEO-MVA into pivotal clinical evaluation. “With GMP clinical product available and released, an expedited regulatory pathway established, clinical operations progressing and encouraging preclinical immunogenicity data in hand, we believe completion of these integrated milestones has substantially de-risked GEO-MVA and positions the program to advance into the Phase 3 study." GEO-MVA is being developed to expand global manufacturing capacity for non-replicating MVA vaccine, supporting government preparedness programs and future procurement opportunities for this critically needed mpox/smallpox vaccine. Key Development Milestones Manufacturing Readiness: Successfully manufactured, filled, packaged and released GMP clinical product for use in the pivotal immune-bridging clinical study, completing a key requirement for clinical development. Regulatory Alignment: Development strategy aligned with European Medicines Agency (EMA) Scientific Advice supporting an expedited immune-bridging pathway comparing GEO-MVA with the licensed MVA-BN vaccine. Clinical Readiness: Advanced clinical operations through CRO engagement, and clinical site identification, supporting planned initiation of the targeted 500-participant study in the fourth quarter of 2026. Preclinical Immunogenicity: A preclinical study generated neutralizing antibody data for GEO-MVA and MVA-BN that support the planned immune-bridging clinical strategy. Commercial & Procurement Planning: In parallel with clinical development, GeoVax continues active discussions with government agencies and international preparedness organizations regarding future procurement opportunities and long-term MVA vaccine supply requirements. GeoVax expects initiation of its targeted 500-participant immune-bridging clinical study during the fourth quarter of 2026. The study is designed to compare immune responses generated by GEO-MVA with those of the licensed MVA-BN vaccine using established neutralizing antibody endpoints. The Company expects to report results in mid-2027. Additional CEO Commentary GeoVax Chairman and Chief Executive Officer David Dodd provides additional context on the GEO-MVA development milestones, manufacturing readiness and planned Phase 3 study initiation. Watch the video here: https://www.youtube.com/watch?v=oxB4C1MPzm0 About GEO-MVA GEO-MVA is GeoVax's Modified Vaccinia Ankara (MVA)-based vaccine being developed for protection against mpox and smallpox. Following Scientific Advice from the European Medicines Agency (EMA), the program is advancing under an expedited immune-bridging clinical development strategy designed to compare immune responses generated by GEO-MVA with those of the licensed MVA-BN vaccine. GeoVax is developing GEO-MVA to expand global access to MVA vaccine supply, scalable production capabilities, and a capital-efficient regulatory pathway. The Company believes GEO-MVA has the potential to become an important strategic preparedness asset by providing governments and international public health organizations with an additional, reliable source of MVA vaccine to support biosecurity and orthopoxvirus preparedness. About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company focused on the development of vaccines and immunotherapies addressing high-consequence infectious diseases and solid tumor cancers. GeoVax’s priority program is GEO-MVA, a Modified Vaccinia Ankara (MVA)–based vaccine targeting mpox and smallpox. The program is advancing under an expedited regulatory pathway, with plans to initiate a pivotal Phase 3 clinical trial in the second half of 2026, to address critical global needs for expanded orthopoxvirus vaccine supply and biodefense preparedness. In oncology, GeoVax is developing Gedeptin®, a gene-directed enzyme prodrug therapy (GDEPT) designed to enhance immune checkpoint inhibitor activity. Gedeptin has completed a multicenter Phase 1/2 clinical trial in advanced head and neck cancer and is being advanced into combination strategies, including planned neoadjuvant and first-line settings. GeoVax maintains a global intellectual property portfolio supporting its infectious disease and oncology programs and continues to evaluate strategic partnerships and funding opportunities aligned with its development priorities. For more information, visit www.geovax.com. Forward-Looking Statements This release contains forward-looking statements regarding GeoVax’s business plans. The words “believe,” “look forward to,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax’s immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax’s immuno-oncology products and preventative vaccines will be safe for human use, GeoVax’s vaccines will effectively prevent targeted infections in humans, GeoVax’s immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax’s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Company Contact: info@geovax.com 678-384-7220 Media Contact: Jessica Starman media@geovax.com View the original release on www.newmediawire.com
SASKATOON, SASKATCHEWAN - August 6, 2026 (NEWMEDIAWIRE) - Omineca Mining and Metals Ltd. (TSXV: OMM) (OTCQB: OMMSF) ("Omineca" or the "Company") is pleased to announce the discovery of a hard rock (“lode”) gold zone from the 2025 winter drill program results at the Wingdam gold exploration program located in the Cariboo Mining District in south-central British Columbia. The initial gold intercepts, drilled 500 meters west of and at depths lower than the elevation of our Wingdam underground paleoplacer gold project, validate our assertion of a proximal lode source for the rich paleoplacer gold found beneath Lightning Creek. These results coincide with recent empirical evidence in the underground placer workings that Lightning Creek flowed from west to east (opposite its present direction) when the gold was eroded into the valley, indicating that the source lies downstream of the placer deposits. Omineca’s ongoing exploration program will focus on expanding the footprint of this discovery with details to be announced once finalized. Highlights include: - WD25-41, 4.84 g/t gold from 158.98-160.05 meters (1.07 meters) (Photo 1) - WD25-42, 1.25 g/t gold from 345.00-347.00 meters (2.0 meters). Photo 1: Core WD25-41 (158.98-160.05 m). 165 years after placer gold was first discovered in the Lightning Creek valley, Omineca has now discovered a lode source that can explain the incidence of autochthonous (close distance from source) placer gold in the rich paleoplacer deposit. The well-known structural relationship between ophiolites (the ancient sea floor thrust upward) and orogenic gold deposits in British Columbia is of particular interest at Wingdam given that the Slide Mountain Terrane (dominant in ophiolites) is well preserved along the Eureka Thrust Fault in the immediate area of Wingdam. The highest grade intercept from this program was found in a section of amygdaloidal basalt associated with the Slide Mountain Terrain. These ultramafic oceanic crustal rocks are affiliated with many of British Columbia’s orogenic gold camps, including, but not limited to, the Barkerville Gold (Osisko Development) camp 30 kilometers east of Wingdam, the Cassiar gold camp in northern B.C., the historic Bralorne mining camp to the west, and the Greenwood Mining District in southern B.C., all of which are structurally associated with ophiolitic seafloor rocks. The Hard Rock Source of the Rich Placer Gold Beneath Lightning Creek The Company’s exploration thesis is based on evident changes in the watershed flow direction caused by isostatic depression of the crust under the tremendous weight of the Cordilleran glacial ice sheet. This weight pushed down the area to the west of Wingdam enough to cause the Fraser River to switch from northerly flow to its present southern course some 760,000 years ago and later, approximately 200,000 years ago, Lightning Creek to change from flowing east to flowing west. These forces combined with the potential re-activation and subsidence of the Eureka Thrust Fault explain why the recently identified lode source of the rich placer gold beneath Lightning Creek is located downstream (west) at depths equivalent to and below the level of the Wingdam underground placer project workings, where 173.4 ounces of placer gold was recovered from a single 2.4 meter wide, 2.4 meter high and 23.5-meter-long crosscut sample in 2012. The reversed water flow thesis has now been confirmed in Omineca’s underground workings. The opening of Crosscut #2 viewed as a cross section looking north (see Pictures) shows the imbrication (overlapping arrangement of pebbles and cobbles) in the brown gravel layer indicating the water flow was left to right (west to east) along the Lightning Creek valley in a direction now reversed to the present flow direction west. Pictures: Imbrication Diagram • Crosscut #2 Imbrication The 2025 Drill Program A total of 3,091.9 meters was completed in 6 NQ diamond drill holes at the Wingdam gold exploration project during the 2025 season. Drilling was completed by Newmac and the core was logged and sampled by TerraLogic Exploration of Cranbrook, BC. A total of 1978 drill core samples and 179 QA/QC samples were collected. The 2025 drill program was designed to follow up on mineralization found in the 2024 program, with continuation drilling further to depth at elevations below the Wingdam underground placer workings, specifically in areas downdip of mineralization in the ultramafic unit intersected in WD24-37. Additional drilling was conducted southeast of WD24-37 along strike of the mapped Eureka Thrust Fault toward the UAV (unmanned aerial vehicle) magnetic high. WD25-41 was drilled at a northward azimuth (see Map 1) and was a downdip follow-up hole of WD24-37, which aimed to test the most anomalous gold results from the 2024 season. The anomalous gold concentrations (870.00 ppb Au from 93.40 to 95.40 m) were in a brecciated and faulted ultramafic amygdular basalt. WD24-37 also intersected veining deeper in the hole along the transition from a magnetic high to low as outlined by the drone mag survey completed in 2024. WD25-41 aimed to re-test all of these features and intersected the most anomalous gold result in diamond drilling on the Property to date from 158.9 to 160.05 meters (1.07 meters) returning 4.84 g/t gold (Sample F722656, Photo 1). This sample displayed localized fracturing and contained 2.0-6.0 cm calcite-quartz veins and disseminated pyrite traces in the groundmass. Maps: 2025 Drill Holes. • Topographic • Geophysics • Eureka Thrust Fault WD25-42 (see Map 1) was drilled from the same pad as WD25-41 at a northeasterly azimuth and targeted the magnetic high outlined by the 2024 UAV Magnetic survey and the anomalous mineralization identified southeast along strike in WD24-37. This hole intersected mineralization deeper than the previous hole from 345.00 to 347.00 meters in which 1.25 g/t gold was reported in a lithic wacke containing minor quartz veinlets and 0.1-0.3% disseminated pyrrhotite and pyrite in the veinlets and groundmass. Drilling during the 2025 season confirmed the presence of high grade gold mineralization on the southeastern side of Lightning Creek associated with ultramafic rocks and quartz-calcite veining. With the discovery of lode gold in close proximity to the underground paleoplacer at Wingdam, Omineca will ramp up investigation of hydrothermal gold mineralization associated with the Eureka Thrust Fault. The next phase of exploration on the Wingdam Project will focus on the immediate vicinity of this exciting discovery. *NQ Drillholes were sampled top to bottom and all the drill core was cut and 1/2 core samples were sent to AGAT Laboratories of Calgary, AB. All samples were prepped, fire assayed for gold with four acids digested for metals and trace elements by ICP-OES/MS. True thickness of mineralization is yet unknown. Qualified Person All scientific and technical information in this news release has been prepared by, or approved by Stephen Kocsis, P.Geo. Mr. Kocsis is an independent qualified person for the purposes of National Instrument 43-101 - Standards of Disclosure for Mineral Projects. About Omineca Mining and Metals Ltd. Wingdam, BC Omineca’s flagship Wingdam hard rock exploration and placer gold recovery projects are located along the Barkerville Highway 45 km east of the City of Quesnel. The Wingdam Property includes mineral tenures totaling 61,392 hectares (613 square kms) and in excess of 15 linear kilometers of placer claims, both encompassing the Lightning Creek valley where topographic conditions created thick layers of overburden, which preserved a large portion of a buried paleochannel containing placer gold-bearing gravels. Omineca also has a program exploring for the potential multiple hard rock sources of the placer gold at Wingdam. Fraser Canyon, BC Part of Omineca’s original acquisitions in the Cariboo Mining District, the Fraser Canyon Project located 12 kilometers northwest of Quesnel, BC, is now slated to reinitiate the development of the underground paleochannel for the recovery of placer gold. Historically, two mines north and south of the Fraser River collectively produced 1,482 oz of raw placer gold. For further information, please contact: Tom MacNeill President and CEO 306-653-2692 Forward Looking Statements: This release includes forward-looking statements regarding Omineca and its business. Such statements are based on the current expectations and views of future events of Omineca's management. In some cases, the forward-looking statements can be identified by words or phrases such as "may", "will", "expect", "plan", "anticipate", "intend", "potential", "estimate", "believe" or the negative of these terms, or other similar expressions intended to identify forward-looking statements. The forward-looking events and circumstances discussed in this release may not occur and could differ materially with other factors beyond the control of Omineca. No forward-looking statement can be guaranteed. Forward-looking statements and information by their nature are based on assumptions and involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statement or information. Accordingly, readers should not place undue reliance on any forward-looking statements or information. Forward-looking statements speak only as of the date on which they are made and Omineca undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. View the original release on www.newmediawire.com
Fiscal 2026 Third Quarter Sales Revenues Were Best in Company History. 8th Consecutive Quarter of Profitability. Accelerating Sales Growth Near 40% Revenue Increase Over Fiscal Q3 of 2025. Retail Dealers of Insultex House Wrap® Now Grown to Nearly 200. Independent Laboratory Re-Certification Process in Final Stages. PITTSBURGH, PA - August 6, 2026 (NEWMEDIAWIRE) - Innovative Designs, Inc. (OTCQB: IVDN) closed its fiscal third quarter for the period ending July 31st with a strong continuation of the Company’s ascending sales growth and profitability, now extending to eight (8) trailing quarters. IVDN management can state today that fiscal 2026 Q3 revenues will be reported as the highest ever in Company history. When final figures are released in the next financial statement there will be a near 40% revenue increase over the same period in the previous year. Our superior home insulation product, Insultex House Wrap®, continues to gain more market presence with nearly 200 retail locations in the US, and more coming on board ever week in multiple states across the country. Insultex House Wrap® meets or exceeds new government building codes specifying continuous insulation and exterior R-Value requirements. For new construction, Insultex House Wrap® adds an R-6 moisture barrier membrane that does not need additional insulation boards or other support as with competitor products. For full product specifications and details visit: http://www.insultexhousewrap.com. Very important as well, the Insultex® independent laboratory testing program, contracted for with BRC Laboratories, a qualified independent testing company, has now entered the final stages towards its goals for re-certification of the R-Value testing equipment. All material testing has also moved forward with positive results. IVDN CEO Joseph A. Riccelli, Jr. has personally visited the BRC facility and been in regular communication with its manager throughout the progress of the program. The ultimate purpose of this program is to allow Insultex® to qualify for the requirements of a much wider range of building applications and projects of larger scale and scope with retailers and customers on every level of the multibillion-dollar homebuilding industry. Randy Kimbler, Director of Business Development for Built Link Solutions, commented, “The popularity of Insultex House Wrap® continues to grow steadily. New building material suppliers are adopting this multi-advantage product almost every week. Individual builders and contractors are also calling us almost every day to capitalize on the value and cost savings that Insultex® brings to their building projects.” Joseph A. Riccelli Jr., CEO of Innovative Designs, added, “Achieving the highest revenue of any quarter in the Company’s history and our 8th straight quarter of profitability is a gratifying milestone for all the dedicated work that our team has put in. We plan on filing our official 2026 fiscal third quarter financial report on time for its mid-September requirement with full results. I am also especially pleased to be able to announce that the re-certification program we have pursued since the start of 2026, under contract with independent BRC Laboratories, has moved to the final phase of the re-certification process for the R-Value testing equipment. We expect to have official documentation in hand soon and will make more detailed announcements at that time. Considering the value of this certification, the outcome could result in revenues that have never been achieved by Innovative Designs. Expediting this certification continues to be a high priority. The company will continue to issue updates as the process progresses. We will issue additional updates as goals are met.” About Innovative Designs, Inc. Innovative Designs, Inc. manufactures the Insultex House Wrap® and Arctic Armor® Line, under the "i.d.i.gear" label featuring INSULTEX®. Patented INSULTEX® is the thinnest, lightest and warmest insulator in the market today. For more information, please visit: http://www.insultexhousewrap.com and http://www.idigear.com Disclaimer Certain statements in this press release constitute "forward-looking" statements as defined by federal law. Such statements are based on assumptions, but there is no assurance that actual outcomes will not be materially different as those implied. Any such statements are made in reliance on the "Safe Harbor" protections provided under the Private Securities Reform Act of 1995 and are subject to various factors, including the risks and matters discussed in the Company's SEC filings available at http://www.sec.gov. CONTACT: Innovative Designs, Inc. Joseph A. Riccelli Jr., CEO 412-799-0350 Riccellijjr@insultexhousewrap.com http://www.insultexhousewrap.com Built Link Solutions, LLC Randy Kimbler, Director of Business Development 616-443-3200 RandyK@BuiltLinkSolutions.com View the original release on www.newmediawire.com
By Meg Flippin, Benzinga DETROIT, MICHIGAN - August 6, 2026 (NEWMEDIAWIRE) - Seanergy Maritime Holdings Corp. (NASDAQ: SHIP), the U.S.-listed pure-play Capesize shipping company, reported record revenue for the second quarter and six months ended June 30 and declared its 19th consecutive quarterly dividend, exceeding Wall Street expectations for the payout. Supported by record quarterly Chinese iron ore imports and continued strength in global bauxite trade, the Greece-based company said it delivered a strong second quarter that demonstrated the earnings power and operating leverage of its business model. Seanergy currently operates a fleet of 19 large bulk carriers, including 2 Newcastlemax and 17 Capesize vessels, with an aggregate cargo carrying capacity of 3,463,843 dwt. Net revenue increased to $55.7 million, compared with $37.5 million in the prior-year period, while net income and adjusted net income surged to $26.2 million and $28.5 million, respectively, from $2.9 million and $3.8 million a year ago. The company generated EBITDA of $39.3 million and Adjusted EBITDA of $41.5 million, more than doubling year-over-year from $17.4 million and $18.3 million, respectively. Seanergy said this reflected strong market fundamentals and disciplined fleet management. Fleet performance remained robust, according to the company, with second-quarter time charter equivalent (TCE) rates reaching $32,355 per day, representing a 63% year-over-year increase. Seanergy said this highlighted the company's strong positioning in the large dry bulk segment. With global demand for iron ore, coal and bauxite continuing to support the dry bulk market, Seanergy said the company remains well positioned to benefit from favorable trade dynamics, strong cash generation and improving shareholder value creation. For the six months ended June 30, Seanergy reported net revenue of $97.8 million, up from $61.7 million in the first half of 2025. Meanwhile, net income was $35.9 million and adjusted net income was $42 million, compared to a net loss of $4 million and adjusted net loss of $1.7 million in the first half of 2025. Adjusted EBITDA increased by 165% to $69.6 million, while Adjusted EPS reached $1.96, compared to an adjusted loss per share of $0.09 in the prior-year period. Fleet TCE increased by 69% to $28,244 per day. Seanergy had $59.5 million in cash as of June 30. Quarterly Dividends Keep On Coming As for its 19th quarterly dividend, which was $0.35 per common share, Seanergy said it underscores the company’s strong earnings generation and disciplined approach to capital allocation. “Building on our solid performance, we continued to execute on our disciplined capital return policy. Our board of directors declared a quarterly cash dividend of $0.35 per share, our 19th consecutive distribution, bringing cumulative dividends to $3.19 per share, or approximately $63.2 million in aggregate,” said Stamatis Tsantanis, Seanergy’s Chairman & Chief Executive Officer. The quarterly dividend of $0.35 per share marked Seanergy’s 19th consecutive quarterly distribution. Seanergy said this reflected the company’s strong earnings generation and disciplined capital allocation approach. The dividend represented approximately 27% of Q2 Adjusted EPS, while Seanergy has returned approximately $108.4 million to shareholders since the inception of its capital return program through cash dividends and repurchases of shares, warrants and convertible notes. The distribution was also viewed positively by analysts, with Arctic Research noting that the payout exceeded its and consensus expectations. Shoring Up Capital To Strengthen The Balance Sheet During the quarter, Seanergy also successfully completed a €100 million 5-year unsecured corporate bond offering in Greece, which it said further diversifies its capital resources and supports its fleet growth and renewal program. Seanergy also entered into a $60 million sale/leaseback agreement to partially fund the acquisition of a Capesize vessel due for delivery in the fourth quarter of 2027. Upon delivery, the vessel will be sold and chartered back for a period of 18 months. “The bonds provide a shareholder-friendly funding of the company's newbuilding program and second-hand vessel acquisitions,” wrote B. Riley Securities, which raised its price target on Seanergy to $25 from $22 and reiterated its buy rating on the stock. Looking ahead, Seanergy said the market outlook remains “constructive” with a low orderbook against a rapidly ageing fleet, strong iron ore export growth and resilient coal and bauxite volumes. In this environment, the company said it has fixed about 55% of its ownership days for the second half of the year at a daily rate of $30,800, providing significant earnings visibility while preserving meaningful index-linked exposure in a strong Capesize market. What’s more, Seanergy expects third quarter 2026 daily TCE of approximately $31,000, which it says further reinforces its positive earnings outlook and its ability to continue generating attractive returns in the quarters ahead. “Our strategic direction remains clear: deliver consistent shareholder distributions, invest strategically in modern tonnage and preserve financial flexibility. We believe this balanced approach positions Seanergy to create meaningful long-term shareholder value,” said Tsantanis. The company’s fleet growth strategy remains a key component of its long-term value creation plan. Upon the sale of the M/V Dukeship and the delivery of the seven newbuilding vessels and one secondhand Capesize vessel, the company will own or operate under finance lease 26 vessels (3 Newcastlemax and 23 Capesize), with an aggregate cargo carrying capacity of approximately 4,763,552 dwt. United Maritime Unit Continues To Reward Shareholders, Too Separately, Seanergy's spin-off, United Maritime Corp. (NASDAQ: USEA), reported net revenue for its second quarter of $10 million, which was flat year-over-year despite fewer ownership days, and paid a quarterly dividend, its 15th consecutive one. United Maritime said its quarterly performance was achieved despite fewer ownership days resulting from its ongoing fleet repositioning strategy. “Based on our strong performance, United will distribute a quarterly dividend of $0.10 per share, corresponding to a running yield of 16% on our last closing share price. Our fifteenth consecutive quarterly cash dividend reflects a sustainable distribution supported by contracted cash flows and highlights our continued focus on delivering strong capital returns to shareholders,” said Tsantanis. Net Income and adjusted net Income for the quarter were $1.2 million and $1.5 million, respectively, compared to $1 million and $0.2 million, respectively, in the second quarter of 2025. Adjusted EBITDA remained stable at $5.2 million, compared to $5.1 million for the same period of 2025. The TCE rate of the fleet was $18,654 per day, compared to $15,421 for the same period of 2025. For the first six months of the year, United Maritime reported net revenue of $17.9 million, compared to $20.2 million a year earlier. The company ended the quarter with $12.1 million in cash. United Maritime also continued executing its strategic fleet repositioning program during the quarter, strengthening its focus on the Capesize segment while enhancing earnings potential and financial flexibility. The company agreed to sell the 2011-built Panamax M/V Exelixsea for approximately $17.5 million, with expected net cash proceeds of approximately $8.5 million after debt repayment, following the earlier sale of the 2009-built Kamsarmax M/V Cretansea for $14.7 million. United also completed the profitable exit from its Offshore Energy Construction Vessel investment, generating approximately $15.1 million in cash proceeds, while continuing its transition toward a more Capesize-focused fleet with the acquisition and delivery of modern Capesize tonnage, including the 2010-built M/V Squireship. The company provided third-quarter 2026 TCE guidance of approximately $20,400 per day, reflecting the expected benefits of its repositioned fleet and supportive dry bulk market fundamentals. Following the completion of the M/V Exelixsea sale, United Maritime’s fleet will consist of five dry bulk vessels, including two Capesize, one Kamsarmax and two Panamax vessels, with an aggregate cargo carrying capacity of approximately 589,899 dwt, reflecting the Company’s continued strategic shift toward a more Capesize-focused fleet. Looking out to the remainder of 2026, United Maritime said it expects a constructive outlook for freight rates. “Dry bulk market conditions remain strong, driven by strong growth in all major dry bulk commodities,” said Tsantanis. “With a repositioned fleet, improved earnings and a consistent distribution record, United is well positioned to benefit in this market environment.” To learn more about Seanergy and United Maritime, click here. Featured image courtesy of Seanergy Maritime. This content was originally published on Benzinga. Read further disclosures here. This post contains sponsored content and was created in collaboration with a third-party partner. Benzinga is a publisher and does not provide personalized investment advice or act as a broker or dealer. This content is for informational purposes only and is not intended to be investing advice or an offer or solicitation to buy or sell any security. View the original release on www.newmediawire.com
BOULDER, CO - August 6, 2026 (NEWMEDIAWIRE) - Affluence Corporation (OTCID: AFFU), through its subsidiary Mingothings SLU (“MTi”), today reported strong results for the first quarter of 2026, reinforcing its position as a technology partner in IoT, smart infrastructure, connected industries, and digital transformation. During Q1 2026, MTi was awarded approximately EUR 5.6 million in new projects, reflecting solid commercial performance and continued demand for its integrated technology solutions across strategic sectors. The awarded projects have not yet been recognized as revenue and remain subject to the timing of contract execution and delivery. MTi’s Q1 results highlight the company’s ability to convert market opportunities into high-value projects while continuing to expand its capabilities in IoT platforms, systems integration, real-time monitoring, digital twin technologies, and data-driven operational solutions. MTi’s activity reflects the growing need for connected infrastructure, intelligent asset management, and secure digital transformation solutions across public and private-sector environments. As organizations increasingly seek to modernize operations and improve decision-making through real-time data, MTi continues to position itself as a partner for complex technology deployments. MTi’s business strategy remains focused on delivering high-value professional services and scalable technology solutions that support clients in managing connected assets, improving operational visibility, and unlocking the value of data. This approach supported strong Q1 activity across areas such as smart infrastructure, industrial IoT, mobility, energy efficiency, and connected industry solutions. MTi’s project activity in the first quarter of 2026 demonstrates the relevance of its portfolio in markets where digital transformation, automation, and operational intelligence are becoming increasingly important. MTi continues to support organizations that require robust, adaptable, and secure technology platforms capable of integrating multiple systems, devices, and data sources. In addition to its Q1 performance, MTi continued to strengthen its international positioning and technology offering during the quarter, with ongoing work in IoT, AI, digital twins, and real-time data analytics aimed at driving measurable improvements in performance, efficiency, and sustainability for its clients. “Our Q1 results reflect the strength of our technology portfolio and the trust our clients place in our ability to deliver reliable, scalable solutions. The EUR 5.6 million in project awards is an encouraging indicator of the demand we continue to see for IoT, smart infrastructure, and digital transformation solutions,” said Francesc Domingo, CEO of MTi. “We look forward to updating shareholders as these projects are executed and as our pipeline develops over the remainder of the year.” Looking ahead, MTi is focused on building on its strong Q1 results and continuing to strengthen its project pipeline throughout the remainder of 2026, with a growing portfolio across smart infrastructure, industrial IoT, mobility, energy efficiency, and connected industry solutions. About Affluence Corporation Affluence Corporation (OTCID: AFFU) is a diversified technology company focused on smart city, industrial IoT, and data-driven infrastructure solutions. Through its operating subsidiaries, including Mingothings, Affluence delivers AI-enabled IoT platforms, data visualization, and intelligent infrastructure technologies to enterprise, industrial, and municipal clients worldwide. For more information go to https://affucorp.com About Mingothings SLU Mingothings SLU (“MTi”) is a specialist in integrated IoT solutions and data analytics for smart cities and connected industries. With expertise in real-time data processing, sensor integration, and adaptable IoT platforms, MTi provides innovative solutions designed to support efficiency, sustainability, and operational performance in diverse IoT applications. https://www.mingothings.com/ This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding MTi’s project pipeline, business momentum, and expected execution of awarded projects during 2026. Words such as “anticipate”, “expect”, “suggest”, “plan”, “believe”, “intend”, “estimates”, “targets”, “projects”, “should”, “could”, “would”, “may”, “will”, and “forecast”, and similar expressions, are intended to identify forward-looking statements. These forward-looking statements are based on management’s current expectations and assumptions and are subject to significant risks and uncertainties that could cause actual results to differ materially, including: the Company’s ability to convert awarded projects and its pipeline into completed, revenue-generating engagements on the timeline currently anticipated, or at all; general economic and business conditions; competitive and technological factors; the Company’s limited operating history; the availability and cost of capital; the Company’s ability to retain key management and employees; and other risks discussed in the Company’s filings with OTC Markets. Forward-looking statements speak only as of the date they are made, are inherently uncertain, and should not be relied upon as predictions of actual future results. Readers are cautioned not to place undue reliance on forward-looking statements. Affluence Corporation assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Media and investor contact – press@affucorp.com
VANCOUVER, BC - August 6, 2026 (NEWMEDIAWIRE) - Engineer Gold Mines Ltd. (the "Company") (TSX-V: EAU | OTC: EGMLF | WKN: A3EEVJ ) is pleased to announce that crews, supplies and equipment have arrived on site at its 100% owned Engineer Gold Project, located 30 kilometres southwest of Atlin in northwestern British Columbia. The crews have arrived to re-establish and rehabilitate the two 20-person camps at its Engineer Mine Project and at the TAG Project in order to expand its2026 exploration programs (see news release July 28, 2026). Both camps are already in place and fully built but have not been used since 2009 (TAG) and 2021 (Engineer). Spiro Kletas, President and CEO commented, “We are very excited to re-establish the camps at the Engineer and TAG project sites. The fact that both camps are already in place, built and paid for, is an enormous advantage for Engineer Gold Mines and our shareholders. This will allow the Company to have full teams at both sites very shortly and will enable the Company to expedite our exploration programs.” About Engineer Gold Mines Ltd. The Engineer Gold Project encompasses approximately 18,319 hectares in northwestern British Columbia and is subdivided into three principal target areas: the Engineer Gold Mine, the TAG Property, and the Wann River prospect. ENGINEER GOLD MINE The historic Engineer Gold Mine is a past-producing, underground gold-silver operation. Historical production between 1910 and 1952 totalled approximately 14,263 tonnes grading 39.4 g/t (1.15 oz/ton) gold and 19.5 g/t (0.57 oz/ton) silver (BC Minfile 104M014). In 2011, an historical Inferred Mineral Resource as defined under National Instrument 43-101, including only the Engineer and Double Decker veins, was completed (Snowden, 2011, amended and restated in 2018, O’Brien et al - www.sedarplus.ca). The historical resource, based on a 5.0 g/t gold cut-off, gave an inferred 25,000 ounces of gold at a grade of 19 g/t. The historical mineral resource was calculated using mining industry standard practices and is deemed to be reliable and relevant in that it demonstrates the mineral potential of the property. This estimate was based on the following method and parameters: (1) VLP (long section) approach with projection of mineralized shoots down-dip and along strike based on surface exposure and/or underground development; (2) The global grade applied to each vein structure is based on a probabilistic approach, with grades assigned to domains from historical production figures; (3) All grades were diluted to minimum stoping width of 1 m; and (4) A density factor of 2.8 t/m3 was used which is believed to be conservative. A thorough review of all historic data performed by an independent QP, along with additional exploration work, including diamond drilling, is required to confirm results and to produce a current mineral resource estimate. TAG PROPERTY The TAG Property is located approximately 6 kilometres north of the historic Engineer Mine and is associated with a 6km long structurally controlled mineralized system related to splays off of the Llewellyn Fault. The majority of the diamond drilling to date has concentrated on the southern 2 km section of the structure. Significant historical diamond drill intervals from TAG include: Hole TAG06-23 which assayed 1.7 g/t Au and 5.1 g/t Ag over 26.7 m (including 3.52 g/t Au over 4.7 m); hole TAG07-29 which assayed 1.3 g/t Au and 5.9 g/t Ag over 35.0 m; TAG08-51 which assayed 1.8 g/t Au and 7.4 g/t Ag over 24.3 m; and TAG08-59 which assayed 1.5 g/t Au and 8.05 g/t Ag over 42.1 m (Fekete and Simper (2009), Fekete and Skinner (2007); ARIS reports #30931 and #29581). WANN RIVER PROSPECT The Wann River prospect is located 4 kilometres south of the Engineer Mine and represents a highly prospective, underexplored target. Exploration work to date has identified a mineralized corridor approximately 800 metres by 180 metres in extent. While mineralization at the Engineer Mine and TAG Property is characteristic of epithermal-style systems, the Wann River prospect represents an orogenic gold target associated with the prolific Llewellyn Fault and has returned significant gold and silver values, including a quartz grab sample of 263 g/t gold and 1,350 g/t silver from the Lum showing (Aspinall (2011); ARIS Report #32004). Historic diamond drilling of 17 holes in 2011 returned numerous gold and silver intercepts. The most significant intervals were from hole WR030211 which assayed 11.3 g/t Au and 76.2 g/t Ag over 1 m, and hole WR040111 assaying 11.3 g/t Au and 94.8 g/t Ag over 1.0 m (Aspinall, 2011; BC ARIS Report #32478). In addition to prior drilling, Wann River has undergone several surface sampling programs which returned good gold-silver and base metal values. On Behalf of the Board of Directors “Spiro Kletas” Spiro Kletas CEO, President & Director For further information please contact: Engineer Gold Mines Ltd. Tel: +1 604-669-6463 E-Mail: spiro@engineergoldmines.com Website: engineergoldmines.com Neither the TSX Venture Exchange nor its Regulation Services Provider (as defined in the policies of the TSX Venture Exchange) has reviewed this news release and does not accept responsibility for the adequacy or accuracy of its contents. Disclaimer for Forward-Looking Information This news release contains “forward-looking statements” or “forward-looking information” (collectively, “forward-looking statements”) within the meaning of applicable securities laws. These statements are not statements of historical fact and may include, without limitation, statements regarding the Company’s beliefs, plans, expectations, intentions, objectives, strategies, future performance, and anticipated events or results. Forward-looking statements are based on management’s current expectations, estimates, and assumptions, which are subject to change and may ultimately prove to be inaccurate. Such statements involve known and unknown risks, uncertainties, and other factors that could cause actual results, performance, or achievements to differ materially from those expressed or implied in the forward-looking statements. There is no assurance that the anticipated events or outcomes described in these forward-looking statements will occur, or, if they do occur, what benefits Engineer Gold Mines will derive from them. Factors that could cause actual results to differ materially include, but are not limited to, exploration results, the availability of financing, fluctuations in commodity prices, permitting and regulatory risks, operational risks, and other risks detailed in the Company’s public disclosure record. Forward-looking statements contained in this release are made as of the date hereof, and Engineer Gold Mines assumes no obligation to update or revise them to reflect new information, future events, or otherwise, except as required by applicable securities laws. Readers are cautioned not to place undue reliance on forward-looking statements. View the original release on www.newmediawire.com
Nearly a Century of Exploration, Historical High-Grade Gold, Modern Drilling, Advanced 3D Modelling and 25 High-Priority Targets Position Arrowhead for Its Next Major Phase of Exploration VANCOUVER, BC - August 6, 2026 (NEWMEDIAWIRE) - Opawica Explorations Inc. (TSXV: OPW) (FSE: A2PEAD) (OTCQB: OPWEF) (the “Company” or “Opawica”) is pleased to provide a comprehensive exploration update on its 100%-owned Arrowhead Gold Property (“Arrowhead” or the “Property”), located in the prolific Abitibi Greenstone Belt of Quebec. Following years of geological compilation, geophysics, seismic surveying, artificial-intelligence-assisted targeting, three-dimensional geological modelling and diamond drilling, Opawica believes Arrowhead has reached an important stage in its evolution. The next phase is about drilling. The Company has previously outlined a strategy for approximately 10,000 metres of high-priority drilling at Arrowhead, where Opawica holds drill permits covering 25 drill-pad locations. The planned program is intended to systematically test high-priority targets generated from one of the most comprehensive modern geological datasets assembled over the Property, while testing the continuity, extensions and potential depth of known gold mineralization. Arrowhead is located within an established Quebec mining district and immediately adjacent to properties held by Agnico Eagle Mines Limited (“Agnico Eagle”), including the producing LaRonde Complex. The LaRonde Complex has produced more than eight million ounces of gold since commercial production began in 1988 and remains a major producing operation. Opawica considers Arrowhead's combination of historical high-grade gold occurrences, extensive historical workings, modern drill-confirmed mineralization, geophysical and seismic datasets, 3D geological modelling, numerous untested targets, existing drill permits and location within an established producing gold district to represent a compelling exploration opportunity. Mineralization hosted on adjacent and/or nearby properties, including the LaRonde Complex, is not necessarily indicative of mineralization hosted at Arrowhead. ARROWHEAD - BUILT FOR THE DRILL BIT Arrowhead is not an early-stage conceptual exploration project. Exploration of the Property dates back approximately a century, beginning with prospecting in approximately 1920. Historical exploration subsequently included: - Prospecting; - Trenching; - Pitting; - Underground workings; - Diamond drilling; - Geological mapping; and - Sampling of multiple mineralized structures. Historical work focused primarily on shear zones containing quartz-carbonate veins associated with free gold. Historical gold values of approximately 45.05 g/t Au were reported during early exploration. Additional historical information compiled by Opawica includes chip sampling reported as high as approximately: 90.75 g/t Au over 1.0 metre Historical work also identified numerous gold-copper mineralized zones across the Property. These historical results have not necessarily been independently verified by Opawica's Qualified Person and should not be considered indicative of future exploration results. What differentiates Arrowhead today is the amount of modern geological information that has subsequently been layered over this historical mineralized system. OPAWICA HAS ALREADY DRILLED ARROWHEAD In 2022, Opawica completed its inaugural modern diamond-drill program at Arrowhead. The program consisted of: - 4,306 metres of drilling - 14 diamond drill holes - 1,590 rock samples submitted for assay - 13 drill targets tested The program successfully confirmed gold mineralization across the Property. Importantly: 11 drill holes intersected gold zones grading greater than 1.0 g/t Au along an approximately one-kilometre stratigraphic strike length. Selected results included: - 18.7 g/t Au over 0.35 metres, together with 0.72% Cu, in hole AR-22-01; - 1.58 g/t Au over 0.60 metres in AR-22-02; - 1.70 g/t Au over 1.00 metre in AR-22-03; - 1.52 g/t Au over 14.8 metres in AR-22-04; and - Broader anomalous gold zones extending up to approximately 29.5 metres. Reported intervals represent core lengths and true widths have not necessarily been determined. The drilling identified gold mineralization in two principal geological settings, including shear zones containing quartz-carbonate-tourmaline veins within mafic volcanic rocks and mineralized felsic tuffs containing quartz-tourmaline veining. Significantly, following completion of the 2022 campaign, nine target zones associated with that program remained untested. For Opawica, that program represented confirmation. The next phase is designed to test scale. Qualified Person Yvan Bussieres, P.Eng., an independent “Qualified Person” under National Instrument 43-101, has reviewed and approved the scientific and technical information in this news release. Forward-Looking Information This news release contains forward-looking information within the meaning of applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements concerning the Company's proposed approximately 10,000-metre drilling strategy at Arrowhead; the timing, scope and commencement of future drilling; the testing of high-priority, deeper, structural and extension targets; interpretations regarding potential continuity or extension of mineralization; the potential significance of geological, geophysical and seismic targets; future exploration programs; and the possibility that exploration results could ultimately support future resource-definition activities. Forward-looking information is based on assumptions considered reasonable by management as of the date such statements are made and is subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those anticipated or implied. Such risks include exploration risk; geological interpretations proving incorrect; historical information being inaccurate or incomplete; permitting and regulatory requirements; availability of financing and contractors; commodity-price fluctuations; environmental and operational risks; the possibility that planned exploration may be modified, delayed or cancelled; and the possibility that exploration will not result in the discovery or delineation of a mineral resource or economically viable mineral deposit. Readers are cautioned not to place undue reliance on forward-looking information. The Company undertakes no obligation to update such information except as required by applicable securities laws. About Opawica Explorations Inc. Opawica Explorations Inc. is a junior Canadian exploration company with a strong portfolio of precious and base metal properties within the Rouyn-Noranda region of the Abitibi Gold Belt in Quebec. The Company’s management has a great track record in discovering and developing successful exploration projects. The Company’s objective is to increase shareholder value through the development of exploration properties using cost effective exploration practices, acquiring further exploration properties, and seeking partnerships by either joint venture or sale with industry leaders. FOR FURTHER INFORMATION CONTACT: Blake Morgan President and Chief Executive Officer Opawica Explorations Inc. Telephone: 236-878-4938 Neither the TSX Venture Exchange nor its Regulation Service Provider (as the term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of accuracy of this news release. Forward-Looking Statements This news release contains certain forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Readers are cautioned that these forward-looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected including, but not limited to, market conditions, availability of financing, actual results of the Company’s exploration and other activities, environmental risks, future metal prices, operating risks, accidents, labor issues, delays in obtaining governmental approvals and permits, and other risks in the mining industry. All the forward-looking statements made in this news release are qualified by these cautionary statements and those in our continuous disclosure filings available on SEDAR at www.sedar.com. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required by applicable law. View the original release on www.newmediawire.com
The New tZERO UX Brings Together Onboarding, Primary Offerings, Secondary Trading, and Custody for Tokenized Securities Through a Single Platform Available as part of tZERO’s End-To-End, Multi-Asset Infrastructure for Institutional Clients, as Well as for Direct Investors NEW YORK, NY - August 6, 2026 (NEWMEDIAWIRE) - tZERO Group, Inc., a leader in blockchain-based financial infrastructure, unveiled a next-generation user experience (UX) for its tokenized securities platform and white label infrastructure offering, bringing onboarding, investing, trading, custody and payments together through a single, seamless experience, with additional asset classes to come. The launch of the new UX represents a significant milestone in tZERO's evolution. For the first time, it will be complemented with a native iOS mobile app that will be available shortly, once pending App Store review is completed, followed by an Android version. For institutional infrastructure clients, tZERO’s B2B2C offering makes the same technology available through co-brand and white label deployments, enabling broker-dealers and other partners to deliver branded digital investment experiences powered by tZERO’s regulated brokerage, custody, clearing, settlement, transfer agency and tokenization infrastructure. Broker-dealer partners can enable custody solutions for their end customers using tZERO’s correspondent clearing and custody model. For individual investors, the new tZERO platform provides a direct, intuitive way to discover investment opportunities, participate in primary offerings and trade eligible securities in secondary markets – all through a single, connected account. The platform introduces a streamlined, single sign-on experience that simplifies every stage of the investment journey – from opening an account and funding it to investing in primary offerings and trading in secondary markets. The platform has been architected to support a broad range of asset classes (including prediction markets and crypto), AI-driven capabilities, and expanded DeFi functionality. "We built the new tZERO platform to bring investing, trading and digital asset infrastructure together in a single, unified experience,” said Alan Konevsky, Chief Executive Officer of tZERO. “As more assets move on-chain, investors and institutions should have one secure gateway into digital markets - not a collection of disconnected systems. This also slots into our unique, vertically integrated infrastructure stack for tokenized assets, providing a flexible front-end available for a range of financial institutions and other customers." The new tZERO delivers: A single sign-on account experience Streamlined investor onboarding Integrated payment setup Access to primary investment opportunities Secondary market trading White label platform for financial institutions Architecture designed to support multiple asset classes (including prediction markets and crypto) and DeFi interoperability Today’s launch marks a major milestone in the platform's evolution. Future releases will expand payment options, introduce additional onboarding capabilities, launch mobile iOS and Android versions, and extend support for additional asset classes and emerging technologies. "The new tZERO platform reflects where financial markets are heading," added Konevsky. "Our goal is to remove complexity so institutions can enable their customers to access the benefits of modern market infrastructure through a single, intuitive experience available as part of our end-to-end, turnkey solution." Sign in to an existing account or create a new account. MEDIA CONTACTS: tZERO Julie Ros, Head of Marketing & Communications jros@tzero.com KCSA Strategic Communications tzero@kcsa.com About tZERO Group, Inc. tZERO Group, Inc. (tZERO) and its broker-dealer subsidiaries provide an innovative liquidity platform for private companies and assets. We offer institutional-grade solutions for issuers looking to digitize their capital table through blockchain technology, and make such equity available for trading on an alternative trading system. tZERO, through its broker-dealer subsidiaries, democratizes access to private assets by providing a simple, automated, and efficient trading venue to broker-dealers, institutions, and investors. All technology services are offered through tZERO Technologies, LLC. For more information, please visit our website. About tZERO Digital Asset Securities, LLC tZERO Digital Asset Securities, LLC is a broker-dealer registered with the SEC and a member of FINRA and SIPC. It is the broker-dealer custodian of all digital asset securities offered on tZERO’s online brokerage platform. Digital asset securities may not be “securities” as defined under the Securities Investor Protection Act (SIPA) – and in particular, digital asset securities that are “investment contracts” under the Howey test but are not registered with the Securities and Exchange Commission are excluded from SIPA’s definition of “securities” – and thus the protections afforded to securities customers under SIPA may not apply. More information about tZERO Digital Asset Securities may be found on FINRA’s BrokerCheck. About tZERO Securities, LLC tZERO Securities, LLC is a broker-dealer registered with the SEC and a member of FINRA and SIPC. It is the operator of the tZERO Securities ATS. More information about tZERO Securities may be found on FINRA’s BrokerCheck. Investor Notice Digital asset securities, as well as any particular investment, may not be suitable or appropriate for everyone. Investors should note that investing or trading in securities could involve substantial risks, including no guarantee of returns, costs associated with selling and purchasing, and no assurance of liquidity which could impact their price and investors’ ability to sell, and possible loss of principal invested. There is always the potential of losing money when you invest in securities. There are also unique risks specific to digital asset securities, including, without limitation, fraud, manipulation, theft, and loss. No Offer, Solicitation, Investment Advice or Recommendations This release is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, nor does it constitute an offer to provide investment advisory or other services by tZERO or any of its affiliates, subsidiaries, officers, directors or employees. No reference to any specific security constitutes a recommendation to buy, sell, or hold that security or any other security. Nothing in this release shall be considered a solicitation or offer to buy or sell any security, future, option or other financial instrument or to offer or provide any investment advice or service to any person in any jurisdiction. Nothing contained in this release constitutes investment advice or offers any opinion with respect to the suitability of any security, and the views expressed in this release should not be taken as advice to buy, sell or hold any security. In preparing the information contained in this release, we have not taken into account the investment needs, objectives, and financial circumstances of any particular investor. This information has no regard to the specific investment objectives, financial situation, and particular needs of any specific recipient of this information and investments discussed may not be suitable for all investors. Any views expressed in this release by us were prepared based upon the information available to us at the time such views were written. Changed or additional information could cause such views to change. All information is subject to possible corrections. Information may quickly become unreliable for various reasons, including changes in market conditions or economic circumstances. Forward-Looking Statements by tZERO This release contains forward-looking statements. In addition, from time to time, tZERO, its subsidiaries, or its representatives may make forward-looking statements orally or in writing. These forward-looking statements are based on expectations and projections about future events, which is derived from currently available information. Such forward-looking statements relate to future events or future performance, including financial performance and projections; growth in revenue and earnings; and business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including, without limitation: the ability of tZERO and its subsidiaries to change the direction; tZERO’s ability to keep pace with new technology and changing market needs; performance of individual transactions; regulatory developments and matters; and competition. These and other factors may cause actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or their respective representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions. tZERO, its subsidiaries, and its representatives are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this release and other statements made from time to time by tZERO, its subsidiaries or its representatives might not occur. This press release is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any security. The securities described herein are subject to qualification by the U.S. Securities and Exchange Commission under Regulation A+ (Tier 2) and have not yet been so qualified. No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is qualified, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance given after the date of qualification. A person's indication of interest involves no obligation or commitment of any kind. View the original release on www.newmediawire.com
MONTEREY PARK, CA - August 6, 2026 (NEWMEDIAWIRE) - Focus Universal Inc. (NASDAQ: FCUV) ("Focus" or the "Company"), a provider of patented hardware and software design technologies for Internet of Things (IoT), 5G and SEC Financial Reporting AI-Driven Automation Software, today announced that Focus will showcase its multi-industry Deterministic AI technology. This includes Focus’ SEC Financial Reporting Automation, including its novel Edgarization and XBRL tag components, its Financial Auditing Automation, and its noteworthy Deterministic AI Forms Auto-Populate Engine. The H.C. Wainwright 28th Annual Global Investment Conference is to be held at the Lotte New York Palace Hotel in New York City on September 14-16, 2026, with the company presentation slated to be on demand within the Technology, Media & Telecommunications, Growth Track. Gamechanger for Deterministic AI Financial Reporting Focus believes that its SEC Financial Reporting software is not only potentially 10,000 times faster than traditional manual methods, demonstrating the transformative power of automation and AI-driven innovation, but also the accuracy of the SEC financial reporting software is well beyond human professional-level accuracy. With a single click, months of complex SEC financial reporting work can be completed within a few short minutes. The Company is excited to showcase all the groundbreaking technologies to the public, delivering on our commitment to our shareholders and the global technology community. The Company cordially invites all prospective customers, investors, and shareholders to experience firsthand the remarkable power, efficiency, and potential of our technology at the Wainwright Annual Global Investment Conference and schedule a meeting with the Company during this period. The Company will be available for one-on-one meetings during the conference. Interested investors should contact H.C. Wainwright to schedule an in-person meeting. For more information, please visit the conference website at: https://hcwevents.com/annualconference/. Automated EDGARization and XBRL Tagging from Raw Documents SEC filings must be prepared in XBRL (eXtensible Business Reporting Language), a standardized machine-readable format that enables investors, regulators, and analysts to automatically extract, analyze, and compare financial information across companies and reporting periods. Because XBRL is based on XML programming language and requires specialized technical expertise, most CPAs, CFOs, auditors, and securities attorneys do not perform this work themselves. As a result, many issuers rely on specialized EDGAR filing agents to handle Edgarization and XBRL tagging. The current process is often expensive, labor-intensive, and time-consuming. To meet filing deadlines, issuers frequently must deliver their draft reports to filing agents several days in advance, creating additional pressure on management teams and reducing flexibility during the reporting process. Deterministic AI is designed to process SEC filings using only the Word document as input. Leveraging accumulated domain knowledge from large volumes of filings, the system is designed to: Identify financial reporting concepts within disclosures Determine appropriate XBRL taxonomy elements Perform EDGARization formatting Generate structured, compliance-ready outputs Improve consistency of taxonomy selection over time The Company noted that as additional filings are processed, the system refines its ability to align disclosures with standard GAAP taxonomy elements and reduce reliance on company-specific custom tags, while maintaining deterministic output behavior. One of the most significant advantages of Deterministic AI is its ability to perform complex tasks with minimal user input. Traditional automation systems generally require users to provide structured data, predefined workflows, mapping instructions, templates, or prior-period information before a task can be completed. Generative AI systems often require detailed prompts, extensive context, supporting documents, and multiple rounds of user interaction to achieve acceptable results. Deterministic AI Forms Auto-Populate Engine This Engine enables organizations to upload raw business documents from multiple sources and automatically identify, extract, validate, correlate, and populate information across downstream business forms. Unlike conventional automation software that depends on predefined templates or workflow programming, the platform is designed to process diverse document types using embedded domain knowledge and deterministic business logic. Organizations simply upload their business documents - including purchase orders, bills of lading, arrival notices, invoices, contracts, shipping documents, customs documentation, and other structured or semi-structured business records. The platform automatically recognizes document types, understands relationships among documents, validates information across multiple sources, and generates completed business forms such as commercial invoices, packing lists, certificates of origin, customs declarations, shipping instructions, export documentation, financial reports, contracts, and other operational documents. “Deterministic AI is an execution AI designed to automate business processes with certainty and consistency. Organizations that adopt Deterministic AI can improve operational efficiency by several orders of magnitude compared with traditional manual workflows. The productivity gains are so significant, the subscription fee is negligible relative to the value it delivers. Business owners can verify efficiency, accuracy, and return on investment almost immediately after deployment. Since the benefits are measurable, tangible, and easy to demonstrate, we believe that marketing and selling Deterministic AI can be straightforward,” Dr. Desheng Wang, CEO of Focus Universal said. Dr. Desheng Wang continues, “The completion of the Deterministic AI Engine marks only the beginning. Built upon this core technology, we expect rapid expansion into numerous business domains, including accounting, tax preparation, medical billing, freight forwarding, insurance, and many other industries were deterministic, rule-based automation can dramatically improve productivity.” About Focus Universal: Focus Universal Inc. is a provider of patented hardware and software design technologies for Internet of Things (IoT) and 5G. The company has developed five disruptive patented technology platforms with 26 patents and patents pending in various phases and eight trademarks pending in various phases to solve the major problems facing hardware and software design and production within the industry today. For maintenance cost control, the company has also omnibus patents encompassing these patents into patent family groups. These technologies combined to have the potential to reduce costs, product development timelines and energy usage while increasing range, speed, efficiency, and security. Focus Universal is a publicly listed company committed to innovation and long-term value creation through strategic investments and business development. Through its global subsidiaries, the Company continues to expand into high-growth markets while delivering sustainable business solutions to customers worldwide. Focus currently trades on the Nasdaq Markets. Forward-Looking Statements: Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward looking statements include statements regarding the platform being designed to serve consumers and business partners across multiple international markets while supporting the growing demand for seamless global commerce; the Company strengthening its global competitiveness, diversifying its revenue streams, and creating lasting value for customers, business partners, and shareholders by expanding its presence in the international e-commerce sector; the new venture further enhancing the Company’s international footprint and supporting its long-term strategic objectives; the business beginning to generate both revenue and income in the near term and the Company creating long-term value through innovation, global collaboration, operational excellence, and exceptional customer service Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to the Company’s ability to derive the benefits from the partnership including its ability to generate near term revenue, diversify revenue streams, strengthen its global competitiveness; expand its international presence and create value for shareholders; market conditions, and other factors discussed in the "Risk Factors" section of the Company’s most recent Annual Report on Form 10-K and its subsequent quarterly reports on Form10-Q filed with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof and Focus Universal specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise. For investor and media inquiries, please contact: Investor Relations 626-272-3883 ir@focusuniversal.com
Showcasing Global Foods, Tea Culture, Healthy Living and Smart Home Innovations Under "Live Well.Stay Well" Theme HONG KONG - August 6, 2026 (NEWMEDIAWIRE) - Organised by the Hong Kong Trade Development Council (HKTDC), the 36th Food Expo, 10th Beauty & Wellness Expo and 12th Home Delights Expo will be held from 13 to 17 August at the Hong Kong Convention and Exhibition Centre (HKCEC). The 4th Food Expo PRO and 17th Hong Kong International Tea Fair take place from 13 to 15 August, with the Tea Fair once again fully open to both trade buyers and public. The five fairs will bring together more than 1,850 exhibitors from over 30 countries and regions, featuring international delicacies, premium teas and innovative tea beverages, health and beauty products, as well as smart home solutions. The events offer a one-stop platform for sourcing, business networking and retail experiences for both industry professionals and the public. Also running from 13 to 15 August is the International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM), jointly organised by the Modernized Chinese Medicine International Association (MCMIA), the HKTDC and 10 scientific research institutions. The event will provide industry participants with the latest developments in Chinese medicine while fostering the advancement of the sector. HKTDC Associate Executive Director Smilely Lam said: “Under the theme of ‘Live Well.Stay Well’, the fairs reflect growing market interest in wellness, quality living and holistic wellbeing. As an international food trading hub, Hong Kong provides food companies with an ideal gateway to the Chinese Mainland and global markets. For the first time, the two trade fairs bring together exhibitors from all ASEAN member states, including debut participations from Brunei and Timor-Leste. We are also delighted to welcome exhibitors from Colombia and Greece for the first time. In addition, the Agricultural Trade Promotion Center of the Ministry of Agriculture and Rural Affairs of China has organised delegations from multiple provinces and municipalities to showcase premium agricultural products, using Hong Kong as a platform to expand overseas.” This year, the five fairs feature a total of 43 group pavilions, showcasing distinctive products from around the world, including pavilions from various provinces and municipalities in the Chinese Mainland, as well as Brazil, Malaysia, the Philippines, Sri Lanka and Thailand. The Korea Pavilion has expanded by 40% compared to last year, hosting more than 130 exhibitors to make it the largest overseas pavilion at the fairs. Food Expo PRO introduces new “Meat Zone” and a more international “Coffee Zone” In response to increasing market demand for premium meat products, Food Expo PRO introduces a brand-new “Meat Zone”, showcasing quality meats and related products. Highlights include Korean exhibitors featuring frozen marinated Korean barbecue products that can be served in just three minutes, while a long-established Hong Kong brand enters the business-to-business (B2B) market with halal-certified beef tendon balls made entirely from premium beef and manufactured locally. The popular “Coffee Zone” returns, featuring exhibitors from Yunnan - the largest coffee-producing region in the Chinese Mainland - alongside new exhibitors from Colombia, Macao, Myanmar, Thailand and the United States, highlighting a wider range of coffee beans, accessories and brewing equipment. The “Food Science and Technology Zone” focuses on the rapidly growing wellness market, featuring alternative and future foods as well as the latest food-service technologies. Highlights include a Hong Kong exhibitor demonstrating an intelligent food-service robot that showcases how automation and artificial intelligence can deliver highly efficient dining solutions. Held during the fair, the Food Tech Symposium will explore how emerging technologies are driving innovation in the food industry and supporting healthier lifestyles. Hong Kong’s pet-friendly market continues to expand. This year, Food Expo PRO introduces Pet Food products for the first time. A Hong Kong exhibitor uses patented packaging technology to preserve the nutritional value of pet food meat without preservatives or cold-chain logistics, enabling room-temperature storage and unlocking new opportunities in the pet economy. Demand for Halal food continues to grow. For the third consecutive year, Food Expo PRO and Food Expo feature the halal food and beverage label, with more than 130 exhibitors from the Chinese Mainland, Brunei, Colombia, Korea, Singapore, Taiwan, Thailand and other markets participating. A networking reception on 14 August will connect halal food exhibitors and buyers to facilitate business opportunities. Tea culture meets contemporary lifestyle This year’s Hong Kong International Tea Fair showcases renowned teas and specialty tea beverages from around the world, including the extremely rare first-flush Kunlu Mountain naturally mutated purple bud raw pu'er tea from Yunnan, white tea from Laos, premium tea from Kenya and world-renowned Ceylon tea from Sri Lanka. The new Chinese Mainland Matcha Pavilion makes its debut, presented by Guizhou and Zhejiang - the mainland’s two leading matcha-exporting regions – showcasing ceremonial-grade matcha, beverage-grade matcha and matcha desserts. The inaugural Yixing Zisha Teaware Pavilion highlights the exquisite craftsmanship of traditional Yixing purple clay teaware. Going beyond traditional tea appreciation, the Tea Fair’s new “Tea Lifestyle” zone introduces a range of innovative tea products, including sparkling tea, tea-based cocktails and Pu-er coffee blend tea. Visitors can also explore tea pastries, Zen-inspired bonsai, elegant teaware and immersive tea meditation experiences, demonstrating how tea culture can be seamlessly integrated into modern living. During the fair, the Hong Kong International Tea Culture Forum will explore opportunities for the internationalisation of Chinese tea brands. A series of tea art performances, themed seminars by contemporary tea beverage brands and cultural programmes will also be staged, allowing both industry players and the public to gain a deeper understanding of the heritage, innovation and enduring appeal of tea culture. Five Themed Days highlight the “Live Well.Stay Well” experience This year’s fairs adopt the new theme “Live Well.Stay Well” and feature the Five Themed Days: “Happy Eat Happy Life”, “The World in Blink”, “Coffee or Tea'”, “Stay Fresh, Stay Ahead”, and “Let’s Chill”. Through different elements covering food, wellness, quality sleep and lifestyle inspirations, the themed days encourage visitors to explore wellness trends and discover new ideas for better living. Programmes include celebrity chef demonstrations, health seminars, silver-age products and technology showcases, hand-drip coffee demonstrations, wellness forums and horticultural therapy workshops. Food Expo showcases global gourmet delights with dessert and gelato highlights The 36th Food Expo returns with five days of gastronomic delights from around the world. Highlights include pandan chiffon cakes and premium cookies from Singapore’s iconic confectionery brand Old Seng Choong, freshly made artisanal doughnuts from Thailand’s popular donut brand Drop by Dough, Korean probiotic yoghurt products, local delicacies from Hualien and Taitung, alongside KUAICHE, one of Taiwan’s most renowned jerky brands, Macao’s famous shrimp roe noodles, and specialty products from 16 provinces and regions across the Chinese Mainland, including Sichuan, Henan, Yunnan and Tibet. The Agricultural Trade Promotion Center of the Ministry of Agriculture and Rural Affairs of China has organised exhibitors from Hunan, Hainan, Anhui, Guangdong, Shandong, Xinjiang, Hebei and other provinces and regions, leveraging Hong Kong as a gateway to international markets. In addition, Hong Kong’s Fish Marketing Organization and Vegetable Marketing Organization have expanded their participation this year and will promote a new unified brand, “Hong Kong Harvest”, showcasing the unique appeal of local fishery and agricultural products. The Food Expo has also sourced more than 100 dessert products and will introduce a brand-new Dessert and Gelato Theme. Highlights include innovative ice cream flavours and Hong Kong people’s beloved chewy traditional desserts. Local exhibitor AkkMore Gelato will showcase low-fat gelato made with patented AkkMore mushroom extract developed by Hong Kong Polytechnic University to replace conventional animal fats. Another local ice cream brand, Cookieism, will present its summer signature dessert, Cookie and Cream Carnival, combining chocolate cookies with creamy ice cream. Celebrating its 15th edition, the Gourmet Zone will host 15 celebrity chefs to demonstrate the preparation of a range of exquisite dishes. A commemorative premium recipe book, “Star Chef’s Culinary Creations”, jointly presented with food distributor Ng Fung Hong, which celebrates its 75th anniversary this year, will be made available to participants in the cooking demonstrations. Participants will also be able to sample the dishes prepared on-site. The fair also pays close attention to the dietary needs of the elderly. On 16 August, the “Silver Q-Mark "Care Food" Culinary Competition”, organised by the Federation of Hong Kong Industries and the Hong Kong Q-Mark Council, will demonstrate the diversity of care foods and promote awareness of care food preparation and certification among caregivers. Exhibitors will also feature innovative food-processing equipment capable of transforming everyday dishes into refined care food that meet international standards. Beauty & Wellness Expo highlights holistic wellbeing The 10th Beauty & Wellness Expo welcomes back the popular “Scentsation” zone dedicated to perfume and fragrance experiences. Making its debut this year is the Xuelei Fragrance Museum, which presents “Meet Yourself Through Fragrance” – an interactive experience that allows visitors to explore their emotions through scent. Participants can also receive a limited-edition commemorative fragrance created exclusively celebrating the 10th edition of the Expo. Keeping pace with the public’s growing pursuit of holistic wellness, the expo introduces the brand-new “Stay Relax” zone, featuring products such as red-light therapy capsules and medicated wellness balms, allowing visitors to experience innovative solutions for relieving fatigue and promoting relaxation firsthand. With regular exercise forming an essential part of a healthy lifestyle, the Hong Kong Ballet Group, Hong Kong China Bodybuilding and Fitness Association and the Physical Fitness Association of Hong Kong, China will stage demonstrations at the venue, teaching simple exercises to visitors that can be performed at home without the need for specialised equipment. Home Delights Expo – from quality sleep to smart living The 12th Home Delights Expo highlights quality sleep and smart living as its key themes. The Sleep Health Association will participate for the first time and launch the dedicated “Go Sleep Exp”, where visitors can learn about healthy sleep habits and discover a wide range of innovative sleep-related products and solutions. As smart-home technology becomes increasingly popular, HKT will offer exclusive discounts of up to 70% on smart home appliances. The company will also showcase its F5G-A 2500M Super Broadband service, recipient of six awards including recognition as Hong Kong’s and East Asia’s “Fastest” and “Best” fixed broadband service, giving visitors a firsthand experience of the next generation of connectivity. Chinese Medicine Conference promotes international exchange The International Conference of the Modernization of Chinese Medicine & Health Products, organised by the Modernized Chinese Medicine International Association (MCMIA) together with the HKTDC and 10 scientific research institutions, is supported this year by the Chinese Medicine Development Fund of the Hong Kong SAR Government. Under the theme “Clinical Translation, Regulatory Policies and Global Innovative Pathways of Traditional Medicine”, the conference will focus on the twin concepts of “bringing in” and “going global”. It will introduce Hong Kong’s Chinese medicine regulatory framework and support resources to participants from the Chinese Mainland and overseas, while inviting international regulatory authorities to share perspectives on traditional medicine regulations in their respective markets. The conference has been expanded from two days to three days this year and will feature over 30 renowned speakers. Experts from the Chinese Mainland, Hong Kong, Macao, Australia, Canada, Indonesia, Korea, Malaysia, Singapore, Thailand and the United Kingdom will discuss the latest developments in Chinese medicine research and development, regulatory trends and successful industry practices. Held in a hybrid physical-and-online format, the conference aims to facilitate wider participation and interaction between attendees and speakers. Registered Chinese medicine practitioners in Hong Kong can apply for continuing education credits by attending the conference. Public education on Chinese medicine features at Food Expo In addition to putting on the conference for industry professionals, the organisers are demonstrating their commitment to enhancing public understanding of Chinese medicine. A dedicated “Multi-Facet of Chinese Medicines” public education display will be set up at the Food Expo, featuring interactive and educational displays to improve awareness and confidence in Chinese medicine. In addition, the “ICMCM Public Forum” will be held on 15 August, promoting the advantages of Chinese medicine services and offering useful tips on Chinese medicine wellness and preventive healthcare. Admission privileges and shopping rewards for HKTDC’s 60th anniversary To celebrate the 60th anniversary of the HKTDC, a series of special promotions and consumer offers will be launched during the fairs. Members of the public presenting designated official promotional leaflets can enjoy free admission before 12pm each day, with a quota of 600 visitors per day. Exhibitors will also roll out a variety of “6”-themed offers, including stainless-steel cutlery sets for HK$6 and wild purple bud tea at 40% off. And visitors can participate in daily lucky draws and exhibition mini games, with prizes worth more than HK$1 million in total. The HKTDC will continue its “Food Expo VIP ticket online game” campaign. By participating in games on the HKTDC’s 60th Anniversary Facebook page, members of the public will have the opportunity to win VIP admission tickets to the Food Expo. Details will be announced through the HKTDC’s social media channels. Also returning is the “Smart Bidding” session, allowing visitors to bid for selected products starting from just 10% of the original price. For the latest promotions, flash sales and limited-time discounts, visitors are encouraged to visit the “August Happy Buy” campaign website, allowing them to enjoy great savings while shopping and dining in Hong Kong. No physical tickets will be issued for the August fairs. E-tickets can be purchased or redeemed in advance through the 01 Space e-ticketing platform, AlipayHK, Alipay, all 7-Eleven and Circle K convenience stores, the Octopus App and The Club App. Visitors may also purchase admission on-site at the venue entrance using AlipayHK, Alipay, Octopus, or WeChat Pay. In addition, Morning Admission Tickets and Evening Admission Tickets for designated dates will return this year. Photo download: https://bit.ly/4z3xlyU Opening dates and times of the exhibitions: Date HKTDC Food Expo PRO Open to trade buyers only: 13-14 August (Thursday to Friday) Open to trade buyers and public: 15 August (Saturday) Hong Kong International Tea Fair Open to trade buyers and public: 13-15 August (Thursday to Saturday) HKTDC Food Expo, HKTDC Beauty & Wellness Expo, HKTDC Home Delights Expo 13-17 August (Thursday to Monday) International Conference of the Modernization of Chinese Medicine and Health Products 13-15 August (Thursday to Friday) Time HKTDC Food Expo PRO, Hong Kong International Tea Fair 13-14 August: 10am to 6pm 15 August: 10am to 5pm HKTDC Food Expo, HKTDC Beauty & Wellness Expo, HKTDC Home Delights Expo 13-16 August: 10am to 10pm 17 August: 10am to 6pm Venue Hong Kong Convention and Exhibition Centre, Wan Chai Admission - Food Expo Public Hall, Home Delights Expo, Beauty & Wellness Expo and Hong Kong International Tea Fair 2026 single ticket: HK$30 per person (ticketholders can pay a top-up fee of HK$10 for admission to the Gourmet Zone on the same day) - Food Expo Public Hall and Gourmet Zone, Home Delights Expo, Beauty & Wellness Expo and Hong Kong International Tea Fair 2026 combo tickets: HK$40 per person* *HK$36 per person during the pre-sale period from 30 July to 12 August. (Tickets are available for pre-sale and walk-in at all 7-Eleven and Circle K convenience stores for HK$36 per person.) Remarks: Holders of the 15 August single ticket & combo ticket can visit the Food Expo PRO - Morning admission tickets: Entry before 12pm on 13, 14 and 17 August (Thursday, Friday and Monday) to the Food Expo Public Hall, Home Delights Expo, Beauty & Wellness Expo and Hong Kong International Tea Fair on the same day: HK$10 (pay directly by AlipayHK, Alipay, Octopus card or WeChat Pay for admission at the hall entrances only) - Night admission tickets: Entry after 6pm on 13 to 16 August, Thursday to Sunday, to the Food Expo Public Hall, Home Delights Expo, Beauty and Wellness Expo on the same day: HK$10 (pay directly by AlipayHK, Alipay, Octopus card or WeChat Pay for admission at the hall entrances only) - Concessionary price for persons with disabilities: HK$10 (top-up fee for the Gourmet Zone on the same day is HK$10)Note: Persons with disabilities need to present a “Registration Card for Persons with Disabilities”, issued by the Labour and Welfare Bureau (pay directly by AlipayHK, Alipay, Octopus card or WeChat Pay for admission at the hall entrances only) - Tourist tickets: HK$20 (HK$30 including admission to the Gourmet Zone) Note: Tourists need to present valid travel documents at the fairground to purchase tickets - Free admission is available for children aged three and under and senior citizens aged 65 or above (presenting valid age proof) Tickets E-tickets are available for sale at AlipayHK and Alipay, the 01 Space e-ticketing platform, all 7-Eleven and Circle K convenience stores, the Octopus app and The Club app. HKTDC Food Expo PRO foodexpopro.hktdc.com HKTDC Hong Kong International Tea Fair hkteafair.hktdc.com HKTDC Food Expo hkfoodexpo.hktdc.com HKTDC Beauty & Wellness Expo hkbeautyexpo.hktdc.com HKTDC Home Delights Expo homedelights.hktdc.com The International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM) icmcm.hktdc.com August Happy Buy website ecoupon.hktdc.com/food/ Media enquiries HKTDC’s Communications & Public Affairs Department: Katy Wong Tel: (852) 2584 4524 Email: katy.ky.wong@hktdc.org Winnie Kan Tel: (852) 2584 4055 Email: winnie.wy.kan@hktdc.org Clayton Lauw Tel: (852) 2584 4472 Email: clayton.y.lauw@hktdc.org HKTDC Media Room: http://mediaroom.hktdc.com About HKTDC The Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. View the original release on www.newmediawire.com
JOST has signed a business transfer agreement to sell its Indian tipper body operations to Belrise Industries Limited Completion is anticipated in the fourth quarter of 2026 Outlook for fiscal year 2026 confirmed NEU-ISENBURG, GERMANY - August 5, 2026 (NEWMEDIAWIRE) - JOST Werke SE (“JOST”), one of the world's leading suppliers of safety- and mission-critical systems for the commercial vehicle industry, has entered into an agreement to transfer its Tipper Body Business in India to Belrise Industries Limited (“Belrise”). Following the acquisition and integration of Hyva in February 2025, JOST continues to refine Hyva’s portfolio to concentrate on tipping cylinders, hydraulic components and digital tipping systems. The divestment lowers JOST’s vertical integration and enhances operational flexibility in India. On an annual basis, the Indian tipper body business generates revenue of EUR 30 to EUR 40 million and an EBITDA of about EUR 1 million. The agreed purchase price amounts to about EUR 5 million. As the closing of the transaction is expected in the 4th quarter of 2026 it will not have any material impact on the revenue and earnings outlook for JOST for 2026 fiscal year and JOST confirms its outlook for 2026. Closing remains subject to customary regulatory approvals and conditions. Joachim Dürr, CEO of JOST Werke SE, said: “This divestment is a further step in aligning our portfolio with our long-term strategy for profitable growth. It allows us to focus even more strongly on the core hydraulic and tipping solutions offered under the Hyva brand and to direct our R&D capabilities toward mission-critical systems.” Mr. Shrikant Badve, Managing Director of Belrise Industries Limited, said: “We are pleased to welcome Hyva’s India Tipper Body Business into the Belrise family. The business has established a strong reputation in the Indian commercial vehicle market and represents a compelling strategic fit for Belrise, complementing our manufacturing and engineering capabilities. We are committed to investing in its future growth while ensuring seamless continuity for customers, employees, suppliers, and business partners throughout the transition, in collaboration with JOST.” Contact: JOST Werke SE Romy Acosta Head of Investor Relations T: +49 6102 295-379 romy.acosta@jost-world.com About JOST: JOST is a world-leading producer and supplier of safety-critical systems for the commercial vehicle industry. Under the umbrella brand of JOST, the comprehensive range of products is categorized into systems for On-Highway (transport industry) and Off-Highway applications (agriculture and construction industries). JOST’s global leadership position is driven by the strength of its brands JOST, ROCKINGER, TRIDEC, Quicke and Hyva, its long-standing client relationships serviced through its global distribution network, and its efficient and asset-light business model. With its five core brands, the company is the global leading producer of fifth wheel couplings, landing gears, agricultural front loaders and front-end tipping cylinders. Since the acquisition of Hyva in 2025, JOST employs over 6,500 staff worldwide, has sales and production sites in more than 35 countries, and operations on six continents. JOST is listed on the Frankfurt Stock Exchange. Further information on JOST can be found here: https://www.jost-world.com. View the original release on www.newmediawire.com
naoo Sense 3 is a completely rebuilt feed that combines multiple content sources - interests, trends, location and community signals - in real time First feed built end-to-end on naoo’s matured AI organization and infrastructure Runs on naoo’s scalable in-house AI and data infrastructure Built to improve continuously through real-time experimentation, testing multiple algorithm versions in parallel ZUG, SWITZERLAND - August 5, 2026 (NEWMEDIAWIRE) - naoo AG (Dusseldorf: Ticker: NAO; ISIN: CH1323306329; WKN: A40NNU), operator of an AI-powered social discovery, activation, and commerce platform, today announced naoo Sense 3, a completely rebuilt version of its AI-powered content feed. naoo Sense 3 marks the next evolution of naoo’s proprietary recommendation system and significantly upgrades how content is discovered, personalized and surfaced across the app. Unlike the previous feed algorithm, naoo Sense 3 reacts to each user in real time. The feed shows something new every time it is opened, adapts on the spot as a user's behavior and interests shift, and helps new users find what they are looking for far faster - a personal, relevant feed from the very first session instead of the same generic content everyone else sees. naoo Sense 3 is the first feed built by naoo’s now-matured AI organization. naoo Sense 2, launched in mid-2025, was an early milestone; in the year since, naoo’s AI team has delivered a full stack of infrastructure and products. In rapid succession, naoo shipped the foundations of an AI-personalized discovery platform - a scalable data and AI infrastructure (GAIA), a machine-learning framework for automated model training and real-time serving (ModelKnife), and a real-time experimentation layer (METIS) - alongside a series of user-facing products, including a semantic, multilingual search across content, creators, places and products (naoo Search), AI-driven video recommendations (naoo Loops) and semantic matching that connects users with relevant people and communities (People Matching). Crucially, naoo Sense 3 is built to keep getting better. Using its real-time experimentation framework, naoo can run multiple versions of the feed algorithm side by side, measure how each performs against real engagement signals, and roll out the strongest configurations with confidence - so the feed continuously improves rather than staying fixed. Dr. David Liu, Head of AI and Lead Data Scientist, naoo commented: “naoo Sense 3 is a step-change in how our feed works - and the first feed we’ve built end-to-end on the AI foundation we’ve put in place over the past year. It brings together everything that makes naoo unique - interests, location, community and, increasingly, our business ecosystem - in real time, so users discover not only the content they love but also the local businesses, offers and point-earning opportunities around them.” For naoo, this marks an important strategic step. A more relevant, fresher and more personal feed is the engine that the world’s leading social platforms have relied on to deepen engagement, retain users and, ultimately, grow their audiences. By bringing this class of feed technology to its local-discovery model, naoo aims to strengthen user retention and engagement and to support sustained growth of its active user base over time - turning a better feed into a foundation for scaling the platform. A phased rollout for naoo Sense 3 is planned for the month of August 2026. About naoo naoo AG is shaping the future of creator-driven media, social interaction, and local engagement through a business model that combines digital attention with measurable results in the real world. At the heart of the group is the naoo platform - a next-generation social media and engagement ecosystem that links digital attention with geographic relevance and interaction with local businesses. The platform offers a unique user experience through personalized content, gamification, and an innovative points and rewards system. At the same time, it creates significant added value through local incentives, measurable engagement centered around physical locations, and new forms of real-world interaction enabled by naoo business. Business customers can create personalized offers tailored to users’ needs and incentivize visits to physical locations with naoo points, which can be redeemed for various rewards.Together with Kingfluencers AG - Switzerland’s largest influencer agency and one of the largest in the DACH region - naoo combines platform innovation with industry-leading expertise in the areas of creators, campaigns, and brand storytelling. This creates new opportunities to expand the marketing funnel between digital campaigns and real-world interaction. In addition, naoo is continuously expanding its ecosystem through its own creator-driven media formats, such as Vertical Shorts and Content Hubs. These expand reach, deepen user engagement, and support a diversified, IP-driven business model. naoo AG is headquartered in Zug, Switzerland, employs 41 people across the group’s activities, and is listed on the Dusseldorf Stock Exchange (Ticker: NAO, ISIN: CH1323306329). Contact for media and investors Karl Fleetwood Chief Operating Officer Email: karl.fleetwood@naoo.com Phone: +41 (0)79 867 10 10 View the original release on www.newmediawire.com
BADEN, SWITZERLAND - August 5, 2026 (NEWMEDIAWIRE) - Accelleron today announced the appointment of Ravin Pillay-Ramsamy as President of the Service Division and member of the Executive Committee, effective October 1, 2026. He will be based in Baden. Ravin Pillay-Ramsamy will succeed Roland Schwarz, who has been appointed CEO of OMT, an Accelleron company specialized in fuel injection. Klaus Heim, currently CEO of OMT, will retire at the end of September 2026. “We are very pleased to welcome Ravin to Accelleron,” said Daniel Bischofberger, CEO of Accelleron. “He brings extensive international leadership experience in industrial services, engineering, business development and M&A, combined with deep expertise in power generation, oil and gas, and industrial infrastructure. His proven track record in leading global service organizations will be highly valuable as we continue to strengthen our service business and create value for our customers worldwide.” Ravin Pillay-Ramsamy joins Accelleron from Sulzer, where he currently serves as Division President Services and is a member of the Executive Committee. Previously, he held several senior leadership positions within Sulzer’s Services division across EMEA and Asia Pacific. He began his career in the United States at Turbine Services Ltd., where he served as Business Development Director and Vice President Engineering. He holds a Global MBA from Columbia Business School and London Business School, a Master’s degree in Management and Finance from Rensselaer Polytechnic Institute, and a Bachelor of Science in Electrical and Computer Engineering from The Ohio State University. Accelleron Industries Ltd (ACLN: SIX Swiss Exchange) is accelerating sustainability in the marine and energy industries as a global technology leader in turbocharging, fuel injection, and digital solutions for heavy-duty applications. Building on a heritage of over 100 years as a trusted industry partner, the company serves customers in more than 100 locations in over 50 countries. Accelleron’s more than 3,200 employees are continuously innovating to deliver best-in-class products, services, and solutions that are mission-critical for the energy transition. Media resources Images and other digital assets are available at: https://accelleron.com/media/media-resources For more information please contact: Media Relations Sandro Hofer Phone: +41 79 644 76 55 Email: media@accelleron-industries.com Accelleron Industries Ltd Bruggerstrasse 71A 5400 Baden Schweiz https://accelleron.com Additional features: File: Press Release (PDF) File: Ravin Pillay-Ramsamy (PNG) View the original release on www.newmediawire.com
Repowering projects “Wulfsdorf A” and “Kuhstedt III” with a combined capacity of 45 MW sold Clean electricity for around 31,000 three-person households per year energy consult to provide operational management services for the wind farms CUXHAVEN, GERMANY - August 5, 2026 (NEWMEDIAWIRE) - The PNE Group has successfully sold two wind farm projects to a small group of private investors. The projects are the “Wulfsdorf A” wind farm in Schleswig-Holstein and the “Kuhstedt III” wind farm in Lower Saxony. Together, the two wind farms have a total nominal capacity of 45 megawatts (MW). Both wind farms are repowering projects, replacing older turbines with modern, more powerful wind energy technology. This enables significantly higher renewable electricity generation at sites that are already being used for wind energy production. The “Wulfsdorf A” wind farm is located in the district of Ostholstein in Schleswig-Holstein. The project comprises two Vestas V150 turbines with a capacity of 6.0 MW each and two Vestas V162 turbines with a capacity of 6.2 MW each, resulting in a total capacity of 24.4 MW. Construction is already underway, and commissioning is scheduled for December 2026. The “Kuhstedt III” wind farm is located in the district of Rotenburg (Wümme) in Lower Saxony and has a total capacity of 20.6 MW. It will consist of two Nordex N175 turbines with a capacity of 6.8 MW each and one Nordex N163 turbine with a capacity of 7.0 MW. Construction is also already in progress. The project is expected to be commissioned around the turn of 2026/27. Based on the expected electricity generation of both wind farms, the projects will be capable of supplying the equivalent annual electricity demand of approximately 31,000 three-person households per year. “By selling ‘Wulfsdorf A’ and ‘Kuhstedt III’, we continue our successful marketing of high-quality wind farm projects,” says Roland Stanze, COO of PNE AG. “Both projects demonstrate the value of repowering: we are making more efficient use of existing sites, deploying modern and highly efficient turbine technology, and significantly increasing renewable energy generation. At the same time, the transaction underscores the attractiveness of our projects to investors. Through the operational management services, we will also remain closely connected to the wind farms.” Operational management of both wind farms will be provided by energy consult GmbH, a company within the PNE Group. With the sale of the “Wulfsdorf A” and “Kuhstedt III” wind farms, the PNE Group continues its successful track record of project disposals this year. Most recently, PNE sold the “Romescamps” wind farm in France with a capacity of 10.8 MW. Other recent transactions include the “Bokel” wind farm in Germany with a capacity of 25.2 MW, a wind farm project in Poland with a planned total capacity of 72 MW, and a photovoltaic project in Poland with a capacity of approximately 40 MW. About the PNE Group The internationally operating PNE Group is listed on the SDAX. For more than 30 years, it has been one of the most experienced project developers in the field of onshore wind farms. The focus is on the development of wind energy and photovoltaic projects worldwide as well as on power generation with its own wind farms. Its portfolio covers all project planning phases, from site investigation, permit procedures and financing to construction, operation and repowering. As a Clean Energy Solutions Provider, the PNE Group also offers services for the entire life cycle of wind farms and photovoltaic plants, as well as battery storage solutions for the more efficient use of renewable energies. Your contact persons: PNE AG Alexander Lennemann Head of Corporate Communications Tel: +49 47 21 7 18 – 453 E-mail: alexander.lennemann@pnegroup.com PNE AG Head of Investor Relations Christopher Rodler Tel: +49 40 879 33 – 114 E-mail: christopher.rodler@pnegroup.com View the original release on www.newmediawire.com
SOFIA, BULGARIA and MUNICH, GERMANY - August 5, 2026 (NEWMEDIAWIRE) - Shelly Group SE (Ticker SLYG / ISIN: BG1100003166) ("Shelly Group"), a provider of IoT and smart building solutions based in Sofia, Bulgaria, invites investors and analysts to an earnings webcast/call with the Management Board members on 13 August 2026, 09.00 CEST (10.00 EEST). The unaudited 6M 2026 consolidated results will be announced on 12 August 2026 after the close of trading. Earnings Call: Co-CEOs Dimitar Dimitrov and Wolfgang Kirsch will comment on the unaudited consolidated 6M 2026 results by means of a webcast presentation. The webcast/call will be held in English. Please register to participate in the webcast/call at: Shelly Group – Earnings Call 6M 2026. About Shelly Group Shelly Group SE develops, designs, and distributes IoT and smart building solutions for DIY and professional users, offering advanced technology, seamless interoperability, and a high degree of technological flexibility. Shelly products enable remote control and automation as well as energy management of electrical appliances and smart building solutions via smartphones, PCs, or third-party home automation systems. In addition to the sale of devices, the Shelly Group generates revenue from its cloud applications. The Shelly Group benefits from asset-light production through the use of contract manufacturers. The Company has a strong presence in German-speaking countries and is represented with its products in more than 100 countries. With sales organizations in the regions of DACH (Germany, Austria, Switzerland), Benelux (Belgium, the Netherlands, Luxembourg), the Nordics (Denmark, Sweden, Norway, and Finland), Iberia (Spain and Portugal), as well as in Poland, Italy, France, the United Kingdom, Bulgaria, Slovenia, the United States and China, the Shelly Group has a broad international presence. Contact Investor Relations CROSS ALLIANCE communication GmbH Sven Pauly Phone: +49 89 125 09 0331 Mail: sp@crossalliance.de www.crossalliance.de View the original release on www.newmediawire.com
LOS ANGELES, CA - August 5, 2026 (NEWMEDIAWIRE) - Wrap Technologies (NASDAQ: WRAP) announced it will host a conference call on Tuesday, Aug. 11, 2026, at 4:30 p.m. ET to discuss financial and operational results for the second quarter ended June 30, 2026. Company management will provide an update on quarterly performance followed by a question-and-answer session. Investors may submit questions in advance by email through 5 p.m. ET on Aug. 10, with responses subject to relevance and public disclosure considerations. The company said its second-quarter 2026 earnings release and related materials will be available in the Investors section of its website before the call. Participants may join the webcast or register for dial-in access through the links provided by the company. To view the full press release, visit https://ibn.fm/wQrcn About Wrap Technologies, Inc. Wrap Technologies, Inc., a global leader in innovative public safety technologies and non-lethal tools, delivering cutting-edge technology with exceptional people to address the complex, modern day challenges facing public safety organizations. WRAP’s complete public safety portfolio includes the non-lethal BolaWrap(R) 150 device, Wrap Reality(R) immersive training platform, WrapVision(TM) body-worn camera system, WrapTactics(TM) training programs, and next-generation C-UAS solutions like PAN-DA and the 1KC Kinetic Anti-Drone Cassette, all of which supports the Company’s mission to provide safer, scalable, and cost-effective technologies for public safety, defense, and critical infrastructure markets. With a growing demand for non-lethal tools and techniques to create time, distance and tactical advantage in non-criminal calls, Wrap’s BolaWrap(R) 150 incorporates a multi-sensory distraction of sight and sound as a first response, followed by a non-lethal restraint if further escalation is required. This approach reduces the risk of injury to officers, subjects, and the community. Wrap’s BolaWrap(R) 150 solution is intended to provide law enforcement with a safer choice for nearly every phase of a critical incident. This innovative, patented device deploys a multi-sensory, cognitive disruption to expand the pre-escalation period and gives officers the advantage and critical time to manage non-compliant subjects before resorting to higher-force options. The BolaWrap(R) 150 is not pain-based compliance. It does not shoot, strike, shock, or incapacitate, instead, it helps officers strategically operate pre-escalation on the force continuum, reducing the risk of injury to both officers and subjects. Used by over 1,000 agencies across the U.S. and in 60 countries, BolaWrap(R) is backed by training certified by the International Association of Directors of Law Enforcement Standards and Training (IADLEST), reinforcing Wrap’s commitment to public safety through cutting-edge technology and expert training. WrapReality(TM) VR is a fully immersive training simulator to enhance decision-making under stress. As a comprehensive public safety training platform, it provides first responders with realistic, interactive scenarios that reflect the evolving challenges of modern law enforcement. By offering a growing library of real-world situations, WrapReality(TM) is intended to equip officers with the skills and confidence to navigate high stakes encounters effectively, which we believe leads to safer outcomes for both responders and the communities they serve. WrapVision is an all-new body-worn camera and evidence management system built for efficiency. Designed for efficiency, security, and transparency to meet the rigorous demands of modern law enforcement, WrapVision captures, stores, and helps manage digital evidence, ensuring operational security, regulatory compliance, and enhanced video picture quality and field of view. The WrapVision camera, powered by IONODES, boasts streamlined cloud integration and final North American assembly, with a critical made-in-America roadmap projected for early 2026. This track helps ensure data integrity and helps eliminate critical concerns over unauthorized access or foreign surveillance risks. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to WRAP are available in the company’s newsroom at https://ibn.fm/WRAP Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
LOS ANGELES, CA - August 5, 2026 (NEWMEDIAWIRE) - Beeline Holdings (NASDAQ: BLNE) outlined its strategic vision for an AI-powered residential equity and finance platform following its previously announced non-binding letter of intent to acquire TYTL Corp. The proposed combination would integrate Beeline’s mortgage origination, Non-QM lending, title and settlement capabilities with TYTL’s blockchain-enabled residential equity infrastructure, enabling qualified homeowners to monetize home equity through equity transactions rather than traditional borrowing while providing institutional investors access to real estate-backed digital securities. The companies said they have spent more than a year integrating their platforms and will continue developing a wholesale distribution network and tokenized residential mortgage-backed securities roadmap during the LOI period. Management said the combined company expects to build a treasury of residential real estate-backed digital assets, diversify revenue beyond interest rate-driven mortgage activity and pursue strategic capital markets initiatives, including monetizing TYTL’s existing digital real estate portfolio. To view the full press release, visit https://ibn.fm/YTuGp About Beeline Holdings, Inc. Beeline Holdings, Inc. is a technology-driven mortgage platform focused on simplifying home financing through AI-powered digital mortgage origination, Non-QM lending, title, and settlement services. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to BLNE are available in the company’s newsroom at https://ibn.fm/BLNE Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law. View the original release on www.newmediawire.com
AZIO AI is building an integrated technology infrastructure platform focused on AI data centers, enterprise GPU compute, high-performance computing and digital power solutions. In July 2026, the company completed its merger with AZIO AI Corporation and subsequently changed its corporate name and Nasdaq ticker symbol from EVTV to AZIO, completing its transformation into a dedicated AI infrastructure company. AZIO AI has announced a $27.9 million AI infrastructure and capacity agreement with Power Champion Investment Limited that is scalable to as much as $100 million as deployment expands. The company has reported receiving initial deposits under the agreement. The company recently executed a Master Services Agreement with AT&T to provide enterprise fiber connectivity for its planned 500-megawatt Texas AI infrastructure platform. Under the AT&T agreement, AZIO AI has committed approximately $2.4 million for high-capacity fiber services designed to support AI training, inference, GPU cloud computing, enterprise colocation and other high-performance computing workloads. AZIO AI has also reported entering into a Power Purchase and Hosting agreement with a GPU customer, supporting the need for an initial modular buildout at the company’s Texas site. The company’s business model encompasses AI data center development, GPU and server infrastructure sales and distribution, power hosting, compute leasing and strategic technology investments. AZIO AI’s strategy is designed to create multiple potential revenue channels across infrastructure development, equipment sales, hosting, power services and recurring compute capacity. The company is pursuing domestic and international opportunities serving enterprise, institutional, hyperscale and government-related customers. AZIO AI is positioning its Texas campus around scalable, energy-backed infrastructure intended to address rising demand for power-intensive AI and GPU computing workloads. LOS ANGELES, CA - August 5, 2026 (NEWMEDIAWIRE) - Azio AI Holdings (NASDAQ: AZIO) is a technology infrastructure company focused on developing, owning and operating artificial intelligence data centers, enterprise GPU compute infrastructure, high-performance computing systems, digital power solutions and digital asset mining operations. The company is building an integrated AI infrastructure platform designed to serve enterprise, institutional, hyperscale and government-related customers across domestic and international markets. Its operating strategy encompasses the development of AI data center capacity, the sale and distribution of… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to AZIO are available in the company’s newsroom at https://ibn.fm/AZIO Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
Warehouse Management Platform Analysis Reveals Operators are Accelerating Order Fulfillment While Improving Freight Efficiency Amid Rising Transportation Costs KEY TAKEAWAYS SC Codeworks’ H1 2026 platform data shows the logistics industry is moving faster, with total freight orders up 6.9% year over year and June posting the strongest month at 14.6% growth over June 2025. Average order-to-ship cycle times fell 34% year over year - from 19.76 days in H1 2025 to 13.04 days in H1 2026 - as businesses ordered closer to actual demand and expected faster warehouse execution. Warehouse operators consolidated LTL freight more efficiently, raising average orders per load 19% (from 4.87 to 5.79) and growing high-density loads of 20+ orders from 5.2% to 6.5% of all consolidations. Even as diesel prices climbed after geopolitical disruptions, operators shipped 26% more LTL volume while holding consolidation rates steady at 74–75% - maximizing trailer utilization instead of adding trucks. COLUMBUS, OH - August 5, 2026 (NEWMEDIAWIRE) - SC Codeworks, a provider of warehouse management software (WMS) for logistics operators, released its H1 2026 supply chain performance data, revealing a logistics industry that is becoming faster, more efficient and increasingly resilient despite ongoing economic and transportation challenges. Supply Chains Are Moving Faster Using SC Codeworks platform data to compare the first-half of 2026 performance against the same period in 2025, the report found total freight orders increased 6.9% year over year during the first half of 2026, signaling continued demand across the logistics sector. June recorded the strongest monthly performance, with freight orders climbing 14.6% compared to June 2025. At the same time, average order-to-ship cycle times fell dramatically. Average fulfillment time decreased 34% year over year, dropping from 19.76 days in H1 2025 to 13.04 days in H1 2026. The trend suggests businesses are placing orders closer to actual demand while expecting significantly faster warehouse execution, reflecting a more agile and responsive supply chain environment. Operators Improve LTL Efficiency as Transportation Costs Rise The report also found that warehouse operators became more efficient in consolidating less-than-truckload (LTL) shipments during a period of elevated fuel costs. From January through April 2026: Average orders per consolidation load increased 19%, rising from 4.87 to 5.79 orders per load. High-density loads carrying 20 or more orders grew from 5.2% of all consolidations in January to 6.5% in February, remaining elevated through April. Overall shipped LTL volume increased 26%, while consolidation rates remained consistently between 74% and 75%, demonstrating that operators maintained shipping discipline even as freight volumes increased. These trends coincided with a significant increase in diesel prices following geopolitical disruptions earlier this year, suggesting organizations responded by maximizing trailer utilization instead of increasing truck deployments. "The data tells a clear story. Companies are compressing their planning horizons, ordering closer to actual need and expecting the supply chain to keep pace," said Amy Dean, Vice President of Operations at SC Codeworks. "On the LTL side, operators are responding the right way, packing more work into every load rather than adding trucks. And underneath all of it, volume is growing. That combination tells us the logistics industry is not just surviving a demanding environment. It is adapting to it." SC Codeworks is an award-winning logistics software company, including recent recognitions from the Institute for Supply Management's Supply Chain Trailblazer Awards, Inbound Logistics' Top 100 Logistics & Supply Chain Technology Providers list and the SupplyTech Breakthrough Awards as Warehouse Automation Platform of the Year. To learn more about SC Codeworks, please visit https://www.sccodeworks.com/. About SC Codeworks SC Codeworks, headquartered in Columbus, OH, offers multiple warehouse management system platforms including Codeworks Essentials and Codeworks Enterprise, which can be tailored to meet the needs of warehouse logistics companies of all sizes. Built by logistics experts for logistics experts, the platforms provide a fully integrated, one-stop solution that includes essential modules like yard management and inventory control, coupled with more advanced features such as line-side knitting and CODI, the company’s AI-powered orchestration engine that supports day-to-day warehouse decisions. In addition to its leading software solution, SC Codeworks provides consultancy services to logistics companies, offering operational support to clients with varying technology needs. For media inquiries, contact: Virgo PR sccodeworks@virgo-pr.com View the original release on www.newmediawire.com
Onsetto’s SwitchAssist Helps Banks Turn New Business Accounts Into Activated Primary Relationships Through Structured Onboarding and Account Transition Support MINNEAPOLIS, MN - August 5, 2026 (NEWMEDIAWIRE) - Onsetto, a fintech company helping financial institutions grow business deposits and activate primary business banking relationships, today announced that Live Oak Bank has selected Onsetto’s SwitchAssist platform to enhance the way business customers transition and activate their banking relationships. As competition for business deposits intensifies, banks are increasingly focused not only on acquiring new business accounts, but also on ensuring those accounts become fully engaged, primary operating relationships. SwitchAssist helps financial institutions close the gap between account opening and account activation by providing a structured activation experience for business customers and bankers. Through SwitchAssist, Live Oak Bank will be able to guide business customers through the critical steps involved in moving a banking relationship, including updating payment instructions, transitioning recurring transactions, notifying vendors and customers, activating treasury and payment services, and establishing new operating workflows. “At Live Oak Bank, we are committed to helping business owners succeed with banking experiences that are simpler, easier, faster, and more efficient,” said Live Oak’s Chief Banking Officer Mark Moroz. “SwitchAssist provides a structured approach that helps reduce friction, improve onboarding, and accelerate activation so customers can realize value from their banking relationship more quickly.” For many banks, business account opening is only the first step. The greater challenge is helping customers move their real financial activity; deposits, payments, payroll, treasury services, and vendor relationships to the new institution. Without a structured activation process, new accounts may remain underutilized, deposits may stay elsewhere, and customer attrition risk can increase. Onsetto was built to help banks solve this challenge. SwitchAssist provides the growth infrastructure banks need to operationalize business account activation, reduce customer friction, support banker follow-up, and convert newly acquired accounts into deeper, more valuable commercial relationships. “Banks are under pressure to grow business deposits, deepen relationships, and reduce attrition, but many still rely on manual processes to help customers transition after account opening,” said Cale Johnston, Founder and CEO of Onsetto. “SwitchAssist gives financial institutions a structured activation framework that helps business customers move their operating activity and establish the bank as their primary financial partner. Live Oak Bank’s selection of Onsetto reinforces the importance of activation as a core part of business banking growth.” SwitchAssist combines customer-facing workflows, banker enablement tools, progress visibility, and activation best practices to create a more consistent and scalable transition experience. For banks, the platform supports deposit growth, treasury services adoption, customer engagement, operational efficiency, and long-term relationship value. With 21 financial institutions currently live on the platform, Onsetto continues to help banks and credit unions move beyond account acquisition and build repeatable processes for business banking activation. About Onsetto Onsetto is the Commercial Banking Operating Platform that helps financial institutions identify, activate, expand, and retain primary commercial banking relationships. Through a connected suite of solutions, including business account switching, prospecting intelligence, and treasury growth. Onsetto equips banks to accelerate commercial deposit growth, increase treasury adoption, and strengthen long-term customer relationships. Founded by the team behind ClickSWITCH, Onsetto is helping financial institutions modernize commercial banking by turning relationship growth into a repeatable operating model. Learn more at www.onsetto.com. Contact: Lindsey Johnston lindsey@onsetto.com View the original release on www.newmediawire.com
CARACAS, VENEZUELA - August 5, 2026 (NEWMEDIAWIRE) - LataMed AI Corp. (OTC: LMED) (“LataMed AI” or the “Company”), a healthcare technology company developing digital health and artificial intelligence solutions for Latin America, today announced that, through its Venezuelan operating subsidiary LATAMEDAI VE, it will participate in Artificial Intelligence & Health Markets 2026, an educational conference scheduled for August 13 and 14, 2026, at Universidad Santa Maria in Caracas. The event is expected to bring together students, faculty members, and participants from the university’s systems engineering and healthcare-related academic communities, including pharmacy, dentistry, and laboratory sciences, to examine practical applications of artificial intelligence and automation across medical and technical environments. LataMed AI will be represented by Dr. Kevin Rodan Levy, Chief Executive Officer, and Carlos Pena, Chief Financial Officer. Their presentation is expected to address the evolving role of artificial intelligence in healthcare, systems engineering, digital infrastructure, and professional decision-making. During the conference, LataMed AI intends to discuss how artificial intelligence-supported tools may assist healthcare professionals with medical-data evaluation, clinical workflows, and operational decision-making. The Company also plans to examine how automation may support the organization, reliability, and efficiency of technology systems used in healthcare and other complex operating environments. The presentation will emphasize the importance of maintaining qualified professional oversight when implementing artificial intelligence. LataMed AI’s technologies are intended to enhance human capabilities and support informed decision-making rather than replace the independent judgment of healthcare professionals, engineers, laboratory personnel, or other qualified individuals. Additional conference topics are expected to include the integration of artificial intelligence and automation into existing systems, responsible data use, privacy and information security, operational risk management, and the practical considerations involved in developing and deploying technology in healthcare settings. LataMed AI also intends to discuss the continued development of its healthcare technology ecosystem and the role of CardioAI, PulmoAI, and NeuroAI within the Company’s broader strategy. These artificial intelligence-supported platforms are being developed to assist healthcare professionals in the evaluation and management of cardiovascular, pulmonary, and neurological health information, subject to continued development, testing, applicable regulatory requirements, and commercial implementation. “Artificial Intelligence & Health Markets 2026 provides an important opportunity to engage directly with students, educators, and future professionals who will help shape the responsible use of artificial intelligence in healthcare and systems engineering,” said Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp. “Our objective is to share practical perspectives on how intelligent technologies can support professional decision-making, improve digital workflows, and contribute to the continued development of healthcare infrastructure in Latin America.” Management believes that engagement with universities and educational institutions can help increase awareness of emerging healthcare technologies, encourage responsible discussion regarding artificial intelligence, and strengthen relationships with future healthcare, engineering, laboratory, and technology professionals. The Company also views its participation as an opportunity to better understand the perspectives of students, educators, researchers, and technical professionals as it continues developing digital health and artificial intelligence-supported solutions for the Latin American market. LataMed AI’s participation at Universidad Santa Maria is consistent with its broader strategy of supporting education, professional collaboration, and the responsible adoption of digital healthcare infrastructure throughout the region. The Company intends to continue evaluating opportunities to participate in academic, healthcare, and technology forums that align with its business and educational objectives. Participation in the conference does not constitute an endorsement of LataMed AI or its technologies by Universidad Santa Maria. The event does not guarantee future research collaborations, employment arrangements, commercial relationships, technology adoption, regulatory authorization, revenue, or other financial benefits. For additional information, please visit https://latamed.ai, follow the Company’s official social media channels, or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov. About LataMed AI Corp. LataMed AI Corp. is a healthcare technology company focused on developing digital health infrastructure and artificial intelligence-supported medical solutions for Latin America. The Company’s strategy includes the development of a telemedicine ecosystem designed to improve access to healthcare services and support connections among patients, medical professionals, pharmacies, insurers, payment providers, wellness organizations, educational institutions, and other participants in the healthcare system. The Company is also developing CardioAI, PulmoAI, and NeuroAI, artificial intelligence-supported platforms intended to assist healthcare professionals in the evaluation and management of cardiovascular, pulmonary, and neurological health information. These platforms remain subject to continued development, testing, applicable regulatory requirements, and commercial implementation. Forward-Looking Statements This press release contains forward-looking statements within the meaning of applicable securities laws. These statements include, among others, statements regarding LataMed AI’s anticipated participation in Artificial Intelligence & Health Markets 2026 at Universidad Santa Maria on August 13 and 14, 2026; the expected attendees, academic areas, speakers, subject matter, presentations, and conference themes; the Company’s intended discussion of artificial intelligence, automation, digital healthcare infrastructure, CardioAI, PulmoAI, and NeuroAI; potential engagement with students, faculty members, researchers, healthcare professionals, engineers, laboratory professionals, and technology professionals; and the Company’s broader educational, academic-engagement, healthcare technology, and artificial intelligence strategies. Forward-looking statements are based on current expectations, estimates, plans, and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. These risks include changes to the conference dates, format, agenda, speakers, or attendance; the Company’s ability to participate as anticipated; the continued development and testing of the Company’s technologies; compliance with applicable legal and regulatory requirements; the availability of necessary financing and qualified personnel; and the Company’s ability to establish future academic, professional, research, or commercial relationships. There can be no assurance that the conference will occur according to the anticipated schedule or format, that the Company or its identified speakers will participate as planned, that its participation will result in academic or commercial relationships, that its technologies will achieve regulatory authorization or market acceptance, or that the event will generate revenue or other financial benefits. The Company undertakes no obligation to update any forward-looking statement except as required by law. Disclaimer The Company’s technologies are under development and are not intended to replace the independent professional judgment of qualified healthcare providers, engineers, researchers, laboratory personnel, or other authorized professionals. No statement in this release should be interpreted as a representation or guarantee regarding technology performance, medical outcomes, regulatory authorization, academic endorsement, commercial adoption, revenue, market acceptance, or financial performance. This announcement is being issued solely to provide shareholders and market participants with information regarding the Company’s business development and educational activities. It does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company. Investor Relations LataMed AI Corp. ir@latamed.ai +1 (787) 476-2350 https://latamed.ai View the original release on www.newmediawire.com
TORONTO, ONTARIO - August 5, 2026 (NEWMEDIAWIRE) - NeuroThera Labs Inc. (TSXV: NTLX) (the "Company" or "NeuroThera"), a clinical-stage biotech company and a majority-owned subsidiary of SciSparc Ltd., today announced the initiation of its Phase IIb clinical trial site at the Yale Child Study Center, Yale School of Medicine, New Haven, Connecticut, USA. The study, led by Dr. Michael H. Bloch, will evaluate SCI-110, NeuroThera’s proprietary cannabinoid-based drug candidate for the treatment of Tourette Syndrome (“TS”) in adults. The trial is now progressing at the Yale Child Study Center, one of the study’s key clinical sites. SCI-110 combines dronabinol with the endocannabinoid-like palmitoylethanolamide in a single, innovative dosage form designed to reduce tics and associated comorbid symptoms in adults with TS while aiming to minimize side effects. In addition to the Yale site, the Phase IIb trial is also underway at Hannover Medical School in Hanover, Germany, and Tel Aviv Sourasky Medical Center in Tel Aviv, Israel. Dr. Adi Zuloff-Shani, Chief Technology Officer of NeuroThera, commented: “Launching a U.S. site at the Yale Child Study Center represents a significant milestone in our global development program for SCI-110. TS remains a major unmet medical need with limited therapeutic options, particularly in adults who continue to experience persistent, severe, and often debilitating symptoms. We believe SCI-110 has the potential to introduce a novel, more effective and safer treatment approach. We are deeply committed to advancing this promising therapy and generating meaningful clinical data to support its future regulatory approval.” Building on the positive safety and efficacy results from the Phase IIa study, which showed an average tic reduction of 21% across the entire participants sample, as measured by the gold standard, Yale Global Tic Severity Scale Total Tic Score, the Phase IIb study is a randomized, double-blind, placebo-controlled, cross-over trial designed to evaluate the efficacy, safety, and tolerability of daily oral SCI-110. Patients aged 18-65 will be randomized to receive either SCI-110 or placebo, with the primary efficacy endpoint being the change in tic severity measured by the Yale Global Tic Severity Scale at weeks 12 and 26 compared to the baseline. Safety will be assessed through monitoring of adverse events. About NeuroThera Labs Inc. NeuroThera Labs Inc. (TSXV: NTLX) is a clinical-stage pharmaceutical company focused on developing novel therapeutics for central nervous system disorders and other underserved health conditions through collaborations and innovative combinations. For further information, please contact: MichalEfraty IRManager NeuroThera Labs Inc. Telephone:+972-3-7617108 Email:michal@efraty.com Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. Cautionary Notice on Forward-Looking Statements This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking information and are based on expectations, estimates and projections as at the date of this news release. Forward-looking information in this news release includes statements regarding: potential benefits, safety efficacy, advantages and capabilities of SCI-110and the Company’s belief that SCI-110 has the potential to introduce a novel, more effective and safer treatment approach. These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking information necessarily involves known and unknown risks and uncertainties, which may cause the Company's actual performance and results to differ materially from any projections of future performance or results expressed or implied by such forward-looking information. Such factors include, without limitation the risks described in the Company's continuous disclosure documents filed on SEDAR+ (www.sedarplus.ca). The Company does not undertake any obligation to update or revise any forward-looking information, except as required by applicable securities laws. View the original release on www.newmediawire.com
HAMBURG, GERMANY and CHICAGO, IL - August 4, 2026 (NEWMEDIAWIRE) - The Nordex Group has secured three new orders in the United States with a combined capacity of more than 480 MW. The contracts comprise the supply of 81 N163/5.X turbines. The names of the customers and of the projects are not being disclosed. The projects will be delivered in accordance with customer-specific requirements and further strengthen the Nordex Group’s presence in the U.S. market. “These new orders reflect once again the trust our customers place in Nordex and in our ability to deliver and service projects reliably and efficiently. We are grateful for that confidence. Driven by strong customer partnerships, the dedicated execution and service capabilities of our teams, and our robust manufacturing capabilities, we are seeing continued momentum in this region,” says Manav Sharma, CEO of Nordex North America. “Our focus remains on delivering value and supporting our customers’ long-term energy goals.” The new orders will be manufactured in the Nordex Group’s production plant in Iowa. About the Nordex Group The Group has commissioned more than 64 GW of wind power capacity in over 40 markets since 1985 and generated consolidated sales of around EUR 7.6 billion in 2025. The Company currently has more than 11,100 employees with a manufacturing network that includes factories in Germany, Spain, Brazil, India and USA. Its product portfolio is focused on onshore turbines in the 4 to 7 MW+ classes which are designed to meet the market requirements of countries with limited available space and regions with constrained grid capacity. A global service network ensures the smooth operation of the turbines. Nordex SE is listed on the MDAX and TecDAX of the Frankfurt Stock Exchange (ISIN: DE000A0D6554) in Germany. Contact person for press: Nordex SE Felix Losada Telephone: +49 (0) 40 30030 1141 E-mail: flosada@nordex-online.com Contact for investor inquiries: Nordex SE Anja Siehler Phone: +49 162 3515 334 E-mail: asiehler@nordex-online.com View the original release on www.newmediawire.com
Preliminary FY 2025 sales and EBITDA confirmed Solid financial footing provides scope to consistently advance strategic initiatives aimed at optimizing production, logistics and sales AHLEN, GERMANY - August 4, 2026 (NEWMEDIAWIRE) - LR Health & Beauty SE, Europe’s leading social commerce company for high-quality nutritional supplements and beauty products, has today published its final annual report for 2025. The sales and earnings figures for the 2025 financial year, as communicated in the preliminary results, are thereby confirmed: for the full 2025 year, the LR Group generated sales (revenue from goods sold) of EUR 277.1 million (2024: EUR 289.2 million). Meanwhile, one-off effects arising from the reorganization of the financing structure weighed on earnings performance. For the full 2025 year, this resulted in reported EBITDA of EUR 16.5 million, compared with EUR 27.3 million in the previous year. Normalized EBITDA for the year amounted to EUR 22.5 million (2024: EUR 32.6 million). Jorg Korfer, CEO of LR Health & Beauty SE, comments: “The 2026 financial year is a transitional year for LR, during which we have laid the groundwork – both financially and strategically – for sustainable business growth and performance. The newly established financing structure gives us the momentum we need to continue to consistently pursue the initiatives we have launched in production, logistics and sales in the second half of the year. In this context, we are committed to working closely with our partners and are continuing to expand these relationships internationally.” Expanding in-house production is a key strategic pillar. As part of its strategic measures, LR is investing over 2 million euros in a new, high-performance production line, thereby centralizing the manufacture of the 5in1 product category entirely at its site in Ahlen in the future. This includes the established products LR 5in1 Beauty Elixir and LR 5in1 Men’s Shot. The new production facility is designed to have an annual capacity of up to 40 million units and also paves the way for further product innovations in the area of modern nutritional supplement concepts. The full 2025 Annual Report is available from today on the company’s website at https://ir.lrworld.com. LR Group Under the motto “More quality for your life”, the LR Group – headquartered in the town of Ahlen/Westphalia – successfully produces and distributes various high-quality nutritional supplements and cosmetic products in 32 countries. As an attractive Social Commerce Company, LR supports the personal exchange in its community with efficient, digital solutions. The holistic tool “LR neo” offers the international partnership all business-relevant key figures and information for their LR business in one dashboard. Since 1985, LR has been firmly established in the market as a “people business” with a focus on people and personal consultation. In times of changing working environments, the business model is particularly appealing to those who are looking for more flexibility, a better work-life balance and greater financial independence. The processing of aloe vera has been one of LR’s core competencies for over 20 years. Only the leaf’s valuable inside is used for the products. In Ahlen, the company has built one of the most modern aloe vera production facilities for aloe vera drinking gels in Europe. In the fall of 2009, LR founded the LR Global Kids Fund e.V., which supports disadvantaged children and their families in many countries around the world efficiently and without the usual red tape in cooperation with local institutions. For further information on our commitment to sustainability, please read our Sustainability Report. Contact: PR Contact: LR Health & Beauty SE Almut Kellermeyer Head of Corporate Communication KruppstraBe 55 59227 Ahlen Phone: +49(0)2382 7658-106 E-mail: a.kellermeyer@LRworld.com https://ir.LRworld.com/ IR Contact: cometis AG Thorben Burbach FriedrichstraBe 22 65185 Wiesbaden Phone: +49(0)611 - 205855-23 Fax: +49(0)611 - 205855-66 E-mail: burbach@cometis.de View the original release on www.newmediawire.com
BERLIN - August 4, 2026 (NEWMEDIAWIRE) - Medios AG (“Medios”), a leading provider of Specialty Pharma in Europe, has appointed Katrin Neuffer (49) as Director Investor Relations & Communications, effective immediately. In this role, she will be responsible for the Company’s communications with investors, analysts, the media, and the public. She succeeds Claudia Nickolaus, who is handing over leadership of the department to her. Katrin Neuffer holds a degree in business administration and has around 20 years of experience in capital markets communications. After beginning her career at an Investor Relations agency, she was responsible for the Capital Markets and Corporate Communications of SDAX-listed Wacker Neuson SE as Head of Investor Relations & Corporate Communications from 2007 to 2018 – from its IPO through its establishment as a consistently attractive investment. In addition, she led the Strategy and Sustainability departments there. She subsequently headed an international 20-member team as Vice President Investor Relations & Corporate Communications and Marketing at the Exyte Group (formerly M+W Group), where she was responsible for preparing an IPO with a targeted market capitalization of more than EUR 2 billion. Since 2020, she has supported publicly listed companies as an independent consultant in the areas of investor relations, IPO preparation, and crisis and restructuring communications. Claudia Nickolaus played a key role in building and shaping Medios’ Investor Relations activities – from financial reporting and ESG communications to the Company’s first Capital Markets Day in 2022. Prior to joining Medios, she held senior Investor Relations positions at publicly listed companies, including Merck KGaA. Thomas Meier, Chief Executive Officer (CEO) of Medios AG: “With Katrin Neuffer, we are gaining a proven capital markets expert who has guided publicly listed companies through decisive phases of development, from IPOs to strategic repositioning. Her experience will help us reposition Medios in the capital markets and intensify our dialogue with investors, analysts, and the media. On behalf of the Company, I would like to express my sincere thanks to Claudia Nickolaus: Over many years, she shaped Medios’ capital markets communications with tremendous dedication, a high level of professionalism, and personal reliability. She deserves our sincere gratitude for this.” Important events for the Medios Group in the 2026 financial year: August 12 Half-Year Financial Report 2026 September 21 to 23 Berenberg and Goldman Sachs 15th German Corporate Conference – München September 28/29 Medios Capital Markets Day November 10 Quarterly Statement as of September 30, 2026 About Medios AG Medios is a leading provider of Specialty Pharma in Europe. With locations in Germany, the Netherlands, Belgium and Spain, the Company supports key partners in the supply chain with innovative solutions and intelligent services. Medios has focused on pioneering individualized medicine to make the most innovative therapies available to everyone together with pharmacies, specialist practices and pharmaceutical companies. Medios AG is Germany's first listed specialty pharmaceutical Company. The shares (ISIN: DE000A1MMCC8) are listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) and are included in the SDAX selection index. www.medios.group More information on individualized medicine: https://app.medios.group/en/individualizedmedicine Contact Claudia Nickolaus Head of Investor & Public Relations Medios AG Heidestraße 9 | 10557 Berlin T +49 30 232 566 800 ir@medios.group www.medios.ag Additional features: File: Foto Katrin Neuffer View the original release on www.newmediawire.com
LOS ANGELES, CA - August 4, 2026 (NEWMEDIAWIRE) - SRX Global (NYSE American: SRXH) announced that it has acquired a stake in Vistagen Therapeutics, a late clinical-stage biopharmaceutical company developing intranasal neuroscience therapies based on its proprietary pherine platform. SRX said the investment aligns with its strategy of creating long-term shareholder value through investments in high-conviction operating companies and strategic assets. SRX said it believes Vistagen shares are undervalued and intends to engage constructively with the company’s leadership team and board of directors to discuss opportunities to unlock shareholder value. To view the full press release, visit https://ibn.fm/NEczV About SRX Global Inc. SRX Global is an AI-driven platform focused on generating long-term shareholder value through investments in high-conviction operating companies, strategic assets, and technology-enabled opportunities. The Company leverages proprietary technology, data analytics, and disciplined capital allocation to identify and manage investments across multiple sectors. For more information on the company, please visit: www.SRXGlobalInc.com Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law. View the original release on www.newmediawire.com
LOS ANGELES, CA - August 4, 2026 (NEWMEDIAWIRE) - Beeline Holdings (NASDAQ: BLNE) announced a non-binding letter of intent to acquire TYTL Corp. in an all-stock transaction that would combine Beeline’s AI-powered mortgage, Non-QM lending, title and settlement platform with TYTL’s blockchain-enabled residential equity infrastructure. The companies said the combined platform would enable qualified homeowners to access home equity without incurring additional debt while providing institutional investors with access to real estate-backed digital securities. Management estimates an initial addressable market of approximately $1 trillion based on qualifying U.S. homeowners. The companies said they have spent more than a year integrating TYTL’s Regulation D-compliant digital securities platform with Beeline’s lending and title operations. TYTL has completed its first blockchain-recorded residential equity transactions involving homes valued at more than $1 million, with its current portfolio valued about 26% above aggregate acquisition cost. Beeline said the combined company expects to generate higher revenue per transaction, build a treasury of real estate-backed digital assets and create a revenue stream less dependent on interest rates. To view the full press release, visit https://ibn.fm/xWs5h About Beeline Holdings, Inc. Beeline Holdings, Inc. is a technology-driven mortgage platform focused on simplifying home financing through AI-powered digital mortgage origination, Non-QM lending, title, and settlement services. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to BLNE are available in the company’s newsroom at https://ibn.fm/BLNE Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
DETROIT, MICHIGAN - August 4, 2026 (NEWMEDIAWIRE) - Benzinga is inviting investors of all experience levels to attend a free virtual educational event, "From Binary Outcomes to Ranges: Converting Opinions to Expectations," taking place on Thursday, August 6. Register for free today: https://www.benzinga.com/events/binary-outcomes-to-ranges/ Financial markets don't simply reflect opinions—they price expectations. This interactive virtual session will help participants move beyond binary thinking by exploring how investors can translate their views on future outcomes into structured market expressions. Using prediction market frameworks, attendees will learn how to convert probabilities into prices, identify potential market edge and better understand what today's markets are signaling. The session will introduce two key contract structures: Yes/No Contracts – Expressing conviction around all-or-nothing outcomes. Plus (Spread) Contracts – Capturing directionally correct views across a range of potential outcomes. The discussion will also connect these concepts to the broader S&P 500® Index ecosystem, highlighting how liquidity and market structure help support these products. Who Should Attend? This complimentary class is designed for: Newer investors looking to build a stronger foundation in how financial markets price expectations. Individuals with limited or developing market experience seeking practical ways to interpret market probabilities. Experienced investors interested in fresh approaches to evaluating risk, conviction and translating opinions into actionable trading ideas. Whether you're just beginning your investing journey or looking to expand your market toolkit, this session offers valuable insights into understanding expectations rather than simply predicting outcomes. The event will feature expert perspectives from: Stacey Gilbert, Sr. Director, The Options Institute Gianni Di Poce, Analyst, The Mercator LLC Event Details Event: From Binary Outcomes to Ranges: Converting Opinions to Expectations Date: Thursday, August 6 Cost: Free Format: Virtual Registration: https://www.benzinga.com/events/binary-outcomes-to-ranges/ Space is limited. Reserve your spot today and discover how understanding market expectations can help you develop more informed investing and trading strategies. View the original release on www.newmediawire.com
By Meg Flippin, Benzinga AI is driving the IPO market. Learn how to get access to the next red-hot offering with SoFi. DETROIT, MICHIGAN - August 4, 2026 (NEWMEDIAWIRE) - Whether it's a semiconductor company, a SaaS enterprise or a tech startup going public, all too many companies getting the attention of investors today have one thing in common - artificial intelligence. For good reason: companies of all sizes are pouring billions of dollars into AI initiatives, which means the chip manufacturers, AI companies, software makers and data center providers that support those efforts stand to benefit. One only has to look at what’s been going on in the IPO market for evidence. In May, an AI chip maker that went public raised over $5 billion. Then in July, a leading supplier of high-bandwidth memory - a critical component for AI accelerators - debuted on the public market. Its stock rose by double digits, underscoring the investor demand for AI-facing companies. The company now has a market cap around $1 trillion. AI IPO Market Heating Up There are several reasons why AI is driving the IPO market and why retail and institutional investors are clamoring to get in. AI has already proven it boosts productivity, creates jobs, builds new consumer markets, streamlines workflows and accelerates digital transformations. It is also proving not to be a flash-in-the-pan type investment theme, where these companies with multi-billion dollar valuations go bust a year later. After all, market forecasts call for the AI ecosystem to continue to experience strong growth, with AI spending increasing to $4.7 trillion in 2029 from $1.8 trillion last year. SoFi levels the playing field, bringing AI IPOs to regular investors. Click here to learn how. SoFi Brings AI IPOs To Investors Amid all this demand for access to AI companies going public, there is a bit of an imbalance. While all types of investors want to invest in AI startups, traditionally it’s largely the institutions, high-net-worth individuals or investors with connections who get access to these red-hot IPOs. Retail investors can typically either buy shares through a mutual fund or ETF if they are lucky, or buy the stock with everyone else after it debuts. But that is changing thanks to platforms like SoFi. SoFi enables everyday investors to request pre-IPO shares with no account minimums. Because of its large user base and strategic partnerships, SoFi acts as part of the underwriting syndicate, getting access to IPOs directly from underwriters and distributing those shares to regular investors. SoFi makes it easy to invest in AI IPOs by allowing users to browse upcoming offerings directly in the app, review the prospectus and submit an Indication of Interest to request a specific number of shares before the company begins public trading. As the AI IPO pipeline expands, SoFi is in a position to bring more access to regular investors, which is a win-win for everyone. Retail investors have more IPOs to choose from, SoFi has more engaged customers, and companies looking to go public have a wider investor base to allocate shares directly to. For issuers, SoFi acts as a retail distribution channel, enabling companies to allocate shares directly to employees, customers and individual investors as part of their IPO strategy. The IPO market is heating up, and it has AI to thank in big part. SoFi is giving regular investors access to that and capturing retail demand for issuers. Whether you are interested in chip companies or design enterprises, there’s an AI IPO for that. Ready to get started investing in IPOs with SoFi? Click here to learn how. INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA(www.finra.org)/SIPC(www.sipc.org). Investing in an Initial Public Offering (IPO) involves substantial risk, including the risk of losing principal. Key risks include, but are not limited to, unproven management, significant company debt, and lack of operating history. For a comprehensive discussion of these risks, please refer to SoFi Securities' IPO Risk Disclosure Statement. This is not a recommendation and does not constitute an offer of any securities for sale. Investors must carefully read the offering prospectus to determine if an offering is consistent with their objectives, risk tolerance, and financial situation. New offerings often have high demand and limited shares. Many investors may receive no shares, and any allocations may be significantly smaller than the shares requested in their initial offer (Indication of Interest). For more information on the allocation process, please visit IPO Allocation. Featured image from Shutterstock. This content was originally published on Benzinga. Read further disclosures here. This post contains sponsored content and was created in collaboration with a third-party partner. Benzinga is a publisher and does not provide personalized investment advice or act as a broker or dealer. This content is for informational purposes only and is not intended to be investing advice or an offer or solicitation to buy or sell any security. View the original release on www.newmediawire.com
By Meg Flippin, Benzinga DETROIT, MICHIGAN - August 4, 2026 (NEWMEDIAWIRE) - Vision Marine Technologies Inc. (NASDAQ: VMAR), a marine technology and recreational boating company combining proprietary high-voltage electric propulsion technology with a retail, marina and service platform, is making progress on the strategy it laid out over the past year. The company recently announced double-digit sequential revenue growth for its third quarter and the completion of a $16.3 million at-the-market equity offering program. The company says both milestones showcase the progress it's making in advancing E-Motion™ commercialization, expanding its electric boat portfolio, optimizing its retail, marina and service platform and building long-term shareholder value. Vision Marine Technologies' E-Motion 180e electric propulsion system is a fully integrated, high-voltage electric powertrain designed to replace traditional internal combustion engines on recreational boats. In addition to manufacturing proprietary electric propulsion systems, Vision Marine also operates Nautical Ventures, its Florida-based retail and service platform, which it acquired in June 2025. Double-Digit Revenue Growth For the fiscal third quarter ending May 31, Vision Marine posted revenue of $18.4 million, up about 27% from $14.5 million in the fiscal second quarter. For the first nine months of fiscal 2026, revenue was $48.6 million, compared with $0.4 million during the same period in the prior year, primarily reflecting the contribution from the acquisition of Nautical Ventures. Gross profits for the first nine months were $11.8 million, representing a gross margin of 24.3%. That compares with a gross loss in the year-earlier period. Inventory during the quarter declined about 44% to $20.7 million while floorplan financing declined about 69% to $10.2 million. The company ended the quarter with $2.4 million in cash. “The third quarter reflects the progress we have been working toward across revenue generation, working capital management and capital efficiency,” said Alexandre Mongeon, Chief Executive Officer and Co-Founder of Vision Marine. “Our expanded operating platform is beginning to demonstrate how stronger commercial execution and disciplined capital management can reinforce one another.” During the quarter, Vision Marine said it also expanded its recurring and repeat-revenue activities across marina operations, service, storage, rentals, boat club memberships and aftersales support. The company said it believes these activities can increase customer engagement throughout the boating lifecycle and support a more diversified business model beyond individual boat sales. Equity Offering Complete Separately, Vision Marine announced it successfully completed its at-the-market equity offering program, originally announced on January 23, 2026, raising $16.3 million in aggregate gross proceeds. Following completion of the ATM program and final settlement, Vision Marine has about 6.5 million common shares outstanding and approximately $9.5 million of unrestricted consolidated cash. The completion of the ATM program comes at the same time the company reached agreements to sell three of its non-core commercial properties in Florida for a total of $13.1 million in aggregate gross proceeds. Vision Marine is selling the real estate to optimize its Florida footprint. Combined, Vision Marine says it puts it in a good position to execute its operational priorities while maintaining financial flexibility to support future growth initiatives. “Completing the ATM program, together with the expected non-dilutive capital from our pending real estate transactions, strengthens the foundation from which we can continue executing our strategy,” says Mongeon. “Building on the operational progress achieved over the past year, we remain firmly focused on advancing E-Motion commercialization, expanding our electric boat portfolio, optimizing our retail, marina and service platform and building a more scalable foundation for the future of boating.” Coming off a stronger third quarter and with cash in the bank, Vision Marine Technologies is executing on its strategy to advance E-Motion commercialization, expand its electric boat portfolio and boost shareholder value. To learn more about its plans, click here. Featured photo from Vision Marine Technologies. This content was originally published on Benzinga. Read further disclosures here. This post contains sponsored content and was created in collaboration with a third-party partner. Benzinga is a publisher and does not provide personalized investment advice or act as a broker or dealer. This content is for informational purposes only and is not intended to be investing advice or an offer or solicitation to buy or sell any security.
TORONTO, ON - August 4, 2026 (NEWMEDIAWIRE) - Noble Mineral Exploration Inc. ("Noble" or the "Company") (TSXV: NOB) (OTCQB: NLPXF) is pleased to announce that it has entered into an agreement to acquire the North Bradshaw Property from Gravel Ridge Resources Ltd. (“Gravel Ridge”) and 1544230 Ontario Inc. (“1544230”). The purchase price payable by Noble for the North Bradshaw Property is a total of $73,000 in cash, payable over three (3) years, as well as the issuance of 600,000 common shares of Noble. $10,000 on Signing $15,000 on the First Anniversary $18,000 on the Second Anniversary $30,000 on the Third Anniversary In addition, the Company has agreed that the vendors will be granted at 1.5% net smelter returns royalty (the “Royalty”) on the North Bradshaw Property, which shall be subject to the Company holding a right to buyback one third of the Royalty, equal to 0.5% of the 1.5% Royalty, for a payment of $500,000. Closing of the transaction is subject to satisfaction of certain conditions, including obtaining approval of the Board of Directors of Noble, as well as any required approval of the TSX Venture Exchange. Location The property is contiguous to the Gowest Bradshaw Gold Property (historically known as the Frankfield East Deposit). The Bradshaw Gold Property is held by GoWest Gold Ltd. A pre-feasibility study (amended at September 15, 2015) was completed on the Gowest Bradshaw Gold Property, identifying inferred resources and indicated resources of gold. That report is posted on the website of GoWest Gold Ltd. at www.gowestgold.com. Geological Profile The Gowest Bradshaw Gold Property and Noble’s North Bradshaw property both lie within the Abitibi Greenstone Belt, one of Canada’s premier Archean gold-producing districts. The Gowest Bradshaw Gold Property deposit is hosted within a sequence of: - Mafic volcanic rocks - Ultramafic units - Strongly altered shear zones - Local intrusive rocks Gold mineralization occurs in a broad, altered and brecciated structural zone rather than a narrow quartz vein. Previous exploration of the property identified the principal orebody as following the contact between hanging-wall basalt and footwall ultramafic rocks and consists of a thick tabular body with excellent continuity. That previous exploration also reported that higher-grade gold is concentrated along the margins of the main shear zone. Gold occurs primarily as: - Disseminated pyrite - Fine free gold - Quartz-carbonate alteration - Silica flooding - Sericite and carbonate alteration Noble’s CEO, H. Vance White, said “We are pleased to be proceeding with the purchase of prospective mining claims in Ontario. Noble believes these projects offer significant potential for new discoveries and continued exploration success.” Qualified Person The technical content of this release has been reviewed and approved by Wayne Holmstead, P.Geo., an independent Qualified Person as defined by National Instrument 43-101 - Standards of Disclosure for Mineral Projects. Post-Arrangement Information Noble is pleased to confirm certain post-completion details with its respect to its recently completed plan of arrangement (the “Arrangement”) under the Business Corporations Act (Ontario). Please refer to the news release issued by Noble on May 27, 2026 describing the completion of the Arrangement, and also the management information circular of Noble (the “Circular”) that was provided for the special meeting of Noble shareholders held on May 7, 2026. (Both documents are available under Noble's profile at www.sedarplus.com.) The Arrangement took effect at 12:01 a.m. on May 27, 2026 (the “Effective Time”). A copy of that circular is also available under Noble's profile on SEDAR+ at www.sedarplus.com. Under the Arrangement, pre-Arrangement common shares of Noble (“Old Noble Share”) are exchanged for one new common share of Noble (a “New Noble Share”) and a pro rata portion of 9,000,000 common shares of Homeland Nickel Inc. (the “Homeland Shares”), at an exchange ratio of approximately 0.034060787614 of a Homeland share, plus one New Noble Share, for each Old Noble Share held. No fractional shares or cash in lieu thereof (or any other form of payment) are payable as part of the distribution of Homeland Shares, with the number of Homeland Shares due to any shareholder being rounded down to the nearest whole share. The Company is using Homeland Nickel Inc.’s closing price of $0.39 per share on May 26, 2026 as the fair market value of each Homeland Share for the purposes of the Arrangement. In addition, the Company is treating $0.39 per whole Homeland Share as a return of capital to Noble’s shareholders. However, Noble disclaims any responsibility for the tax treatment adopted by any or all shareholders with respect to the Arrangement, as the tax position that applies to any shareholder will depend on a number of factors that are particular to that shareholder. Shareholders are encouraged to seek their own advice as to the tax treatment of the Arrangement applicable to them. About Noble Mineral Exploration Inc. Noble Mineral Exploration Inc. is a Canadian-based junior exploration company, which has holdings of securities in Canada Nickel Company Inc., Homeland Nickel Inc., East Timmins Nickel Inc. (20%), and its interest in the Holdsworth gold exploration property in the area of Wawa, Ontario. Noble holds mineral and/or exploration rights in ~70,000ha in Northern Ontario and ~14,000ha elsewhere in Quebec and Newfoundland, upon which it plans to generate option/joint venture exploration programs. Noble holds mineral rights and/or exploration rights in ~18,000 hectares in the Timmins-Cochrane areas of Northern Ontario known as Project 81, ~2,215 hectares in Thomas Twp/Timmins, as well as an additional 20% interest in ~38,700 hectares in the Timmins area and ~175 hectares of mining claims in Central Newfoundland. Project 81 hosts diversified drill-ready gold, nickel-cobalt and base metal exploration targets at various stages of exploration. Noble also holds ~4,600 hectares in the Nagagami Carbonatite Complex and its ~3,200 hectares in the Boulder Project both near Hearst, Ontario, as well as ~3,700 hectares in the Buckingham Graphite Property, ~10,152 hectares in the Havre St Pierre Nickel, Copper, PGM property, and ~1,573 hectares in the Cere-Villebon Nickel, Copper, PGM property, ~569 hectare Uranium/Rare Earth property (Chateau) and a ~461 hectare Uranium/Molybdenum property (Taser North), ~4,465 hectares REE Mehmet Property; the ~3,300 hectare Gull Lake REE Property; and the ~1,232 hectare Opawica Scandium and REE Property all of which are in the province of Quebec. In Newfoundland and Labrador, it holds the~ 647 hectare Chapiteau REE property. Noble’s common shares trade on the TSX Venture Exchange under the symbol “NOB.” More detailed information on Noble is available on the website at www.noblemineralexploration.com. Cautionary Note and Statement Concerning Forward Looking Statements This press release contains certain information that may constitute "forward-looking information" under applicable Canadian securities legislation. Forward-looking information is necessarily based upon several assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Factors that could affect the outcome include, among others: future prices and the supply of metals, the future demand for metals, the results of drilling, inability to raise the money necessary to incur the expenditures required to retain and advance the property, environmental liabilities (known and unknown), general business, economic, competitive, political and social uncertainties, results of exploration programs, risks of the mining industry, delays in obtaining governmental approvals, failure to obtain regulatory or shareholder approvals. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. Noble disclaims any intention or obligation to update or revise any forward-looking information, whether because of new information. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Contacts: H. Vance White, President Phone: 416-214-2250 Fax: 416-367-1954 Email: info@noblemineralexploration.com Investor Relations Email: ir@noblemineralexploration.com
TULSA, OK - August 4, 2026 (NEWMEDIAWIRE) - Ladybug Resource Group, Inc. (OTC: LBRG) ("Ladybug" or the "Company") today announced its financial results for the second quarter ended June 30, 2026. The reported results reflect the operating performance of the Company's operating subsidiary, Guangzhou Jingdiao Automobile Equipment Manufacturing Co., Ltd., and include year-over-year improvements in gross profit, operating income, net income, operating cash flow and liquidity. Management believes the reported financial results reflect continued operational execution, production efficiencies, disciplined cost management and improvements in manufacturing margins during the quarter. There can be no assurance that the results achieved during the second quarter will be indicative of future operating results or financial performance. Second Quarter 2026 Financial Highlights Gross profit increased 56.5% compared with the second quarter of 2025, which management attributes primarily to improved production efficiency, favorable manufacturing margins and continued cost discipline. Operating income increased 153% compared with the prior-year period, reflecting improved operating performance and expense management. Net income increased 225% compared with the second quarter of 2025, reflecting improved profitability during the reporting period. Net cash provided by operating activities increased 501% compared with the prior-year period, reflecting stronger operating cash generation and improvements in working capital management. Cash and cash equivalents increased 320% as of June 30, 2026, compared with June 30, 2025, further strengthening the Company's liquidity position. "Management is pleased with the Company's operating performance during the second quarter," said Shicai Li, Chief Executive Officer of the Manufacturing Division. "We believe these results reflect the continued execution of our operating strategy, our focus on manufacturing efficiency and disciplined financial management. Management intends to continue pursuing operational improvements, expanding manufacturing capabilities and evaluating strategic opportunities designed to support the Company's long-term objectives. However, future operating results will depend on numerous factors, many of which are outside the Company's control." Management intends to remain focused on expanding manufacturing capabilities, increasing operational efficiencies, strengthening customer relationships, and pursuing strategic opportunities that it believes will support sustainable long-term growth. While management believes the Company's financial performance demonstrates meaningful operational progress, future results remain subject to market conditions, customer demand, supply chain dynamics, and other factors discussed in the Company's public filings. About Ladybug Resource Group, Inc. Ladybug Resource Group, Inc. (OTC: LBRG) is focused on building a diversified advanced manufacturing and industrial technology platform through strategic acquisitions and operational excellence. Through its operating businesses, the Company provides precision manufacturing solutions while pursuing opportunities that enhance sustainable financial performance and long-term shareholder value. Stay connected: Website: Ladybug Resource Group Inc. OTC Markets: LBRG Stock Quote X (formerly Twitter) LinkedIn Instagram Media & Investor Relations Contact Warren Booth Ladybug Resource Group Inc. 1408 S. Denver Avenue, Tulsa, OK 74119 info@ladybuglbrg.com +1 918-727-7137 Safe Harbor Statement This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as "believes," "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan". Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that the actual results will meet management's expectations. Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the Date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
New FUE Offering in Zona Rio, MX, 20 Minutes South of San Diego, Marks the Latest Expansion for the U.S.-based Company Focused on Removing Barriers to Provide Trusted Care, Regenerative Solutions and Increasing Healthspan Key Highlights: TreVita expands its premium medical travel platform with the launch of Hair transplant Services just 20 minutes South of San Diego, in the Medical Hub District located in Zona Del Rio, Mexico. The new offering combines advanced FUE technology, qualified physicians and TreVita's fully coordinated U.S.-based concierge care model The launch advances TreVita's long-term vision to remove barriers and provide innovative solutions to quality medical care that increase healthspan. SAN DIEGO, CA - August 4, 2026 (NEWMEDIAWIRE) - TreVita, a U.S.-based medical travel company helping Americans access vetted medical care abroad, today announced the launch of its new Hair transplant offering in Zona Rio, MX. The new service expands TreVita's growing portfolio of premium medical travel offerings, giving Americans access to advanced hair restoration through a fully coordinated, U.S.-based care model just 20 minutes south of San Diego. Demand for hair restoration services continues to accelerate worldwide. According to Grand View Research, the global hair restoration and transplant market is projected to grow nearly 90% by 2030, with North America already accounting for more than 32% of the global market. As more Americans seek specialized hair transplant services, TreVita believes patients are increasingly looking for internationally recognized expertise without the need for long-haul travel, offering a premium medical travel experience just 20 minutes south of San Diego. TreVita's Hair Transplant Services use follicular unit extraction (FUE), an advanced extraction technology designed to minimize trauma to follicular grafts while supporting natural-looking, permanent results. Procedures are performed by world-class physicians in Zona Rio, many with more than 20 years of experience, while TreVita's U.S.-based team coordinates consultations, accommodations, transportation and recovery support throughout the client journey. "Our goal has never been to simply help people travel for healthcare," said Blake Schroeder, CEO of TreVita. "We're building a company that raises the standard for what medical travel should look like. That means partnering with exceptional physicians, developing long-term clinical partnerships, investing in our own care infrastructure, carefully vetting every aspect of the patient experience, and surrounding clients with support before, during and after treatment. Hair transplant is just another step toward building a broader platform focused on healthspan, regenerative medicine and the future of accessible, innovative healthcare." The launch represents another step in TreVita's broader mission to make world-class medical care more accessible for Americans seeking treatments that are cost-prohibitive, difficult to access, not covered by traditional insurance, or unavailable in the United States. Rather than simply connecting clients with physicians, TreVita manages the entire experience, from initial consultation and attractive financing to travel coordination, accommodations and post-procedure support. Founded in 2022 and headquartered in San Diego, TreVita was created in response to a growing gap between the healthcare Americans want and the care many are able to access through the traditional healthcare system. The company began by helping clients pursue bariatric procedures abroad and has since expanded into plastic surgery, regenerative medicine, including stem cell therapies, and other specialty services, building a reputation around physician vetting, concierge-level coordination and long-term client support. Unlike many referral services, TreVita is a long-term care partner. The company helps clients evaluate providers, coordinate every aspect of their medical travel experience and remain supported well beyond their procedure. Medical decisions and treatments remain under the direction of independent physicians partners, while TreVita serves as the trusted guide throughout the journey. Hair transplant services represent the latest addition to what TreVita sees as a much broader future. The company is building a premium medical travel platform centered on healthspan, helping people gain greater access to innovative care that supports healthier, more active lives over the long term. As TreVita continues to expand into new specialties and emerging technologies, it remains committed to the principles that have guided the company from the beginning: safety, caring for people, and integrity. TreVita defines that vision as creating "a world where healthspan is maximized and lives are changed positively." TreVita's Hair Transplant Services are now available to qualifying clients through the company's U.S.-based care consultant team. To make treatment accessible, the company offers flexible financing options with a financing approval rate of more than 99% for qualified applicants. About TreVita Medical Travel TreVita is a U.S.-based medical travel company dedicated to helping Americans access vetted specialty care abroad through a trusted, fully coordinated care experience. Headquartered in San Diego, TreVita partners with a network of carefully vetted physicians in Zona Rio and leading medical destinations around the world, providing end-to-end support across bariatric surgery, plastic surgery, hair transplant and regenerative medicine. Driven by its purpose to remove barriers and provide innovative solutions that help people achieve outcomes far greater than imagined, TreVita is building a next-generation medical travel platform focused on healthspan, longevity and access to emerging medical innovations. Guided by its core values of safety, caring for people and integrity, the company is working toward its vision of a world where health span is maximized and lives are changed positively. Media Contact trevita@emergenthouse.com View the original release on www.newmediawire.com
VANCOUVER, BRITISH COLOMBIA - August 4, 2026 (NEWMEDIAWIRE) - Western Star Resources Inc. (CSE: WSR) (OTC: WSRIF) (FRA: 4K2) (the “Company” or “Western Star”) is pleased to provide a corporate and exploration update following a significant period of growth, during which the Company assembled and began advancing a portfolio of past-producing tungsten assets in the United States. Since the end of 2025, Western Star has: Built a portfolio of three active U.S. tungsten projects across Nevada and New Mexico; - Expanded the past-producing Rowland Tungsten Property by approximately 170%; - Acquired the adjacent past-producing White Star Tungsten Project, creating an approximately six-kilometre prospective exploration corridor across the Company's Nevada position; - Acquired a 100% interest in the past-producing Eagle Point Tungsten Project in New Mexico; - Commenced modern systematic exploration programs at Rowland and White Star; - Completed high-resolution UAV magnetic geophysical work and extensive surface exploration; - Identified an approximately one-kilometre tungsten-skarn geochemical corridor at Rowland, including a peak soil result of approximately 1,425 ppm WO(3), equivalent to approximately 0.14% WO(3); - Commenced drill-permitting activities at Rowland; - Engaged Dahrouge Geological Consulting to assist with the evaluation and future exploration of the Company's Nevada and New Mexico tungsten assets; - Begun technical work aimed at defining drill targets across the known surface mineralization at Eagle Point; - Targeted a maiden Eagle Point drill program during 2026, subject to permitting, final program design and other customary considerations; - Closed approximately C$3.69 million through an oversubscribed private placement; and - Submitted an application in response to a U.S. Defense Industrial Base Consortium solicitation relating to reliable supplies of strategic critical minerals. Western Star has now moved beyond portfolio assembly. The Company’s focus is on disciplined execution: advancing priority targets toward drilling, testing for discovery and establishing the scale of its U.S. tungsten platform. THREE PAST-PRODUCING U.S. TUNGSTEN PROJECTS Western Star's U.S. tungsten portfolio now provides exposure to three historically productive tungsten systems: EAGLE POINT – NEW MEXICO Historical production of approximately 1,800 tons of scheelite-bearing material, historical U.S. Government estimates outlining significant near-surface tungsten-bearing material, eight historically mapped skarn bodies, modern USGS sampling returning up to 27.6% WO(3) and 0.98% Mo, and a U.S. Government-supported exploration program that was planned but never executed. ROWLAND - NEVADA Historical production exceeding approximately 1,000 tons, with historical reported grades reaching approximately 3.38% WO(3). Western Star has expanded the property approximately 170%, identified more than 17 historical workings and completed the first phase of an integrated modern exploration program designed to advance targets toward drilling. WHITE STAR - NEVADA Part of a broader historical tungsten-mining complex with reported historical production of approximately 10,000 tons grading approximately 1.0% WO(3) during 1954, together with additional historical production in 1956. Its acquisition provides Western Star with a substantially larger district-scale exploration position adjoining Rowland. Historical production and historical estimates referenced herein have not necessarily been independently verified by the Company and should not be considered indicative of future results. Historical estimates are not current mineral resources or mineral reserves. EAGLE POINT - FROM HISTORICAL ESTIMATE TOWARD MODERN RESOURCE DEFINITION Eagle Point is a key asset within Western Star’s U.S. tungsten portfolio. The Company's objective is to systematically test the historically identified mineralization using modern exploration and drilling and, if supported by sufficient geological and analytical data, advance Eagle Point toward the potential preparation of a maiden mineral resource estimate in accordance with NI 43-101. Historical U.S. Government work identified substantial near-surface tungsten mineralization through trenching, surface sampling and geological mapping. Historical estimates reported various tonnage and grade ranges, including approximately 100,000 to 150,000 tons grading approximately 0.5% WO(3), while other historical government examinations outlined approximately 150,000 to 200,000 tons of scheelite-bearing material. These estimates are historical in nature. A Qualified Person has not completed sufficient work to classify the historical estimates as current mineral resources or mineral reserves, and Western Star is not treating the historical estimates as current mineral resources or mineral reserves. They should not be relied upon. Western Star intends to evaluate the geological basis of that historical work through modern exploration and drilling. The planned program is designed not only to test historically identified mineralized areas, but also to assess whether tungsten-bearing skarn mineralization continues along strike, at depth or into areas that received limited historical attention. This provides Western Star with two distinct exploration objectives at Eagle Point: 1. RESOURCE DEFINITION Drill the historically identified mineralized zones with sufficient modern geological, analytical and QA/QC information to determine whether the data can ultimately support the preparation of a maiden NI 43-101 mineral resource estimate. 2. RESOURCE EXPANSION POTENTIAL Test extensions of the known skarn bodies along strike and at depth, together with additional historically mapped skarn occurrences and targets generated through modern geophysics, mapping and geochemistry. There can be no assurance that exploration will result in the definition of a mineral resource or that mineralization will extend beyond historically identified areas. WHY EAGLE POINT STANDS OUT Several attributes make Eagle Point a priority for Western Star: PAST PRODUCTION Approximately 1,800 tons of tungsten-bearing material was historically mined and shipped from Eagle Point, with historical grades reported at approximately 0.5% WO(3). HISTORICAL U.S. GOVERNMENT ESTIMATE Historical federal exploration work outlined significant near-surface tungsten-bearing material through trenching and surface sampling. EXCEPTIONALLY HIGH-GRADE MODERN SURFACE SAMPLE USGS/NMBGMR sampling returned a selective composite skarn-outcrop sample grading: 27.6% WO(3) 219,000 ppm tungsten 0.98% molybdenum The sample is selective in nature and is not necessarily representative of average mineralization across the Property. MULTIPLE MINERALIZED SKARN BODIES Historical mapping identified approximately eight separate skarn/tactite bodies around the principal workings. LIMITED HISTORICAL DRILLING Despite the extensive surface work, the system received very limited historical drilling. U.S. GOVERNMENT-BACKED EXPLORATION During the 1950s, the U.S. Government entered into a Defense Minerals Exploration Administration agreement to support further exploration of Eagle Point. The proposed program included underground development and diamond drilling, but was never executed. Consequently, several of the principal exploration objectives identified during the historical government work remained untested. 2026 EAGLE POINT DRILLING STRATEGY Western Star has engaged Dahrouge Geological Consulting to assist with technical evaluation and future exploration across the Company's tungsten portfolio. At Eagle Point, this work is focused on integrating historical geological information with modern datasets and building a practical geological model to support drill targeting. The Company’s near-term objective is to design a program capable of systematically testing the historical, non-compliant estimate. Subject to permitting, final drill design, contractor availability and other customary considerations, Western Star is targeting a maiden drill program at Eagle Point during 2026. The program would represent an important step in advancing Eagle Point from a historically recognized tungsten occurrence toward modern exploration and potential resource definition. Western Star intends for drilling to: - Test the principal historically identified mineralized zones; - Investigate grade and geological continuity; - Test the geometry and thickness of tungsten-bearing skarn; - Provide modern geological and analytical information; - Test selected extensions along strike and at depth; - Evaluate additional targets generated through modern exploration; - Provide information that may, if sufficient, support future mineral-resource estimation; and - Establish the geological framework required for subsequent, potentially larger exploration campaigns. THE OBJECTIVE: DEFINE, THEN EXPAND Western Star’s strategy at Eagle Point is straightforward: - Validate the historical geological model. - Drill the historically identified mineralization. - Establish continuity. - Test extensions. - If supported by results, advance toward a maiden NI 43-101 mineral resource estimate while continuing to evaluate the broader scale of the system. A HISTORICAL U.S. GOVERNMENT TARGET MOVING TOWARD MODERN DRILLING Blake Morgan, President and CEO of Western Star Resources, commented: “Eagle Point is an important opportunity for Western Star because we are not starting from first principles. The project has historical production, historical U.S. Government exploration, multiple skarn bodies exposed at surface, historical estimates of tungsten-bearing material and modern USGS sampling that returned up to 27.6% WO(3). A government-supported program was once planned to advance Eagle Point through underground development and diamond drilling, but that drilling was never completed. Our goal is to bring modern exploration standards to that historical opportunity. We intend to drill the historically identified mineralization and generate the geological and analytical information required to determine whether Eagle Point can support a maiden NI 43-101 mineral resource estimate. At the same time, we intend to test beyond the historical footprint. With eight historically mapped skarn bodies, high-grade tungsten exposed at surface and limited drilling across the broader system, we believe Eagle Point warrants a systematic program that evaluates both the known mineralization and its potential extensions along strike and at depth. Rowland is also moving toward drilling in Nevada, and White Star gives us an adjoining district-scale exploration opportunity. In less than a year, Western Star has assembled three past-producing U.S. tungsten projects, strengthened its balance sheet, put technical teams in the field and begun moving these assets toward drilling. The next phase is execution.” FROM ACQUISITION TO DRILLING Western Star’s progress since the end of 2025 has positioned the Company for a new phase of development. The Company's strategy has progressed through three stages: ACQUIRE - Assemble past-producing tungsten assets in established U.S. mining jurisdictions. DEFINE - Apply modern geophysics, geochemistry, mapping and geological modelling to identify and prioritize drill targets. DRILL & EXPAND - Test historical mineralization, evaluate extensions and, where supported by sufficient data, advance projects toward maiden mineral resource estimates. Western Star believes the combination of historical production, high-grade tungsten occurrences, multiple untested targets, modern exploration programs, a strengthened treasury and exposure to U.S. critical-mineral supply priorities provides a differentiated position within the North American tungsten exploration sector. 2026 IS ABOUT EXECUTION With Rowland advancing toward drilling, White Star undergoing its first integrated modern exploration program and Eagle Point being prepared for a maiden drill campaign, Western Star intends to advance its U.S. tungsten portfolio in a disciplined and systematic manner through the remainder of 2026. The Company’s objective remains clear: Discover and define meaningful domestic tungsten resources capable of contributing to a secure North American critical-mineral supply chain. There can be no assurance that exploration will result in the discovery or definition of a mineral resource or an economically viable mineral deposit. Qualified Person The scientific and technical information contained in this news release has been reviewed and approved by a consultant to the company, Jasper Mowatt, MIMMM (Membership No. 0486653) and MAusIMM (Membership No. 3178851), a Qualified Person as defined by National Instrument 43-101 - Standards of Disclosure for Mineral Projects. About Western Star Resources Western Star Resources is an emerging junior mineral exploration company focused on revitalizing North America's tungsten supply. The Company is advancing its entry into the U.S. market through past-producing tungsten assets in historically important mining districts and is positioning itself to participate in the growing need for secure domestic critical mineral supply. For more information, please visit www.westernstarresources.com. Contact Information Blake Morgan President, CEO and Director Email: blake@acvc.vc Forward-Looking Information Certain statements contained in this news release may constitute forward-looking information within the meaning of applicable securities laws. Forward-looking information may include, but is not limited to, statements regarding the Company's exploration plans, permitting activities, future work programs, potential drill targets, critical minerals strategy, use of social media platforms, and expectations regarding the development of the Company's properties. Forward-looking information is based on management's current expectations, estimates, projections, and assumptions and is subject to a number of risks and uncertainties. Actual results may differ materially from those expressed or implied by such forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information. Except as required by applicable securities laws, the Company undertakes no obligation to update or revise any forward-looking information. Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release. View the original release on www.newmediawire.com
INTERLAKEN, SWITZERLAND - August 3, 2026 (NEWMEDIAWIRE) - MRH Switzerland AG, the hotel division of AEVIS VICTORIA SA, continued to grow in the first half of 2026 amid a slightly declining Swiss hotel market. Revenue rose by 1.0% to CHF 104.9 million, while maintaining high operating profitability. The average room rate increased by 2.8% and RevPAR by 3.2%, confirming the portfolio’s resilience and qualitative outperformance. MRH Switzerland AG (“MRH”) reported consolidated revenue of CHF 104.9 million during the first six months of 2026, representing an increase of 1.0%. Revenue from Accommodation rose to CHF 61.5 million (H1 2025: CHF 60.9 million). The Food & Beverage business also grew, with revenue of CHF 38.0 million (H1 2025: CHF 37.7 million). Outperforming a Declining Swiss Market According to provisional data and estimates from the Federal Statistical Office (FSO), the Swiss hotel industry recorded 16.2 million overnight stays between January and May 2026, representing a 0.3% decrease compared to the same period in 2025. The second estimate available for June 2026 shows a 2.2% decline in overnight stays, including a 4.6% drop in foreign demand. Based on this, the Swiss hotel market is expected to post a decline of approximately 0.7% for the first half of 2026 as a whole. The final figures for June will be published by the FSO on 4 August 2026. In this less favorable environment, MRH recorded a 1.0% increase in revenue and a more pronounced rise in its key revenue-per-room indicators. The average room rate increased by 2.8% to CHF 651 (H1 2025: CHF 633). Revenue per available room (RevPAR) rose by 3.2% to CHF 354 (H1 2025: CHF 343). The occupancy rate remained virtually stable at 54.3% (H1 2025: 54.1%). The increase in RevPAR is therefore primarily due to an improvement in the average rate rather than an increase in occupancy. This demonstrates MRH’s ability to create value through the positioning of its properties, pricing discipline, and the quality of its offerings. Maintenance of Strong Operating Profitability The EBITDAR margin - a key indicator of MRH’s operating performance given the AEVIS Group’s integrated real estate structure - is expected to remain largely stable compared to the historically high level recorded in the first half of the previous year (26.1%). This trend is driven in particular by the increase in the margin for the Food & Beverage business, which reached 16.6% (H1 2025: 15.1%), as well as by effective control of administrative, energy, and operational expenses. Outlook Following the completion of a major investment cycle in its properties, MRH is continuing its strategy focused on revenue quality, pricing discipline, and the continuous improvement of each asset’s operational performance, leveraging the synergy between AEVIS’s hotel portfolio and the expertise of Michel Reybier Hospitality. MRH is entering the second half of the fiscal year with confidence, while remaining attentive to changes in international demand, geopolitical volatility, and general economic conditions. For more information: Media and investor relations: c/o Dynamics Group, Zurich Marion Schihin, msc@dynamicsgroup.ch, + 41 79 705 88 15 About MRH Switzerland AG MRH Switzerland AG is a hotel chain operating eleven hotels in Switzerland and abroad, under the Michel Reybier Hospitality brand. The hotels are located in premium destinations, including Zurich, Interlaken, Bern, Crans Montana, Zermatt, Davos, Flims and London. MRH Switzerland AG manages a portfolio with 1’180 rooms in operation, generating substantial annual traffic with 367’819 overnight stays. The chain employs 1’153 staff members. MRH Switzerland AG is a 100% subsidiary of AEVIS VICTORIA SA. www.michelreybierhospitality.com About Michel Reybier Hospitality For more than 20 years, Michel Reybier has been blazing the trail for a singular, highly contemporary vision of luxury and hospitality. Each of the Michel Reybier Hospitality destinations upholds his cherished values of excellence, authenticity and simplicity. Whether in a hotel, a villa or a private apartment, in the mountains or by the sea, in the countryside, in the heart of the vineyards or in the city... A sole requirement: namely exceptional places that throb with a distinctive emotion. A sole ambition: to share a refined art of living, dedicated above all else to our guests’ well-being and pleasure. This holistic approach is based on unforgettable experiences, where sport, food, wellness and passion form an inseparable whole. This approach is supported by the medical expertise of Nescens, whose ultimate goal is to ensure people live better, healthier lives for as long as possible. The promise of instilling meaning into each and every moment. www.michelreybierhospitality.com About AEVIS VICTORIA SA AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS’s main shareholdings are Swiss Medical Network Holding SA (76.3%, directly and indirectly), the only Swiss private network of hospitals present in the country’s three main language regions, MRH Switzerland AG, a luxury hotel group managing eleven hotels in Switzerland and abroad, Infracore SA (22.6%, directly and indirectly), a listed real estate company (INFRAC.SW) dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com View the original release on www.newmediawire.com
HAMBURG, GERMANY - August 3, 2026 (NEWMEDIAWIRE) - The Nordex Group has received an order from the Swedish renewable energy company OX2 for the supply and installation of 11 N175/6.X turbines in Romania. The contract for the Urleasca wind farm with a total installed capacity of 77 MW also includes a 35-year Premium Service agreement. In parallel, OX2 has sold the Urleasca 77 MW ready-to-build wind farm to the Norwegian renewable energy solutions provider Scatec ASA. OX2 is contracted to oversee the entire construction phase scheduled to commence in Q3 2026, with commissioning planned for the second half of 2028. The Urleasca wind farm holds a long-term Contract-for-Difference (CfD) with the Romanian State. The wind farm will be located near the village of Urleasca in Brăila County, around 150 kilometers northeast of Bucharest in southeastern Romania. “We are delighted to further strengthen our transnational cooperation with OX2 – this time in Romania. The country continues to offer attractive opportunities for the deployment of modern wind energy technology. By combining OX2’s international project development expertise with our latest N175/6.X technology, all companies will deliver efficient and competitive renewable electricity to the Romanian market,” says Slava Feklin, Country Manager Romania and Ukraine of the Nordex Group. The project Urleasca further strengthens the Nordex Group’s position in Romania, where the company has contracted more than 500 MW in the last months. About OX2 AB OX2 is a leading renewable energy developer that operates a large and diverse project portfolio across all major technologies, including onshore and offshore wind, solar, and storage. The total portfolio including development, construction, asset management and operations amounts to about 33 GW. OX2 is present in five European markets, and Australia. The company has about 500 employees and is headquartered in Stockholm, Sweden. OX2 is owned by EQT, one of the world’s largest private equity investors. www.ox2.com About the Nordex Group The Group has commissioned more than 64 GW of wind power capacity in over 40 markets since 1985 and generated consolidated sales of around EUR 7.6 billion in 2025. The Company currently has more than 11,100 employees with a manufacturing network that includes factories in Germany, Spain, Brazil, India, Türkiye and USA. Its product portfolio is focused on onshore turbines in the 4 to 7 MW+ classes which are designed to meet the market requirements of countries with limited available space and regions with constrained grid capacity. A global service network ensures the smooth operation of the turbines. Nordex SE is listed on the MDAX and TecDAX of the Frankfurt Stock Exchange (ISIN: DE000A0D6554) in Germany. Contact person for press: Nordex SE Felix Losada Telephone: +49 (0) 40 30030 1141 E-mail: flosada@nordex-online.com Contact for investor inquiries: Nordex SE Anja Siehler Phone: +49 162 3515 334 E-mail: asiehler@nordex-online.com View the original release on www.newmediawire.com
The 120 bps uplift was generated at US insurance broker Foundation Risk Partners and represents USD 10 million of financial impact The AI program was delivered by UK digital transformation specialist Version 1 and led to a significant fall in policy processing times at FRP The collaboration demonstrates how transformational AI value creation can be driven through private equity portfolio partnerships DENVER - August 3, 2026 (NEWMEDIAWIRE) - Partners Group, one of the largest firms in the global private markets industry, has driven a 120 bps EBITDA margin uplift at portfolio company Foundation Risk Partners ("FRP"), one of the fastest-growing insurance brokerages in the US, through an AI transformation program. The program was delivered in collaboration with Version 1, another Partners Group portfolio company and a leader in AI-first digital transformation services. Founded in 2017, FRP has over 3,000 employees across 68 locations. FRP built a clean, proprietary policy-level dataset that laid the foundation for measurable AI-driven value creation. Leveraging this data, Version 1's AI Labs built two agentic AI solutions. The first reduces the average policy processing cycle for new clients by 94%, which has led to a doubling in close rates, and the second automates the human-intensive policy checking task. In total, the program represents USD 10 million of EBITDA impact for FRP. The program was delivered by a seven-person team augmented by Version 1, with the first use case taken from concept to production in just 14 weeks. Partners Group acquired FRP and Version 1 in 2022, recognizing the tailwinds across both the insurance brokerage sector in the US and AI-first digital transformation services in the UK and Ireland. Both companies have delivered strong performance since acquisition, with FRP and Version 1 having doubled their respective revenues. Wolf Scheider, Head of Private Equity, Partners Group, says: "We have delivered synergies within our own portfolio to create tangible value, in this case pairing a US insurance brokerage with an AI technology partner in the UK and Ireland. Through this, we have turned a clean dataset into USD 10 million EBITDA uplift and real, measurable growth. We continue to look for opportunities to leverage AI expertise across our portfolio companies." About Partners Group Partners Group is one of the largest firms in the global private markets industry, with around 2’000 professionals and over USD 186 billion in assets under management globally. The firm has investment programs and custom mandates spanning private equity, private credit, infrastructure, real estate, royalties, and special opportunities. With its heritage in Switzerland and primary presence in the Americas in Colorado, Partners Group is built differently from the rest of the industry. The firm leverages its differentiated culture and its operationally oriented approach to identify attractive investment themes and to transform businesses and assets into market leaders. For more information, please visit www.partnersgroup.com or follow us on LinkedIn. Partners Group media relations contact Henry Weston Phone: +44 207 575 2593 Email: henry.weston@partnersgroup.com View the original release on www.newmediawire.com
LOS ANGELES, CA - August 3, 2026 (NEWMEDIAWIRE) - Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article that discussed its efforts to advance GelrinC, a potentially first-in-class, off-the-shelf cartilage regeneration platform, and the company’s broader mission to establish a new standard of care in cartilage repair. “Regentis is developing regenerative biomaterial technology as healthcare shifts toward therapies designed to restore damaged tissue rather than simply manage symptoms. With cartilage defects affecting hundreds of thousands of patients each year and contributing to pain, reduced mobility, and degenerative joint disease, the company is targeting one of orthopedic medicine’s largest unmet needs,” reads the article. “GelrinC’s commercial potential is rooted in the combination of clinical differentiation and practical adoption. The product is designed to deliver advanced cartilage repair through a practical, approximately 10-minute, single-step procedure, without cell harvesting, laboratory expansion, patient-specific manufacturing, or a second surgery. At the same time, clinical data generated to date have shown meaningful and durable improvements in pain and function, together with evidence of high-quality cartilage repair tissue. The result is a rare value proposition in orthopedics: a regenerative treatment designed to be clinically differentiated, economically practical, scalable across surgical centers, and capable of supporting faster return to daily activity and work.” To view the full article, visit https://ibn.fm/rMfpS About Regentis Biomaterials Ltd. Regentis Biomaterials is a regenerative medicine company dedicated to developing innovative tissue repair solutions that restore health and enhance quality of life. With an initial focus on orthopedic treatments, Regentis’ Gelrin platform technology, based on synchronized, degradable hydrogel implants, regenerates damaged or diseased tissue including inflamed cartilage and bone. Regentis’ lead product GelrinC(R) is a cell-free, off-the-shelf hydrogel that is eroded and resorbed in the knee, allowing the surrounding cells to regenerate the cartilage in a controlled and synchronous process. GelrinC(R) aims to address a market of approximately 470,000 cases for cartilage knee repair annually in the U.S. where no off-the-shelf treatment is available. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to RGNT are available in the company’s newsroom at https://ibn.fm/RGNT Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law. View the original release on www.newmediawire.com
LOS ANGELES, CA - August 3, 2026 (NEWMEDIAWIRE) - Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) has reached the halfway point in patient enrollment for its pilot MS imaging study with Massachusetts General Hospital, with preliminary PET imaging data showing encouraging signals in acute MS lesions. The novel imaging technique is designed to distinguish demyelinated nerve fibers that may still be viable from permanent nerve damage, potentially offering a more precise way to measure myelin loss and repair. “These findings are directly relevant to Lucid-MS, the company’s investigational compound designed to inhibit demyelination by targeting the enzyme PAD2, which is implicated in myelin degradation,” reads a recent article. “A more precise imaging tool and a drug candidate designed to address the underlying cause of MS make for a compelling combination. Reaching the enrollment midpoint with promising early data suggests the science is holding up under real clinical conditions.” To view the full article, visit https://nnw.fm/fsDHa About Quantum BioPharma Ltd. Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), Quantum BioPharma is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum BioPharma invented unbuzzd and spun out its OTC version to a company, Unbuzzd Wellness Inc. (“UWI”), led by industry veterans. Quantum BioPharma retains ownership of 19.84% (as of March 31, 2026) of UWI at www.unbuzzd.com. The agreement with UWI also includes royalty payments of 7% of sales from unbuzzd(TM) until payments to Quantum BioPharma total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Quantum BioPharma retains 100% of the rights to develop similar product or alternative formulations specifically for pharmaceutical and medical uses. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to QNTM are available in the company’s newsroom at https://ibn.fm/QNTM Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
The company will host a stakeholder update call on August 13, 2026, to discuss second-quarter financial results and business initiatives. Beeline is using artificial intelligence and automation to shorten mortgage approval and closing timelines while serving both homebuyers and real estate investors. Beeline is addressing financing challenges facing Millennials and Generation Z through digital underwriting designed to provide rapid qualification assessments. The company is also expanding products aimed at older homeowners seeking to access home equity without refinancing existing low-rate mortgages. Q1 2026 results showed revenue and loan originations more than doubling from the prior-year period despite a challenging mortgage market. Beeline’s strategy combines mortgage origination, title services and software solutions to create multiple revenue opportunities within residential real estate finance. LOS ANGELES, CA - August 3, 2026 (NEWMEDIAWIRE) - Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to homeownership, is preparing to provide investors with its latest operating update as the mortgage technology company continues expanding its digital lending platform during a period of ongoing change in the U.S. housing market. The company announced it will host a stakeholder update call on August 13, 2026, following the release of its second-quarter financial results. Chief Executive Officer Nick Liuzza and Chief Financial Officer Chris Moe are expected to review… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to BLNE are available in the company’s newsroom at https://ibn.fm/BLNE Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
Gold Camps, Hydrogen Wells, AI Agents, and Clinical Pipelines on One Venture Market Meet With Management Teams From OTCQB Venture Market Companies, Many Dual-Listed on the ASX, TSX, TSX Venture Exchange, CSE, and AQSE NEW YORK, NY - August 3, 2026 (NEWMEDIAWIRE) - B2i Digital, Inc. invites investors to its latest Featured Conference: the OTCQB Virtual Investor Conference, taking place Wednesday and Thursday, August 5-6, 2026. B2i Digital, as the Official Marketing Partner, brings the two-day event into its ecosystem. A distribution and media engine drives a qualified audience to the presentations and the meetings that follow. Unlike the sector-focused events in the series, this conference is organized around the OTCQB Venture Market itself. Gold, silver, and critical minerals anchor the agenda, with natural hydrogen, artificial intelligence software, clinical-stage biotechnology, and specialty construction materials rounding out the two days. Every presenting company trades on the OTCQB Venture Market. Each company has 30 minutes for a live presentation and Q&A. One-on-one meetings can be requested through the conference platform, and replays are posted to the B2i Digital and OTC Markets YouTube channels. Before, during, and after both days, B2i amplifies the event across its platform. That puts these venture-stage companies in front of more than 1.7 million retail and institutional market participants. It is the same visibility engine that has carried presenting companies From Marketing to Meetings℠ at more than 120 investor conferences. “I think like an investor, an investment banker, and a marketer all at once, and the three rarely agree on anything except this: nothing beats hearing a CEO answer a question they didn’t script. The OTCQB Venture Market is where growth stories get written early, and for two days investors can question the authors directly, from gold exploration in the Northwest Territories to conversational AI in Vancouver,” said David Shapiro, Chief Executive Officer of B2i Digital. For more details: https://b2idigital.com/vic-august-5th-and-6th-otcqb-virtual-investor-conference Presenting Companies as of August 3, 2026 (subject to change) Wednesday, August 5 11:00 AM ET: Nord Precious Metals Mining Inc. 12:00 PM ET: Pecoy Copper Corp. 12:30 PM ET: Tocvan Ventures Corp. 1:00 PM ET: Liberty Star Uranium & Metals Corp. Thursday, August 6 9:00 AM ET: Sparc Technologies Limited 9:30 AM ET: MDJM Ltd. 10:00 AM ET: Connecting Excellence Group Plc 10:30 AM ET: HyTerra Ltd. 11:00 AM ET: Bold Ventures, Inc. 11:30 AM ET: Green Bridge Metals Corporation 12:00 PM ET: Thunder Gold Corp. 12:30 PM ET: SalesCloser Technologies Ltd. 1:00 PM ET: Star Gold Corp. 1:30 PM ET: Valor Gold Corp. 2:30 PM ET: Oncotelic Therapeutics, Inc. 3:00 PM ET: LibertyStream Infrastructure Partners Inc. 3:30 PM ET: Avanti Gold Corp. 4:00 PM ET: Cematrix Corp. For registration and company profiles, please visit: https://www.virtualinvestorconferences.com/wcc/eh/4814904/category/149947/august-6th-otcqb-virtual-investor-conference?utm_source=b2i&utm_medium=marketing&utm_campaign=0806AugOTCQBVIC Throughout the year, Virtual Investor Conferences feature public companies from exchanges worldwide, including NYSE, Nasdaq, TSX, TSXV, CSE, ASX, LSE, and the OTC Markets. Virtual Investor Conferences is an OTC Markets Group Inc. property. About B2i Digital, Inc. B2i Digital, Inc. is The Capital Markets Matchmaker℠, connecting public companies, investor conferences, and capital markets advisors with a proprietary network of more than 1.7 million retail and institutional market participants. Its Featured Conference, Featured Company, and Featured Expert programs run on media B2i owns, web, video, social, and email, amplified by national newswire syndication. The firm has supported the public companies at more than 120 investor conferences From Marketing to Meetings℠. B2i Digital was founded in 2021 by former Maxim Group investment banker and Chief Marketing Officer David Shapiro. B2i Digital Contact Information David Shapiro Chief Executive Officer B2i Digital, Inc. https://b2idigital.com 212.579.4844 Office david@b2idigital.com https://www.linkedin.com/in/davidshapironyc B2i Digital Social Media https://www.linkedin.com/company/b2i-digital https://x.com/b2idigital https://www.facebook.com/b2idigital https://www.instagram.com/b2i_digital https://www.youtube.com/@b2idigital https://www.tiktok.com/@b2idigital https://stocktwits.com/B2iDigital https://www.reddit.com/user/b2idigital/ https://www.pinterest.com/b2idigital https://www.threads.net/@davidshapironyc https://bsky.app/profile/b2idigital.bsky.social About Virtual Investor Conferences Virtual Investor Conferences is the proprietary investor conference series that provides an interactive forum for publicly traded companies to meet directly with investors online. VIC offers companies efficient access to a broad investor audience through live presentations, Q&A sessions, and one-on-one meetings. Investors benefit from direct access to executive management teams and the ability to view presentations live or on demand. Virtual Investor Conferences Contact Information OTC Markets Group Inc. Virtual Investor Conferences www.virtualinvestorconferences.com info@virtualinvestorconferences.com Disclosure & Disclaimer B2i Digital, Inc. is the Official Marketing Partner of Virtual Investor Conferences. Content related to any specific company referenced in this release was provided by that company, approved by that company, or obtained from publicly available sources. B2i Digital, Inc. has not independently verified the accuracy or completeness of such information, and no representation or warranty, express or implied, is made as to its accuracy. This content is provided for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security, nor should it be relied upon as the basis for any investment decision. B2i Digital, Inc. is not a registered broker-dealer, investment adviser, or financial adviser, and nothing herein should be construed as investment, legal, tax, or accounting advice. Readers should consult their own advisers and conduct their own due diligence before making any investment decision. View the original release on www.newmediawire.com
Recent Third-Party Research Reinforces Scientific Rationale for Evaluating Broad-Spectrum Filovirus Preparedness Approaches ATLANTA, GA - August 3, 2026 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and solid tumors, today highlighted recently published independent scientific research that reinforces growing interest in vaccine strategies capable of providing broader protection across multiple ebolavirus species. A recent independent study, discussed by MedPage Today (July 23, 2026) and released as a scientific preprint by independent investigators, reported that immune responses generated by licensed vaccines against Zaire ebolavirus (EBOV) recognized Bundibugyo ebolavirus (BDBV), an emerging ebolavirus species responsible for recent outbreaks in Central Africa. The investigators concluded that these findings support further evaluation of existing and next-generation vaccine strategies against Bundibugyo virus and other related filoviruses. While the vaccines included in the study do not demonstrate protection against Bundibugyo virus, it provides additional scientific support for the concept that vaccine-induced immune responses may extend across related ebolavirus species and underscores the importance of developing broadly applicable filovirus vaccine platforms. GeoVax has previously demonstrated significant protective efficacy in published non-human primate studies with separate Modified Vaccinia Ankara (MVA)-based vaccine candidates targeting both Zaire Ebola virus (EBOV) and Sudan Ebola virus (SUDV). Together with the Company's Marburg virus vaccine program, these vaccine candidates comprise a differentiated filovirus vaccine portfolio built upon GeoVax's proprietary MVA platform. David A. Dodd, Chairman and Chief Executive Officer of GeoVax, commented: "Independent scientific validation plays an important role in advancing preparedness strategies for emerging infectious diseases. These newly reported findings reinforce the growing recognition that future outbreak preparedness will benefit from platform technologies capable of addressing multiple related pathogens rather than individual viruses. GeoVax has extensive institutional experience in developing MVA-based vaccines against several of the world's highest-consequence filoviruses, and we believe our technology platform is well positioned to support future preparedness initiatives." Mark J. Newman, Ph.D., Chief Scientific Officer of GeoVax, added: "The recently published findings provide encouraging support for an important scientific hypothesis - that immune responses against one ebolavirus may extend to related viruses. GeoVax's MVA-VLP, multi-antigen experimental vaccines, which have been evaluated in animal models and shown to provide significant protective efficacy, are designed to induce broadly protective immune responses, invoking both the antibody and cellular arms of the immune system. These independent findings demonstrate the potential of the GeoVax MVA-VLP platform." GeoVax's filovirus vaccine portfolio currently includes vaccine candidates targeting: Zaire Ebola virus (EBOV) Sudan Ebola virus (SUDV) Marburg virus (MARV) Each program utilizes the Company's Modified Vaccinia Ankara (MVA) platform, providing a common development and manufacturing foundation for addressing multiple high-consequence infectious diseases. As governments and global health organizations continue strengthening preparedness against emerging infectious diseases, GeoVax believes platform technologies capable of supporting multiple biodefense and public health applications will become increasingly important. The Company will continue evaluating strategic opportunities for its filovirus vaccine portfolio, including government collaborations, global health partnerships, and potential licensing opportunities, while maintaining its primary strategic focus on advancing GEO-MVA, its lead vaccine candidate for the prevention of mpox and smallpox, and Gedeptin®, its clinical-stage immuno-oncology program. Reference The scientific findings discussed in this release are based on recent independent research evaluating cross-reactive immune responses following licensed Ebola vaccination, as reported by MedPage Today (July 23, 2026) and described in a 2026 scientific preprint in The New England Journal of Medicine by the study investigators. GeoVax was not involved in conducting the study, and the findings should not be interpreted as demonstrating efficacy of GeoVax vaccine candidates against Bundibugyo ebolavirus. About GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company focused on the development of vaccines and immunotherapies addressing high-consequence infectious diseases and solid tumor cancers. GeoVax’s priority program is GEO-MVA, a Modified Vaccinia Ankara (MVA)–based vaccine targeting mpox and smallpox. The program is advancing under an expedited regulatory pathway, with plans to initiate a pivotal Phase 3 clinical trial in the second half of 2026, to address critical global needs for expanded orthopoxvirus vaccine supply and biodefense preparedness. In oncology, GeoVax is developing Gedeptin®, a gene-directed enzyme prodrug therapy (GDEPT) designed to enhance immune checkpoint inhibitor activity. Gedeptin has completed a multicenter Phase 1/2 clinical trial in advanced head and neck cancer and is being advanced into combination strategies, including planned neoadjuvant and first-line settings. GeoVax maintains a global intellectual property portfolio supporting its infectious disease and oncology programs and continues to evaluate strategic partnerships and funding opportunities aligned with its development priorities. For more information, visit www.geovax.com. Forward-Looking Statements This release contains forward-looking statements regarding GeoVax’s business plans. The words “believe,” “look forward to,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax’s immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax’s immuno-oncology products and preventative vaccines will be safe for human use, GeoVax’s vaccines will effectively prevent targeted infections in humans, GeoVax’s immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax’s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. Company Contact: info@geovax.com 678-384-7220 Media Contact: Jessica Starman media@geovax.com
CARACAS, VENEZUELA - August 3, 2026 (NEWMEDIAWIRE) - LataMed AI Corp. (OTC: LMED) (“LataMed AI” or the “Company”), a healthcare technology company developing digital health and artificial intelligence solutions for Latin America, today announced that, through its Venezuelan operating subsidiary LATAMEDAI VE, it has entered into an agreement with DROGUERIAS LALA C.A. to develop artificial intelligence-supported and automated software tools for pharmaceutical and laboratory operations. Under the agreement, the parties intend to collaborate on the design, development, testing, and evaluation of customized technology intended to support selected workflows associated with pharmaceutical research, laboratory testing, quality-control processes, documentation, operational coordination, and data analysis. The proposed technology is expected to incorporate software tools designed to organize and analyze information generated during pharmaceutical development and laboratory activities. Planned functionality may include workflow automation, testing coordination, document management, data review, quality-control support, and predictive analytical tools intended to help qualified personnel identify potential inconsistencies or operational issues at an earlier stage. LataMed AI and DROGUERIAS LALA C.A. will begin identifying the specific workflows to be addressed, defining the platform’s technical and operational requirements, and establishing a phased development and testing process. The parties also intend to establish appropriate confidentiality, information-security, data-management, and access-control procedures. The parties will evaluate whether the proposed technology can assist qualified personnel with the organization and review of information associated with pharmaceutical formulas, laboratory results, quality standards, testing procedures, and applicable approval processes. Any such functionality would be designed as a decision-support and workflow-management resource and would not independently approve pharmaceutical formulas, laboratory results, medical products, or regulatory submissions. Any pharmaceutical, scientific, laboratory, or quality-control determinations would remain the responsibility of appropriately qualified professionals and applicable regulatory authorities. The proposed technology would not replace the independent professional judgment of scientists, pharmacists, laboratory personnel, healthcare providers, or other authorized professionals. “This agreement represents an opportunity to apply our artificial intelligence and automation capabilities within complex pharmaceutical and laboratory environments,” said Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp. “Our objective is to work with DROGUERIAS LALA C.A. to develop responsible technology that supports data analysis, documentation, testing coordination, quality-control processes, and other operational requirements while preserving appropriate professional oversight.” Management believes the collaboration may provide an opportunity to expand LataMed AI’s technology into enterprise pharmaceutical and laboratory applications beyond its patient-facing telemedicine services. The initiative is also consistent with the Company’s broader strategy of developing digital infrastructure and artificial intelligence-supported tools for healthcare providers, pharmacies, laboratories, institutions, and other participants in the healthcare ecosystem. If successfully developed and implemented, management believes the resulting technology may provide a framework that could potentially be adapted for other pharmaceutical, laboratory, and healthcare organizations in Venezuela and elsewhere in Latin America. Any future expansion would remain subject to separate agreements, successful development and testing, operational readiness, applicable regulatory requirements, and the needs of participating organizations. The parties will also evaluate the ownership, licensing, permitted use, and protection of any software, technology, data, or other intellectual property developed through the collaboration. The specific intellectual-property and commercialization terms will be governed by the agreement and any additional documentation entered into by the parties. The agreement establishes the framework under which LataMed AI and DROGUERIAS LALA C.A. intend to develop and evaluate the proposed technology. It does not guarantee a specific implementation schedule, commercial deployment, reduction in operating costs or development timelines, scientific or regulatory outcomes, revenue, profitability, or expansion to additional organizations. The Company will provide additional information regarding development, testing, and potential implementation as appropriate. For additional information, please visit https://latamed.ai, follow the Company’s official social media channels, or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov. About LataMed AI Corp. LataMed AI Corp. is a healthcare technology company focused on developing digital health infrastructure and artificial intelligence-supported medical solutions for Latin America. The Company’s strategy includes the development of a telemedicine ecosystem designed to improve access to healthcare services and support connections among patients, medical professionals, pharmacies, insurers, payment providers, wellness organizations, laboratories, institutions, and other participants in the healthcare system. The Company is also developing CardioAI, PulmoAI, and NeuroAI, artificial intelligence-supported platforms intended to assist healthcare professionals in the evaluation and management of cardiovascular, pulmonary, and neurological health information. These platforms remain subject to continued development, testing, applicable regulatory requirements, and commercial implementation. Forward-Looking Statements This press release contains forward-looking statements within the meaning of applicable securities laws. These statements include, among others, statements regarding the agreement between LATAMEDAI VE and DROGUERIAS LALA C.A.; the proposed design, development, testing, functionality, implementation, and possible commercialization of artificial intelligence-supported and automated software tools; potential applications involving pharmaceutical research, laboratory testing, quality-control processes, documentation, operational coordination, workflow automation, and data analysis; potential intellectual-property and licensing arrangements; and the Company’s broader pharmaceutical, laboratory, enterprise technology, and healthcare ecosystem strategies. Forward-looking statements are based on current expectations, estimates, plans, and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. These risks include the Company’s ability to successfully design, develop, and test the proposed technology; satisfy DROGUERIAS LALA C.A.’s technical and operational requirements; retain qualified personnel; protect confidential, proprietary, and health-related information; establish and comply with applicable intellectual-property and commercial terms; comply with applicable legal and regulatory requirements; obtain necessary financing; integrate its technology with third-party systems; achieve commercial acceptance; and generate revenue. There can be no assurance that the proposed technology will be completed or commercially implemented, that it will reduce operating costs or development timelines, that it will improve pharmaceutical, scientific, quality-control, or regulatory outcomes, that the agreement will generate revenue, or that the technology will be adapted for additional organizations or markets. The Company undertakes no obligation to update any forward-looking statement except as required by law. Disclaimer The Company’s technologies are under development and are not intended to replace the independent professional judgment of qualified scientists, pharmacists, laboratory personnel, healthcare providers, regulatory authorities, or other authorized professionals. No statement in this release should be interpreted as a representation or guarantee regarding pharmaceutical development, laboratory results, product safety or efficacy, formula approval, regulatory authorization, cost savings, development timelines, commercial implementation, revenue, market acceptance, or financial performance. This announcement is being issued solely to provide shareholders and market participants with information regarding the Company’s business development activities. It does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company. Investor Relations LataMed AI Corp. ir@latamed.ai +1 (787) 476-2350 https://latamed.ai View the original release on www.newmediawire.com
EDEN PRAIRIE, MINN. - August 3, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, will release financial results for its fiscal third quarter ended June 30, 2026, before market open on August 13, 2026. Management will host an investor conference call and webcast at 8:30 a.m. Eastern time on Thursday, August 13, 2026, to discuss the Company’s fiscal third quarter 2026 financial results, provide a corporate update, and conclude with Q&A from telephone participants. To participate, please use the following information: Fiscal Third Quarter 2026 Earnings Conference Call Date: Thursday, August 13, 2026 Time: 8:30 a.m. Eastern time U.S. Dial-In (Toll Free): 888-506-0062 International Dial-In: 973-528-0011 Participant Access Code: 549778 Webcast: NMTC FY Q3 2026 Earnings Call Webcast Please join at least five minutes before the start of the call to ensure timely participation. A playback of the call will be available through Thursday, August 27, 2026. To listen to the replay, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 54304. A webcast replay will also be available using the webcast link above through August 13, 2027. About NeuroOne NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne markets a minimally invasive and high-definition/high-precision electrode technology platform with four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering diagnostic and therapeutic functions. The Company is engaged in research and development for drug delivery, basivertebral nerve ablation and spinal cord stimulation programs. For more information, visit nmtc1.com. IR Contact MZ Group – MZ North America NMTC@mzgroup.us View the original release on www.newmediawire.com
CUMMING, GA - August 3, 2026 (NEWMEDIAWIRE) - Metavesco, Inc. (OTCID: MVCO), a diversified holding company, today announced preliminary, unaudited July 2026 results for its on-demand staffing subsidiary, Epic Labor, Inc. Epic Labor generated top line revenue of $340,410.16 in July 2026, compared to $89,458.63 in July 2025, an increase of 280%. July 2026 was a five week fiscal month for the company, while July 2025 was a four week fiscal month. On an average weekly basis, revenue increased 204%, to approximately $68,082 per week from approximately $22,365 per week in the prior-year period. During the month, Epic Labor recorded a weekly sales high-mark, exceeding $100,000 in a single week. Gross profit margin for July 2026 was approximately 24%, up from 21.74% in July 2025. “A five-week month gave us a longer runway in July, but the weekly run rate tells the real story, we've tripled the business year over year. The Epic Labor team has earned these wins and I’m excited to say I think we’re just getting started,” stated Ryan Schadel, President and CEO of Metavesco, Inc. About Epic Labor, Inc. Epic Labor delivers fast, reliable, on-demand labor to small and mid-sized businesses. Services span construction, warehousing, hospitality, manufacturing, and event staffing, available 24/7 with Epic Labor's trademark 2-Hour Guarantee. About Metavesco, Inc. Metavesco, Inc. is a publicly traded holding company focused on building infrastructure and opportunity for the OTC market. Metavesco operates with a long-term, co-owner-aligned philosophy and is committed to supporting the strength, transparency, and integrity of the OTC market. The Company operates Epic Labor and other wholly owned subsidiaries. Learn more at metavesco.com. Safe Harbor Statement This press release contains statements that constitute forward-looking statements. These statements appear in a number of places in this press release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; and (iii) growth strategy and operating strategy. The words "may", "would", "will", "expect", "estimate", "can", "believe", "potential", and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is included in the Company's filings on otcmarkets.com. MEDIA CONTACT: Ryan Schadel 678-341-5898 info@metavesco.com View the original release on www.newmediawire.com
CALGARY, ALBERTA - July 31, 2026 (NEWMEDIAWIRE) - Ocumetics Technology Corp. (“Ocumetics” or the “Corporation”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it has completed the second tranche of the private placement previously announced by the Corporation on July 7, July 29 and July 30, 2026 (the “Offering”). The Corporation has issued an aggregate of 6,250,000 units (“Units”) at a price of $0.40 per unit for aggregate gross proceeds of $2,500,000. Each Unit consists of one common share in the share capital of the Corporation (“Common Share”) and one common share purchase warrant (“Warrant”). Each Warrant entitles the holder to purchase one additional Common Share at an exercise price of $0.50 for a period of three years from the date of issuance of the Warrant. To date, the Corporation has raised an aggregate of $2,948,130 in gross proceeds under the Offering. In consideration for the assistance of Ventum Financial Corp. in finding subscribers for the Offering, the Corporation paid Ventum cash commissions of $200,000 and issued 500,000 Warrants. The Warrants are subject to an acceleration clause such that if the volume weighted average trading price of the Common Shares on the TSX Venture Exchange is at least $0.75 per Common Share for a period of 30 consecutive trading days, the expiry date of such warrants may be accelerated by the Corporation to a date that is not less than 30 days after the date that notice of such acceleration is provided to the warrant holders by way of a press release. The total offering is for up to 8,000,000 Units at a price of $0.40 per Unit for gross proceeds of up to $3,200,000. The Corporation intends to close the rest of the Offering in one or more subsequent tranches. Net proceeds of the Offering are expected to be used to fund the Corporation’s continuing first in-human clinical trials, for ongoing research and development and for general working capital. Although the Corporation intends to use the proceeds of the offering as described above, the actual allocation of proceeds may vary from the uses set out above, depending upon future operations, events or opportunities. The Common Shares and Warrants are subject to a hold period of four months and one day from the date of issuance provided that any Warrants that were issued to Finders are non-transferrable. Closing of the Offering was subject to the conditional approval from the TSX Venture Exchange, which was obtained. About Ocumetics Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is a Canadian research and product development company that is dedicated to developing advanced vision correction solutions that enhance the quality of life for patients. Through innovative research and development, Ocumetics aims to transform the field of ophthalmology with state-of-the-art intraocular lenses and other vision-enhancing technologies. Ocumetics is in the first-in-human early feasibility study phase of a game-changing technology for the ophthalmic industry. Ocumetics has developed a dynamic intraocular lens that fits within the natural lens compartment of the eye, potentially to eliminate the need for corrective lenses. It is designed to allow the eye’s natural muscle activity to shift focus from distance to near, providing clear vision at all distances without the help of glasses or contact lenses, and without perceptible time lag. FOR FURTHER INFORMATION, PLEASE CONTACT: David Burwell Director, Investor Relations dave.burwell@ocumetics.com (403) 410-7907 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the commencement, timing and scope of the Corporation’s planned clinical trial program and other research and development activities and that they will be conducted as expected. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include but are not limited to: operational matters, historical trends, current conditions and expected future developments, access to financing as well as other considerations that are believed to be appropriate in the circumstances. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. View the original release on www.newmediawire.com
TORONTO, ONTARIO - July 31, 2026 (NEWMEDIAWIRE) - Noble Mineral Exploration Inc. ("Noble" or the "Company") (TSXV: NOB) (OTCQB: NLPXF) congratulates Canada Nickel Company Inc. (“Canada Nickel”) on the announcement that Canada Nickel’s Crawford Nickel Project has received a positive Decision Statement from the Minister of Environment, Climate Change and Nature, marking the first mining approval issued under Canada's amended Impact Assessment Act since 2019. The Crawford Nickel Project was referred to Canada’s Major Projects Office by the Government of Canada and selected as one of the first projects to advance under Ontario's One Project, One Process framework. Highlights: The Minister of Environment, Climate Change and Nature has issued a positive Decision Statement for Canada Nickel Company Inc.’s Crawford Nickel Project The Crawford Nickel Project is the first mining project to receive a Decision Statement under Canada’s amended Impact Assessment Act, 2019 The Crawford Nickel Project is estimated to contribute approximately $70 billion to Canada's GDP and support ~185,000 person-years of employment Until 2019, the Crawford Nickel Project was held by Noble. The project was sold to Canada Nickel in the transaction that resulted in the creation of Canada Nickel as a publicly listed company and in the distribution of shares of Canada Nickel to Noble’s shareholders under a plan of arrangement. Noble continues to hold shares of Canada Nickel (see the Company’s filed financial statements, available on SEDAR+, for more details). Noble CEO Vance White said: “We congratulate Canada Nickel on their announcement today of having secured Federal Approval for the Crawford Nickel Project. This development confirms the Company’s vision in having transferred the Crawford Nickel Project to the team at Canada Nickel in 2019, and as a company we are proud to see Canada Nickel advance through this milestone. This is an extremely important development. It should also serve as a model for the development of other properties held by East Timmins Nickel Ltd., a company established between Noble and Canada Nickel in which Noble has a 20% interest.” About Noble Mineral Exploration Inc. Noble Mineral Exploration Inc. is a Canadian-based junior exploration company, which has holdings of securities in Canada Nickel Company Inc., Homeland Nickel Inc., East Timmins Nickel Inc.(20%), and its interest in the Holdsworth gold exploration property in the area of Wawa, Ontario. Noble holds mineral and/or exploration rights in ~70,000ha in Northern Ontario, ~14,000ha elsewhere in Quebec and Newfoundland, upon which it plans to generate option/joint venture exploration programs. Noble holds mineral rights and/or exploration rights in ~18,000 hectares in the Timmins-Cochrane areas of Northern Ontario known as Project 81, ~2,215 hectares in Thomas Twp/Timmins, as well as an additional 20% interest in ~38,700 hectares in the Timmins area and ~175 hectares of mining claims in Central Newfoundland. Project 81 hosts diversified drill-ready gold, nickel-cobalt and base metal exploration targets at various stages of exploration. Noble also holds ~4,600 hectares in the Nagagami Carbonatite Complex and its ~3,200 hectares in the Boulder Project both near Hearst, Ontario, as well as ~3,700 hectares in the Buckingham Graphite Property, ~10,152 hectares in the Havre St Pierre Nickel, Copper, PGM property, and ~1,573 hectares in the Cere-Villebon Nickel, Copper, PGM property, ~569 hectare Uranium/Rare Earth property (Chateau) and a ~461 hectare Uranium/Molybdenum property (Taser North), ~4,465 hectares REE Mehmet Property; the ~3,300 hectare Gull Lake REE Property; and the ~1,232 hectare Opawica Scandium and REE Property all of which are in the province of Quebec. In Newfoundland and Labrador, it holds the ~647 hectare Chapiteau REE property. Noble’s common shares trade on the TSX Venture Exchange under the symbol “NOB.” More detailed information on Noble is available on the website at www.noblemineralexploration.com. Contacts: H. Vance White, President Phone: 416-214-2250 Fax: 416-367-1954 Email: info@noblemineralexploration.com View the original release on www.newmediawire.com
LOS ANGELES, CA - July 31, 2026 (NEWMEDIAWIRE) - Greenland Mines (NASDAQ: GRML) announced the start of its 2026 field season at the Skaergaard Project as its support vessel, Argus, departed Reykjavik, Iceland, for southeast Greenland carrying drill rigs, geophysical equipment, drone survey systems, bulk-sampling machinery, fuel and other exploration infrastructure. The initial field team includes more than 40 technical experts, drillers and logistics personnel, with additional specialists scheduled to rotate in throughout the season. The program encompasses resource drilling, bulk sampling, environmental baseline studies, geotechnical and engineering work, and advanced aerial and ground-based surveys designed to support a resource upgrade and advance the project toward its next development phase, including evaluation of a potential initial open-pit mining scenario alongside existing underground mining concepts. To view the full press release, visit: https://ibn.fm/VGQNA About Greenland Mines Greenland Mines Ltd is a Nasdaq-listed company with two operating divisions: (1) Mining, focused on the exploration and development of the Skaergaard Project in southeast Greenland and, subject to closing of the previously announced transaction, the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland; and (2) Biotech, including Klotho’s KLTO‑202 primary indication for ALS. The Company’s strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to GRML are available in the company’s newsroom at https://ibn.fm/GRML Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com
The company is expanding its presence in the global surgical robotics market through its proprietary SSi Mantra robotic surgery platform. The company’s strategy combines world-class robotic systems, including telesurgery capabilities, with affordability, physician training, and international market expansion. More than 200 SSi Mantra systems have been installed worldwide, supporting over 12,000 robotic procedures across more than 170 surgical indications. SS Innovations continues pursuing U.S. FDA clearance and European regulatory approvals while building its installed base internationally. Growing demand for minimally invasive surgery and broader access to robotic procedures continues to create opportunities for emerging high-tech medical technology companies. LOS ANGELES, CA - July 31, 2026 (NEWMEDIAWIRE) - The market for robotic-assisted surgery continues to evolve as healthcare systems seek technologies that can improve surgical precision while expanding patient access. Within that landscape, SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has positioned itself around a strategy centered on unmatched technology, physician training, international expansion, and affordability. Serving as the foundation of its commercial efforts is the company’s proprietary SSi Mantra surgical robotic system. Unlike many developers focused primarily on premium hospital systems, SS Innovations has concentrated on reducing the economic barriers that have limited adoption of robotic surgery in many regions. The company believes lowering acquisition and operating costs can allow more hospitals to introduce robotic-assisted procedures without sacrificing advanced… Read More Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII Forward Looking Statements Certain statements in this article are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management's control, including the risks set forth under the heading "Risk Factors" discussed under the caption "Item 1A. Risk Factors" in Part I of the Company's most recent Annual Report on Form 10-K or any updates discussed under the caption "Item 1A. Risk Factors" in Part II of the Company's Quarterly Reports on Form 10-Q and in the Company's other filings with the SEC. Undue reliance should not be placed on the forward-looking statements in this article in making an investment decision, which are based on information available to us on the date hereof. All parties undertake no duty to update this information unless required by law View the original release on www.newmediawire.com